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1.1.  Herpesviridae 
Herpesviruses are widespread among both vertebrates and invertebrates, making them one of 
the most successful viruses. All existing herpesviruses are believed to be evolutionary 
derivates of one distant progenitor (divergent evolution) (299). Their extreme ability to co-
adapt to and co-evolve with a single host species allowed them to persist over time. A seminal 
study of McGeoch and Cook showed that the phylogeny of the subfamily of the 
Alphaherpesvirinae is nearly an exact copy of that of their hosts (235). The evolutionary rate 
of herpesviruses is estimated to be 30 times faster than that of the hosts. Although their 
evolutionary rate is several orders less than RNA-viruses, herpesviruses have exploited many 
mechanisms for generating diversity including substitutions, deletions or insertions of 
nucleotides; capture of genes from the host genome via an RNA intermediate; duplication of 
genes via recombination and large scale gene rearrangement. The frequency of these events 
seems to be sufficient for efficient adaptation (73). Despite their differences at the level of 
gene content, host range and duration of the reproductive cycle; Herpesviridae share 
significant biological properties: (i) they encode for a variety of enzymes involved in 
processing of proteins and in DNA replication, (ii) synthesis of viral DNA and encapsidation 
occurs in the nucleus, (iii) productive infection results in cell destruction and (iv) a hallmark 
is the ability to establish latency to persist within the host (300). 
 
1.1.1. Classification and virion structure 
Classification   
The recently revised order of the Herpesvirales contains three different families: 
Alloherpesviridae, Malacoherpesviridae and Herpesviridae. Alloherpesviridae contain fish 
and frog viruses, whereas Malacoherpesviridae consist of a bivalve virus. The family of the 
Herpesviridae incorporates pathogenic members that can cause disease in mammals, birds 
and reptiles (75). The Herpesviridae are subdivided according to biological properties in three 
distinct subfamilies, alpha-, beta- and gamma-herpesviruses. Alphaherpesvirinae and 
Betaherpesvirinae can be considered as ‘lytic’. Typically, most cells support lytic replication 
of these viruses whereas only a minority of cell types are able to harbor latent virus. On the 
contrary, Gammaherpesvirinae often remain latent/persistent in cells, while only a small 
subset of cells support lytic replication (6). 
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Alphaherpesvirinae 
These viruses are present in many different species and are known to have a broad host cell 
range, a short replication cycle with a fast destruction of infected cells and a rapid spread 
among susceptible cells. They are able to establish latency primarily but not exclusively in 
sensory ganglionic neurons. Four distinct genera are present within this subfamily 
Simplexvirus, Varicellovirus, Mardivirus and Iltovirus (75, 300). Known species of the 
Simplexvirus genus are bovine herpesvirus 2 (BoHV-2), human herpes simplex virus 1 (HSV-
1) and 2 (HSV-2). Animal herpesviruses bovine herpesvirus 1 (BoHV-1) and 5 (BoHV-5), 
equine herpesvirus 1 (EHV-1), pseudorabies virus (PRV), feline herpesvirus 1 (FeHV-1) and 
human herpesvirus varicella-zoster virus (VZV) are the best studied varicelloviruses. Gallid 
herpesviruses such as Marek’s disease virus (GaHV-2 and GaHV-3) and infectious 
laryngotracheitis virus (GaHV-1) are the most important members of the genus Mardivirus 
and Iltovirus respectively (74, 75). 
Betaherpesvirinae 
The host cell range of the members of this family is much more restricted. Next to that, 
betaherpesviruses know a long productive cycle which is reflected by the slow infection 
progress in cultures. Typically, cells frequently become enlarged, known as cytomegalia. 
Latency can be established in different tissues including secretory glands, kidneys, 
lymphoreticular cells and others. Cytomegalovirus, Muromegalovirus, Roseolovirus, 
Proboscivirus are the different betaherpesvirus genera (75, 300). The prototype member of 
this subfamily belongs to the Cytomegalovirus genus and is human herpesvirus 5 also known 
as human cytomegalovirus (CMV). The best studied animal model for CMV is murine 
herpesvirus 1 (MuHV-1) and is a member of the Muromegalovirus genus (304). However, 
several studies exist about human roseolovirus human herpesvirus 6 and 7 (HHV-6/-7) (230, 
338) and research on veterinary proboscivirus elephant endotheliotropic herpesvirus (ElHV-1) 
is on the increase (211). 
Gammaherpesvirinae 
Somewhat misleading is the host range of this subfamily. For these viruses a clear difference 
has to be made between infection and productive replication. Upon entry, the virus often 
prefers to enter the latency program instead of causing a lytic replication, which contributes to 
the fact that gammaherpesviruses are believed to infect a limited number of species. However, 
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for some veterinary gammaherpesviruses both the host range and the tissue tropism are quite 
broad. Latent virus is often demonstrated in lymphoid tissues. Gammaherpesvirinae 
encompasses the Lymphocryptovirus, the Rhadinovirus, the Macavirus and the Percavirus 
genus (6, 75, 300). Human herpesvirus 4 or Epstein-Barr virus (EBV) belongs to the 
lymphocryptoviruses. Bovine herpesvirus 4 (BoHV-4) together with human herpesvirus 8 
(Kaposi’s sarcoma-associated herpesvirus or KSHV) and murine herpesvirus 4 (MuHV-4) 
belong to the rhadinoviruses. Alcelaphine herpesvirus 1 (AlHV-1) and ovine herpesvirus 2 
(OvHV-2), both causative agents of malignant catarrhal fever (MCF) belong to the 
macaviruses. Equine herpesvirus 2 (EHV-2) and 5 (EHV-5) belong to the percaviruses (75).   
Data presented in the next sections mainly focus on the key players of this thesis namely 
BoHV-1 and HSV-1. 
 
Virion structure 
Mature fully assembled herpesvirus particles (referred to as H-particles) are on average 200-
250 nm in size and consist of 4 indispensable structural elements: the genome, the capsid, the 
tegument and the envelope (27). The general architecture of a herpesvirus particle is given in 
Figure 1. 
The DNA molecule of the herpesvirus genome is a linear double strand of about 150kbp. Two 
distinct regions interspersed by inverted repeats exist within the genome: the unique long 
region (UL) and the unique short (US). 162 capsomers form a rigid icosahedral capsid which 
protects the genetic information. Around the capsid more than 20 proteins make up for the 
tegument. Finally, a lipoprotein membrane, the envelope, surrounds the nucleocapsid (27, 
245, 289). The envelope, which is from cellular origin, harbors different viral proteins with 
the majority of them being glycosylated transmembrane proteins, termed glycoproteins. The 
genome of BoHV-1 encodes at least 10 different glycoproteins whereas HSV encodes 11 
(316). Glycoproteins are important in essential virus-cell interactions like adherence, 
penetration and spread (8, 357). They also evoke a strong immune response within the host 
(94). 
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Figure 1. Structure of a herpesvirus virion. (A) Image taken by transmission electron microscopy of a 
herpesvirus particle. (B) Cutaway view of the virion interior by single virion tomography (pp, 
proximal pole; dp, distal pole). Scale bar: 100 nm. Adapted from (134). 
 
Viral glycoproteins 
gB (UL27) 
Glycoprotein B is highly conserved among herpesviruses and the target of many neutralizing 
antibodies (92). BoHV-1 gB (932aa) and HSV-1 gB (904aa) share 45.9% homology at the 
amino acid level (360). gB is an essential part of the herpesvirus core fusion machinery. It 
initially binds to heparan sulfate moieties on the cell membrane and causes fusion of the viral 
envelope with the host cell (92, 343). The crystal structure provides the most convincing 
evidence that gB acts as a viral fusion protein and more specific, a Class III fusion protein, as 
the gB ectodomain was found to have an unexpected homology to glycoprotein G from 
vesicular stomatitis virus, which is a known Class III fusion protein (150). In the structure, 
Class III fusion proteins are trimeric with three long central α-helices (92). The gB 
ectodomain trimer forms a spike-like molecule and these spikes have been observed on HSV-
1 virions using electron microscopy (333). However, the exact mechanism behind the 
conversion of the inactive pre-fusion to the active post-fusion form of gB is still unkown. 
Assumedly, gH/gL uses triggering mechanisms that are functionally analogous to known 
fusion triggering mechanisms like low pH or protease cleavage. In addition, pH was found to 
play a minor role in HSV fusion when it occurs in endosomes (92). 
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gC (UL44) 
Glycoprotein C is composed of 508aa and 511aa for BoHV-1 and HSV-1 respectively (68, 
114). Like gB, this glycoprotein mediates binding to heparan sulfate molecules on cells and is 
involved in cell entry of the virus (13). Moreover, gC of HSV-1 was found to bind to the 
macrophage receptor with collagenous structure (MARCO) for enhanced adsorption to 
epithelial cells and infection (220). gC is also known to bind complement factor C3b. This 
allows the virus to mediate inhibition of complement-mediated neutralization of cell-free 
virus and complement-mediated lysis of infected cells (13). Recently, gC was found to play a 
role in the exploitation of the host coagulation system by HSV-1. Once attached to the cell 
surface, HSV1 assembles a proteolytic complex, consisting of both cellular co-factors of 
coagulation such as Tissue Factor (TF) and viral gC, in proximity to protease activated 
receptor 2 (PAR2). These low levels of virus-bound proteases enhance host cell infection by 
activating PAR (334). 
gD (US6) 
Glycoprotein D determines cell tropism by binding to cellular receptors (92). Several entry 
mediators have been described for many herpesviruses, including nectins (nectin-1 and 
nectin-2), herpesvirus entry mediator (HVEM) and 3-O-sulfated heparan sulfates (339). The 
structure reveals that the binding site for nectin-1 on gD differs from the binding site of the 
HVEM receptor (81). Stable binding of gD to one of the above mentioned receptors triggers 
membrane fusion (92). HSV-1 gD is composed of 394aa and gD of BoHV-1 consists of 417aa 
(68, 237). Viruses, including BoHV-1 and HSV, lacking a functional gD protein are severely 
impaired in cell entry and spread within the host (260, 358). 
gE (US8) 
Glycoprotein E forms a non-covalently bound heterodimer with glycoprotein I. This 
nonessential protein is 575aa long in BoHV-1 and 552aa in HSV-1 (68, 270). The gE is a 
multifunctional virulence protein. It plays a role in immunomodulation by acting, together 
with gI, as an Fc-receptor but is also crucial for efficient antibody-induced viral glycoprotein 
capping (105). Moreover and most importantly gE is necessary for efficient spread of the 
virus between neurons and from cell-to-cell (105). Indeed, alphaherpesviruses mimic 
intracellular sorting pathways to transport virus particles towards the plasma membrane and 
gE/gI facilitates the envelopment into cytoplasmic vesicles (f.e. TGN) that are sorted to 
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epithelial junctions (173). Deletion of gE causes attenuation of the virus and current marker 
vaccines for BoHV-1 are based on this deletion (178). 
gG (US4) 
Glycoprotein G of HSV-1 and BoHV-1 is 238aa and 444aa long respectively (68, 346). 
Except for HSV-1 gG, secreted forms of gG have been identified for many alphaherpesviruses 
(261). It is the least conserved glycoprotein between HSV-1 and HSV-2 and is antigenically 
distinct in HSV-1 versus HSV-2. Thus, the antibody response to gG is type specific and 
therefore widely used as a discriminating tool for serological identification (280). gG is 
known for its immunomodulatory activities. The secretory part of HSV-2 gG has been shown 
to cause activation of phagocytes and downregulation of NK activity (21). Also, gG might 
postpone apoptosis in infected cells and contribute to efficient cell-to-cell spread (261). 
Finally, glycoprotein G functions as a host chemokine binding protein, a mimicry which 
allows modulation of the host immune response (38). 
gH (UL22) 
Glycoprotein H is essential and forms a heterodimer with glycoprotein L. The gH/gL complex 
is, together with gB, part of the fusion machinery of many herpesviruses (92). The protein has 
a quite large ectodomain and reaches 838aa for HSV-1 and 842aa for BoHV-1 (68, 92). 
gH/gL can bind cellular integrins as a regulator for fusion. At present, based on the unique 
structure of gH/gL, resolved in whole or in part for several herpesviruses, the complex is 
proposed to not function as a fusogenic protein in itself but instead regulates the fusogenic 
activity of gB (92). 
gI (US7) 
Glycoprotein I, together with gE, is present within the gE/gI complex. HSV gI (411aa) and 
BoHV-1 gI (382aa) associate soon after synthesis with gE to form a stable complex (68, 270). 
Knock-out of gI results in an export and modification defect of gE. However, this defect is 
kinetic in nature and not absolute as gE can be detected on the surface of BoHV-1 gI null 
infected cells (361). Functions of the gE/gI complex are described above. 
gK (UL53) 
For both HSV-1 and BoHV-1, glycoprotein K consists of 338aa (68, 270). gK is important for 
cell-to-cell spread, syncytia formation, neurovirulence and immunomodulation (188). HSV-1 
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gK physically interacts with UL20, which is mandatory for their intracellular transport and 
subsequent membrane expression, and functions in virion egress, virus-induced cell fusion 
and virus entry. Moreover, the amino terminus of gK interacts with gB and gH to regulate cell 
fusion (53). 
gL (UL1)   
Glycoprotein L is a small glycoprotein of 224aa in HSV-1 and 158aa in BoHV-1 (68, 92). 
The protein lacks a transmembrane region but is maintained within the stable heterodimeric 
complex gH/gL. In viruses lacking gH, gL is either secreted or retained in cells in its 
immature form. On the other hand, gL is necessary for correct folding and trafficking of gH 
(92). Functions of the complex gH/gL are mentioned above. 
gM (UL10)  
Glycoprotein M is a type III integral membrane protein with multiple transmembrane domains 
that form a complex with pUL49.5 (gN). The functions of gM, which is 438aa long in BoHV-
1 and 473aa long in HSV-1, are promoting spread (neurovirulence) and retaining viral 
glycoproteins in the TGN or retrieving them from the plasma membrane to the TGN (68, 
191). The heterodimer gM/gN complex is thought to modulate membrane fusion (191). 
gN (UL49.5)  
Glycoprotein N is a 91aa long glycoprotein in HSV-1 (236). However, in BoHV-1, this 
protein is not glycosylated and therefore, considered as a false glycoprotein (96aa) (260). 
Next to the functions that it exerts within the complex gM/gN mentioned above, UL49.5 plays 
a major immunomodulatory role. Herpesviruses evade elimination by cytotoxic T 
lymphocytes through specific interfering with the transporter associated with antigen 
processing (TAP) and subsequent antigen-presenting function of major histocompatibility 
complex class I (MHC I). For several herpesviruses, UL49.5 has been shown to act as a TAP-
inhibiting molecule (352). 
 
1.1.2. Replication cycle 
A detailed overview of the alphaherpesvirus productive replication cycle, valid for BoHV-1 
and HSV, is depicted in Figure 2. 
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Virion entry and transport to the nucleus 
As described above, attachment to susceptible cells happens trough interaction of gC (and to a 
lesser extent gB) with heparan sulfate proteoglycans. Next, gD will form a stable binding with 
one of the possible cellular entry receptors (see above). This binding will trigger membrane 
fusion governed by the fusion apparatus gB and gH/gL (92). Although a non-endocytotic 
pathway via direct fusion with the cell membrane is still considered as the major entry mode 
for herpesviruses, there is growing evidence that, at least in some cell types, entry might also 
happen through low-pH-dependent endocytosis (110, 286). Once inside, capsids misuse the 
cellular motor protein dynein for direct microtubule-based transport towards the nuclear pore 
complexes. At the nuclear pores, docking complexes are formed and the viral DNA is 
released within the nucleus (323, 371). 
 
Gene expression and replication  
Upon arrival in the nucleus, the genome circularizes. Next, transcription is initiated and this 
happens in a tightly regulated cascade manner. Viral genes can be subdivided into three 
categories and are sequentially transcribed: immediate-early (IE), early (E) and late (L) genes 
(264). The latter are currently being subdivided in leaky-late genes and true-late genes (271). 
First, IE genes are transcribed which results in the production of regulatory proteins that are 
crucial for activating transcription of E and L genes. This IE transcription is orchestrated by a 
transactivator protein, brought into the cell as a tegument protein, namely VP16 (203). Vhs 
(virion host shut-off), another tegument protein, is part of the viral arsenal to express viral 
transcripts at the expense of cellular protein synthesis by affecting the stability of cellular 
mRNAs (99). HSV-1 encodes 5 IE genes: ICP0, ICP4, ICP22, ICP27 and ICP47 (140); 
whereas BoHV-1 only encodes four different IE genes: BICP0, BICP4, BICP22 and circ 
protein (310). Second, the E gene products are formed and mainly play a role in nucleotide 
metabolism (e.g.UL23 and UL50) and DNA synthesis (e.g. UL5 and UL42) (210). Third, 
expression of L genes is triggered by DNA synthesis, which typically encode structural 
proteins, such as glycoproteins, required for virus assembly and egress (210). 
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Assembly and egress 
Rolling circle replication generates tandem head to tail concatemers consisting of multiple 
unit-length genomes that accumulate in the nucleus. These concatemers are cleaved to 
monomeric units and packaged in individual, pre-formed capsids (251). Since all viral 
proteins are synthesized in the cytoplasm and viral DNA replication takes place inside the 
nucleus, a translocation of capsid proteins to the nucleus is necessary for nucleocapsid 
formation (241, 242). The encapsidation process is tightly regulated and requires for HSV-1 
the action of at least 7 HSV-1 gene products (157, 160). Fully assembled nucleocapsids are 
too large to pass through the nuclear pores, hence they utilize an envelopment/development 
mechanism for transport to the cytoplasm (242). Although the virus was thought to hijack a 
membrane disassembly mechanism, recent data suggest that it may instead be subverting an 
endogenous pathway. Indeed, the mechanism by which large ribonucleoprotein particles exit 
the nucleus is quite reminiscent of that used by herpesviruses during the release of viral 
capsids (175, 315). First, nucleocapsids bud through the inner nuclear membrane thereby 
gaining both tegument proteins and a primary envelope. For all herpesviruses, 2 viral proteins 
UL31 and UL34 are required in this process (242). Primary enveloped nucleocapsids, located 
in the perinuclear space, will undergo a subsequent fusion with the outher nuclear membrane. 
Thus de-enveloped nucleocapsids will be released in the cytosol. Once here, the majority of 
the tegument is added to the nucleocapsids, which obtain their final envelope by budding into 
glycoprotein-containing Golgi derived vesicles (242, 244). 
 
Intercellular spread      
Once fully assembled and enveloped, virions use two different pathways to infect naïve 
susceptible cells. Either progeny virus is released via exocytosis in the extracellular space. 
These then bind to new cells via the traditional entry pathway. Or, virus can spread directly 
from one cell to another. A quite ingenious mechanism as this allows the virus to escape from 
antibodies, complement and phagocytes. Different mechanisms of cell-to-cell spread have 
been described (262). This process is mediated by many proteins, including gB, gD, gE/gI and 
US3 (106, 262). 
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1.1.3. Pathogenesis of bovine herpesviruses 
Bovines host both alpha- and gammaherpesviruses. Table 1 provides an overview of the  
different herpesviruses that are associated with diseases in ruminants (93, 260). Transmission 
of herpesviruses in ruminants happens mainly via direct contact between infected animals, via 
aerosols or via semen but also intrauterine (93). We will focus on bovine herpesvirus 1 and 
bovine herpesvirus 4 as they are the bovine viruses used in this thesis. 
 
Table 1. Herpesviruses isolated from naturally infected cattle 
Virus species Acronym Natural host Subfamily Clinical signs 
Bovine herpesvirus 1 BoHV-1 Cow α Respiratory disease (IBR), 
genital disease (IPV/IPB), 
abortion, high fever, milk 
drop, diarrhea (260) 
Bovine herpesvirus 2 BoHV-2 Cow α Mammilitis (341) 
Bovine herpesvirus 4 BoHV-4 Cow γ Associated with post-partum 
metritis, mastitis, infertility 
(137) 
Bovine herpesvirus 5 BoHV-5 Cow α Meningo-encephalitis in 
calves (169) 
Bovine herpesvirus 6 BoHV-6 Cow γ Lymphotrophic herpesvirus – 
disease image unknown (56) 
Alcelaphine herpesvirus 1 AlHV-1 Wildebeest γ Malignant catarrhal fever 
(MCF) (303) 
Ovine herpesvirus 2 OvHV-2 Sheep γ Malignant catarrhal fever 
(MCF) (303) 
Pseudorabies virus PRV Pig α Aujeszky’s disease (262) 
 
Bovine herpesvirus 1 
Bovine herpesvirus 1 (BoHV-1) is the known etiological agent of infectious bovine 
rhinotracheitis (IBR) and infectious pustular vulvovaginitis/balanoposthitis (IPV/IPB) in 
cattle and may replicate in both respiratory and genital mucosa. However, respiratory and 
genital infections have been assigned to different BoHV-1 strains in the past (260). 
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Although there is proof of the existence of the virus as early as 1941, BoHV-1 was firstly 
isolated in 1955 (125, 221). In the late 1950’s both the respiratory disease prototype strain 
Cooper and the genital disease prototype strain K22 were isolated from field cases of 
respectively IBR and IPV in the United States (186, 367). Importantly, before 1977, a 
continental discrepancy was present. Genital infections were predominant throughout Europe 
whereas respiratory infections were mainly prevalent at feedlots in the United States and 
Canada. Some authors believe that the virulent respiratory strains emerged out of the less 
virulent genital strains. They state that the enhanced virulence of the virus for the respiratory 
epithelium is a consequence of rapid passages of the virus in crowded susceptible populations 
present in “feedlots”, typically for the United States at that time. Since 1977, severe “North 
American like” IBR emerged on the European continent (162, 238, 322).  
An attempt was made to see if BoHV-1 could be subdivided into distinct types with different 
tropisms i.e. whether a correlation could be found between IBR and IPV on the one hand and 
distinct virus subtypes on the other hand. Using restriction endonuclease digestion and 
reactivity tests to a panel of monoclonal antibodies, a classification was made of different 
BoHV-1 subtypes. BoHV-1.1 was associated with respiratory disease and abortion whereas 
BoHV-1.2 was regarded as a genital type (232, 246, 249). Subtype BoHV-1.3 was renamed 
into BoHV-5 as new findings showed significant differences in genomic and antigenic 
properties between BoHV-1.3 and other BoHV-1 strains (59, 247). Furthermore, a distinction 
was made between different BoHV-1.2 subtypes. BoHV-1.2b causes local genital lesions and 
possibly mild respiratory illness; BoHV-1.2a seems to have both tropism for the genital and 
respiratory mucosa and is associated with abortion (232, 246, 329). However, this postulation 
about several subtypes possessing diverse mucosa tropisms has been contested since several 
studies showed no correlation between the different genotypes and their clinical 
manifestations (54, 66, 162, 222, 238, 257, 329). 
Respiratory and genital infection 
Upon entering the host at the respiratory or genital tract, BoHV-1 will initiate replication in 
epithelial cells. The pathogenesis of BoHV-1 is shown in Figure 3. BoHV-1 sets up a lytic 
replication cycle which will result in cell ballooning and eventually in cell death (260). 
Primary encounter with the virus will result in extensive nasal shedding of progeny virus 
which will last 10 to 16 days post infection. Maximum virus titers within nasal and genital 
secretions can reach up to 108-1011 Tissue Culture Infectious Dose (TCID50)/ gram mucus. 
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These high titers are substantial considering the fact that 102 TCID50/gram mucus is enough to 
cause infection in cattle and will allow the virus to quickly disseminate within a herd (82). 
  
 
Figure 3. Pathogenesis of BoHV-1. The primary replication sites of BoHV-1 are either the respiratory 
or genital tract (1.) After local dissemination, the virus gains access to the blood vessels and spreads 
via viremia to internal organs (2.) In pregnant cows, the virus might reach the uterus and causes 
extensive replication within the fetus, resulting in abortion (3.). Moreover, the virus will invade nerve 
endings at primary replication sites and establishes life-long latency within the host (4.)  
 
The basic reproduction ratio (R0) is a parameter for the average amount of secondary cases 
generated by one primary case and describes the infection dynamics within a herd. For 
BoHV-1, R0 is estimated to be at least 7 (260). Clinical symptoms of respiratory infection are 
mucopurulent discharge from the nose and eyes, high fever (>41°C), anorexia, 
hypersalivation and milk drop. Secondary bacterial colonization is a common complication 
and might aggravate the clinical image. These animals are in severe dyspnee, show open 
mouth breathing and often succumb. The clinical entity is called infectious bovine 
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rhinotracheitis (IBR) and causes significant economical losses worldwide if not controlled (7). 
Initial genital manifestations of BoHV-1 are pustules in the caudal vagina and/or vulva for 
cows and pustules on the penis for bulls, termed infectious pustular vulvovaginitis (IPV) and 
infectious pustular balanoposthitis (IPB) respectively. Additionally, hyperemia and edema can 
be observed. In general, genital infections are less severe than respiratory infections and also 
less common, as the use of artificial insemination (AI) and negative bulls repressed this 
clinical image (82, 260). Importantly, subclinical BoHV-1 infections are common. Indeed, the 
severity of disease is influenced by multiple factors such as virus strain, age and host 
resistance factors (260). After local dissemination the virus can go up two ways: (i) reaching 
internal organs via leukocytes (viremia) and (ii) invade nerve endings and hide in the infected 
host (latency). 
Systemic spread via viremia 
Very little information is known regarding the mechanisms by which this virus gains access to 
blood vessels and spreads to internal organs. Although a cell-associated viremia is readily 
described for equine herpesvirus 1 (EHV-1) and pseudorabies virus (PRV), it is less clear for 
BoHV-1. Only one report describes the isolation of BoHV-1 from peripheral blood monocytic 
cells (PBMC) after nasal infection (46). If the virus reaches the uterus in seronegative 
pregnant cows, it can induce abortion. Under field circumstances, BoHV-1 induced abortion 
is mainly seen at 4 to 8 months of gestation. The mechanism by which the virus spreads 
through the placenta to the fetus is unknown but happens most likely via the umbilical vein. 
The incubation period between inoculation with BoHV-1 and abortion is 15 to 64 days (254, 
260). Fatal systemic infections might occur in young seronegative calves following congenital 
or early post-natal exposure (179, 260). 
Neuroinvasion and latency 
Within the mucosa, herpesviruses in general can gain access to local sensory nerve endings 
and ascend towards the central nervous system. BoHV-1 uses either the trigeminal nerve in 
the nasal mucosa or sacral nerves in the genital mucosa. Unlike, BoHV-5 and PRV, BoHV-1 
rarely passes beyond the first order neurons in the trigeminal and sacral ganglia respectively. 
Therefore, BoHV-1 induced central nervous disorders are only seen sporadically in the field 
(69, 296). 
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A hallmark of herpesviruses is to establish latency within its natural host. Thus, after primary 
BoHV-1 infection, animals become latent carriers of the virus within neuronal cell bodies 
located in the previously mentioned nervous ganglia. Unlike in epithelial cells, only the 
BoHV-1 region containing the latency associated-transcripts is expressed in neurons which 
will inhibit a lytic viral cycle and induce an anti-apoptotic state. Consequently, no production 
of progeny viruses occurs. Latency in this particular cell type is a strategy of the virus for life-
long survival in the host and enables the virus to avoid clearance by the host immune system. 
Upon specific natural stimuli (such as stress, parturition,…) or corticosteroid treatment, 
reactivation from this quiescent state might occur and give rise to recurrent viral spread. It has 
become clear that latency of alphaherpesviruses is a multi-factorial process, dependent on the 
interplay between neuron, virus and immune system (176, 177, 260). 
 
Bovine herpesvirus 4    
Bovine herpesvirus 4 (BoHV-4) is a gammaherpesvirus belonging to the Rhadinovirus genus 
and is associated with postpartum metritis and chronic infertility in cows (65). Nevertheless, 
this association is not absolute as BoHV-4 has been isolated from different pathologies 
including conjunctivitis, dermatitis and respiratory disease; and even from healthy animals 
(84, 111). At present, there is increasing evidence that BoHV-4 more likely plays a secondary 
pathogenic role in postpartum metritis (111). The first reported isolation of BoHV-4 
originates from a case of bovine metritis in 1973 (272). Although the virus seems to have a 
tropism for endometrial stromal cells and epithelial cells, the exact pathogenesis remains to be 
elucidated (84). 
         
1.1.4. Pathogenesis of human herpesviruses 
Nine different herpesviruses are known to use humans as hosts (Table 2) (75). Human 
herpesvirus 1 and 2 will be discussed in this section as they are the human viruses used in this 
thesis. 
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Table 2. Overview of herpesviruses known to infect humans 
Virus species Acronym Natural host Subfamily Clinical signs 
Human herpesvirus 1 
Herpes simplex virus 1 
HHV-1 
HSV-1 
Humans α Gingivostomatitis, mucosal 
blisters, genital herpes, 
encephalitis, keratitis (12) 
Human herpesvirus 2 
Herpes simplex virus 2 
HHV-2 
HSV-2 
Humans α Gingivostomatitis, mucosal 
blisters, genital herpes, 
encephalitis, keratitis (12) 
Human herpesvirus 3 
Varicella-zoster virus 
HHV-3 
VZV 
Humans α Chickenpox, shingles, 
chronic pain, rash, 
vasculopathy, zoster 
paresis, ocular disorders 
(124) 
Human herpesvirus 4 
Epstein-Barr virus 
HHV-4 
EBV 
Humans γ Associated with lymphoid 
and epithelial malignancies 
e.g. Burkitt’s lymphoma 
and nasopharyngeal 
carcinoma, infectious 
mononucleosis (24, 166) 
Human herpesvirus 5 
Human cytomegalovirus 
HHV-5 
HCMV 
Humans β Congenital infections – 
neurodevelopmental delay, 
infectious mononucleosis 
(226, 295) 
Human herpesvirus 6 HHV-6 Humans β Linked with neurological 
disease, multiple sclerosis, 
exanthema subitum (290, 
359) 
Human herpesvirus 7 HHV-7 Humans β Linked with exanthema 
subitum, largely unknown 
(117, 230) 
Human herpesvirus 8 
Kaposi’s sarcoma-
associated herpesvirus 
HHV-8 
 
KSHV 
Humans γ Low-grade vascular tumor 
induction, often muco-
cutaneous (104) 
Macacine herpesvirus 1 
B-virus 
McHV-1 Monkeys α Encephalitis, 
encephalomyelitis, death 
(100) 
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Human herpesvirus 1 and 2   
Human herpesvirus 1 (HHV-1), also known as herpes simplex virus 1 (HSV-1) and human 
herpesvirus 2 (HHV-2), termed herpes simplex virus 2 (HSV-2) are both members of the 
Simplex genus within the alphaherpesviruses. HSV infections are prevalent worldwide and 
have no seasonal variation (12). Transmission of HSV happens through direct contact with 
virus-containing body fluids (aerosol, genital secretions, saliva, exsudates of active 
lesions,…). Importantly, viral shedding of HSV occurs often during the prodromal phase of 
primary or recurrent infections and results in nearly 60% of the cases without clear symptoms 
(12, 307). In Europe, the seroprevalence of HSV-2 within the adult population varies from 4% 
to 24% which is comparable to that in the United States (2% to >25%). For HSV-1, a 
seroprevalence of 52-84% in Europe and of 90% in the United States among adolescents was 
registered (275). At present, no efficacious HSV-vaccine is present on the market, and the 
likelihood of one coming to market soon is low: a relatively recent publication in the journal 
Science describes the failure of a potential HSV-vaccine in a clinical trial (57). When treating 
herpes virus infections with antiviral compounds, resistance occurs frequently which limits 
the application of these products (87, 181). 
In general, HSV-1 is accepted to cause infections ‘above the waist’ and HSV-2 ‘below the 
waist’. Nevertheless, the frequency of for example primary genital herpes infections caused 
by herpes simplex virus type 1 (HSV-1) is on the increase (50). Therefore, both HSV-1 and 
HSV-2 are nowadays considered as causative agents of similar clinical manifestations at 
multiple sites of the body (12). 
Primary respiratory/oral infection 
HSV can infect the oral mucosa and cause primary gingivostomatitis in children and young 
adults (12). Recently, HSV-1 was found to also severely infect human nasal mucosa (127) and 
possibly the neuroepithelium (320). However, most primary herpes simplex infections in 
children are asymptomatic. The incubation period is on average 2-20 days after which non-
specific symptoms may arise like myalgia and malaise. 1-3 days after the onset of disease, the 
typical muco-cutaneous vesicular eruptions might arise. Lesions are usually accompanied by 
pyrexia, lethargy, loss of appetite,… Blisters heal gradually within 14 days, if not complicated 
by secondary bacterial infections (12, 197). If during HSV invasion nerve endings or blood 
vessels are reached, these viruses can spread in the host, resulting in establishment of latency 
and potentially nervous disorders and viremia respectively (174, 250). 
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Primary genital infection          
Human genital herpes is worldwide one of the most prevalent causes of genital ulcer disease 
and with a prevalence reaching up to 80% (developing countries), one of the most important 
sexually transmitted infections (STI). Genital manifestations of initial infection display an 
array of symptoms going from asymptomatic to severe bilateral vesicular lesions which arise 
typically 4-7 days after initial infection. Because of extensive replication of the virus these 
lesions can be purulent, and in some cases lead to necrotic trauma. Systemic consequences 
consist of flu-like symptoms (fever, headache, myalgia) and dysuria (12). Moreover, genital 
herpes lesions promote the transmission of HIV (50, 287). Within the genital tract, similar as 
for BoHV-1, sacral ganglia may become latently infected by HSV after primary herpes 
genitalis (347). Importantly, in women experiencing primary genital herpes infections, the 
majority show signs of HSV-induced viremia (174). 
Recurrent herpetic infections (herpes labialis and herpes genitalis) 
Different stimuli can trigger the virus to reactivate from sensory ganglia. Typically, symptoms 
in the respiratory/oral region and genital region are less severe during a recurrent infection 
compared to a primary infection. Often, intervals of asymptomatic shedding periods exist and 
are key for HSV transmission (306, 307). The vast majority of lesions is located on muco-
cutaneous junctions such as the lips and the labiae vulva (12).   
Other manifestations of HSV infection 
In Table 3, an overview of other manifestations of HSV infection is given. Congenital and 
perinatal herpes infections, and brainstem encephalitis in neonates, are well known 
complications of maternal genital herpes (250). Neonates often get exposed to the virus 
during vaginal delivery or a seldom intrauterine transmission. A clinical episode of genital 
maternal herpes is an important reason to perform a caesarian section (145, 216, 292). 
Primary or recurrent ocular infection can give rise to blepharitis, conjunctivitis, epithelial and 
stromal keratitis and more. Moreover, around 20% of HSV-induced keratitis can lead to a 
blinding stromal keratitis. Although the exact pathogenesis of herpetic stromal keratitis 
remains poorly understood, repeated bouts of recurrent HSV stromal keratitis initiate and 
sustain a chronic inflammatory reaction in the eye, which will lead to progressive irreversible 
cornea scarring and blindness (12, 301). 
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Table 3. Additional disease images caused by HSV infection 
Name Clinical signs 
Herpetic whitlow Pain, burning eruption of distal phalanx/fingers 
Herpetic rash Atopic dermatitis, eczema herpeticum 
Herpes gladiatorum Trigeminal, cervical or lumbo-sacral dermatomes 
Ocular herpetic infections Blepharitis, conjunctivitis, epithelial keratitis, stromal keratitis, 
iridocyclitis or retinitis 
Neonatal herpetic infections Meningo-encephalitis, death 
Erythema multiforme Cutaneous and oral lesions 
Behcet’s disease Oculo-urogenital syndrome, immune-mediated disorder 
Bell’s palsy Neuropathy, facial nerve paralysis 
Meniere’s disease Hearing and balance disorders 
Herpes lymphadenitis Haematological malignancies 
Herpes encephalitis Neurological disorders 
 
1.2.  Characteristics of respiratory and genital mucosae 
Upon entering the host, viruses face different barriers that hamper their invasion (Figure 4). 
At the level of the mucosa; mucus, epithelium, basement membrane (BM) and lamina propria 
are the principal barriers these viruses have to overcome. These structures will be considered 
briefly below. In addition, mucosa innervation and resident immune cells are summarized. 
 
Figure 4. Schematic representation of the respiratory mucosa. Starting from the lumen several layers 
can be distinguished: a mucus layer (i) lying on top of a ciliated pseudostratified epithelium (ii). 
Underneath the epithelium a basement membrane (iii) separates the epithelium from the underlying 
lamina propria (iv). Adapted from (1). 
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1.2.1. Mucus 
The epithelial surface of the respiratory tract is covered by a layer of airway surface liquid 
(ASL), mainly produced by the goblet cells and submucosal mucous and serous glands. The 
ASL is composed of a mucus layer overlying a watery periciliary liquid (PCL) layer. The low 
viscosity aspect of the PCL hydrates cilia and allows them to beat in a coordinated way. 
Interestingly, epithelial cells maintain ASL composition and volume by exchanging Cl- and 
Na+ ions through ion canals. All these elements are part of what is called the mucociliary 
clearance apparatus, a defense mechanism which captures and expulses foreign particles (146, 
298, 327). Movement of tracheal mucus in healthy adult humans has been found to be on 
average 4-20 mm/min (305). 
In humans, the mucus network contains two major structural types of mucins: MUC5AC and 
MUC5B, which are mainly produced by goblet cells and submucosal glands, respectively. In 
this context, it is also important to note that both secretory and membrane-associated forms of 
mucins exist (297). In bovines, respiratory mucus likely contains similar structural elements 
(164, 335). The specific interactions of these mucins with foreign particles is not yet fully 
elucidated. Likely, such interactions are mediated by glycan-binding lectins. Indeed, in mucin 
protein backbones many serine and threonine residues are covalently linked with O-glycosidic 
carbohydrate structures (62). Several proteins with proven antimicrobial functions reside 
within the mucus network including lysozyme, lactoferrin, secretory IgA, defensins, secretory 
leukocyte peptidase inhibitor (SPLI), lactoperoxidase, CCSP, SP-A and SP-D (62, 146, 156, 
318, 356).  
Like the respiratory tract, also the genital tract is covered by a thick mucus layer. Whilst the 
majority of mucus lining the vaginal cavity finds its origin in the gland-like crypts of the 
cervical canal and is transported towards the vulva, ruminants contain both glandulae 
vestibulare minors and majors in the vestibule of the vagina for additional on-site mucus 
production (79, 108, 331). Functions of cervical mucus are protection of the female 
reproductive tract from pathogenic invasion (cfr. respiratory mucus) and fluid loss and 
moreover regulation and facilitation of sperm transport to the upper reproductive tract (139). 
Incoming pathogens have to devise ways to overcome this vivid barrier to reach the 
underlying epithelium. 
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1.2.2. Epithelium 
1.2.2.1. Respiratory epithelium 
We will focus in this section on the upper respiratory tract, as this is the major entry route for 
herpesviruses.  
The airway epithelium is a dynamic epithelium likely renewing every 30-50 days (62). The 
airway tract can be subdivided into two zones. The first zone, in which inhaled air is cleaned, 
moistened and transported towards the distal airways, is called the conditional zone and 
reaches from the pars respiratoria of the nasal cavity over the nasopharynx, larynx, trachea 
and bronchi to the large and terminal bronchioles. Through most of the conditional zone, the 
airways are lined by a ciliated pseudostratified columnar epithelium. All cells are in contact 
with the basement membrane, however, basal cells do not reach the airway lumen. This 
organization, called pseudostratified, gives the impression that nuclei are not aligned in the 
same plan and are multilayered (Figure 4). At the end of the conditional zone (i.e. the last 
branches of bronchi and the bronchioles), a second zone termed the respiratory zone 
commences. At the level of the respiratory zone an extensive oxygenation of the blood takes 
place. Typically, at this junction the epithelium changes from pseudostratified to a simple 
cuboidal epithelium. Several morphologically distinct epithelial cell types are present in 
respiratory epithelium, although based on ultrastructural, functional and biochemical criteria 
these may be classified into three categories: basal, ciliated and secretory (172, 327, 337). In 
the context of this thesis, only the main cell types present in ciliary pseudostratified columnar 
epithelium will be considered in brief.  
Ciliated cells are the main cell type within ciliated pseudostratified columnar epithelia. They 
arise from either basal or secretory cells. Typically, they possess up to 300 cilia/cell 
projecting into the lumen, have a small basal cell side and wide apical side; and contain 
numerous mitochondria apically. Their main function consists in directional transport of 
mucus from the lungs to the throat by ciliary beating in coordinated waves. This mucociliary 
clearance is an important initial defense mechanism against incoming foreign particles (195, 
327).   
Goblet cells are periodic acid Schiff’s (PAS) positive, columnar epithelial cells that secrete, 
together with the submucosal glands, mainly high molecular weight mucus glycoproteins 
(‘mucins’) but also lipids and smaller glycoproteins. This mucus layer serves as the body’s 
first line of defense against microorganisms but also assists in nutrient transport and viscosity 
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regulation (366).  Discharge of mucus from the membrane-bound electron-lucent mucous 
granules is accomplished remarkably rapidly in response to a wide variety of stimuli, 
including proteinases, irritant gases, inflammatory mediators, reactive oxygen species, nerve 
activation and changes in the biophysical environment. Importantly, goblet cells have a direct 
role in epithelial homeostasis as they possess the potential to differentiate into ciliated cells 
(298, 327). However, columnar cells are documented to lack sufficient telomerase activity to 
restore a fully differentiated epithelium (141). 
Brush cells are a sparse, randomly distributed, special type of projection-containing cells 
found in the alimentary and respiratory tract. Their ‘brush’-like appearance originates from 
the presence of multiple large thick microvilli on the apical side of the cell. Although their 
function is not fully elucidated yet, they are believed to function mainly as chemosensory 
cells. Also, absorptive and secretory functions of brush cells are described (288, 309, 327).   
Basal cells are considered to be the resident epithelial stem cells as they play an indispensible 
role in epithelium homeostasis and tissue renewal post injury. Indeed, their potential to flatten 
out and cover the BM when contacts with neighboring columnar cells are lost is considered as 
a defense mechanism (96). The basal cell has a sparse electron-dense cytoplasm containing 
bundles of cytokeratin, a small polyhedral shape and does not reach the airway lumen. On the 
contrary, it is the only cell type within the respiratory epithelium that is firmly attached with 
its wide basal side to the BM via necessary hemidesmosomes (discussed below). Hence, basal 
cells function as anchors for more superficial cells in the epithelium by connecting with them 
through desmosomes (discussed below). They also modulate the regulation of neurogenic 
inflammation, the inflammatory response, transepithelial water movement, oxidant defense 
and formation of lateral intercellular spaces (98, 195, 327). 
In addition, a variety of immune cells, inflammatory cells and phagocytic cells migrate to and 
remain within the epithelium or transit through to the lumen (184). An overview of immune 
cells and this transmigration process is provided in part 1.2.5. and 1.3.3. of this thesis. 
 
1.2.2.2. Genital epithelium 
Structures involved in the pathogenesis of herpesviruses will be considered below. 
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The vulva is formed by the labiae vulvae which physically seal the external opening of the 
genital tract. They are covered externally by skin epithelium, a keratinized stratified 
squamous epithelium, that is richly supplied by several apocrine and sebaceous glands. 
Internally, they are lined by a stratified squamous epithelium, much like the vagina. The 
vaginal cavity encompasses the vestibule (vestibulum vaginae), the vagina and the ectocervix 
(portio vaginalis cervicis). The entire cavity is lined by a nonkeratinized stratified squamous 
epithelium except in the anterior portion of the bovine vagina which shows a stratified 
columnar epithelium interspersed with goblet cells. The transformation zone, also called 
squamocolumnar junction, represents an abrupt transition between ectocervix and endocervix 
and is characterized by a transitional epithelium. The endocervical canal, termed endocervix, 
is leading towards the uterus and consists of a highly active simple columnar epithelium with 
numerous glands (14, 79, 170, 283). Finally, the endometrium, as part of the uterus, is lined in 
most mammals by a simple cuboidal or columnar epithelium but may be stratified or 
pseudostratified in ruminants (14). Interestingly, the different types of epithelia mentioned 
above are affected differently by reproductive hormones and differ in susceptibility to 
infection by different organisms. In humans, Candida albicans and Trichomonas vaginalis 
colonize the vagina whereas Chlamydia trachomatis and Neiseria gonorrhea settle within the 
endocervix. The transformation zone is the main target for human papillomavirus (HPV) 
(170, 283). The three types of epithelia that are present in the lower genital tract will be 
discussed in brief below.  
 
Nonkeratinized stratified squamous epithelium 
Three layers can be found within this epithelium: basal cells (stratum basale), parabasal cells 
and intermediate cells (stratum spinosum) and superficial cells (stratum superficiale). Basal 
and parabasal cells are round cells with small nuclei. Intermediate cells are larger than 
parabasal cells and have rounded edges. Superficial cells are fully matured and have pyknotic 
nuclei or lack nuclei. Often these cells are filled with glycogen and are eventually sloughed 
off. Only basal and parabasal cells have the ability to divide (14, 102, 331). Interestingly, 
estrogen induces proliferation, maturation and desquamation, and superficial cells 
predominate during periods of high estrogen levels. During episodes of high progesterone 
levels, partial maturation is observed and especially intermediate cells are present (170). 
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Transitional epithelium 
The original neonatal position of the squamocolumnar junction changes over time, especially 
in humans. Reproductive hormones strongly influence tissue morphology, size and activity. 
As the endocervical mucosa is relatively stable in length and anatomically restrained because 
of its strong attachment to a muscular wall, endocervical expansion under influence of 
reproductive hormones can only occur downwards onto the ectocervix. Consequently, a 
protrusion occurs into the vaginal cavity and endocervical epithelium becomes exposed to the 
vaginal environment. This phenomenon is general referred to as cervical ectopy and is most 
prevalent in adolescents, pregnant women and women using oral contraceptives (170, 258). 
Moreover, two remarkable findings can be observed in the transitional epithelium. First, the 
exposed simple columnar epithelium changes into squamous epithelia most likely due to a 
pH-induced reduction in buffering capacity of overlying mucus, estrogen influences and 
growth of vaginal bacterial flora. This remodeling event is called squamous metaplasia. 
Second, squamous epitheliazation takes place whereby tongues of squamous epithelium from 
the native squamous epithelium of the ectocervix are thought to grow underneath reactive 
columnar epithelium within the transformation zone for replacement. Thus the resulting 
squamous epithelium in the transformation zone might originate from exposed subcolumnar 
cells (squamous metaplasia) or from remodeling events out of the ectocervix (squamous 
epitheliazation) (153, 170, 258, 283).  
 
Simple columnar epithelium 
This epithelium consists of a highly polarized, single layer of mucin-secreting cells. 
Underneath and adjacent to columnar cells, several subcolumnar or reserve cells are present 
which are believed to multiply and differentiate into squamous epithelium upon certain 
stimuli. The endocervical epithelium is elevated into several folds and forms crypts or 
pseudoglands (14, 39, 170). 
As in respiratory epithelium, different immune cells are present for immune surveillance (see 
1.2.5.).  
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1.2.2.3. Cell-cell and cell-matrix adhesions 
Epithelial barrier integrity is maintained by the physical interactions of intercellular junction 
molecules on opposing epithelial cells. They do not only maintain integrity but are also 
required for regulating molecular and cellular traffic. During tissue remodeling events such as 
wound healing and tissue repair, these junctions can be quickly disassembled and reassembled 
to facilitate these processes. There are two types of adhesion mechanisms (Figure 5). A first 
group consists of weak, unorganized intercellular interactions, called non-junctional, and 
simply link adjacent interacting plasma membranes close enough to provide traction and to 
allow transmembrane adhesion proteins to interact but still allowing cell motility. A second 
group are called junctional, referring to their highly organized structure and their tight 
anchorage to the cytoskeleton, and generally immobilize the cell. It is believed that non-
junctional cell-cell adhesion proteins initiate cell-cell adhesions, which are then oriented and 
stabilized by the assembly of true junctional intercellular adhesive structures (9). Based on 
functionality, junction molecules can be classified as either occluding, anchoring or 
communicating (Figure 5). There are four major types of cell-cell adhesions: occluding tight 
junctions (zonulae occludens); anchoring adherens junctions (zonulae adherens) and 
desmosomes (maculae adherens); and communicating gap junctions. The first three are 
usually present as well organized tripartite complexes. Next to cell-cell contacts, cells also 
need to interact with the underlying extracellular matrix (ECM). Inside-out and outside-in 
signaling between epithelial cells and the connective tissue happens through two kinds of 
anchoring junctions namely hemidesmosomes and focal adhesions. All junction complexes 
are roughly constituted by three major types of proteins: (i) essential structural proteins, 
required for initiation of junctions; (ii) plaque proteins associated with the cytoskeleton; and 
(iii) regulatory signaling/polarity proteins. Tight junctions, adherens junctions and focal 
adhesions interact with actin filaments while desmosomes and hemidesmosomes connect to 
intermediate filaments (9, 60, 123, 265, 312). 
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Figure 5. Junctional and non-junctional adhesive complexes in mammalian cells. Adapted from (9, 
344). 
 
Tight junctions 
First described by Farquhar and Palade in 1963, tight junctions are the most apical structure of 
the tripartite junction complex bordering the apico-baso-lateral membrane (101, 265). In the 
tight junction a near-continuous plasma membrane contact zone in between adjacent cells 
with negligible intercellular space is present, hence their alternative name zonulae occludens 
(9). They function as gate and selective regulators of paracellular flux of both ions and small 
molecules (116). In addition, they regulate cell differentiation, proliferation and adhesion 
(312, 344).  
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Figure 6. Schematic representation of a tight junction (265). 
There are three different structural transmembrane proteins that have the ability to mediate 
cell-cell contacts including the IgG-like family of junctional adhesions molecules (JAMs), the 
occludins family and claudins family (265, 312, 344) (Figure 6). Recently, a novel structural 
protein was discovered with structural similarity to occludin, called tricellulin. However, the 
latter is only enriched at tricellular tight junctions (167). Both occludins and claudins are 
Ca2+-dependent proteins and have four-membrane spanning regions, two extracellular and one 
intracellular loop; and both N-terminal and C-terminal domains are cytosolic. Occludins were 
the first discovered proteins associated with tight junctions and although present in most of 
them, their function remains obscure. Claudins are on the other hand better characterized. So 
far, 24 members have been described with different tissue and organ specificity (116, 265). 
The EC loops within occludins contain few charged amino acids compared to those of 
claudins. This implies that because of their charge, claudins selectively regulate ion transport. 
Changing the charge within claudins has been shown to alter barrier ion specificity. JAMs are 
Ca2+-independent glycosylated proteins containing one transmembrane domain, two 
extracellular V-type Ig domains and one intracellular C-terminus. They are tethered to 
claudins via both ZO-1 and MUPP-1 and selectively recruit regulatory intracellular proteins 
such as cell polarity proteins to the tight junction complex. The cytosolic plaque proteins 
associated with the structural proteins are zonula ocludens (ZO)-1, -2 and -3; and MUPP-1. 
These adaptor proteins serve as links between the integral TJ proteins and the actin 
cytoskeleton and recruit cytosolic molecules implicated in cell signaling. Interestingly, the 
formation and maintenance of tight junctions is dependent on the formation and maintenance 
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of adherens junctions (101, 112, 196, 265, 312, 344). Recently, a study performed by Maiers 
and co-workers identified α-catenin as a binding partner of ZO-1 thereby linking the 
tight junction barrier machinery to the adherens junction adhesion complex (223). 
 
Adherens junctions 
Underneath tight junctions, adherens junctions are the second element of the tripartite junction 
complex for linkage of neighboring cells (265). Their principal function is to anchor cells to 
each other but they also coordinate movement of cells, cell polarity and metabolism (60, 147, 
161, 168, 265, 336). Recently, loss of anchoring junctions, both adherens junctions and 
desmosomes, was found to play an important role in metastasis during tumor progression. 
Indeed, cells in the primary tumor, lose epithelial characteristics such as cytokeratin and E-
cadherin expression and gain mesenchymal markers including N-cadherin and vimentin; a 
mechanism also known as epithelial-to-mesenchymal transition (EMT) (136). Two basic 
adhesive units exist within adherens junctions: the nectin-afadin complex and/or the classical 
cadherin-catenin complex (265) (Figure 7).  
 
Figure 7. Structural overview of adherens junctions (265). 
The nectin IgG-like adhesion protein family consists of 4 members, nectin-1 to -4 and 
functions Ca2+-independent. They provide the first scaffold upon which adherens junctions, 
tight junctions and desmosomes are eventually formed. Three extracellular IgG-like loops, 
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one transmembrane region and a cytoplasmic tail constitute this adhesion receptor. Nectins 
form lateral homodimers that can engage in both homophilic and heterophilic adhesion with 
other nectins or nectin-like receptors (168, 265). Interaction of nectins with the actin 
cytoskeleton is mediated via their binding to afadin, a ubiquitous expressed adapter protein 
(161, 336). The classical cadherin-catenin complex contains as major structural protein 
cadherin, often E-cadherin. E-cadherin has an extracellular region containing five tandemly 
repeated domains (EC1-EC5), a single transmembrane region and a cytoplasmic region. In 
contrast to nectins, E-cadherin interaction is Ca2+-dependent and mainly results in 
homodimers. Catenins including α-, β-, and p120 catenin form a complex with E-cadherin and 
interact via eplin with actin filaments. All catenins, with exception of the structurally 
unrelated α-catenin, contain a central Armadillo domain. γ-catenin, also known as 
plakoglobin, can substitute for β-catenin in adherens junctions but is usually present in 
desmosomal junctions. As mentioned before, nectin-based junctions form first and their 
formation is followed by formation of the E-cadherin-based junctions (60, 147, 161, 234, 265, 
266). 
 
Desmosomes 
The third component of the tripartite complex boarding the apico-basolateral membrane are 
desmosomes (265). They do not only provide mechanical stability because of their 
hyperadhesive potential but also function as communicating junction with neighboring cells. 
In addition, they participate in cell signaling, proliferation and differentiation (36, 52, 60, 119, 
131). Some well known autoimmune diseases like pemphigus foliaceus and pemphigus 
vulgaris wherein autoantibodies directed against desmoglein 1 and desmoglein 3 respectively 
cause a blistering disease, point out their main role in epithelial integrity (52). The structural 
proteins in desmosomes are transmembrane desmosomal cadherins like desmoglein and 
desmocollin (Figure 8).  
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Figure 8. Schematic composition of a desmosomes in between two adjacent cells (36). 
These cadherins bind to cytoplasmic armadillo family proteins such as plakoglobin and 
plakophilin, which in turn interact with desmoplakin, a plakin family member, for successful 
attachment to the cytoskeleton. Unlike tight junctions and adherens junction, desmosomes 
connect with intermediate filaments. Electron microscopical (EM) analysis revealed that each 
desmosomal plaque shows a complex structure and organization containing an apparent thick 
outer dense plaque and a translucent inner dense plaque (36, 52, 60, 119). 
 
Hemidesmosomes 
These epithelial specific cell-matrix adhesion complexes directly link the cytoskeleton to the 
extracellular matrix. In addition to their anchoring function, they play a role in cell division, 
differentiation and migration. Hemidesmosomal structures contain the integrin α6β4, the type 
XVII collagen BP180, the tetraspanin CD151 and the two plakin family members plectin and 
BP230 (212, 213, 345) (Figure 9). Integrins are the major adhesion receptors for cell-matrix 
adhesion. They are constituted of an α subunit and a β subunit and regulation of integrin 
activation is believed to happen through interaction of the β subunit tail. Integrins are 
normally kept in a low-affinity state by both a clasp in the membrane-proximal region of 
integrin α and β subunits as well as a clasp in the transmembrane domain in the outer leaflet 
of the membrane. Disruption of those clasps activates integrins (190). 
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Figure 9. Schematic drawing of the structure and components of hemidesmosomes present in 
pseudostratified epithelia, linking intracellular keratin filaments (K) via α6β4 integrins to Laminin-
332 (Ln-332) (227). 
At present, 24 different integrin combinations have been identified in various tissues of which 
nine have been described to be present in epithelial cells. Nevertheless, two specific types 
α3β1 and α4β6 are the major anchors for extracellular matrix adhesion (190, 195). As stated 
above, α4β6 functions in mature hemidesmosomes and acts as a major linker to laminin-332 
(Ln-332), a component of the ECM, although XVII collagen BP180 has been described to 
bind Ln-332 as well. CD151 is required for formation of hemidesmosomes. It plays an 
indispensible role because of its association with the laminin-binding integrin α3β1 in ‘pre-
hemidesmosomal’ structures. During maturation and association of the former complex with 
α6β4 integrins, α3β1 is recruited into focal adhesions or is redistributed to cell-cell contacts 
whilst CD151 remains part of the mature hemidesmosomes (30, 213). Similar as in other 
junctions, both plakin family members plectin and BP230 function as intermediates to link 
integrins to the cytoskeletal intermediate filaments such as keratin. BP230 also associates with 
BP180 (30, 213, 227). Growth factors such as epidermal growth factor (EGF) can trigger 
hemidesmosome disassembly by inducing phosphorylation of the β4 intracellular domain 
(227). 
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Focal adhesions 
These anchoring complexes are transient and self-assembling. Beyond their scaffolding 
function, they also serve as sensory structures through intracellular signaling cascades upon 
stimuli of the surrounding microenvironment (30, 42, 72, 129, 248). The major component of 
focal adhesions are integrins (described above) which are responsible for linking the ECM to 
the cellular actin skeleton (219). Over 180 adhesion-associated proteins have thus far been 
described, although for most of them their exact role remains elusive. Some of them are 
however well characterized, such as talin, filamin, migfilin, kindlins, paxillin and vinculin 
amongst others (Figure 10). Talin promotes integrin clustering and subsequent activation by 
binding to the β cytoplasmic tail of integrins. In addition, talin links actin to integrins (30, 
129). On the contrary, filamin is a strong inhibitor of integrin activation by both competing 
with talin for integrin binding and by binding migfilin, an agonist of integrin activation, and 
displacing migfilin from integrin β cytoplasmic tails (72). Kindlins interact with the integrin β 
cytoplasmic tail but also interact with the actin skeleton via recruitment of filamin/migfilin 
complexes. They are believed to function as critical regulators of integrin activation (248). 
Paxillin and vinculin act as cross-linkers for several proteins within focal adhesion complexes 
(42). At present, on the basis of all these data, kindlins are speculated to recruit migfilin to the 
integrin β cytoplasmic tail, where migfilin displaces the inhibitor, filamin, resulting in talin 
binding and integrin activation (30, 42, 72, 129, 248). 
 
Figure 10. Schematic diagram illustrating a focal adhesion complex (ILK, integrin-linked kinase). 
Adapted from (248, 365). 
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1.2.3. Extracellular matrix 
All cells need a framework to be able to exhibit their main functions including cell 
metabolism and polarization. In the structure, several proteins and polysaccharides are 
present. Within the mucosa, the extracellular matrix (ECM) consists of 2 structural entities 
namely the basement membrane and the lamina propria (9). 
 
1.2.3.1. Basement membrane 
The basement membrane (BM) (Figure 12) is an amorphous sheet-like scaffold of 50-100nm 
first identified by transmission electron microscopy (180). The BM is considered to be a 
specialized form of ECM and reasons are threefold (i) it contains the same structural elements 
as normal ECM, (ii) it has a higher density than normal ECM and (iii) on the contrary, is 
always associated with cells. BM’s are usually found basolateral of epithelium, endothelium, 
fat cells, muscle cells and nerve axons; and separate these structures from the underlying 
stroma in any tissue (9, 180, 302). Although the basic elements are similar for most tissues, a 
heterogeneity in BMs is present due to variations in amounts of components, splice variants, 
age and so one (200, 208). The main function of this thin, rugged network is to provide 
structural support and compartmentalization within tissues. In addition, they regulate cell 
behavior as the BM displays adhesion receptors and harbors a repertoire of matrix-bound 
growth factors (180, 369). With a pore size of around 50nm, only small molecules are able to 
diffuse freely across this rigid selective barrier (4, 5). Nonetheless, immune cells have to be 
able to rapidly cross this barrier as part of our immune system (302, 313). The exact 
mechanism behind this traversing event is briefly considered in section 1.3.3. Crossing of the 
basement membrane of large molecules requires ECM breakdown and this is nearly always 
mediated by enzymatic activity (41). These proteolytic enzymes, also known as proteases, are 
also required for normal physiological functions such as remodeling events during wound 
repair or angiogenesis. Tissues normally have a well-balanced homeostatic mechanism 
involving protease inhibitors to prevent uncontrolled breakdown of the ECM. In many disease 
states, there might be a shift however favoring protease activity and remodeling of ECM. In 
this context, the best studied pathology during recent years is probably tumor invasiveness in 
which metastatic cells remodel ECM to gain access to blood vessels (118, 233). Proteases can 
be subdivided into 4 major classes: serine proteases, cysteine proteases, aspartyl proteases and 
matrix metalloproteases. Mainly serine proteases and matrix metalloproteases are involved in 
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ECM breakdown as they function at neutral pH whereas aspartyl and cystein proteases are 
active at low pH  and mainly act intracellularly (18).  
TEM revealed the presence of two layers within the BM: the lamina basalis (basal lamina, 
lamina densa) and the lamina reticularis. A small region of about 40nm in between basal 
sides of basal cells and the lamina densa, contains the extracellular portion of cell adhesion 
molecules such as integrins. This layer has been confirmed by immune EM applying epitope-
specific antibodies and is called lamina lucida (33, 239). These anchoring cell-matrix 
molecules containing integrins were discussed above. The predominant components of the 
lamina basalis are intertwined meshworks of polymeric laminins and type IV collagens. As 
such, both constitute the main frame of the BM in a self-assembly process for which binding 
to cellular receptors such as integrins or dystroglycan is a prerequisite. This network is further 
bridged by various non-covalent interactions with nidogens and perlecans (Figure 6). All the 
components are secreted by epithelial cells. The lamina reticularis on the contrary is formed 
by bundles of type III collagen reticular fibers and thus belongs to the connective tissue. 
Minor components of the basement membrane zone include agrin, SPARC/BM-
40/osteopontin, fibulins, type XV collagen, type XVIII collagen and fibronectin (9, 61, 95, 
180, 208, 302, 370). We will discuss briefly below some of the main components of BMs 
including type IV collagen, collagen type VII, laminin, heparan sulfate proteoglycans 
(HSPGs) and nidogen/entactin. 
Collagen type IV, is a major element of the BM and defines BM structure and function. Three 
collagen polypeptide chains, called α chains, are rich in proline and glycine and constitute 
together a long, stiff, ropelike superhelix, known as the typical collagen molecule. There exist 
up to 6 different α chains although they can only assemble into three different heterotrimers 
(200). These tissue-specific heterotrimeric protomers contain a central discontinuous triple-
helical domain rich in Gly-X-Y motifs. In addition, an N-terminal 7S domain and a C-
terminal globular non-collagenous 1 (NC1) domain are present. Eventually these protomers 
assemble into polymeric meshworks through interactions of the N-terminal 7S domains (302). 
Many different cells including tumor cells have been shown to bind to collagen IV, mediated 
by integrin and non-integrin receptors (189). 
Collagen type VII is a specific element of anchoring fibrils, a part of a supracellular anchoring 
network responsible for attaching the epithelium to the BM. Collagen VII binds to laminin 5 
proteins within the lamina densa and to collagen I proteins in the underlying lamina 
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binding to cellular receptors. At present, a total of 16 isoforms have been identified. Laminins 
-111, -332 and -511 are present in epithelia (9, 158, 200). 
Heparan sulfate proteoglycans are heterogenic molecules. To be typed as a proteoglycan, at 
least one of the sugar side chains has to be a glycosaminoglycan (GAG). All GAGs are 
covalently bound, via a tetrasaccharide link, to a serine amino acid in the core protein, the 
central polypeptide chain of proteoglycans (9). Much of the volume of the lamina densa is 
probably derived from the elaborate presence of these proteins as they form a highly hydrated 
gel (208). In addition, proteoglycans play a structural role, embed growth factors including 
fibroblast growth factor 2 (FGF-2), vascular endothelial growth factor (VEGF) and platelet-
derived growth factor (PDGF), sequester extracellular ions, regulate cell differentiation and 
confer charge-dependent selective filtration properties to BMs. Some of these roles have been 
shown for perlecan, probably the best studied member as the other proteoglycans are less well 
characterized. Perlecan, together with nidogen, is responsible for non-covalent linkage of the 
collagen and laminin networks (32, 95, 208, 302). 
Members of the nidogen family are composed of a series of sulfated monomeric 
glycoproteins. They do not have the potential to self-assemble into polymers. Three globules 
G1, G2, G3 and one rod-like part, possessing different domains, make up the typical three 
globular shape of nidogen (9). Nidogens have strong affinity for collagens and laminins and 
therefore are considered as typical linker molecules that bridge both networks. In addition, 
they form complexes with perlecan and fibulins. Nidogens or entactins are highly susceptible 
to proteolytic degradation, however linkage to laminin provides a mutual protection. Removal 
of nidogen is believed to initiate BM disintegration (32, 95, 200). 
  
1.2.3.2. Lamina propria 
The lamina propria consists of an intricate network of collagen fibers, elastin fibers, 
fibronectin and proteoglycans; located underneath the BM. The density of this connective 
tissue varies according to the tissue but harbors local cells (e.g. fibroblasts), mucus-producing 
glands, blood- and lymphatic vessels, and nerve endings (9). The main types of collagen 
fibers within the lamina propria are type I, II, III, V and XI. They provide tissue structure and 
resistance to tensile forces. Increased deposition of collagen type III and V, together with 
laminin and fibronectin deep into the lamina reticularis of the BM is a classic histological 
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marker of asthma (293). Elastin fibers, bundles of monomeric units consisting of elastin cores 
within sheaths of microfibrils, are an extremely important functional element for tissue 
motion including contraction and relaxation. In the respiratory tract, several coils of elastin 
within the lamina propria function in unison with bigger longitudinal elastic fibers present in a 
lamina elastica underneath the lamina propria (9). Fibronectins, large and essential 
multidomain glycoproteins display multiple adhesive properties and function as key links 
between cells and their extracellular matrices thereby attaching the lamina densa to the lamina 
propria (151). Proteoglycans have been described above. A clear distinction however has to 
be made in this context between cell surface proteoglycans, ECM-associated proteoglycans in 
general and specific proteoglycans residing inside the BM such as agrin and perlecan (208, 
302). 
 
1.2.4. Mucosal innervation 
Mucosa function is regulated by several types of nerves including sensory, parasympathetic 
and sympathetic nerves. Regulation of vasomotor function in the superficial lamina propria, 
stimulation of submucosal gland activity and secretion, and mediation of innate and acquired 
immune responses, all depend upon proper tissue innervations (16, 17, 80). Sensory neurons 
encompass calcitonin gene related peptide (CGRP), gastrin releasing peptide (GRP), 
tachykinins (neurokinins) substance P and neurokinin A (NKA) and possibly other peptides. 
Parasympathetic neurons consist of acetylcholine or vasoactive intestinal peptide (VIP) and 
nitric oxide containing neurons. Two important subpopulations of the sympathetic neurons are 
norepinephrine with or without neuropeptide Y (17, 80).  
Afferent sensory innervation of the nasal respiratory mucosa is constituted of two major 
trigeminal derivate fiber systems, consisting of unmyelinated C-fibers and myelinated Adelta-
fibers (17, 165). Except for a specialized region in the caudal third of the nasal cavity, termed 
the olfactory neuroepithelium which possesses sensory olfactory receptor neurons that 
subserve olfaction, most sensory and proprioceptive information from the nasal cavity relays 
through trigeminal afferents (63, 228). Sensory terminations in or near the epithelium of the 
larynx, trachea and large bronchi are afferent vagal nerve fibers (348). The terminal fibers or 
free nerve endings are extensively branched and detectable near to arteriovenous 
anastomoses, venous sinusoids, submucosal glands, in loose connective tissue but also in 
between epithelial cells (16). In the rat nasal septum, a dense network of unmyelinated nerve 
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fibers is located near the basement membrane of respiratory and squamous epithelium, and 
some fibers send projections between epithelial cells to reach up to the tight junctions (330). 
Several reports mention the existence of dense innervation of the respiratory epithelium of the 
upper respiratory system with numerous free intraepithelial nerve endings (148, 202, 218, 
231). Also the mammalian vagina is richly imbued with sensory, parasympathetic and 
sympathetic nerve fibers. Human vaginal innervation is believed to mainly consist of 
sympathetic and parasympathetic axons with only smaller contributions by sensory fibers 
(133). An investigation of the anatomical distribution of nerves in the human vagina provides 
no evidence for nerves extending in the epithelium. The majority of nerves appeared in both 
the superficial and deep submucosa (274). However, one report describes the presence of free 
intraepithelial nerve endings in the human introitus vaginae region (155). Also, in the rat 
vagina free or specialized nerve endings were observed immediately beneath and within the 
epithelium (340). 
 
Efferents of the parasympathetic and sympathetic nervous system has nerve bundles running 
through the mucosa (126). Electron microscopy showed that choline acetyltransferase 
immunoreactive (ChAT-IR) nerve fibers possess terminations within the epithelium. Some of 
these nerve endings were in close contact with goblet cells (183). In addition, parasympathetic 
VIP-IR fibers in rat nasal mucosa show a similar distribution than ChAT-IR fibers in the 
epithelium (182). 
 
1.2.5. Mucosal immune cells 
Mucosal surfaces are highly vulnerable to colonization and invasion by many 
microorganisms. It is not surprising that these surfaces possess intrinsic defense mechanisms 
including innate and adaptive immune responses. The mucosal immune system can be grossly 
subdivided in inductive sites, where naïve T and B lymphocytes are stimulated by antigens, 
and effector sites, where the effector cells after extravasation and differentiation exert their 
function. Inductive sites are often organized mucosa-associated lymphoid tissues (MALT) and 
regional draining lymph nodes, whereas the effector sites are widespread in the periphery and 
distributed in different histological compartments, including lamina propria and epithelia of 
various mucosae (198, 363). We will discuss in this section briefly the different immune cells 
that are present within respiratory and genital mucosa. An extensive description of mucosal 
immunology falls out of the scope of this thesis and can be found elsewhere (51). 
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Lymphoid cells  
Lymphocytes consist of a heterogeneous population of cells including cytotoxic CD8 T cells, 
helper CD4 T cells, B cells and natural killer (NK) cells (2). Upon infection of peripheral 
tissues, a cascade leading to the priming of T cells initiates, and acts to control pathogens. 
Activated T cells undergo migrational imprinting within the draining lymph nodes which will 
result in memory T cells that provide local and systemic protection. The combination of both 
these migrating and resident memory T cells will confer the host a long-term peripheral 
immunity, especially at the surfaces that form pathogen entry points into the body (120). 
Intraepithelial lymphocytes (IEL) populate all the body’s surfaces. They represent one of the 
largest lymphocyte populations. Many IEL are unconventional as they, in contrast to 
conventional T cells, express antigen receptors with a limited diversity and are kept in a 
heightened state of activation, allowing quick and efficient action-reaction. Intraepithelial 
lymphocytes may be composed of antigen experienced memory-effector T cell subtypes 
bearing the αβ or the γδ T cell receptor (TCRαβ+ or TCRγδ+) (51, 252). Although 
lymphocytes are very skilled in adaptive immune responses, a recently identified branch 
represents a family of innate lymphoid cells (ILC) that play diverse roles in immunity and 
inflammation. The prototypic ILC is the natural killer (NK) cell, which serves as an effector 
lymphocyte through secretion of IFN-gamma and its cytolytic capacity (25). The purpose of 
the mucosal B cell system is to collaborate with secretory epithelia to provide a first-line 
defense through active export of secretory immunoglobulin A and to some extent secretory 
IgM antibodies (31). Antigen-triggered maturation of germinal center B cells into memory B 
lymphocytes and plasmablasts will take place in lymphoid tissues. This maturated and 
differentiated B cell subpopulation will recirculate through peripheral blood into different 
tissues including mucosae, where long-living plasma cells produce antibodies (276). 
Intraepithelial plasma cells are usually positioned in the basal layers of the epithelium 
whereas plasma cells in the lamina propria are more diffusely scattered (225). 
 
Myeloid cells 
Myeloid cells originate from hematopoietic stem cells in the bone marrow and encompass 
monocytes, macrophages, dendritic cells and granulocytes. They represent the major 
leukocytes in the peripheral blood (185). Monocytes are maturated terminally into 
macrophages in various tissues. Macrophages are highly skilled as phagocytic cells with key 
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features such as prominent phagocytic vacuoles, secondary lysosomes and pseudopodia. They 
readily clear pathogens, cellular debris and non-microbial foreign material which makes them 
essential for maintaining tissue homeostasis (121, 185). Moreover, conventional macrophages 
possess the intrinsic capacity to produce pro-inflammatory cytokines, such as TNF-α, IL-1 
and IL-6, and also upregulate co-stimulatory molecules (278). They are both present in the 
epithelium and lamina propria of mucosae although they are found in greatest numbers in the 
lamina propria (159, 259). Monocytes may also differentiate into dendritic cells (DC). 
Dendritic cells, as professional antigen presenting cells (APC), serve as an essential bridge 
between innate and adaptive immunity (328). Mucosal DC recognize and respond to 
pathogens through engagement of pattern recognition receptors. Upon activation, these cells 
migrate to the draining lymph nodes and subsequently induce adaptive immune responses. 
The specialized functions of DCs include the potency to establish an antiviral interferon 
response to viral nucleic acids, the ability to capture organisms in the lumen, the capacity to 
cross-present antigens from other infected cells, and the ability to initiate IgA class switching 
in B cells. The epithelial residents of dendritic cells are Langerhans cells, which serve as true 
"sentinels" of the mucosa (240, 328). Genital mucosa contains at least two important subsets 
of dendritic cells including Langerhans cells and dendritic cells that express the C-type lectin 
receptor DC-Sign. Langerhans cells, characterized by CD1a expression, Langerin and Birbeck 
granules; form a dendrite network both extending within the epithelium and out in the lumen 
for efficient scavenging. However, they are not present in simple columnar epithelium (78). 
On the other hand, DC-Sign+ DC’s are mainly localized subepithelial (88). Within respiratory 
mucosa of the rat trachea roughly 20% of resident DC were found to interdigitate within the 
resting epithelium under physiological conditions, with the remaining 80% residing within the 
subepithelial layers (171). 
Granulocytes are the first cells to be recruited to the local sites upon pathogen invasion and 
act as a crucial first line of defense in immune responses (121). Mature mast cells are well-
known for their contribution in allergic reactions through the release of histamine and ‘‘slow 
reacting substance of anaphylaxis’’ following crosslinking of cell-bound IgE by allergens. In 
addition, mast cells participate in innate immune responses and may also contribute to 
adaptive immune responses because of their capability to produce mediators that can promote 
migration of APC (149). The majority is located within the lamina propria of the respiratory 
tract with only a minority of mast cells located in the epithelium (48, 224). Another 
population of granulocytes are neutrophils. These innate immunity cells quickly migrate 
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towards and accumulate at the site of inflammation and are considered pathognomonic 
features of both acute and chronic inflammatory conditions (109). Neutrophils possess the 
capacity to perform a variety of antimicrobial functions such as degranulation and 
phagocytosis. Pathogens stimulate resident macrophages to produce macrophage-derived 
chemokines which contribute to the recruitment or chemotaxis of neutrophils. As a 
consequence, blood neutrophils traverse the vascular endothelium at the site of inflammation 
and reach the lamina propria. It has been described that under certain physiological or 
pathological conditions, neutrophils cross the epithelium into the lumen. In general, this 
response peaks by 24-48 hours after initiation. At the site of inflammation, neutrophils 
produce on their turn monocyte chemoattractants for a second-wave of immune cell 
(macrophages) influx (58, 109, 324). 
   
1.3.  Microbial interactions with the basement membrane (BM) barrier 
 (Adapted from Steukers, L., Glorieux, S., Vandekerckhove, A.P., Favoreel, H.W., Nauwynck, H.J. Diverse 
microbial interactions with the basement membrane barrier. Trends in Microbiology 20(3), 147-155.)  
During primary contact with susceptible hosts, microorganisms face an array of barriers that 
thwart their invasion process. Passage through the basement membrane (BM), a 50-100 nm 
thick critical barrier underlying epithelia and endothelia, is a prerequisite for successful host 
invasion. Such passage allows pathogens to reach nerve endings or blood vessels in the 
stroma and to facilitate spread to internal organs. During evolution, several pathogens have 
developed different mechanisms to cross this dense matrix of sheet-like proteins. To breach 
the BM, some microorganisms have developed independent mechanisms, others hijack host 
cells that are able to transverse the BM (e.g. leukocytes and dendritic cells) and oncogenic 
microorganisms might even trigger metastatic processes in epithelial cells to penetrate the 
underlying BM. 
A first step during infection is the attachment of microorganisms to various host proteins, 
which could include basement membrane (BM) proteins. Generally, adhesion of bacteria and 
fungi occurs through binding of adhesive molecules, called adhesins, to host proteins. Most 
adhesins are extensively described and some of the motifs participating in these processes 
have been identified (194). In comparison, knowledge about adhesion of viruses with BM 
components is scarce. Upon adhesion, microorganisms have evolved cunning techniques to 
overcome the BM barrier, which otherwise hampers their invasive process. Breakdown of the 
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BM, via activation of microbial and/or host proteases, in order to cross the BM has been 
shown for many bacteria, fungi and, recently, for some viruses. Pathogens might also gain 
access to the connective tissue by hijacking host cells, particularly local immune cells, to 
cross the BM. This chapter provides an overview on recent insights in different pathogen-BM 
interactions during host invasion,  discusses these findings and projects how they could 
contribute to the design of novel strategies to interfere with microbial invasions and 
pathology. 
 
1.3.1. Adhesion of pathogens to BM components 
A crucial initial event in the pathogenesis of many microorganisms is adhesion to host tissues.  
Major players during these early steps in infection are microbial adhesive cell surface 
molecules, termed adhesins (194). Microbial surface components recognizing adhesive matrix 
molecules (MSCRAMMs) are adhesins that attach to extracellular matrix (ECM) including 
the BM. Many MSCRAMMs are capable of binding more than one ECM component, and a 
single strain often possesses several different proteins that bind the same host component. 
Although current data about viral ECM adhesion and adhesins is still scarce, their importance 
in virulence has been shown for most bacteria and many fungi. For example in many animal 
models of staphylococcal infections, CNA, a collagen binding adhesin of pathogenic 
Staphylococcus aureus, increases disease severity. The ability to interact with collagen has 
been suggested to grant these bacteria a clear advantage in pathogenesis (372). For bacteria, 
adhesins are roughly subdivided according to the appendage morphology: there are fimbrial 
or non-flagellar adhesins (chaperone-usher pili, curli, type IV pili, type III secretion needle 
and type IV secretion pili) and non-fimbrial adhesins (autotransporters; outer membrane, 
secreted and biofilm-associated adhesins). Pili are further classified according to physical 
properties, antigenic determinants, adhesion characteristics, characteristics of the major 
protein subunits or assembly pathways (10, 107). Although adhesins form a heterogeneous 
group with diverse architecture, domain content and binding mechanism, some do possess 
similarity in structure, ECM-binding domain organization and function (214, 308). ECM-
binding MSCRAMMs of many pathogenic Gram-positive species are cell wall-anchored 
surface proteins (CWPs). Common features of CWPs are an N-terminal signal peptide 
followed by a so-called A-region or -domain, segments of repeated domains and a 
characteristic C-terminal sorting signal. The sorting signal contains an important cell wall-
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anchoring site or LPXTG motif, which covalently binds to the cell wall (263, 277). However, 
recently, the collagen-binding adhesin Slr of Gram-positive Streptococcus pyogenes has been 
shown to lack the LPXTG motif, but uses a cell wall-anchoring TLIA lipobox instead (26). 
The structure and organization of viral and fungal adhesins to ECM is at present less well 
documented, although there is proof of diversity in fungal adhesins (308, 364). Some fungal 
adhesins show structural and/or functional similarities with bacterial adhesins (308, 364). 
Agglutinin-like sequence (Als) adhesins of Candida albicans are composed of a signal 
peptide, an N-terminal region, a nonrepeat Thr-rich (TR) region, a central region with a 
variable number of repeats, and a Ser/Thr/Asn-rich C-terminal domain which anchors the 
CWP via a glycophosphatidylinositol (GPI) remnant (47, 364). In many cases, ECM-binding 
domains recognize carbohydrate residues or oligosaccharides, but not exclusively as many of 
them also bind host protein binding sites (76, 268, 277). Besides this direct microbial adhesin-
ligand binding, microorganisms have developed other interesting indirect adhesive 
approaches. Haemophilus influenzae, Moraxella catarrhalis and Shigella spp. prevent cell 
detachment of infected cells from the BM, through stabilization of focal adhesions. This 
strategy counteracts rapid exfoliation, which is an effective intrinsic defensive system of 
intestinal epithelium (192). C. albicans promotes laminin 5 and type IV collagen protein 
secretion to enhance binding to the BM (55). In the following paragraphs, adhesion of 
bacteria, fungi and viruses to the major BM components collagen, laminin, proteoglycans, 
entactin/nidogen, BM-40 and fibulin will be discussed in more detail. Bacteria, fungi and 
viruses also show binding capacity to fibronectin, a minor component of the BM zone, 
extensively described elsewhere (151). 
 
Collagen, the superhelix 
Numerous bacteria are able to interact with collagens via their proper adhesins (143, 199, 
321). For many bacterial species, the ability to interact with collagen in the BM is a 
prerequisite for invasiveness. For example, PilA from Streptococcus agalactiae, causing 
meningitis in newborns, has been found to bind collagen I, which promotes interaction with 
integrins and subsequently promotes penetration of the blood-brain barrier (BBB) (15).    
Some fungal pathogens also interact with collagens during host invasion using distinct fungal 
receptors. Aspergillus fumigatus contains a sialic acid-specific lectin that interacts with 
collagen type I and IV (342). Similarly for C. albicans, the Als3p glycoprotein, a major player 
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in C. albicans pathogenesis, has been shown to be responsible for binding collagen IV (269). 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and glycoprotein gp43 of 
Paracoccidioides brasiliensis bind type I collagen. Gp43 also binds type IV collagens and 
laminin, probably via a sialic acid recognition system, similar to A. fumigatus (342). However 
for most fungi, adhesins and adhesive mechanisms are still largely unknown (47, 364). 
So far, viral binding to collagen has not been described. 
 
The multidomain glycoprotein laminin 
As described for collagen, many different bacteria and fungi are able to interact with laminins 
via adhesive proteins (10, 34, 144, 285, 353). Most adhesins recognize multiple molecules. 
However, there are adhesins that bind laminin but not collagen. Lsa24 and Lsa27 of L. 
interrogans (353) Lmb of Streptococcus agalactiae (285) and others act as specific laminin-
binding adhesins. Recently, ErpX of Borellia burgdorferi was found to have a unique mode of 
laminin binding through a hydrophobic segment at the center of the bacterial protein. This 
protein motif has not been identified yet in other bacterial laminin adhesins (34).   
For human papillomaviruses (HPV), recent work has put laminin 5 forward as a possible basal 
ECM receptor. This interaction localizes virus particles to the basal surface of epithelial cells 
where they can reach their entry receptor, integrin 64, the physiological binding partner of 
laminin 5 (193). However, another recent publication demonstrated that different HPV types 
show different binding characteristics (37) (Figure 13). The nonstructural protein NSP4 of 
rotavirus plays a key role in development of severe gastroenteritis by binding ECM proteins 
laminin β3 and fibronectin. Moreover, rotavirus induces phosphatidylinositol 3-kinase (PI3K) 
activation in intestinal cells, causing upregulation of integrin expression, prolonged 
attachment of infected cells to collagen and increased virus production (29, 142). 
 
The heterogenic molecule: proteoglycan  
The ability to interact with proteoglycans, often heparan sulfate proteoglycans, is widespread 
in viruses and bacteria (19, 49). A clear distinction has to be made in this context between cell 
surface proteoglycans, ECM-associated proteoglycans in general and specific proteoglycans 
residing inside the BM. Despite the numerous reports on pathogens interacting with ECM-
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associated proteoglycans in general (19, 49); so far, no specific pathogen BM agrin nor 
pathogen BM perlecan interactions have been described. 
Currently, only one specific BM proteoglycan–pathogen interaction is known. The 
proteoglycan bamacan is a cellular ligand of vaccinia virus neurovirulence factor N1L. This 
interaction promotes viral growth and might contribute to virulence of the virus (253). 
  
Entactin/nidogen, BM-40/osteonectin and fibulins: versatile ECM proteins 
Members of the nidogen family are composed of a series of sulfated monomeric 
glycoproteins. Three globules G1, G2, G3 and one rod-like part, possessing different domains, 
make up the typical three globular shape of nidogen (180, 208, 302). BM-40 is a glycoprotein 
of the ECM that binds calcium, collagen and hydroxyapatite and regulates the cell–matrix 
interaction (180, 208, 302). All fibulins contain epidermal growth factor-like repeats and a 
unique fibulin-type module at its C terminus that define this family (61). Up till now, only one 
bacterium has been reported to use nidogen as a potential ligand for ECM-binding. SgrA of 
Enterococcus faecium has been identified as a bacterial receptor for nidogen and fibronectin 
(152). The opportunistic bacterium Finegoldia magna depends on BM-40 interaction for 
colonization and survival (113). Serum opacity factor is a streptococcal receptor for fibulin-1 
(61). 
No other bacteria, fungi or viruses are known to bind nidogen/entactin, BM-40 or fibulins 
during host invasion. 
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Several bacteria encode or modulate BM-degrading proteases, either directly or by engaging 
host-derived systems. 
Various bacterial pathogens including Bacteroides fragilis and Clostridium perfringens (281) 
encode or modulate matrix metalloproteinases (MMPs). Other bacteria degrade the BM 
barrier by encoding or modulating serine proteases. Indeed, many bacterial pathogens, such as 
Enterobacteriaceae, Fusobacteriaceae, Helicobacteriaceae, Legionellaceae, 
Mycobacteriaceae, Neisseriaceae, Pasteurellaceae, Peptostreptococcaceae, 
Porphyromonadaceae, Pseudomonadaceae, Spirochaetaceae, Staphylococcaceae and 
Streptococcaceae, modulate the plasminogen (Plg)/plasmin system (22) and the structural and 
functional aspects of this system are described elsewhere (311). Briefly, through the activity 
of the two main physiological plasminogen activators, urokinase-type plasminogen activator 
(uPA) and tissue-type plasminogen activator (tPA), plasminogen is converted into plasmin 
which degrades laminin and fibronectin and activates precursors of MMPs. Several bacterial 
pathogens express plasminogen receptors thereby recruiting plasminogen to the bacterial 
surface which leads to enhanced plasminogen activation. Additionally, some bacteria bind 
and/or induce uPA or tPA (22, 89) and/or express bacterial plasminogen activators. Moreover, 
some bacteria inactivate plasmin inhibitors (204). 
Some bacterial species modulate multiple proteases to cross the BM. In addition to 
modulating the plasminogen/plasmin system, Streptococcus pyogenes also expresses a 
cysteine protease (40). Fusobacterium nucleatum can invade the BM in a strain-dependent 
manner, by binding plasminogen (71) and pro-MMP-9 and stimulating MMP-9 and MMP-13 
secretion (138). Helicobacter pylori induces expression of the cysteine protease cathepsin X 
in gastric epithelial cells and macrophages. In epithelial cells, H. pylori induces 
morphological and motility changes, partly by MMP-9 (201) and probably also by other 
proteases. The mechanisms by which H. pylori induces expression of proteases in epithelial 
cells and macrophages is unknown. The proteolytic activities are suggested to play a role in 
gastric tumourigenesis (201). H. pylori also increases the expression of the uPA system in 
gastric epithelial cells (187). Mycobacterium tuberculosis (55, 255) and Neisseria 
meningitidis (89, 314) modulate both MMPs (MMP-8 and MMP-9 respectively) and the 
plasminogen/plasmin system. Both morphotypes of Peptostreptococcus micros possess 
plasminogen receptors. For P. micros, both bacterial (streptokinase) and human plasminogen 
activators (uPA) can activate plasminogen to plasmin. Rough morphotypes also possess 
chymotrypsin-like and gelatinase serine proteases (132). Porphyromonas gingivalis 
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upregulates MMPs, modulates the plasminogen/plasmin system and expresses cysteine 
protease gingipains. Gingipains contribute to BM penetration, either directly or by modulating 
MMP-2 and MMP-9 (11). Pseudomonas aeruginosa expresses a MMP and modulates the 
plasminogen/plasmin system (70). Treponema pallidum expresses a MMP-like and serine 
protease (163), induces MMPs and modulates the plasminogen/plasmin system (22). Vibrio 
spp. express both MMPs and serine proteases (319). 
 
Protease activity has also been implicated in tissue penetration by pathogenic fungi. Different 
fungi have been associated with multiple BM-degrading proteases. However, knowledge on 
substrate specificities and their contribution to virulence and pathogenesis is rather poor. 
During Aspergillus spp. infection, a serine protease, MMP and aspartic protease have been 
identified (209). Candida spp. activate host MMP-9, decrease tissue inhibitor of 
metalloproteinase 2 (TIMP-2) secretion (55), secrete aspartic proteases and unidentified MMP 
and serine protease activity (273). Cryptococcus neoformans expresses a serine protease 
(294). A total of 53 cDNAs encoding proteases were shown in Paracoccidioides brasiliensis 
including one unidentified gelatinase (collagenolytic protease) and an extracellular serine-
thiol protease (282). P. brasiliensis also induces MMP-9 (267). Also Nectriaceae, 
Saccharomycetaceae and Trichocomaceae induce host MMPs (83). 
 
Viruses have also been reported to modulate host-derived proteolytic activity to alter barrier 
properties of BMs, thereby enhancing viral dissemination (Figure 13). Most viral-induced 
alterations of BMs involve MMPs. The latent membrane protein-1 (LMP-1) of Epstein-Barr 
virus (EBV) induces MMP-9 and uPA (368). Hepatitis B virus x protein (HBx) drives MMP-
14 expression (206). HPV has been reported to induce MMP-2, MMP-9 and MMP-14 (43). 
The glycoprotein K1 of Kaposi's sarcoma-associated herpesvirus (KSHV) modulates the 
production of MMP-1, MMP-2 and MMP-9 (284). Apart from the involvement of viral-
induced proteolytic activities in EBV-, hepatitis B virus-, HPV- and KSHV-induced 
metastasis, it is presently unclear whether this induction plays a role in viral pathogenesis. A 
similar mechanism is observed in human T-cell leukemia/lymphoma virus type I (HTLV-1)-
associated adult T-cell leukemia/lymphoma, where MMP-9 expression is increased in HTLV-
1-infected malignant cells (20, 256). HTLV-1 encephalitis is associated with MMP-2 and 
MMP-9 (20). Other viral infections have also been implicated in neurological conditions due 
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to their involvement in BBB impairment by damaging the vascular BM. Human 
cytomegalovirus (HCMV) infection of human microvascular endothelial cells (HMEC) 
induces collagenase type IV secretion, which may lead to BM degradation and subsequent 
release of infected endothelial cells into the circulation and access into the CNS (279). Viral 
hijacking of immune cells might also modulate vascular permeability. Bunyaviridae (Andes 
virus or ANDV), Dengue virus, HIV and West Nile Virus (WNV) enhance dendritic cell (DC) 
maturation, MMP-9 expression and plasma vascular leakage (229). MMP-9 is also 
upregulated both in the periphery and brain upon WNV infection and is partly localized to the 
brain's blood vessels. WNV may enter into the brain either directly through the BBB or be 
carried within infected leukocytes (described in the next section). WNV also upregulates 
MMP-1 and MMP-3 (351). Coronaviruses can also induce MMPs in susceptible cells and 
have been associated with multiple sclerosis-like disease in rodents. However, the role of 
MMPs in coronavirus CNS infection is unknown (90). Finally, it has been postulated that 
bovine herpesvirus 5 (BoHV-5) entry into the CNS is facilitated by leukocytes and MMP-9. 
However, induction of MMP-9 expression by BoHV-5 has not been directly demonstrated so 
far (44). 
Reports describing the involvement of serine protease activity in viral-induced BM distortion 
are scarce. As described above, EBV also induces uPA (368). An unidentified trypsin-like 
serine protease is involved in BM crossing by the porcine pseudorabies virus (PRV) in 
porcine nasal respiratory explants (128).  
In summary, several bacteria, fungi and viruses enhance invasion through the BM barrier by 
(mis)using proteolytic systems via encoding and/or modulating host-derived proteases. 
 
1.3.3. Hitchhiking across the BM 
During physiological processes, such as development and immune surveillance, and during 
the pathology of many diseases, such as metastatic cancer, cells frequently traverse the BM 
barrier. Transmigration across the BM is a three-stage process (Figure 14). First, invadopodia-
like protrusions perforate the BM. Then these protrusions elongate in the degraded zone and 
infiltrate in the underlying compartment. The rod-like shape of invadopodia is believed to 
allow for focal delivery of proteases to restrictive areas of the BM (313).  
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Although the primary function of immune cells is to sample pathogens to initiate an immune 
response, over time, several pathogens have developed mechanisms to use these cells as 
Trojan horses to cross the BM barrier and disseminate throughout the host. Mechanisms of 
intracellular survival due to inhibition of immune cell activation by altering their phenotype 
and function has been implied or demonstrated to contribute to cell migration (86). 
Several bacteria survive in polymorphonuclear neutrophil granulocytes (PMN) or neutrophils: 
Anaplasma phagocytophilum, Bordetella pertussis, Brucella abortus, Chlamydia psittaci, 
Chlamydia trachomatis, Escherichia coli, Francisella tularensis, Mycobacterium leprae, 
Neisseria gonorrhoeae, Salmonella typhi, Salmonella typhimurium, S. aureus, S. pyogenes 
and Yersinia enterolytica. This may provide a mechanism by which bacteria infect distant site 
although this needs further experimental confirmation. Burkholderia pseudomallei, 
Chlamydia pneumoniae, Haemophilus somnus and Legionella pneumophila not only survive 
but also multiply in PMN. Afterwards, pathogens may enter through the uptake of infected 
apoptotic PMN, survive and multiply in macrophages, which subsequently may transport 
bacteria throughout the body (207, 332).  
The Trojan horse hypothesis is also valid for DCs. Coxiella burnetii survives in DCs during 
infection (35). DCs also transport intracellular Listeria monocytogenes, M. tuberculosis and S. 
typhimurium from the mucosal areas towards the draining lymph nodes (85).  
Mononuclear phagocytes (monocytes and macrophages) can also be misused by intracellular 
bacteria to disseminate throughout the host. This has been reported or suggested for 
uropathogenic E. coli (28), L. pneumophila, Salmonella enterica (355), S. Typhimurium (86) 
and Y. pestis (115). Furthermore, H. influenzae has been found within mononuclear cells both 
above and below the BM (103). Although Bacillus anthracis is not an intracellular pathogen, 
it can use alveolar macrophages to cross the airway mucosal barriers (135). Mononuclear 
phagocyte-facilitated entry of the CNS across the BBB has been described for Brucella spp., 
Ehrlichia chaffeensis, L. monocytogenes, M. tuberculosis and Streptococcus suis type II in 
swine (86). L. monocytogenes invades both directly or carried within infected leukocytes (85).  
Several pathogens, such as Mycobacterium avium (317) and Shigella flexneri (67) 
predominantly exploit M cells to cross the epithelial barrier into the subepithelial lamina 
propria and subsequently invade macrophages. As described earlier, H. pylori is associated 
with metastatic processes and spread of malignant cells throughout the body (201). 
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Some fungi also exploit immune cells to cross host barriers. Histoplasma capsulatun causes 
systemic mycosis, mainly in immunosuppressed patients, and can survive and multiply in 
PMN (207). The facultative intracellular pathogen C. neoformans has been demonstrated to 
cross the BBB via mononuclear phagocytes (monocytes and macrophages), together with 
other mechanisms involving free yeasts (45). 
 
Several viruses hijack immune cells to transverse the BM (Figure 13). DCs and Langerhans 
cells (LCs), an epidermal DC subtype, are located at mucosal or epidermal sites of entry for 
many viruses, such as herpesviruses, immunodeficiency viruses, HPV, and are thus of key 
importance in their infection. Initial infection of epidermal cells with herpes simplex virus 
type 1 (HSV-1) results in infection of resident LCs. After infection, a drop in epidermal LC 
density and a corresponding increase in the number of langerin-positive cells in the 
underlying dermis has been noticed, arguing for HSV-induced LC migration from the 
epidermal layer (91). During primary infection with varicella zoster virus (VZV), another 
herpesvirus, DCs of the respiratory mucosa can transport VZV to human tonsillar CD4+ T 
lymphocytes, followed by T lymphocyte-mediated dissemination in the host (3). HIV might 
use LCs for trans-epithelial transport of HIV to susceptible CD4+ T cells (64). Measles virus 
(MV) is another virus using DCs to gain access to its main target cells in lymphoid tissues 
(217). As described earlier, ANDV, Dengue virus, HIV and WNV hijack DCs (229). 
HIV may not only use LCs for BM passage, but also mononuclear phagocytes 
(monocytes/macrophages) which could contribute to their ability to invade the brain. Early in 
the course of infection, HIV-1 can enter the CNS. HIV encephalitis is characterized by HIV-
laden monocytes and macrophage infiltration into the CNS parenchyma. Local inflammation 
as well as HIV products such as gp120, Nef and Tat, which upregulate MMP-2 and/or MMP-
9, lead to breaches in the BBB late in HIV-CNS disease. This enables entrance of free virions 
into the brain (130, 215). Also CMV-infected monocytes can enter the CNS in a Trojan horse 
model (86). For WNV, LCs support initial viral replication, followed by replication in 
lymphoid tissues and dissemination to organs and the CNS (291); WNV may enter into the 
brain through the BBB either directly or carried within infected monocytes or macrophages 
(as described earlier) (351). 
Recently, it has been shown that equine herpesvirus 1 (EHV-1) might use monocytes, 
macrophages and lymphocytes as Trojan horses to transport the virus through the BM in nasal 
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mucosae. EHV-1-infected monocytes, macrophages and lymphocytes were found in the 
connective tissue below the BM in close proximity to the epithelial plaques, suggestive for 
leukocyte-mediated viral passage of the BM (349). The closely related EHV-4 did not 
efficiently infect these local immune cells, which might be the reason why EHV-4-induced 
viremia is rare (349). BoHV-5 is postulated to use a similar invasive mechanism as EHV-1 
and BoHV-5 entry into the CNS is facilitated by leukocytes and MMP-9 (44). Lymphocyte-
mediated viral entry of the brain has also been demonstrated for HTLV-1 (20). The 
association with MMP activity was described earlier. 
Some oncogenic viruses such as EBV, hepatitis B virus, HPV, HTLV-1 and KSHV drive 
tumor invasiveness and metastasis by modulating proteases (Figure 13). However, the role of 
spread of viral-infected malignant cells in the pathogenesis of these viruses is unclear at the 
present. 
In conclusion, different bacteria, fungi and viruses exploit host cells, particularly immune 
cells, to cross the BM barrier and disseminate throughout the host. 
 
1.3.4. Concluding remarks and future perspectives 
The BM represents a formidable barrier of the body against the outside world. However, it is 
clear that a wide array of pathogens has developed mechanisms to cross the BM and invade 
the host. There are several important outstanding questions about this still largely unexplored 
topic. One aspect of BM passage that we have not discussed here is the role of local immunity 
in breaking down ECM during a microbial infection. Indeed, immune cells produce a large 
amount of proteases upon stimulation at the site of inflammation and this might rupture 
important barriers such as the BM, allowing pathogens access to deeper tissues. However, 
inflammation increases the risk that pathogens will be neutralized by the immune system. 
As the BM represents one of the first barriers encountered by the pathogen, dissecting 
pathogen interactions with, and mechanisms to cross, the BM may provide interesting leads 
towards developing novel antimicrobial drugs. However, it is important to keep in mind that 
the current existing detailed in vitro knowledge on this topic does not always translate to the 
in vivo situation as axiomatic truth. Improved in vitro models that better reflect the in vivo 
environment will provide excellent tools for identification and characterization of putative 
adhesion and invasion mechanisms before progressing to the use of animal models.  
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An obvious target to prevent pathogen infiltration is the adhesion step of pathogens to the 
BM. Moreover, it is important to know that different microbial invasive strategies might have 
synergistic effects on one another. Indeed, interactions between adhesion and proteolytic 
activity-mediating mechanisms, to improve and enhance pathogen invasion, have been 
described (205). In some bacteria, production of proteases might even depend upon quorum 
sensing (77). Taken into account, hampering bacterial adhesion might also influence their 
proteolytic activity. Mechanisms underpinning binding to and breakdown of the BM are 
generally better understood for bacteria and fungi than for viruses. Hence, it will be 
interesting to identify possible viral factors that are required for efficient penetration through 
the BM and ECM. If protease activity plays a role, as described recently for a herpesvirus 
(128), then the use of protease-inhibitors might be a useful strategy. Still, to further develop 
the potential of proteases as antimicrobial targets, there is a need for identification of all 
concerned signals, factors and domains during microbial invasion. Compounds, if locally 
applied, that interfere with pathogen hijacking of migratory cells or limit interactions of 
metastatic cells with ECM elements could provide an interesting way to prevent or delay 
further microbial invasion.    
In conclusion, several bacteria, fungi and viruses have evolved different finely tuned 
techniques to adhere to, break down and/or hitchhike across the BM. Fundamental insights in 
these invasion mechanisms of pathogens could be a promising road towards new therapeutic 
approaches against these different types of pathogens.  
  
 
 
 
 
 
 
 
 
Introduction 1 
 
69 
 
1.4. References 
1. http://www.admit-online.info/fileadmin/materials/images/cd_rom/142_morphology01.gif. 
2. Abadie, V., V. Discepolo, and B. Jabri. 2012. Intraepithelial lymphocytes in celiac disease 
immunopathology. Seminars in immunopathology 34:551-566. 
3. Abendroth, A., P. R. Kinchington, and B. Slobedman. 2010. Varicella zoster virus immune evasion 
strategies. Curr Top Microbiol Immunol 342:155-171. 
4. Abrams, G. A., S. L. Goodman, P. F. Nealey, M. Franco, and C. J. Murphy. 2000. Nanoscale 
topography of the basement membrane underlying the corneal epithelium of the rhesus macaque. Cell 
and tissue research 299:39-46. 
5. Abrams, G. A., S. S. Schaus, S. L. Goodman, P. F. Nealey, and C. J. Murphy. 2000. Nanoscale 
topography of the corneal epithelial basement membrane and Descemet's membrane of the human. 
Cornea 19:57-64. 
6. Ackermann, M. 2006. Pathogenesis of gammaherpesvirus infections. Veterinary microbiology 
113:211-222. 
7. Ackermann, M., and M. Engels. 2006. Pro and contra IBR-eradication. Veterinary microbiology 
113:293-302. 
8. Akhtar, J., and D. Shukla. 2009. Viral entry mechanisms: cellular and viral mediators of herpes 
simplex virus entry. The FEBS journal 276:7228-7236. 
9. Alberts, B., A. Johnson, J. Lewis, M. Raff, K. Roberts, and P. Walter. 2002. Cell junctions, cell 
adhesion and the extracellular matrix, Molecular biology of the cell. Garland Science, New York. 
10. Amano, A. 2010. Bacterial adhesins to host components in periodontitis. Periodontology 2000 52:12-
37. 
11. Andrian, E., Y. Mostefaoui, M. Rouabhia, and D. Grenier. 2007. Regulation of matrix 
metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an 
engineered human oral mucosa model. Journal of cellular physiology 211:56-62. 
12. Arduino, P. G., and S. R. Porter. 2008. Herpes Simplex Virus Type 1 infection: overview on relevant 
clinico-pathological features. Journal of oral pathology & medicine : official publication of the 
International Association of Oral Pathologists and the American Academy of Oral Pathology 37:107-
121. 
13. Azab, W., K. Tsujimura, K. Maeda, K. Kobayashi, Y. M. Mohamed, K. Kato, T. Matsumura, and 
H. Akashi. 2010. Glycoprotein C of equine herpesvirus 4 plays a role in viral binding to cell surface 
heparan sulfate. Virus research 151:1-9. 
14. Bacha, W. J., and L. M. Bacha. 2000. Female Reproductive System. In D. Balado (ed.), Color Atlas 
of Veterinary Histology, vol. Second Edition. Lippincott Williams & Wilkins, United States. 
15. Banerjee, A., B. J. Kim, E. M. Carmona, A. S. Cutting, M. A. Gurney, C. Carlos, R. Feuer, N. V. 
Prasadarao, and K. S. Doran. 2011. Bacterial Pili exploit integrin machinery to promote immune 
activation and efficient blood-brain barrier penetration. Nature communications 2:462-462. 
16. Baraniuk, J. N. 2008. Neural regulation of mucosal function. Pulmonary pharmacology & therapeutics 
21:442-448. 
17. Baraniuk, J. N., and S. J. Merck. 2009. Neuroregulation of human nasal mucosa. Annals of the New 
York Academy of Sciences 1170:604-609. 
18. Barrett, A. J., D. P. Tolle, and N. D. Rawlings. 2003. Managing peptidases in the genomic era. Biol 
Chem 384:873-882. 
19. Bartlett, A. H., and P. W. Park. 2011. Heparan sulfate proteoglycans in infection, p. 31-62. In M. S. 
G. Pavão (ed.), Glycans in Diseases and Therapeutics, Biology of Extracellular matrix, XII ed. 
Springer-Verlag, Berlin. 
20. Bazarbachi, A., R. Abou Merhi, A. Gessain, R. Talhouk, H. El-Khoury, R. Nasr, O. Gout, R. 
Sulahian, F. Homaidan, H. de The, O. Hermine, and M. E. El-Sabban. 2004. Human T-cell 
lymphotropic virus type I-infected cells extravasate through the endothelial barrier by a local 
angiogenesis-like mechanism. Cancer research 64:2039-2046. 
21. Bellner, L., J. Karlsson, H. Fu, F. Boulay, C. Dahlgren, K. Eriksson, and A. Karlsson. 2007. A 
monocyte-specific peptide from herpes simplex virus type 2 glycoprotein G activates the NADPH-
oxidase but not chemotaxis through a G-protein-coupled receptor distinct from the members of the 
formyl peptide receptor family. Journal of immunology 179:6080-6087. 
22. Bergmann, S., and S. Hammerschmidt. 2007. Fibrinolysis and host response in bacterial infections. 
Thromb Haemost 98:512-520. 
23. Beyer, E. C., X. Lin, and R. D. Veenstra. 2013. Interfering amino terminal peptides and functional 
implications for heteromeric gap junction formation. Frontiers in pharmacology 4:67. 
1 Introduction 
 
70 
 
24. Biggs, T. C., S. M. Hayes, J. H. Bird, P. G. Harries, and R. J. Salib. 2013. Use of the lymphocyte 
count as a diagnostic screen in adults with suspected epstein-barr virus infectious mononucleosis. The 
Laryngoscope. 
25. Bjorkstrom, N. K., E. Kekalainen, and J. Mjosberg. 2013. Tissue-specific effector functions of 
innate lymphoid cells. Immunology 139:416-427. 
26. Bober, M., M. Morgelin, A. I. Olin, U. von Pawel-Rammingen, and M. Collin. 2011. The 
membrane bound LRR lipoprotein Slr, and the cell wall-anchored M1 protein from Streptococcus 
pyogenes both interact with type I collagen. PloS one 6. 
27. Bohannon, K. P., Y. Jun, S. P. Gross, and G. A. Smith. 2013. Differential protein partitioning within 
the herpesvirus tegument and envelope underlies a complex and variable virion architecture. 
Proceedings of the National Academy of Sciences of the United States of America 110:E1613-1620. 
28. Bokil, N. J., M. Totsika, A. J. Carey, K. J. Stacey, V. Hancock, B. M. Saunders, T. Ravasi, G. C. 
Ulett, M. A. Schembri, and M. J. Sweet. 2011. Intramacrophage survival of uropathogenic 
Escherichia coli: differences between diverse clinical isolates and between mouse and human 
macrophages. Immunobiology 216:1164-1171. 
29. Boshuizen, J. A., J. W. A. Rossen, C. K. Sitaram, F. F. P. Kimenai, Y. Simons-Oosterhuis, C. 
Laffeber, H. A. Buller, and A. W. C. Einerhand. 2004. Rotavirus enterotoxin NSP4 binds to the 
extracellular matrix proteins laminin-beta3 and fibronectin. Journal of virology 78:10045-10053. 
30. Bouaouina, M., Y. Lad, and D. A. Calderwood. 2008. The N-terminal domains of talin cooperate 
with the phosphotyrosine binding-like domain to activate beta1 and beta3 integrins. The Journal of 
biological chemistry 283:6118-6125. 
31. Brandtzaeg, P., and F. E. Johansen. 2005. Mucosal B cells: phenotypic characteristics, transcriptional 
regulation, and homing properties. Immunological reviews 206:32-63. 
32. Breitkreutz, D., I. Koxholt, K. Thiemann, and R. Nischt. 2013. Skin basement membrane: the 
foundation of epidermal integrity--BM functions and diverse roles of bridging molecules nidogen and 
perlecan. BioMed research international 2013:179784. 
33. Breitkreutz, D., N. Mirancea, and R. Nischt. 2009. Basement membranes in skin: unique matrix 
structures with diverse functions? Histochemistry and cell biology 132:1-10. 
34. Brissette, C. A., A. Verma, A. Bowman, A. E. Cooley, and B. Stevenson. 2009. The Borrelia 
burgdorferi outer-surface protein ErpX binds mammalian laminin. Microbiology 155:863-872. 
35. Broederdorf, L. J., and D. E. Voth. 2011. Cheating death: a coxiella effector prevents apoptosis. 
Frontiers in microbiology 2:43-43. 
36. Brooke, M. A., D. Nitoiu, and D. P. Kelsell. 2012. Cell-cell connectivity: desmosomes and disease. 
The Journal of pathology 226:158-171. 
37. Broutian, T. R., S. A. Brendle, and N. D. Christensen. 2010. Differential binding patterns to host 
cells associated with particles of several human alphapapillomavirus types. The Journal of general 
virology 91:531-540. 
38. Bryant, N. A., N. Davis-Poynter, A. Vanderplasschen, and A. Alcami. 2003. Glycoprotein G 
isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins. The 
EMBO journal 22:833-846. 
39. Buckner, L. R., D. J. Schust, J. Ding, T. Nagamatsu, W. Beatty, T. L. Chang, S. J. Greene, M. E. 
Lewis, B. Ruiz, S. L. Holman, R. A. Spagnuolo, R. B. Pyles, and A. J. Quayle. 2011. Innate immune 
mediator profiles and their regulation in a novel polarized immortalized epithelial cell model derived 
from human endocervix. Journal of reproductive immunology 92:8-20. 
40. Burns, E. H., Jr., A. M. Marciel, and J. M. Musser. 1996. Activation of a 66-kilodalton human 
endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease. 
Infection and immunity 64:4744-4750. 
41. Buttle, D. J. 2007. Factors controlling matrix turnover in health and disease. Biochem Soc Trans 
35:643-646. 
42. Campbell, I. D. 2008. Studies of focal adhesion assembly. Biochem Soc Trans 36:263-266. 
43. Cardeal, L. B. D., C. A. Brohem, T. C. S. Correa, S. M. B. Winnischofer, F. Nakano, E. Boccardo, 
L. L. Villa, M. C. Sogayar, and S. S. Maria-Engler. 2006. Higher expression and activity of 
metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence. Biochem 
Cell Biol 84:713-719. 
44. Cardoso, T. C., H. F. Ferrari, A. F. Garcia, L. C. Bregano, A. L. Andrade, and A. H. Nogueira. 
2010. Immunohistochemical approach to the pathogenesis of clinical cases of bovine Herpesvirus type 
5 infections. Diagn Pathol 5:57-57. 
45. Casadevall, A. 2010. Cryptococci at the brain gate: break and enter or use a Trojan horse? The Journal 
of clinical investigation 120:1389-1392. 
Introduction 1 
 
71 
 
46. Castrucci, G., M. Ferrari, V. Traldi, and E. Tartaglione. 1992. Effects in calves of mixed infections 
with bovine viral diarrhea virus and several other bovine viruses. Comparative immunology, 
microbiology and infectious diseases 15:261-270. 
47. Chaffin, W. L. 2008. Candida albicans cell wall proteins. Microbiol Mol Biol Rev 72:495-544. 
48. Chen, W., M. R. Alley, B. W. Manktelow, and P. Slack. 1990. Mast cells in the bovine lower 
respiratory tract: morphology, density and distribution. Br Vet J 146:425-436. 
49. Chen, Y., M. Gotte, J. Liu, and P. W. Park. 2008. Microbial subversion of heparan sulfate 
proteoglycans. Molecules and cells 26:415-426. 
50. Chentoufi, A. A., X. Dervillez, P. A. Rubbo, T. Kuo, X. Zhang, N. Nagot, E. Tuaillon, P. Van De 
Perre, A. B. Nesburn, and L. Benmohamed. 2012. Current trends in negative immuno-synergy 
between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2. Current trends in 
immunology 13:51-68. 
51. Cheroutre, H., and Y. Huang. 2013. Crosstalk between adaptive and innate immune cells leads to 
high quality immune protection at the mucosal borders. Adv Exp Med Biol 785:43-47. 
52. Chidgey, M. A. 1997. Desmosomes and disease. Histol Histopathol 12:1159-1168. 
53. Chowdhury, S., V. N. Chouljenko, M. Naderi, and K. G. Kousoulas. 2013. The amino terminus of 
herpes simplex virus 1 glycoprotein K is required for virion entry via the paired immunoglobulin-like 
type-2 receptor alpha. Journal of virology 87:3305-3313. 
54. Christensen, L. S., K. G. Madsen, B. Nylin, and L. Ronsholt. 1996. A contribution to the 
systematization of bovine herpesvirus 1 based on genomic mapping by restriction fragment pattern 
analysis. Virus research 46:177-182. 
55. Claveau, I., Y. Mostefaoui, and M. Rouabhia. 2004. Basement membrane protein and matrix 
metalloproteinase deregulation in engineered human oral mucosa following infection with Candida 
albicans. Matrix Biol 23:477-486. 
56. Cobb, S. P., M. Banks, C. Russell, and M. Thorne. 2006. Bovine lymphotrophic herpesvirus in a UK 
dairy herd. The Veterinary record 158:807-808. 
57. Cohen, J. 2010. Painful Failure of Promising Genital Herpes Vaccine. Science 330:304. 
58. Colgan, S. P., S. F. Ehrentraut, L. E. Glover, D. J. Kominsky, and E. L. Campbell. 2013. 
Contributions of neutrophils to resolution of mucosal inflammation. Immunol Res 55:75-82. 
59. Collins, J. K., V. K. Ayers, C. A. Whetstone, and S. van Drunen Littel-van den Hurk. 1993. 
Antigenic differences between the major glycoproteins of bovine herpesvirus type 1.1 and bovine 
encephalitis herpesvirus type 1.3. The Journal of general virology 74 ( Pt 8):1509-1517. 
60. Costa, A. M., M. Leite, R. Seruca, and C. Figueiredo. 2013. Adherens junctions as targets of 
microorganisms: a focus on Helicobacter pylori. FEBS letters 587:259-265. 
61. Courtney, H. S., Y. Li, W. O. Twal, and W. S. Argraves. 2009. Serum opacity factor is a 
streptococcal receptor for the extracellular matrix protein fibulin-1. The Journal of biological chemistry 
284:12966-12971. 
62. Crystal, R. G., S. H. Randell, J. F. Engelhardt, J. Voynow, and M. E. Sunday. 2008. Airway 
epithelial cells: current concepts and challenges. Proceedings of the American Thoracic Society 5:772-
777. 
63. Cuellar, J. M., N. A. Manering, M. Klukinov, M. I. Nemenov, and D. C. Yeomans. 2010. Thermal 
nociceptive properties of trigeminal afferent neurons in rats. Molecular pain 6:39. 
64. Cunningham, A. L., A. Abendroth, C. Jones, N. Nasr, and S. Turville. 2010. Viruses and 
Langerhans cells. Immunol Cell Biol 88:416-423. 
65. Czaplicki, G., and E. Thiry. 1998. An association exists between bovine herpesvirus-4 seropositivity 
and abortion in cows. Preventive veterinary medicine 33:235-240. 
66. D'Arce, R. C., R. S. Almeida, T. C. Silva, A. C. Franco, F. Spilki, P. M. Roehe, and C. W. Arns. 
2002. Restriction endonuclease and monoclonal antibody analysis of Brazilian isolates of bovine 
herpesviruses types 1 and 5. Veterinary microbiology 88:315-324. 
67. D'Hauteville, H., S. Khan, D. J. Maskell, A. Kussak, A. Weintraub, J. Mathison, R. J. Ulevitch, N. 
Wuscher, C. Parsot, and P. J. Sansonetti. 2002. Two msbB genes encoding maximal acylation of 
lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of 
the intestinal epithelium. Journal of immunology 168:5240-5251. 
68. d'Offay, J. M., R. W. Fulton, and R. Eberle. 2013. Complete genome sequence of the NVSL BoHV-
1.1 Cooper reference strain. Archives of virology 158:1109-1113. 
69. d'Offay, J. M., R. E. Mock, and R. W. Fulton. 1993. Isolation and characterization of encephalitic 
bovine herpesvirus type 1 isolates from cattle in North America. American journal of veterinary 
research 54:534-539. 
1 Introduction 
 
72 
 
70. da Silva, C. M. F., L. de Abreu Vidipo, R. Nishi, and M. Cristina Plotkowski. 2004. Binding of 
plasminogen to Pseudomonas aeruginosa results in formation of surface-associated plasmin and 
enhanced bacterial invasiveness. Microb Pathog 36:59-66. 
71. Darenfed, H., D. Grenier, and D. Mayrand. 1999. Acquisition of plasmin activity by Fusobacterium 
nucleatum subsp. nucleatum and potential contribution to tissue destruction during periodontitis. 
Infection and immunity 67:6439-6444. 
72. Das, M., S. S. Ithychanda, J. Qin, and E. F. Plow. 2011. Migfilin and filamin as regulators of integrin 
activation in endothelial cells and neutrophils. PloS one 6:e26355. 
73. Davison, A. J. 2002. Evolution of the herpesviruses. Veterinary microbiology 86:69-88. 
74. Davison, A. J. 2010. Herpesvirus systematics. Veterinary microbiology 143:52-69. 
75. Davison, A. J., R. Eberle, B. Ehlers, G. S. Hayward, D. J. McGeoch, A. C. Minson, P. E. Pellett, B. 
Roizman, M. J. Studdert, and E. Thiry. 2009. The order Herpesvirales. Archives of virology 
154:171-177. 
76. De Greve, H., L. Wyns, and J. Bouckaert. 2007. Combining sites of bacterial fimbriae. Curr Opin 
Struct Biol 17:506-512. 
77. de Kievit, T. R., and B. H. Iglewski. 2000. Bacterial quorum sensing in pathogenic relationships. 
Infection and immunity 68:4839-4849. 
78. de Witte, L., A. Nabatov, and T. B. Geijtenbeek. 2008. Distinct roles for DC-SIGN+-dendritic cells 
and Langerhans cells in HIV-1 transmission. Trends in molecular medicine 14:12-19. 
79. Dellmann, and Eurell. 1998. Female Reproductive system, p. 260-261. In H. D. Dellmann and J. A. 
Eurell (ed.), Textbook of Veterinary Histology, fifth ed. Lippincott Williams and Wilkins. 
80. Dey, R. D., B. Satterfield, and J. B. Altemus. 1999. Innervation of tracheal epithelium and smooth 
muscle by neurons in airway ganglia. The Anatomical record 254:166-172. 
81. Di Giovine, P., E. C. Settembre, A. K. Bhargava, M. A. Luftig, H. Lou, G. H. Cohen, R. J. 
Eisenberg, C. Krummenacher, and A. Carfi. 2011. Structure of herpes simplex virus glycoprotein D 
bound to the human receptor nectin-1. PLoS pathogens 7:e1002277. 
82. Dinter, Z., and B. Morein. 1990. Infectious bovine rhinotracheitis virus, p. 71-108. In Z. Dinter and B. 
Morein (ed.), Virus infections of ruminants, vol. 3. Elsevier INC. 
83. Dong, X., W. Shi, Q. Zeng, and L. Xie. 2005. Roles of adherence and matrix metalloproteinases in 
growth patterns of fungal pathogens in cornea. Current eye research 30:613-620. 
84. Donofrio, G., V. Franceschi, A. Capocefalo, S. Cavirani, and I. M. Sheldon. 2009. Isolation and 
characterization of bovine herpesvirus 4 (BoHV-4) from a cow affected by post partum metritis and 
cloning of the genome as a bacterial artificial chromosome. Reproductive biology and endocrinology : 
RB&E 7:83. 
85. Drevets, D. A., M. J. Dillon, J. S. Schawang, N. Van Rooijen, J. Ehrchen, C. Sunderkotter, and P. 
J. M. Leenen. 2004. The Ly-6Chigh monocyte subpopulation transports Listeria monocytogenes into 
the brain during systemic infection of mice. Journal of immunology 172:4418-4424. 
86. Drevets, D. A., and P. J. Leenen. 2000. Leukocyte-facilitated entry of intracellular pathogens into the 
central nervous system. Microbes Infect 2:1609-1618. 
87. Duan, R., R. D. de Vries, A. D. Osterhaus, L. Remeijer, and G. M. Verjans. 2008. Acyclovir-
resistant corneal HSV-1 isolates from patients with herpetic keratitis. The Journal of infectious diseases 
198:659-663. 
88. Duluc, D., J. Gannevat, E. Anguiano, S. Zurawski, M. Carley, M. Boreham, J. Stecher, M. 
Dullaers, J. Banchereau, and S. Oh. 2013. Functional diversity of human vaginal APC subsets in 
directing T-cell responses. Mucosal immunology 6:626-638. 
89. Eberhard, T., G. Kronvall, and M. Ullberg. 1999. Surface bound plasmin promotes migration of 
Streptococcus pneumoniae through reconstituted basement membranes. Microb Pathog 26:175-181. 
90. Edwards, J. A., F. Denis, and P. J. Talbot. 2000. Activation of glial cells by human coronavirus 
OC43 infection. Journal of neuroimmunology 108:73-81. 
91. Eidsmo, L., R. Allan, I. Caminschi, N. van Rooijen, W. R. Heath, and F. R. Carbone. 2009. 
Differential migration of epidermal and dermal dendritic cells during skin infection. Journal of 
immunology 182:3165-3172. 
92. Eisenberg, R. J., D. Atanasiu, T. M. Cairns, J. R. Gallagher, C. Krummenacher, and G. H. 
Cohen. 2012. Herpes virus fusion and entry: a story with many characters. Viruses 4:800-832. 
93. Engels, M., and M. Ackermann. 1996. Pathogenesis of ruminant herpesvirus infections. Veterinary 
microbiology 53:3-15. 
94. Enquist, L. W. 1999. Life beyond eradication: veterinary viruses in basic science. Archives of 
virology. Supplementum 15:87-109. 
Introduction 1 
 
73 
 
95. Erickson, A. C., and J. R. Couchman. 2000. Still more complexity in mammalian basement 
membranes. The journal of histochemistry and cytochemistry : official journal of the Histochemistry 
Society 48:1291-1306. 
96. Erjefalt, J. S., I. Erjefalt, F. Sundler, and C. G. Persson. 1995. In vivo restitution of airway 
epithelium. Cell and tissue research 281:305-316. 
97. Evans, M. J., M. V. Fanucchi, L. A. Miller, M. A. Carlson, S. J. Nishio, and D. M. Hyde. 2010. 
Reduction of collagen VII anchoring fibrils in the airway basement membrane zone of infant rhesus 
monkeys exposed to house dust mite. American journal of physiology. Lung cellular and molecular 
physiology 298:L543-547. 
98. Evans, M. J., L. S. Van Winkle, M. V. Fanucchi, and C. G. Plopper. 2001. Cellular and molecular 
characteristics of basal cells in airway epithelium. Experimental lung research 27:401-415. 
99. Everly, D. N., Jr., P. Feng, I. S. Mian, and G. S. Read. 2002. mRNA degradation by the virion host 
shutoff (Vhs) protein of herpes simplex virus: genetic and biochemical evidence that Vhs is a nuclease. 
Journal of virology 76:8560-8571. 
100. Fan, Q., and R. Longnecker. 2012. Is nectin-1 the "master" receptor for deadly herpes B virus 
infection? Virulence 3:405. 
101. Fanning, A. S., C. M. Van Itallie, and J. M. Anderson. 2012. Zonula occludens-1 and -2 regulate 
apical cell structure and the zonula adherens cytoskeleton in polarized epithelia. Molecular biology of 
the cell 23:577-590. 
102. Farage, M., and H. Maibach. 2006. Lifetime changes in the vulva and vagina. Archives of gynecology 
and obstetrics 273:195-202. 
103. Farley, M. M., D. S. Stephens, M. H. Mulks, M. D. Cooper, J. V. Bricker, S. S. Mirra, and A. 
Wright. 1986. Pathogenesis of IgA1 protease-producing and -nonproducing Haemophilus influenzae in 
human nasopharyngeal organ cultures. The Journal of infectious diseases 154:752-759. 
104. Fatahzadeh, M. 2012. Kaposi sarcoma: review and medical management update. Oral surgery, oral 
medicine, oral pathology and oral radiology 113:2-16. 
105. Favoreel, H. W., H. J. Nauwynck, and M. B. Pensaert. 1999. Role of the cytoplasmic tail of gE in 
antibody-induced redistribution of viral glycoproteins expressed on pseudorabies-virus-infected cells. 
Virology 259:141-147. 
106. Favoreel, H. W., G. Van Minnebruggen, D. Adriaensen, and H. J. Nauwynck. 2005. Cytoskeletal 
rearrangements and cell extensions induced by the US3 kinase of an alphaherpesvirus are associated 
with enhanced spread. Proceedings of the National Academy of Sciences of the United States of 
America 102:8990-8995. 
107. Ferlenghi, I., F. Ilaria, and F. Giusti. 2011. EM reconstruction of adhesins: future prospects. Adv Exp 
Med Biol 715:271-284. 
108. Fiore, D. 1981. Cervix and Vagina, p. 238-243. In P. P. di Fiore and A. Schmidt (ed.), Atlas of Human 
Histology, fifth ed. Lea & Febiger, Philadelphia. 
109. Fournier, B. M., and C. A. Parkos. 2012. The role of neutrophils during intestinal inflammation. 
Mucosal immunology 5:354-366. 
110. Frampton, A. R., Jr., D. B. Stolz, H. Uchida, W. F. Goins, J. B. Cohen, and J. C. Glorioso. 2007. 
Equine herpesvirus 1 enters cells by two different pathways, and infection requires the activation of the 
cellular kinase ROCK1. Journal of virology 81:10879-10889. 
111. Franceschi, V., A. Capocefalo, S. Cavirani, and G. Donofrio. 2013. Bovine herpesvirus 4 
glycoprotein B is indispensable for lytic replication and irreplaceable by VSVg. BMC veterinary 
research 9:6. 
112. Franke, W. W., and U. F. Pape. 2012. Diverse types of junctions containing tight junction proteins in 
stratified mammalian epithelia. Annals of the New York Academy of Sciences 1257:152-157. 
113. Frick, I.-M., C. Karlsson, M. Morgelin, A. I. Olin, R. Janjusevic, C. Hammarstrom, E. Holst, M. 
de Chateau, and L. Bjorck. 2008. Identification of a novel protein promoting the colonization and 
survival of Finegoldia magna, a bacterial commensal and opportunistic pathogen. Mol Microbiol 
70:695-708. 
114. Frink, R. J., R. Eisenberg, G. Cohen, and E. K. Wagner. 1983. Detailed analysis of the portion of 
the herpes simplex virus type 1 genome encoding glycoprotein C. Journal of virology 45:634-647. 
115. Fukuto, H. S., A. Svetlanov, L. E. Palmer, A. W. Karzai, and J. B. Bliska. 2010. Global gene 
expression profiling of Yersinia pestis replicating inside macrophages reveals the roles of a putative 
stress-induced operon in regulating type III secretion and intracellular cell division. Infection and 
immunity 78:3700-3715. 
116. Furuse, M., and S. Tsukita. 2006. Claudins in occluding junctions of humans and flies. Trends Cell 
Biol 16:181-188. 
1 Introduction 
 
74 
 
117. Galama, J. M. 1996. [Human herpes viruses type 6 and 7; causative agents of, among others, 
exanthema subitum]. Nederlands tijdschrift voor geneeskunde 140:124-128. 
118. Garcia-Roman, J., and A. Zentella-Dehesa. 2013. Vascular permeability changes involved in tumor 
metastasis. Cancer letters 335:259-269. 
119. Garrod, D., and M. Chidgey. 2008. Desmosome structure, composition and function. Biochimica et 
biophysica acta 1778:572-587. 
120. Gebhardt, T., P. G. Whitney, A. Zaid, L. K. Mackay, A. G. Brooks, W. R. Heath, F. R. Carbone, 
and S. N. Mueller. 2011. Different patterns of peripheral migration by memory CD4+ and CD8+ T 
cells. Nature 477:216-219. 
121. Geissmann, F., M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley. 2010. Development of 
monocytes, macrophages, and dendritic cells. Science 327:656-661. 
122. Giaume, C., L. Leybaert, C. N. C, and C. S. J. 2013. Connexin and pannexin hemichannels in brain 
glial cells: properties, pharmacology, and roles. Frontiers in pharmacology 4:88. 
123. Giepmans, B. N. 2004. Gap junctions and connexin-interacting proteins. Cardiovascular research 
62:233-245. 
124. Gilden, D., R. Mahalingam, M. A. Nagel, S. Pugazhenthi, and R. J. Cohrs. 2011. Review: The 
neurobiology of varicella zoster virus infection. Neuropathology and applied neurobiology 37:441-463. 
125. Gillespie, J. H., K. McEntee, J. W. Kendrick, and W. C. Wagner. 1959. Comparison of infectious 
pustular volvovaginitis virus with infectious bovine rhinotracheitis virus. The Cornell veterinarian 
49:288-297. 
126. Giuliano, F., O. Rampin, and J. Allard. 2002. Neurophysiology and pharmacology of female genital 
sexual response. Journal of sex & marital therapy 28 Suppl 1:101-121. 
127. Glorieux, S., C. Bachert, H. W. Favoreel, A. P. Vandekerckhove, L. Steukers, A. Rekecki, W. Van 
den Broeck, J. Goossens, S. Croubels, R. F. Clayton, and H. J. Nauwynck. 2011. Herpes simplex 
virus type 1 penetrates the basement membrane in human nasal respiratory mucosa. PloS one 6:e22160. 
128. Glorieux, S., H. W. Favoreel, L. Steukers, A. P. Vandekerckhove, and H. J. Nauwynck. 2011. A 
trypsin-like serine protease is involved in pseudorabies virus invasion through the basement membrane 
barrier of porcine nasal respiratory mucosa. Veterinary research 42:58. 
129. Goult, B. T., T. Zacharchenko, N. Bate, R. Tsang, F. Hey, A. R. Gingras, P. R. Elliott, G. C. 
Roberts, C. Ballestrem, D. R. Critchley, and I. L. Barsukov. 2013. RIAM and vinculin binding to 
talin are mutually exclusive and regulate adhesion assembly and turnover. The Journal of biological 
chemistry 288:8238-8249. 
130. Gras, G., and M. Kaul. 2010. Molecular mechanisms of neuroinvasion by monocytes-macrophages in 
HIV-1 infection. Retrovirology 7:30-30. 
131. Green, K. J., and C. L. Simpson. 2007. Desmosomes: new perspectives on a classic. The Journal of 
investigative dermatology 127:2499-2515. 
132. Grenier, D., and R. Bouclin. 2006. Contribution of proteases and plasmin-acquired activity in 
migration of Peptostreptococcus micros through a reconstituted basement membrane. Oral Microbiol 
Immunol 21:319-325. 
133. Griebling, T. L., Z. Liao, and P. G. Smith. 2012. Systemic and topical hormone therapies reduce 
vaginal innervation density in postmenopausal women. Menopause 19:630-635. 
134. Grunewald, K., P. Desai, D. C. Winkler, J. B. Heymann, D. M. Belnap, W. Baumeister, and A. C. 
Steven. 2003. Three-dimensional structure of herpes simplex virus from cryo-electron tomography. 
Science 302:1396-1398. 
135. Guidi-Rontani, C. 2002. The alveolar macrophage: the Trojan horse of Bacillus anthracis. Trends in 
microbiology 10:405-409. 
136. Gunaratne, A., and J. Di Guglielmo. 2013. Par6 is phosphorylated by aPKC to facilitate EMT. Cell 
adhesion & migration 7. 
137. Gur, S., and N. Dogan. 2010. The possible role of bovine herpesvirus type-4 infection in cow 
infertility. Animal science journal = Nihon chikusan Gakkaiho 81:304-308. 
138. Gursoy, U. K., E. Kononen, and V. J. Uitto. 2008. Stimulation of epithelial cell matrix 
metalloproteinase (MMP-2, -9, -13) and interleukin-8 secretion by fusobacteria. Oral Microbiol 
Immunol 23:432-434. 
139. Habte, H. H., C. de Beer, Z. E. Lotz, M. G. Tyler, D. Kahn, and A. S. Mall. 2008. Inhibition of 
human immunodeficiency virus type 1 activity by purified human breast milk mucin (MUC1) in an 
inhibition assay. Neonatology 93:162-170. 
140. Hagglund, R., and B. Roizman. 2004. Role of ICP0 in the strategy of conquest of the host cell by 
herpes simplex virus 1. Journal of virology 78:2169-2178. 
Introduction 1 
 
75 
 
141. Hajj, R., T. Baranek, R. Le Naour, P. Lesimple, E. Puchelle, and C. Coraux. 2007. Basal cells of 
the human adult airway surface epithelium retain transit-amplifying cell properties. Stem cells 25:139-
148. 
142. Halasz, P., G. Holloway, S. J. Turner, and B. S. Coulson. 2008. Rotavirus replication in intestinal 
cells differentially regulates integrin expression by a phosphatidylinositol 3-kinase-dependent pathway, 
resulting in increased cell adhesion and virus yield. Journal of virology 82:148-160. 
143. Hallstrom, T., K. Haupt, P. Kraiczy, P. Hortschansky, R. Wallich, C. Skerka, and P. F. Zipfel. 
2010. Complement regulator-acquiring surface protein 1 of Borrelia burgdorferi binds to human bone 
morphogenic protein 2, several extracellular matrix proteins, and plasminogen. The Journal of 
infectious diseases 202:490-498. 
144. Hallstrom, T., B. Singh, F. Resman, A. M. Blom, M. Morgelin, and K. Riesbeck. 2011. 
Haemophilus influenzae protein E binds to the extracellular matrix by concurrently interacting with 
laminin and vitronectin. The Journal of infectious diseases 204:1065-1074. 
145. Handsfield, H. H., A. B. Waldo, Z. A. Brown, L. Corey, J. L. Drucker, C. W. Ebel, P. A. Leone, L. 
R. Stanberry, and R. J. Whitley. 2005. Neonatal herpes should be a reportable disease. Sexually 
transmitted diseases 32:521-525. 
146. Harkema, J. R., S. A. Carey, and J. G. Wagner. 2006. The nose revisited: a brief review of the 
comparative structure, function, and toxicologic pathology of the nasal epithelium. Toxicologic 
pathology 34:252-269. 
147. Hartsock, A., and W. J. Nelson. 2008. Adherens and tight junctions: Structure, function and 
connections to the actin cytoskeleton. Bba-Biomembranes 1778:660-669. 
148. Hauser-Kronberger, C., G. W. Hacker, P. Franz, K. Albegger, and O. Dietze. 1997. CGRP and 
substance P in intraepithelial neuronal structures of the human upper respiratory system. Regulatory 
peptides 72:79-85. 
149. Heib, V., M. Becker, C. Taube, and M. Stassen. 2008. Advances in the understanding of mast cell 
function. British journal of haematology 142:683-694. 
150. Heldwein, E. E., H. Lou, F. C. Bender, G. H. Cohen, R. J. Eisenberg, and S. C. Harrison. 2006. 
Crystal structure of glycoprotein B from herpes simplex virus 1. Science 313:217-220. 
151. Henderson, B., S. Nair, J. Pallas, and M. A. Williams. 2011. Fibronectin: a multidomain host adhesin 
targeted by bacterial fibronectin-binding proteins. FEMS microbiology reviews 35:147-200. 
152. Hendrickx, A. P. A., M. van Luit-Asbroek, C. M. E. Schapendonk, W. J. B. van Wamel, J. C. 
Braat, L. M. Wijnands, M. J. M. Bonten, and R. J. L. Willems. 2009. SgrA, a nidogen-binding 
LPXTG surface adhesin implicated in biofilm formation, and EcbA, a collagen binding MSCRAMM, 
are two novel adhesins of hospital-acquired Enterococcus faecium. Infection and immunity 77:5097-
5106. 
153. Herfs, M., S. O. Vargas, Y. Yamamoto, B. E. Howitt, M. R. Nucci, J. L. Hornick, F. D. McKeon, 
W. Xian, and C. P. Crum. 2013. A novel blueprint for 'top down' differentiation defines the cervical 
squamocolumnar junction during development, reproductive life, and neoplasia. The Journal of 
pathology 229:460-468. 
154. Herve, J. C., and M. Derangeon. 2013. Gap-junction-mediated cell-to-cell communication. Cell and 
tissue research 352:21-31. 
155. Hilliges, M., C. Falconer, G. Ekman-Ordeberg, and O. Johansson. 1995. Innervation of the human 
vaginal mucosa as revealed by PGP 9.5 immunohistochemistry. Acta anatomica 153:119-126. 
156. Ho, S., C. Pothoulakis, and H. W. Koon. 2013. Antimicrobial peptides and colitis. Current 
pharmaceutical design 19:40-47. 
157. Hodge, P. D., and N. D. Stow. 2001. Effects of mutations within the herpes simplex virus type 1 DNA 
encapsidation signal on packaging efficiency. Journal of virology 75:8977-8986. 
158. Hohenester, E., and P. D. Yurchenco. 2013. Laminins in basement membrane assembly. Cell 
adhesion & migration 7:56-63. 
159. Holt, P. G. 1993. Regulation of antigen-presenting cell function(s) in lung and airway tissues. The 
European respiratory journal : official journal of the European Society for Clinical Respiratory 
Physiology 6:120-129. 
160. Homa, F. L., and J. C. Brown. 1997. Capsid assembly and DNA packaging in herpes simplex virus. 
Reviews in medical virology 7:107-122. 
161. Honda, T., K. Shimizu, A. Fukuhara, K. Irie, and Y. Takai. 2003. Regulation by nectin of the 
velocity of the formation of adherens junctions,and tight junctions. Biochemical and biophysical 
research communications 306:104-109. 
162. House, J. A. 1972. Bovine herpesvirus IBR-IPV. Strain differences. The Cornell veterinarian 62:431-
453. 
1 Introduction 
 
76 
 
163. Houston, S., R. Hof, T. Francescutti, A. Hawkes, M. J. Boulanger, and C. E. Cameron. 2011. 
Bifunctional role of the Treponema pallidum extracellular matrix binding adhesin Tp0751. Infection 
and immunity 79:1386-1398. 
164. Hovenberg, H. W., I. Carlstedt, and J. R. Davies. 1997. Mucus glycoproteins in bovine trachea: 
identification of the major mucin populations in respiratory secretions and investigation of their tissue 
origins. The Biochemical journal 321 ( Pt 1):117-123. 
165. Hummel, T. 2000. Assessment of intranasal trigeminal function. International journal of 
psychophysiology : official journal of the International Organization of Psychophysiology 36:147-155. 
166. Iizasa, H., A. Nanbo, J. Nishikawa, M. Jinushi, and H. Yoshiyama. 2012. Epstein-Barr Virus 
(EBV)-associated gastric carcinoma. Viruses 4:3420-3439. 
167. Ikenouchi, J., M. Furuse, K. Furuse, H. Sasaki, S. Tsukita, and S. Tsukita. 2005. Tricellulin 
constitutes a novel barrier at tricellular contacts of epithelial cells. The Journal of cell biology 171:939-
945. 
168. Irie, K., K. Shimizu, T. Sakisaka, W. Ikeda, and Y. Takai. 2004. Roles and modes of action of 
nectins in cell-cell adhesion. Seminars in cell & developmental biology 15:643-656. 
169. Isernhagen, A. J., M. Cosenza, M. C. da Costa, K. C. Medici, M. R. Balarin, A. P. Bracarense, A. 
A. Alfieri, and J. A. Lisboa. 2011. Asymptomatic encephalitis in calves experimentally infected with 
bovine herpesvirus-5. The Canadian veterinary journal. La revue veterinaire canadienne 52:1312-1318. 
170. Jacobson, D. L., L. Peralta, N. M. H. Graham, and J. Zenilman. 2000. Histologic development of 
cervical ectopy - Relationship to reproductive hormones. Sexually transmitted diseases 27:252-258. 
171. Jahnsen, F. L., D. H. Strickland, J. A. Thomas, I. T. Tobagus, S. Napoli, G. R. Zosky, D. J. 
Turner, P. D. Sly, P. A. Stumbles, and P. G. Holt. 2006. Accelerated antigen sampling and transport 
by airway mucosal dendritic cells following inhalation of a bacterial stimulus. Journal of immunology 
177:5861-5867. 
172. Jeffery, P. K., and D. Li. 1997. Airway mucosa: secretory cells, mucus and mucin genes. The 
European respiratory journal : official journal of the European Society for Clinical Respiratory 
Physiology 10:1655-1662. 
173. Johnson, D. C., and M. T. Huber. 2002. Directed egress of animal viruses promotes cell-to-cell 
spread. Journal of virology 76:1-8. 
174. Johnston, C., A. Magaret, S. Selke, M. Remington, L. Corey, and A. Wald. 2008. Herpes simplex 
virus viremia during primary genital infection. The Journal of infectious diseases 198:31-34. 
175. Jokhi, V., J. Ashley, J. Nunnari, A. Noma, N. Ito, N. Wakabayashi-Ito, M. J. Moore, and V. 
Budnik. 2013. Torsin mediates primary envelopment of large ribonucleoprotein granules at the nuclear 
envelope. Cell reports 3:988-995. 
176. Jones, C., L. F. da Silva, and D. Sinani. 2011. Regulation of the latency-reactivation cycle by 
products encoded by the bovine herpesvirus 1 (BHV-1) latency-related gene. Journal of neurovirology 
17:535-545. 
177. Jones, C., V. Geiser, G. Henderson, Y. Jiang, F. Meyer, S. Perez, and Y. Zhang. 2006. Functional 
analysis of bovine herpesvirus 1 (BHV-1) genes expressed during latency. Veterinary microbiology 
113:199-210. 
178. Kaashoek, M. J., A. Moerman, J. Madic, F. A. Rijsewijk, J. Quak, A. L. Gielkens, and J. T. van 
Oirschot. 1994. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 
1 is an efficacious and safe vaccine. Vaccine 12:439-444. 
179. Kaashoek, M. J., P. H. Straver, E. M. Van Rooij, J. Quak, and J. T. Van Oirschot. 1996. 
Virulence, immunogenicity and reactivation of seven bovine herpesvirus 1.1 strains: clinical and 
virological aspects. The Veterinary record 139:416-421. 
180. Kalluri, R. 2003. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev 
Cancer 3:422-433. 
181. Karaba, A. H., L. K. Cohen, T. Glaubach, S. J. Kopp, J. L. Reichek, H. H. Yoon, X. T. Zheng, and 
W. J. Muller. 2012. Longitudinal Characterization of Herpes Simplex Virus (HSV) Isolates Acquired 
From Different Sites in an Immune-Compromised Child: A New HSV Thymidine Kinase Mutation 
Associated With Resistance. Journal of the Pediatric Infectious Diseases Society 1:116-124. 
182. Katahashi, T., T. Kanda, T. Hanazawa, A. Konno, and H. Tatsuoka. 1997. Distribution of 
vasoactive intestinal polypeptide immunoreactive nerve fiber in the rat nasal mucosa. Auris, nasus, 
larynx 24:59-64. 
183. Katahashi, T., T. Kanda, and A. Konno. 1997. Distribution of choline acetyltransferase (ChAT) 
immunoreactive nerve fibers in the nasal mucosa; especially in the respiratory epithelium. Auris, nasus, 
larynx 24:271-277. 
184. Kato, A., and R. P. Schleimer. 2007. Beyond inflammation: airway epithelial cells are at the interface 
of innate and adaptive immunity. Current opinion in immunology 19:711-720. 
Introduction 1 
 
77 
 
185. Kawamoto, H., and N. Minato. 2004. Myeloid cells. The international journal of biochemistry & cell 
biology 36:1374-1379. 
186. Kendrick, J. W., J. H. Gillespie, and K. McEntee. 1958. Infectious pustular vulvovaginitis of cattle. 
The Cornell veterinarian 48:458-495. 
187. Kenny, S., C. Duval, S. J. Sammut, I. Steele, D. M. Pritchard, J. C. Atherton, R. H. Argent, R. 
Dimaline, G. J. Dockray, and A. Varro. 2008. Increased expression of the urokinase plasminogen 
activator system by Helicobacter pylori in gastric epithelial cells. American journal of physiology. 
Gastrointestinal and liver physiology 295:431-441. 
188. Khadr, A., S. K. Tikoo, L. A. Babiuk, and S. van Drunen Littel-van den Hurk. 1996. Sequence and 
expression of a bovine herpesvirus-1 gene homologous to the glycoprotein K-encoding gene of herpes 
simplex virus-1. Gene 168:189-193. 
189. Khoshnoodi, J., V. Pedchenko, and B. G. Hudson. 2008. Mammalian collagen IV. Microscopy 
research and technique 71:357-370. 
190. Kim, C., F. Ye, and M. H. Ginsberg. 2011. Regulation of integrin activation. Annual review of cell 
and developmental biology 27:321-345. 
191. Kim, I. J., V. N. Chouljenko, J. D. Walker, and K. G. Kousoulas. 2013. Herpes Simplex Virus 1 
Glycoprotein M and the Membrane-Associated Protein UL11 Are Required for Virus-Induced Cell 
Fusion and Efficient Virus Entry. Journal of virology 87:8029-8037. 
192. Kim, M., M. Ogawa, H. Mimuro, and C. Sasakawa. 2010. Reinforcement of epithelial cell adhesion 
to basement membrane by a bacterial pathogen as a new infectious stratagem. Virulence 1:52-55. 
193. Kines, R. C., C. D. Thompson, D. R. Lowy, J. T. Schiller, and P. M. Day. 2009. The initial steps 
leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. 
Proceedings of the National Academy of Sciences of the United States of America 106:20458-20463. 
194. Kline, K. A., S. Falker, S. Dahlberg, S. Normark, and B. Henriques-Normark. 2009. Bacterial 
adhesins in host-microbe interactions. Cell host & microbe 5:580-592. 
195. Knight, D. A., and S. T. Holgate. 2003. The airway epithelium: structural and functional properties in 
health and disease. Respirology 8:432-446. 
196. Kohler, K., and A. Zahraoui. 2005. Tight junction: a co-ordinator of cell signalling and membrane 
trafficking. Biology of the cell / under the auspices of the European Cell Biology Organization 97:659-
665. 
197. Kolokotronis, A., and S. Doumas. 2006. Herpes simplex virus infection, with particular reference to 
the progression and complications of primary herpetic gingivostomatitis. Clinical microbiology and 
infection : the official publication of the European Society of Clinical Microbiology and Infectious 
Diseases 12:202-211. 
198. Kraehenbuhl, J. P., and M. R. Neutra. 1992. Molecular and cellular basis of immune protection of 
mucosal surfaces. Physiological reviews 72:853-879. 
199. Krishnan, V., and S. V. L. Narayana. 2011. Crystallography of gram-positive bacterial adhesins. Adv 
Exp Med Biol 715:175-195. 
200. Kruegel, J., and N. Miosge. 2010. Basement membrane components are key players in specialized 
extracellular matrices. Cell Mol Life Sci 67:2879-2895. 
201. Krueger, S., T. Kalinski, T. Hundertmark, T. Wex, D. Kuster, U. Peitz, M. Ebert, D. K. Nagler, U. 
Kellner, P. Malfertheiner, M. Naumann, C. Rocken, and A. Roessner. 2005. Up-regulation of 
cathepsin X in Helicobacter pylori gastritis and gastric cancer. The Journal of pathology 207:32-42. 
202. Kummer, W., A. Fischer, R. Kurkowski, and C. Heym. 1992. The sensory and sympathetic 
innervation of guinea-pig lung and trachea as studied by retrograde neuronal tracing and double-
labelling immunohistochemistry. Neuroscience 49:715-737. 
203. LaBoissiere, S., and P. O'Hare. 2000. Analysis of HCF, the cellular cofactor of VP16, in herpes 
simplex virus-infected cells. Journal of virology 74:99-109. 
204. Lahteenmaki, K., P. Kuusela, and T. K. Korhonen. 2001. Bacterial plasminogen activators and 
receptors. FEMS microbiology reviews 25:531-552. 
205. Lahteenmaki, K., R. Virkola, A. Saren, L. Emody, and T. K. Korhonen. 1998. Expression of 
plasminogen activator pla of Yersinia pestis enhances bacterial attachment to the mammalian 
extracellular matrix. Infection and immunity 66:5755-5762. 
206. Lara-Pezzi, E., M. V. Gomez-Gaviro, B. G. Galvez, E. Mira, M. A. Iniguez, M. Fresno, A. C. 
Martinez, A. G. Arroyo, and M. Lopez-Cabrera. 2002. The hepatitis B virus X protein promotes 
tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 
expression. The Journal of clinical investigation 110:1831-1838. 
207. Laskay, T., G. van Zandbergen, and W. Solbach. 2008. Neutrophil granulocytes as host cells and 
transport vehicles for intracellular pathogens: apoptosis as infection-promoting factor. Immunobiology 
213:183-191. 
1 Introduction 
 
78 
 
208. LeBleu, V. S., B. Macdonald, and R. Kalluri. 2007. Structure and function of basement membranes. 
Experimental biology and medicine 232:1121-1129. 
209. Lee, J. D., and P. E. Kolattukudy. 1995. Molecular cloning of the cDNA and gene for an elastinolytic 
aspartic proteinase from Aspergillus fumigatus and evidence of its secretion by the fungus during 
invasion of the host lung. Infection and immunity 63:3796-3803. 
210. Lehman, I. R., and P. E. Boehmer. 1999. Replication of herpes simplex virus DNA. Journal of 
Biological Chemistry 274:28059-28062. 
211. Ling, P. D., J. G. Reid, X. Qin, D. M. Muzny, R. Gibbs, J. Petrosino, R. Peng, J. C. Zong, S. Y. 
Heaggans, and G. S. Hayward. 2013. Complete Genome Sequence of Elephant Endotheliotropic 
Herpesvirus 1A. Genome announcements 1:e0010613. 
212. Lipscomb, E. A., and A. M. Mercurio. 2005. Mobilization and activation of a signaling competent 
alpha6beta4integrin underlies its contribution to carcinoma progression. Cancer metastasis reviews 
24:413-423. 
213. Litjens, S. H., J. M. de Pereda, and A. Sonnenberg. 2006. Current insights into the formation and 
breakdown of hemidesmosomes. Trends Cell Biol 16:376-383. 
214. Liu, Q., K. Ponnuraj, Y. Xu, V. K. Ganesh, J. Sillanpaa, B. E. Murray, S. V. Narayana, and M. 
Hook. 2007. The Enterococcus faecalis MSCRAMM ACE binds its ligand by the Collagen Hug model. 
The Journal of biological chemistry 282:19629-19637. 
215. Louboutin, J.-P., L. Agrawal, B. A. S. Reyes, E. J. Van Bockstaele, and D. S. Strayer. 2010. HIV-1 
gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to 
oxidative stress. J Neuropathol Exp Neurol 69:801-816. 
216. Low, L. C., J. Carton, M. Walker, G. Tudor-Williams, and C. Hardman. 2012. Intrauterine herpes 
simplex virus infection presenting with hypopigmented lesions. Pediatric dermatology 29:515-518. 
217. Ludlow, M., I. Allen, and J. Schneider-Schaulies. 2009. Systemic spread of measles virus: 
overcoming the epithelial and endothelial barriers. Thromb Haemost 102:1050-1056. 
218. Lundberg, J. M., T. Hokfelt, C. R. Martling, A. Saria, and C. Cuello. 1984. Substance P-
immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell 
and tissue research 235:251-261. 
219. Luo, B. H., and T. A. Springer. 2006. Integrin structures and conformational signaling. Current 
opinion in cell biology 18:579-586. 
220. Macleod, D. T., T. Nakatsuji, K. Yamasaki, L. Kobzik, and R. L. Gallo. 2013. HSV-1 exploits the 
innate immune scavenger receptor MARCO to enhance epithelial adsorption and infection. Nature 
communications 4:1963. 
221. Madin, S. H., D. G. McKercher, and C. J. York. 1956. Isolation of the infectious bovine 
rhinotracheitis virus. Science 124:721-722. 
222. Magyar, G., J. Tanyi, A. Hornyak, and A. Bartha. 1993. Restriction endonuclease analysis of 
Hungarian bovine herpesvirus isolates from different clinical forms of IBR, IPV and encephalitis. Acta 
veterinaria Hungarica 41:159-170. 
223. Maiers, J. L., X. Peng, A. S. Fanning, and K. A. Demali. 2013. ZO-1 recruitment to alpha-catenin: a 
novel mechanism for coupling the assembly of tight junctions to adherens junctions. Journal of cell 
science. 
224. Mair, T. S., C. R. Stokes, and F. J. Bourne. 1988. Distribution and ultrastructure of mast cells in the 
equine respiratory tract. Equine veterinary journal 20:54-58. 
225. Mair, T. S., C. R. Stokes, and F. J. Bourne. 1988. Immunohistochemical study of the local humoral 
immune system of the equine respiratory mucosa. Research in veterinary science 45:160-165. 
226. Manicklal, S., V. C. Emery, T. Lazzarotto, S. B. Boppana, and R. K. Gupta. 2013. The "silent" 
global burden of congenital cytomegalovirus. Clinical microbiology reviews 26:86-102. 
227. Margadant, C., E. Frijns, K. Wilhelmsen, and A. Sonnenberg. 2008. Regulation of hemidesmosome 
disassembly by growth factor receptors. Current opinion in cell biology 20:589-596. 
228. Margolis, F. L., J. Verhaagen, S. Biffo, F. L. Huang, and M. Grillo. 1991. Regulation of gene 
expression in the olfactory neuroepithelium: a neurogenetic matrix. Progress in brain research 89:97-
122. 
229. Marsac, D., S. Garcia, A. Fournet, A. Aguirre, K. Pino, M. Ferres, A. M. Kalergis, M. Lopez-
Lastra, and F. Veas. 2011. Infection of human monocyte-derived dendritic cells by ANDES 
Hantavirus enhances pro-inflammatory state, the secretion of active MMP-9 and indirectly enhances 
endothelial permeability. Virology journal 8:223-223. 
230. Martikainen, M. H., J. O. Gronroos, and T. Vuorinen. 2013. Detection of human herpesvirus 7 
DNA from the CSF in association with neurosarcoidosis. Journal of medical virology. 
Introduction 1 
 
79 
 
231. Matsuo, H., and T. Shin. 1994. Distribution of intraepithelial nerve fibers in the feline glottis. 
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-
Head and Neck Surgery 111:91-99. 
232. Mayfield, J. E., P. J. Good, H. J. VanOort, A. R. Campbell, and D. E. Reed. 1983. Cloning and 
cleavage site mapping of DNA from bovine herpesvirus 1 (Cooper strain). Journal of virology 47:259-
264. 
233. Mazzocca, A., and V. Carloni. 2009. The Metastatic Process: Methodological Advances and 
Pharmacological Challenges. Current medicinal chemistry 16:1704-1717. 
234. McCrea, P. D., and D. Gu. 2010. The catenin family at a glance. Journal of cell science 123:637-642. 
235. McGeoch, D. J., and S. Cook. 1994. Molecular phylogeny of the alphaherpesvirinae subfamily and a 
proposed evolutionary timescale. Journal of molecular biology 238:9-22. 
236. McGeoch, D. J., M. A. Dalrymple, A. J. Davison, A. Dolan, M. C. Frame, D. McNab, L. J. Perry, 
J. E. Scott, and P. Taylor. 1988. The complete DNA sequence of the long unique region in the 
genome of herpes simplex virus type 1. The Journal of general virology 69 ( Pt 7):1531-1574. 
237. McGeoch, D. J., A. Dolan, S. Donald, and F. J. Rixon. 1985. Sequence determination and genetic 
content of the short unique region in the genome of herpes simplex virus type 1. Journal of molecular 
biology 181:1-13. 
238. McKercher, D. G., E. M. Wada, and O. C. Straub. 1963. Distribution and persistence of infectious 
bovine rhinotracheitis virus in experimentally infected cattle. American journal of veterinary research 
24:510-514. 
239. McMillan, J. R., M. Akiyama, and H. Shimizu. 2003. Epidermal basement membrane zone 
components: ultrastructural distribution and molecular interactions. Journal of dermatological science 
31:169-177. 
240. Merad, M., P. Sathe, J. Helft, J. Miller, and A. Mortha. 2013. The dendritic cell lineage: ontogeny 
and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annual 
review of immunology 31:563-604. 
241. Mettenleiter, T. C. 2002. Herpesvirus assembly and egress. Journal of virology 76:1537-1547. 
242. Mettenleiter, T. C., B. G. Klupp, and H. Granzow. 2006. Herpesvirus assembly: a tale of two 
membranes. Current opinion in microbiology 9:423-429. 
243. Mettenleiter, T. C., B. G. Klupp, and H. Granzow. 2009. Herpesvirus assembly: an update. Virus 
research 143:222-234. 
244. Mettenleiter, T. C., and T. Minson. 2006. Egress of alphaherpesviruses. Journal of virology 80:1610-
1611; author reply 1611-1612. 
245. Mettenleiter, T. C., F. Muller, H. Granzow, and B. G. Klupp. 2013. The way out: what we know 
and do not know about herpesvirus nuclear egress. Cellular microbiology 15:170-178. 
246. Metzler, A. E., H. Matile, U. Gassmann, M. Engels, and R. Wyler. 1985. European isolates of 
bovine herpesvirus 1: a comparison of restriction endonuclease sites, polypeptides, and reactivity with 
monoclonal antibodies. Archives of virology 85:57-69. 
247. Metzler, A. E., A. A. Schudel, and M. Engels. 1986. Bovine herpesvirus 1: molecular and antigenic 
characteristics of variant viruses isolated from calves with neurological disease. Archives of virology 
87:205-217. 
248. Meves, A., C. Stremmel, K. Gottschalk, and R. Fassler. 2009. The Kindlin protein family: new 
members to the club of focal adhesion proteins. Trends Cell Biol 19:504-513. 
249. Misra, V., L. A. Babiuk, and C. L. Darcel. 1983. Analysis of bovine herpes virus-type 1 isolates by 
restriction endonuclease fingerprinting. Archives of virology 76:341-354. 
250. Miura, S., T. Kurita, K. Noda, M. Ayabe, H. Aizawa, and T. Taniwaki. 2009. Symmetrical 
brainstem encephalitis caused by herpes simplex virus. Journal of clinical neuroscience : official journal 
of the Neurosurgical Society of Australasia 16:589-590. 
251. Mocarski, E. S., and B. Roizman. 1982. Structure and role of the herpes simplex virus DNA termini in 
inversion, circularization and generation of virion DNA. Cell 31:89-97. 
252. Moens, E., and M. Veldhoen. 2012. Epithelial barrier biology: good fences make good neighbours. 
Immunology 135:1-8. 
253. Mohan, K. V. K., C. X. Zhang, and C. D. Atreya. 2009. The proteoglycan bamacan is a host cellular 
ligand of vaccinia virus neurovirulence factor N1L. Journal of neurovirology 15:229-237. 
254. Molello, J. A., T. L. Chow, N. Owen, and R. Jensen. 1966. Placental pathology. V. Placental lesions 
of cattle experimentally infected with infectious bovine rhinotracheitis virus. American journal of 
veterinary research 27:907-915. 
255. Monroy, V., A. Amador, B. Ruiz, P. Espinoza-Cueto, W. Xolalpa, R. Mancilla, and C. Espitia. 
2000. Binding and activation of human plasminogen by Mycobacterium tuberculosis. Infection and 
immunity 68:4327-4330. 
1 Introduction 
 
80 
 
256. Mori, N., H. Sato, T. Hayashibara, M. Senba, T. Hayashi, Y. Yamada, S. Kamihira, S. Ikeda, Y. 
Yamasaki, S. Morikawa, M. Tomonaga, R. Geleziunas, and N. Yamamoto. 2002. Human T-cell 
leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating 
adult T-cell leukemia invasiveness. Blood 99:1341-1349. 
257. Morozov, I. A., A. F. Shuliak, S. K. Artiushin, and G. F. Koromyslov. 1991. [Differentiation of 
strains of bovine infectious rhinotracheitis virus using restriction analysis]. Molekuliarnaia genetika, 
mikrobiologiia i virusologiia:29-32. 
258. Morrison, C. S., P. Bright, E. L. Wong, C. Kwok, I. Yacobson, C. A. Gaydos, H. T. Tucker, and P. 
D. Blumenthal. 2004. Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical 
infections. Sexually transmitted diseases 31:561-567. 
259. Mowat, A. M., and C. C. Bain. 2011. Mucosal macrophages in intestinal homeostasis and 
inflammation. Journal of innate immunity 3:550-564. 
260. Muylkens, B., J. Thiry, P. Kirten, F. Schynts, and E. Thiry. 2007. Bovine herpesvirus 1 infection 
and infectious bovine rhinotracheitis. Veterinary research 38:181-209. 
261. Nakamichi, K., Y. Matsumoto, and H. Otsuka. 2002. Bovine herpesvirus 1 glycoprotein G is 
necessary for maintaining cell-to-cell junctional adherence among infected cells. Virology 294:22-30. 
262. Nauwynck, H., S. Glorieux, H. Favoreel, and M. Pensaert. 2007. Cell biological and molecular 
characteristics of pseudorabies virus infections in cell cultures and in pigs with emphasis on the 
respiratory tract. Veterinary research 38:229-241. 
263. Navarre, W. W., and O. Schneewind. 1999. Surface proteins of gram-positive bacteria and 
mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev 63:174-229. 
264. Nicoll, M. P., J. T. Proenca, and S. Efstathiou. 2012. The molecular basis of herpes simplex virus 
latency. FEMS microbiology reviews 36:684-705. 
265. Niessen, C. M. 2007. Tight junctions/adherens junctions: basic structure and function. The Journal of 
investigative dermatology 127:2525-2532. 
266. Niessen, C. M., and C. J. Gottardi. 2008. Molecular components of the adherens junction. Biochimica 
et biophysica acta 1778:562-571. 
267. Nishikaku, A. S., L. C. Ribeiro, R. F. S. Molina, B. P. Albe, C. d. S. Cunha, and E. Burger. 2009. 
Matrix metalloproteinases with gelatinolytic activity induced by Paracoccidioides brasiliensis infection. 
Int J Exp Pathol 90:527-537. 
268. Nobbs, A. H., R. J. Lamont, and H. F. Jenkinson. 2009. Streptococcus adherence and colonization. 
Microbiol Mol Biol Rev 73:407-450. 
269. Nobbs, A. H., M. M. Vickerman, and H. F. Jenkinson. 2010. Heterologous expression of Candida 
albicans cell wall-associated adhesins in Saccharomyces cerevisiae Reveals differential specificities in 
adherence and biofilm formation and in binding oral Streptococcus gordonii. Eukaryot Cell 9:1622-
1634. 
270. Norberg, P., T. Bergstrom, E. Rekabdar, M. Lindh, and J. A. Liljeqvist. 2004. Phylogenetic 
analysis of clinical herpes simplex virus type 1 isolates identified three genetic groups and recombinant 
viruses. Journal of virology 78:10755-10764. 
271. Park, D., J. Lengyel, and S. A. Rice. 2013. The role of immediate-early protein ICP27 in the 
differential sensitivity of herpes simplex viruses type-1 and type-2 to leptomycin B. Journal of virology. 
272. Parks, J. B., and J. W. Kendrick. 1973. The isolation and partial characterization of a herpesvirus 
from a case of bovine metritis. Archiv fur die gesamte Virusforschung 41:211-215. 
273. Parnanen, P., K. Kari, I. Virtanen, T. Sorsa, and J. H. Meurman. 2008. Human laminin-332 
degradation by Candida proteinases. Journal of oral pathology & medicine : official publication of the 
International Association of Oral Pathologists and the American Academy of Oral Pathology 37:329-
335. 
274. Pauls, R., G. Mutema, J. Segal, W. A. Silva, S. Kleeman, V. Dryfhout Ma, and M. Karram. 2006. 
A prospective study examining the anatomic distribution of nerve density in the human vagina. The 
journal of sexual medicine 3:979-987. 
275. Pebody, R. G., N. Andrews, D. Brown, R. Gopal, H. De Melker, G. Francois, N. Gatcheva, W. 
Hellenbrand, S. Jokinen, I. Klavs, M. Kojouharova, T. Kortbeek, B. Kriz, K. Prosenc, K. 
Roubalova, P. Teocharov, W. Thierfelder, M. Valle, P. Van Damme, and R. Vranckx. 2004. The 
seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sexually transmitted infections 
80:185-191. 
276. Perez-Andres, M., B. Paiva, W. G. Nieto, A. Caraux, A. Schmitz, J. Almeida, R. F. Vogt, Jr., G. E. 
Marti, A. C. Rawstron, M. C. Van Zelm, J. J. Van Dongen, H. E. Johnsen, B. Klein, A. Orfao, and 
M. B. L. Primary Health Care Group of Salamanca for the Study of. 2010. Human peripheral blood 
B-cell compartments: a crossroad in B-cell traffic. Cytometry. Part B, Clinical cytometry 78 Suppl 
1:S47-60. 
Introduction 1 
 
81 
 
277. Pieters, R. J. 2011. Carbohydrate mediated bacterial adhesion. Adv Exp Med Biol 715:227-240. 
278. Platt, A. M., and A. M. Mowat. 2008. Mucosal macrophages and the regulation of immune responses 
in the intestine. Immunology letters 119:22-31. 
279. Poland, S. D., G. A. Dekaban, P. C. Costello, and G. P. Rice. 1995. Cytomegalovirus-caused release 
of collagenase IV from human cerebral microvascular endothelial cells. Clin Diagn Virol 4:301-309. 
280. Prince, H. E., C. E. Ernst, and W. R. Hogrefe. 2000. Evaluation of an enzyme immunoassay system 
for measuring Herpes Simplex Virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies. 
Journal of clinical laboratory analysis 14:13-16. 
281. Pruteanu, M., N. P. Hyland, D. J. Clarke, B. Kiely, and F. Shanahan. 2011. Degradation of the 
extracellular matrix components by bacterial-derived metalloproteases: implications for inflammatory 
bowel diseases. Inflamm Bowel Dis 17:1189-1200. 
282. Puccia, R., A. K. Carmona, J. L. Gesztesi, L. Juliano, and L. R. Travassos. 1998. Exocellular 
proteolytic activity of Paracoccidioides brasiliensis: cleavage of components associated with the 
basement membrane. Medical mycology : official publication of the International Society for Human 
and Animal Mycology 36:345-348. 
283. Pudney, J., A. J. Quayle, and D. J. Anderson. 2005. Immunological microenvironments in the human 
vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. 
Biology of reproduction 73:1253-1263. 
284. Qian, L.-W., J. Xie, F. Ye, and S.-J. Gao. 2007. Kaposi's sarcoma-associated herpesvirus infection 
promotes invasion of primary human umbilical vein endothelial cells by inducing matrix 
metalloproteinases. Journal of virology 81:7001-7010. 
285. Ragunathan, P., B. Spellerberg, and K. Ponnuraj. 2009. Structure of laminin-binding adhesin (Lmb) 
from Streptococcus agalactiae. Acta crystallographica. Section D, Biological crystallography 65:1262-
1269. 
286. Rahn, E., P. Petermann, M. J. Hsu, F. J. Rixon, and D. Knebel-Morsdorf. 2011. Entry pathways of 
herpes simplex virus type 1 into human keratinocytes are dynamin- and cholesterol-dependent. PloS 
one 6:e25464. 
287. Rebbapragada, A., C. Wachihi, C. Pettengell, S. Sunderji, S. Huibner, W. Jaoko, B. Ball, K. 
Fowke, T. Mazzulli, F. A. Plummer, and R. Kaul. 2007. Negative mucosal synergy between Herpes 
simplex type 2 and HIV in the female genital tract. Aids 21:589-598. 
288. Reid, L., B. Meyrick, V. B. Antony, L. Y. Chang, J. D. Crapo, and H. Y. Reynolds. 2005. The 
mysterious pulmonary brush cell: a cell in search of a function. American journal of respiratory and 
critical care medicine 172:136-139. 
289. Reske, A., G. Pollara, C. Krummenacher, B. M. Chain, and D. R. Katz. 2007. Understanding HSV-
1 entry glycoproteins. Reviews in medical virology 17:205-215. 
290. Reynaud, J. M., and B. Horvat. 2013. Animal models for human herpesvirus 6 infection. Frontiers in 
microbiology 4:174. 
291. Rios, M., M. J. Zhang, A. Grinev, K. Srinivasan, S. Daniel, O. Wood, I. K. Hewlett, and A. I. 
Dayton. 2006. Monocytes-macrophages are a potential target in human infection with West Nile virus 
through blood transfusion. Transfusion 46:659-667. 
292. Robinson, J. L., W. L. Vaudry, S. E. Forgie, and B. E. Lee. 2012. Prevention, recognition and 
management of neonatal HSV infections. Expert review of anti-infective therapy 10:675-685. 
293. Roche, W. R. 1998. Inflammatory and structural changes in the small airways in bronchial asthma. 
American journal of respiratory and critical care medicine 157:S191-194. 
294. Rodrigues, M. L., F. C. G. dos Reis, R. Puccia, L. R. Travassos, and C. S. Alviano. 2003. Cleavage 
of human fibronectin and other basement membrane-associated proteins by a Cryptococcus neoformans 
serine proteinase. Microb Pathog 34:65-71. 
295. Rodriguez-Bano, J., M. A. Muniain, M. V. Borobio, J. L. Corral, E. Ramirez, E. J. Perea, and R. 
Perez-Cano. 2004. Cytomegalovirus mononucleosis as a cause of prolonged fever and prominent 
weight loss in immunocompetent adults. Clinical microbiology and infection : the official publication of 
the European Society of Clinical Microbiology and Infectious Diseases 10:468-470. 
296. Roels, S., G. Charlier, C. Letellier, G. Meyer, F. Schynts, P. Kerkhofs, E. Thiry, and E. 
Vanopdenbosch. 2000. Natural case of bovine herpesvirus 1 meningoencephalitis in an adult cow. The 
Veterinary record 146:586-588. 
297. Rogers, D. F. 2002. Airway goblet cell hyperplasia in asthma: hypersecretory and anti-inflammatory? 
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 
32:1124-1127. 
298. Rogers, D. F. 1994. Airway goblet cells: responsive and adaptable front-line defenders. The European 
respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 
7:1690-1706. 
1 Introduction 
 
82 
 
299. Roizman, B. 1980. Genome variation and evolution among herpes viruses. Annals of the New York 
Academy of Sciences 354:472-483. 
300. Roizman, B., and J. Baines. 1991. The diversity and unity of Herpesviridae. Comparative 
immunology, microbiology and infectious diseases 14:63-79. 
301. Rowe, A. M., A. J. St Leger, S. Jeon, D. K. Dhaliwal, J. E. Knickelbein, and R. L. Hendricks. 
2013. Herpes keratitis. Progress in retinal and eye research 32:88-101. 
302. Rowe, R. G., and S. J. Weiss. 2008. Breaching the basement membrane: who, when and how? Trends 
Cell Biol 18:560-574. 
303. Russell, G. C., J. P. Stewart, and D. M. Haig. 2009. Malignant catarrhal fever: a review. Veterinary 
journal 179:324-335. 
304. Sacher, T., C. A. Mohr, A. Weyn, C. Schlichting, U. H. Koszinowski, and Z. Ruzsics. 2012. The 
role of cell types in cytomegalovirus infection in vivo. Eur J Cell Biol 91:70-77. 
305. Sackner, M. A., M. J. Rosen, and A. Wanner. 1973. Estimation of tracheal mucous velocity by 
bronchofiberscopy. Journal of applied physiology 34:495-499. 
306. Sacks, S. L., P. D. Griffiths, L. Corey, C. Cohen, A. Cunningham, G. M. Dusheiko, S. Self, S. 
Spruance, L. R. Stanberry, A. Wald, and R. J. Whitley. 2004. HSV-2 transmission. Antiviral 
research 63 Suppl 1:S27-35. 
307. Sacks, S. L., P. D. Griffiths, L. Corey, C. Cohen, A. Cunningham, G. M. Dusheiko, S. Self, S. 
Spruance, L. R. Stanberry, A. Wald, and R. J. Whitley. 2004. HSV shedding. Antiviral research 63 
Suppl 1:S19-26. 
308. Salgado, P. S., R. Yan, J. D. Taylor, L. Burchell, R. Jones, L. L. Hoyer, S. J. Matthews, P. J. 
Simpson, and E. Cota. 2011. Structural basis for the broad specificity to host-cell ligands by the 
pathogenic fungus Candida albicans. Proceedings of the National Academy of Sciences of the United 
States of America 108:15775-15779. 
309. Sato, A. 2007. Tuft cells. Anatomical science international 82:187-199. 
310. Saydam, O., F. Steiner, B. Vogt, and M. Schwyzer. 2006. Host cell targets of immediate-early protein 
BICP22 of bovine herpesvirus 1. Veterinary microbiology 113:185-192. 
311. Schaller, J., and S. S. Gerber. 2011. The plasmin-antiplasmin system: structural and functional 
aspects. Cell Mol Life Sci 68:785-801. 
312. Schneeberger, E. E., and R. D. Lynch. 2004. The tight junction: a multifunctional complex. American 
journal of physiology. Cell physiology 286:C1213-1228. 
313. Schoumacher, M., D. Louvard, and D. Vignjevic. 2011. Cytoskeleton networks in basement 
membrane transmigration. Eur J Cell Biol 90:93-99. 
314. Schubert-Unkmeir, A., C. Konrad, H. Slanina, F. Czapek, S. Hebling, and M. Frosch. 2010. 
Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and 
cleavage of occludin: a role for MMP-8. PLoS pathogens 6:e1000874. 
315. Schuldt, A. 2012. Nuclear transport: A new way out. Nature reviews. Molecular cell biology 13:407. 
316. Schwyzer, M., and M. Ackermann. 1996. Molecular virology of ruminant herpesviruses. Veterinary 
microbiology 53:17-29. 
317. Secott, T. E., T. L. Lin, and C. C. Wu. 2004. Mycobacterium avium subsp. paratuberculosis 
fibronectin attachment protein facilitates M-cell targeting and invasion through a fibronectin bridge 
with host integrins. Infection and immunity 72:3724-3732. 
318. Semple, F., and J. R. Dorin. 2012. beta-Defensins: multifunctional modulators of infection, 
inflammation and more? Journal of innate immunity 4:337-348. 
319. Shinoda, S., and S.-I. Miyoshi. 2011. Proteases produced by vibrios. Biocontrol science 16:1-11. 
320. Shivkumar, M., R. Milho, J. S. May, M. P. Nicoll, S. Efstathiou, and P. G. Stevenson. 2013. Herpes 
simplex virus 1 targets the murine olfactory neuroepithelium for host entry. Journal of virology 
87:10477-10488. 
321. Singh, K. V., S. R. Nallapareddy, J. Sillanpaa, and B. E. Murray. 2010. Importance of the collagen 
adhesin ace in pathogenesis and protection against Enterococcus faecalis experimental endocarditis. 
PLoS pathogens 6:e1000716. 
322. Smith, G. A., P. L. Young, and K. C. Reed. 1995. Emergence of a new bovine herpesvirus 1 strain in 
Australian feedlots. Archives of virology 140:599-603. 
323. Sodeik, B., M. W. Ebersold, and A. Helenius. 1997. Microtubule-mediated transport of incoming 
herpes simplex virus 1 capsids to the nucleus. The Journal of cell biology 136:1007-1021. 
324. Soehnlein, O., and L. Lindbom. 2010. Phagocyte partnership during the onset and resolution of 
inflammation. Nature reviews. Immunology 10:427-439. 
325. Sohl, G., and K. Willecke. 2004. Gap junctions and the connexin protein family. Cardiovascular 
research 62:228-232. 
Introduction 1 
 
83 
 
326. Solan, J. L., and P. D. Lampe. 2005. Connexin phosphorylation as a regulatory event linked to gap 
junction channel assembly. Biochimica et biophysica acta 1711:154-163. 
327. Soleas, J. P., A. Paz, P. Marcus, A. McGuigan, and T. K. Waddell. 2012. Engineering airway 
epithelium. Journal of biomedicine & biotechnology 2012:982971. 
328. Soloff, A. C., and S. M. Barratt-Boyes. 2010. Enemy at the gates: dendritic cells and immunity to 
mucosal pathogens. Cell research 20:872-885. 
329. Spilki, F. R., P. A. Esteves, M. de Lima, A. C. Franco, C. Chiminazzo, E. F. Flores, R. Weiblen, D. 
Driemeier, and P. M. Roehe. 2004. Comparative pathogenicity of bovine herpesvirus 1 (BHV-1) 
subtypes 1 (BHV-1.1) and 2a (BHV-1.2a). Pesquisa Vet Brasil 24:43-49. 
330. Spit, B. J., F. Bretschneider, E. G. Hendriksen, and C. F. Kuper. 1993. Ultrastructure of free nerve 
endings in respiratory and squamous epithelium on the rat nasal septum. Cell and tissue research 
274:329-335. 
331. Squier, C. A., M. J. Mantz, P. M. Schlievert, and C. C. Davis. 2008. Porcine vagina ex vivo as a 
model for studying permeability and pathogenesis in mucosa. Journal of pharmaceutical sciences 97:9-
21. 
332. Staali, L., M. Morgelin, L. Bjorck, and H. Tapper. 2003. Streptococcus pyogenes expressing M and 
M-like surface proteins are phagocytosed but survive inside human neutrophils. Cellular microbiology 
5:253-265. 
333. Stannard, L. M., A. O. Fuller, and P. G. Spear. 1987. Herpes-Simplex Virus Glycoproteins 
Associated with Different Morphological Entities Projecting from the Virion Envelope. Journal of 
General Virology 68:715-725. 
334. Sutherland, M. R., W. Ruf, and E. L. Pryzdial. 2012. Tissue factor and glycoprotein C on herpes 
simplex virus type 1 are protease-activated receptor 2 cofactors that enhance infection. Blood 
119:3638-3645. 
335. Svitacheva, N., H. W. Hovenberg, and J. R. Davies. 1998. Biosynthesis of mucins in bovine trachea: 
identification of the major radiolabelled species. The Biochemical journal 333 ( Pt 2):449-456. 
336. Takai, Y., and H. Nakanishi. 2003. Nectin and afadin: novel organizers of intercellular junctions. 
Journal of cell science 116:17-27. 
337. Tam, A., S. Wadsworth, D. Dorscheid, S. F. Man, and D. D. Sin. 2011. The airway epithelium: more 
than just a structural barrier. Therapeutic advances in respiratory disease 5:255-273. 
338. Tang, H., M. Hayashi, T. Maeki, K. Yamanishi, and Y. Mori. 2011. Human herpesvirus 6 
glycoprotein complex formation is required for folding and trafficking of the gH/gL/gQ1/gQ2 complex 
and its cellular receptor binding. Journal of virology 85:11121-11130. 
339. Taylor, J. M., E. Lin, N. Susmarski, M. Yoon, A. Zago, C. F. Ware, K. Pfeffer, J. Miyoshi, Y. 
Takai, and P. G. Spear. 2007. Alternative entry receptors for herpes simplex virus and their roles in 
disease. Cell host & microbe 2:19-28. 
340. Ting, A. Y., A. D. Blacklock, and P. G. Smith. 2004. Estrogen regulates vaginal sensory and 
autonomic nerve density in the rat. Biology of reproduction 71:1397-1404. 
341. Torres, F. D., S. R. Almeida, M. S. Silva, R. Weiblen, and E. F. Flores. 2009. Distribution of latent 
bovine herpesvirus 2 DNA in tissues of experimentally infected sheep. Research in veterinary science 
87:161-166. 
342. Tronchin, G., M. Pihet, L. M. Lopes-Bezerra, and J.-P. Bouchara. 2008. Adherence mechanisms in 
human pathogenic fungi. Medical mycology : official publication of the International Society for 
Human and Animal Mycology 46:749-772. 
343. Trybala, E., J. A. Liljeqvist, B. Svennerholm, and T. Bergstrom. 2000. Herpes simplex virus types 1 
and 2 differ in their interaction with heparan sulfate. Journal of virology 74:9106-9114. 
344. Tsukita, S., M. Furuse, and M. Itoh. 2001. Multifunctional strands in tight junctions. Nature reviews. 
Molecular cell biology 2:285-293. 
345. Tsuruta, D., S. B. Hopkinson, and J. C. Jones. 2003. Hemidesmosome protein dynamics in live 
epithelial cells. Cell motility and the cytoskeleton 54:122-134. 
346. Tunback, P., J. A. Liljeqvist, G. B. Lowhagen, and T. Bergstrom. 2000. Glycoprotein G of herpes 
simplex virus type 1: identification of type-specific epitopes by human antibodies. Journal of General 
Virology 81:1033-1040. 
347. Umbach, J. L., K. Wang, S. Tang, P. R. Krause, E. K. Mont, J. I. Cohen, and B. R. Cullen. 2010. 
Identification of viral microRNAs expressed in human sacral ganglia latently infected with herpes 
simplex virus 2. Journal of virology 84:1189-1192. 
348. Undem, B. J., and M. J. Carr. 2010. Targeting primary afferent nerves for novel antitussive therapy. 
Chest 137:177-184. 
349. Vandekerckhove, A. P., S. Glorieux, A. C. Gryspeerdt, L. Steukers, J. Van Doorsselaere, N. 
Osterrieder, G. R. Van de Walle, and H. J. Nauwynck. 2011. Equine alphaherpesviruses (EHV-1 
1 Introduction 
 
84 
 
and EHV-4) differ in their efficiency to infect mononuclear cells during early steps of infection in nasal 
mucosal explants. Veterinary microbiology 152:21-28. 
350. Vanlaere, I., and C. Libert. 2009. Matrix metalloproteinases as drug targets in infections caused by 
gram-negative bacteria and in septic shock. Clinical microbiology reviews 22:224-239, Table of 
Contents. 
351. Verma, S., M. Kumar, U. Gurjav, S. Lum, and V. R. Nerurkar. 2010. Reversal of West Nile virus-
induced blood-brain barrier disruption and tight junction proteins degradation by matrix 
metalloproteinases inhibitor. Virology 397:130-138. 
352. Verweij, M. C., M. E. Ressing, W. Knetsch, E. Quinten, A. Halenius, N. van Bel, H. Hengel, J. W. 
Drijfhout, T. van Hall, and E. J. Wiertz. 2011. Inhibition of mouse TAP by immune evasion 
molecules encoded by non-murine herpesviruses. Molecular immunology 48:835-845. 
353. Vieira, M. L., Z. M. de Morais, A. P. Goncales, E. C. Romero, S. A. Vasconcellos, and A. L. T. O. 
Nascimento. 2010. Lsa63, a newly identified surface protein of Leptospira interrogans binds laminin 
and collagen IV. The Journal of infection 60:52-64. 
354. Villone, D., A. Fritsch, M. Koch, L. Bruckner-Tuderman, U. Hansen, and P. Bruckner. 2008. 
Supramolecular interactions in the dermo-epidermal junction zone: anchoring fibril-collagen VII tightly 
binds to banded collagen fibrils. The Journal of biological chemistry 283:24506-24513. 
355. Vranckx, L., E. De Buck, J. Anne, and E. Lammertyn. 2007. Legionella pneumophila exhibits 
plasminogen activator activity. Microbiology 153:3757-3765. 
356. Wahl, S. M., T. B. McNeely, E. N. Janoff, D. Shugars, P. Worley, C. Tucker, and J. M. Orenstein. 
1997. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I. Oral diseases 3 
Suppl 1:S64-69. 
357. Wang, F., E. E. Zumbrun, J. Huang, H. Si, L. Makaroun, and H. M. Friedman. 2010. Herpes 
simplex virus type 2 glycoprotein E is required for efficient virus spread from epithelial cells to neurons 
and for targeting viral proteins from the neuron cell body into axons. Virology 405:269-279. 
358. Wang, K., J. D. Kappel, C. Canders, W. F. Davila, D. Sayre, M. Chavez, L. Pesnicak, and J. I. 
Cohen. 2012. A herpes simplex virus 2 glycoprotein D mutant generated by bacterial artificial 
chromosome mutagenesis is severely impaired for infecting neuronal cells and infects only Vero cells 
expressing exogenous HVEM. Journal of virology 86:12891-12902. 
359. Ward, K. N., H. N. Leong, A. D. Thiruchelvam, C. E. Atkinson, and D. A. Clark. 2007. Human 
herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to 
chromosomal viral integration and have implications for diagnosis of encephalitis. Journal of clinical 
microbiology 45:1298-1304. 
360. Whitbeck, J. C., L. J. Bello, and W. C. Lawrence. 1988. Comparison of the bovine herpesvirus 1 gI 
gene and the herpes simplex virus type 1 gB gene. Journal of virology 62:3319-3327. 
361. Whitbeck, J. C., A. C. Knapp, L. W. Enquist, W. C. Lawrence, and L. J. Bello. 1996. Synthesis, 
processing, and oligomerization of bovine herpesvirus 1 gE and gI membrane proteins. Journal of 
virology 70:7878-7884. 
362. Winter, S. E., A. M. Keestra, R. M. Tsolis, and A. J. Baumler. 2010. The blessings and curses of 
intestinal inflammation. Cell host & microbe 8:36-43. 
363. Wright, P. F. 2011. Inductive/effector mechanisms for humoral immunity at mucosal sites. American 
journal of reproductive immunology 65:248-252. 
364. Xie, X., and P. N. Lipke. 2010. On the evolution of fungal and yeast cell walls. Yeast 27:479-488. 
365. Yam, J. W., E. Y. Tse, and I. O. Ng. 2009. Role and significance of focal adhesion proteins in 
hepatocellular carcinoma. Journal of gastroenterology and hepatology 24:520-530. 
366. Yang, X., K. Forier, L. Steukers, S. Van Vlierberghe, P. Dubruel, K. Braeckmans, S. Glorieux, 
and H. J. Nauwynck. 2012. Immobilization of pseudorabies virus in porcine tracheal respiratory 
mucus revealed by single particle tracking. PloS one 7:e51054. 
367. York, C. J., A. J. Schwarz, and L. A. Estela. 1957. Isolation and identification of infectious bovine 
rhinotracheitis virus in tissue culture. Proceedings of the Society for Experimental Biology and 
Medicine. Society for Experimental Biology and Medicine 94:740-744. 
368. Yoshizaki, T. 2002. Promotion of metastasis in nasopharyngeal carcinoma by Epstein-Barr virus latent 
membrane protein-1. Histol Histopathol 17:845-850. 
369. Yurchenco, P. D., P. S. Amenta, and B. L. Patton. 2004. Basement membrane assembly, stability and 
activities observed through a developmental lens. Matrix Biology 22:521-538. 
370. Yurchenco, P. D., and J. J. O'Rear. 1994. Basal lamina assembly. Current opinion in cell biology 
6:674-681. 
371. Zaichick, S. V., K. P. Bohannon, and G. A. Smith. 2011. Alphaherpesviruses and the cytoskeleton in 
neuronal infections. Viruses 3:941-981. 
Introduction 1 
 
85 
 
372. Zong, Y., Y. Xu, X. Liang, D. R. Keene, A. Hook, S. Gurusiddappa, M. Hook, and S. V. Narayana. 
2005. A 'Collagen Hug' model for Staphylococcus aureus CNA binding to collagen. The EMBO journal 
24:4224-4236. 
 
 
  
  
 
 
  
 
 
 
 
 
 
 
CHAPTER 2.  
 
AIMS 
 
 
 
 
 
 
 
 
 
 
 
2 Aims 
 
88 
 
Many alphaherpesviruses use the epithelium of the respiratory and/or genital tract as a 
preferential site for primary replication. Local dissemination is followed by initiation of 
viremia and subsequent spread to internal organs. In addition, these viruses typically invade 
nerve endings underneath the epithelium and successfully reach the nervous system. 
However, a potent selective barrier underneath the epithelium, the basement membrane (BM), 
hampers free passage of pathogens. Driven by evolution, pathogens have developed various 
mechanisms to overcome the BM. Some microorganisms have developed independent 
mechanisms, others hijack host cells that are able to transverse the BM (e.g. leukocytes). 
However, mechanisms underpinning binding to, breakdown of and passage of the BM are 
generally better understood for bacteria and fungi than for viruses. A better understanding of 
viral invasion mechanisms may generate new leads towards the development of novel 
antiviral strategies.  
Bovine herpesvirus 1 (BoHV-1) in cattle and herpes simplex virus 1 (HSV-1) and 2 (HSV-2) 
in humans are important diseases. Remarkably, there is a striking similarity in between these 
species-specific alphaherpesviruses. Both species harbor herpesvirus isolates with a 
preferential respiratory tropism (BoHV-1.1 and HSV-1) and isolates that exhibit a more 
genital tropism (BoHV-1.2 and HSV-2). A thorough study on mucosal invasion mechanisms 
of both a veterinary alphaherpesvirus and a human alphaherpesvirus will: (i) point out 
differences and similarities at the level of the mucosa and (ii) provide new ideas towards the 
development of alternative preventive and curative approaches for animal and human viruses. 
The thesis aims to identify common and specific mechanisms of herpesviruses at a critical 
stage of their pathogenesis: the entry in the host through mucosae. 
  
Therefore, the specific aims of this thesis are: 
 First, to establish respiratory mucosa and genital mucosa ex vivo models for bovine 
and human, closely mimicking the natural host. Tissue morphology and viability will 
be extensively evaluated during the entire in vitro cultivation time (Chapter 3). 
 To thoroughly analyze the replication characteristics of the alphaherpesvirus BoHV-1 
within mucosa explants derived from the upper respiratory and genital tract. Different 
genital and respiratory subtype strains will be included and compared (Chapter 4). 
 To assess whether another bovine herpesvirus, the gammaherpesvirus bovine 
herpesvirus 4 (BoHV-4), exhibits a similar or distinct mechanism of invasion 
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compared to BoHV-1. Both viruses will be compared for mucosal behavior in 
explants derived from same animals (Chapter 5). 
 To evaluate human alphaherpesviruses HSV-1 and HSV-2 for their mucosal 
dissemination characteristics in a human genital mucosa model. In addition, 
distribution patterns of HSV entry receptors within the female lower genital tract will 
be considered (Chapter 6). 
 Finally, to identify which viral factors are required for plaquewise crossing of the 
basement membrane by alphaherpesviruses. Therefore, emphasis will be put on two 
important virulence genes, US7(gI) and US8(gE), in alphaherpesviruses and their 
potential involvement in efficient mucosal invasion. BoHV-1 and bovine respiratory 
mucosa explants will be used to model viral passage of the BM (Chapter 7).   
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3.1.  Abstract 
An in vitro model of the upper respiratory tract and lower genital tract of cattle was developed 
to study molecular/cellular host-pathogen interactions in various respiratory and genital 
diseases. Different parts of the respiratory tract including distal part of the nasal septum, 
ventral conchae and proximal trachea, as well as vestibulum vaginae, representing the genital 
tract, were collected from at least three different animals. We cultivated mucosa explants in 
air-liquid interface organ cultures for 96h. We performed a thorough morphometrical analysis 
(epithelial integrity/thickness, basement membrane continuity, and lamina propria integrity) at 
different time points of in vitro cultivation, using light microscopy, transmission electron 
microscopy and scanning electron microscopy. We applied a terminal deoxynucleotidyl 
transferase mediated dUTP nick end labeling (TUNEL) staining as a viability test during in 
vitro culture. Bovine upper respiratory tract and genital tract mucosa explants were 
maintained in culture for up to 96h without any significant changes in morphometry and 
viability and thus are an ideal tool to study different aspects of mucosal pathologies. 
 
3.2.  Introduction 
Mucosal surfaces such as the respiratory and genital mucosa are common entry ports for 
many bovine pathogens. Some pathogens can cause devastating clinical entities on their own 
(e.g. bovine herpesvirus 1) whereas others are mainly involved in a disease complex (e.g. 
bovine parainfluenza virus type 3) (7, 19, 31). A common serial event in disease complexes, 
such as enzootic pneumonia in calves and bovine respiratory disease complex, is that 
initiators such as stress and/or viral and parasitic infections pave the way for secondary 
bacterial infections (11, 30). In bovines, bovine respiratory tract disease is responsible for 
major health problems and economical losses. The most common causes of infectious 
respiratory disease include bovine herpesvirus 1 (BoHV-1), bovine viral diarrhea virus type 1 
and 2 (BVD-1/-2), bovine respiratory syncytial virus (BRSV), bovine parainfluenza virus type 
3 (PI-3), Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, Mycoplasma 
bovis and lungworm (7, 11, 19, 21). Genital tract infections of both bulls and cows can have 
serious repercussions on reproductive health in cattle. Bovine herpesvirus 1 and 4 (BoHV-1/-
4), Tritrichomonas foetus and Campylobacter foetus subspecies venerealis among others 
show a tropism for the genital tract (5, 6, 19). How these different previously mentioned 
micro-organisms are able to successfully invade the host at the level of the mucosa remains 
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for many still elusive and is in general better documented for bacteria and parasites than for 
viruses. Clearly, the use of living animals to study these host-pathogen interactions is 
undesirable and raises ethical questions about animal welfare, certainly when accessible, 
reproducible and alternative models can be developed. Organ cultures of respiratory and 
genital mucosa mimic the physiological condition of the natural host and thus provide an ideal 
solution. Such systems allow for multiple and frequent sampling points and in addition, 
defined single or mixed infections can be undertaken in a controlled manner on tissues all 
originating from the same animal. Bovine nasal and tracheal mucosa organ cultures have been 
described in literature (3, 4, 9, 24, 26-28). However, these explant models were only 
maintained for up to 72h without extensive morphometrical analysis during cultivation and 
hence we attempted to include additional parts of the upper respiratory tract, including ventral 
conchae, and maintain the organ culture for at least 96h in vitro. Hitherto, explant models of 
bovine vestibulum vaginae have not been described yet. 
The aim of the present study was to set up in vitro explants models of respiratory tissues and 
genital tissue of cattle. Distal part of the nasal septum, ventral conchae, proximal trachea and 
vestibule were selected as representative tissues for the respiratory and genital tract 
respectively. Explants were cultured on gauze at air-liquid interface for 96h. A thorough 
structural (morphology) and functional (viability) analysis was performed at 0h, 24h, 48h, 72h 
and 96h of cultivation. To this end, we applied light microscopy, transmission electron 
microscopy (TEM) and scanning electron microscopy (SEM) to evaluate different 
morphometrical parameters (epithelial integrity/thickness, basement membrane continuity, 
and lamina propria integrity) for tissue preservation. In addition, we used a terminal 
deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) staining as a 
viability test by means of fluorescence microscopy.  
 
3.3.  Materials and methods 
3.3.1. Selection of animals 
For the design of the respiratory mucosa explant model, bovine respiratory tissue was 
obtained at a slaughterhouse. Samples were taken from three animals aged 6 months. The 
head was cut longitudinal into two pieces, exposing the nasal septum. We cautiously removed 
nasal septum from the caudal two thirds of the nasal cavity (septum), ventral conchae 
(conchae), and proximal trachea (trachea).  
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For the establishment of the genital model, four different cows between 3 and 5 years old 
were selected. A criterion to include the animals in this experiment was based on female 
reproductive hormone levels. At slaughter, a thorough palpation and visual inspection of the 
ovaries was performed to select cows with a clear marked corpus luteum. Moreover, blood 
was collected at slaughter. On all sera, a progesterone determination was performed to 
determine peripheral blood progesterone. 
 
3.3.2. Cultivation of tissue explants 
A similar set up was used for bovine respiratory and genital mucosal explants. Briefly, tissues 
were immediately placed in phosphate buffered saline (PBS), supplemented with 1 µg/mL 
gentamycin (Invitrogen, Paisley, UK), 1 mg/mL streptomycin (Certa, Braine l’Alleud, 
Belgium), 1 mg/mL kanamycin (Sigma, St. Louis, MO, USA), 1000 U/mL penicillin 
(Continental Pharma, Puurs, Belgium) and 5 µg/mL fungizone (Bristol-Myers Squibb, New 
York, USA) for transportation to the laboratory. Respiratory and genital mucosa was stripped 
from the underlying layers. Small square tissue pieces were made and placed on fine-meshed 
gauze for culture. The explants were cultivated in serum-free medium (50% DMEM 
(Invitrogen)/50% Ham’s F-12 GlutaMAX (Invitrogen)) supplemented with 0.1 mg/mL 
streptomycin (Certa), 100 U/mL penicillin (Continental Pharma) and 1 µg/mL gentamycin 
(Invitrogen) for up to 96h (37 °C, 5% CO2). 
 
3.3.3. Evaluation of tissue viability 
Tissues derived from all animals were monitored for occurrence of apoptosis during in vitro 
culture. DNA fragmentation was evaluated using an In Situ Cell Death Detection Kit (Roche), 
which is based on terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling 
(TUNEL). This method is designed as a precise, fast and simple, non radioactive technique to 
detect and quantify apoptotic cell death at single cell level in cells and tissues. We performed 
the TUNEL reaction according to the manufacturer’s guidelines. TUNEL-positive cells were 
counted from five randomly chosen fields of 100 cells in the epithelium as well as in the 
lamina propria with a fluorescence microscope (Leica DM RBE microscope, Leica 
Microsystems). An analysis was made at 0h, 24h, 48h, 72h and 96h of cultivation. 
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3.3.4. Evaluation of tissue morphometry 
The respiratory explants were checked for sufficient ciliary beating on a daily basis using a 
light microscope as a first viability parameter. At 0h, 24h, 48h, 72h and 96h of cultivation, 
explants of both respiratory and genital tissue were gathered for further analysis. A thorough 
morphometrical assessment was performed by means of light microscopy, transmission 
electron microscopy and scanning electron microscopy. 
  
Light microscopy 
Fixation of explants was performed at the different time points by submerging them in a 
phosphate-buffered 3.5% formaldehyde solution for 24h.  Fixation was followed by paraffin 
embedding using an automated system (STP 420D, Micron, Praran, Merelbeke, Belgium). 
Sections of 20 μm thick were successively cut, deparaffinized in xylene, rehydrated in 
descending grades of alcohol, stained, dehydrated in ascending grades of alcohol and xylene, 
and mounted with DPX (DPX mountant, BDH Laboratory Supplies, Poole, UK). As a 
parameter for the effect of in vitro culture on the epithelial morphometry, epithelial integrity 
and/or thickness was measured by means of a haematoxylin-eosin (HE) staining. At 
magnification 40×, five randomly selected places in five randomly chosen fields were 
evaluated/measured in each explant. Next, a reticulin staining to evaluate continuity and 
thickness of the basement membrane was carried out. Five randomly chosen places in 5 
randomly chosen zones were measured in each sample. Finally, the structure of the connective 
tissue was evaluated by means of a Van Gieson staining. In five randomly chosen fields, the 
relative amounts of collagen and nuclei were calculated in a defined region of interest (roi) by 
setting a threshold. All measurements and calculations were performed using the Cell F 
Software linked to a BX61 light microscope (Olympus, Hamburg, Germany) (magnification 
40×). 
 
Transmission electron microscopy 
We performed a transmission electron microscopical analysis to evaluate the structure of the 
explant down to the subcellular level. Explants were fixed overnight at 4°C in Karnovsky’s 
Fixative (2% paraformaldehyde and 2.5% glutaraldehyde in 0.2 M sodium cacodylate buffer 
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(pH 7.4)) to ensure that the structure of the specimens was preserved (15). Later, explants 
were rinsed in 0.1 M sodium cacodylate buffer (pH 7.4) for 8h and underwent an overnight 
postfixation in 2% osmium tetroxide at 4°C. The samples underwent a stepwise dehydratation 
in ascending grades of alcohol, an infiltration in a low viscosity embedding (LVR) medium 
(Agar Scientific) for 2 days, and an embedding in LVR. Lastly, ultrathin sections of 
embedded material were cut using a diamond knife on an Ultramicrotome Ultracut EM UC6 
(Leica Microsystems, Wetzlar, Germany) and stained afterwards with a Leica Microsystems 
EM staining before analysis on a JEM-1010 transmission electron microscope (Jeol) operating 
at 60 kV. 
 
Scanning electron microscopy 
Genital explants were submitted to a scanning electron microscopical analysis. Niesalla and 
co-workers described this previously for bovine respiratory mucosa explants (20). After 
gathering the genital explants at the defined time points, fixation of the explants in a HEPES-
buffer containing 2% paraformaldehyde and 2.5% glutaraldehyde solution during 24h was 
followed by a post-fixation step in an un-buffered 1% osmium tetroxide solution for 2h. Then, 
the fixed explants were dehydrated through ascending grades of alcohol and critical point 
dried with CO2 (CPD 030, Balzers, Sercolab, Merksem, Belgium), mounted on metal stubs, 
platinum-coated (JFC-1300 Autofine Coater, Jeol, Tokyo, Japan) and examined by a Jeol JSM 
5600 LV scanning electron microscope (Jeol). Using 1 500× and 5 000× magnification, the 
integrity of the epithelium was examined. 
 
3.3.5. Statistical analysis 
The obtained data were assessed using SPSS software (ANOVA) to evaluate the variance. 
The results shown represent means + standard deviation of triple (respiratory model) and 
quadruple (genital model) independent experiments. Results with P values of ≤ 0.05 were 
considered significant. 
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3.4.  Results 
3.4.1 Progesterone determination 
The four other animals included for the establishment of the genital model had a peripheral 
blood progesterone (P4) level of > 1 ng/mL, suggesting they were in the luteal phase of the 
reproductive cycle. 
 
3.4.2 Tissue viability 
Respiratory model 
During 96h of in vitro culture, there was no major increase regarding the amount of TUNEL-
positive cells in the epithelium. However, for each tissue, at 96h of cultivation, we noticed a 
small but significant increase in the amount of TUNEL-positive cells in the epithelium. 
Evaluating the viability of the underlying connective tissue, the percentage of apoptotic cells 
in all tissues ranged from 2.9 ± 1.7 to 19.3 ± 4.3 at 0h and 96h, respectively (Table 1). The 
occurrence of apoptosis was more clear in glandular structures. 
 
Table 1. Occurrence of apoptosis in epithelium and lamina propria as a parameter for the effect of in 
vitro culture on the viability of bovine respiratory mucosa explants. Values are given as means ± SD. 
Tissue Layer % of TUNEL-positive cells at … h of cultivation 
  0 24 48 72 96 
Deeper part of 
the nasal septum 
Epithelium 0.4 ± 0.2 2.6 ± 2.0 2.4 ± 2.6 1.5 ± 1.1 5.5 ± 2.7 
Lamina propria 2.9 ± 1.7 10.5 ± 7.2 11.2 ± 4.3 13.3 ± 6.7 19.3 ± 4.3 
Ventral   
conchae 
Epithelium 0.5 ± 0.4 2.0 ± 0.9 1.7 ± 1.6 1.3 ± 0.9 2.8 ± 1.7 
Lamina propria 3.0 ± 2.6 9.9 ± 4.0 11.6 ± 1.8 13.4 ± 4.3 17.5 ± 2.4 
Proximal 
trachea 
Epithelium 0.5 ± 0.3 0.9 ± 1.0 1.6 ± 0.7 1.3 ± 0.5 2.7 ± 0.6 
Lamina propria 3.0 ± 2.2 7.2 ± 1.1 9.5 ± 2.5 15.1 ± 1.9 17.2 ± 2.0 
 
Genital model 
3A In vitro study of bovine respiratory and genital mucosa explants 
 
100 
 
With increasing time of in vitro culture, we saw no major differences in the occurrence of 
apoptosis in the epithelium. However, a small significant increase in apoptotic epithelial cells 
was observed at 96h of cultivation. For the connective tissue, we noticed a small increase in 
the occurrence of apoptosis as culture time passed by (to 7.7 ± 2.7 at 96h). Values of the 
effect of in vitro culture on the viability of bovine genital mucosa explants are given in Table 
2. 
 
Table 2. Percentage of TUNEL-positive cells in epithelium and lamina propria as a parameter for the 
effect of in vitro culture on the viability of bovine genital mucosa explants. Values are given as means 
± SD. 
   % of TUNEL-positive cells at … h of cultivation 
  0 24 48 72 96 
Vestibulum 
Vaginae 
Epithelium 0.3 ± 0.1 0.4 ± 0.3 0.8 ± 0.4 0.3 ± 0.2 1.5 ± 0.5 
Lamina propria 0.9 ± 0.4 3.2 ± 1.5 4.8 ± 3.2 5.8 ± 4.5 7.7 ± 2.7 
 
3.4.3 Ciliary beating 
The cilia covering the respiratory epithelium kept on beating during the entire period of in 
vitro culture (up to 96h, the end of the experiment). 
 
3.4.4 Epithelial morphometry 
Light microscopy 
Respiratory model 
We observed no significant changes in epithelial integrity during the entire cultivation period 
for septum, conchae, and trachea (Figure 1). All samples showed a respiratory epithelium. 
However, concerning septum and conchae we found some zones possessing a stratified 
squamous epithelium. 
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Figure 1. HE-stainings of bovine proximal trachea explants showing preservation of epithelial 
integrity at different time points of in vitro culture (0h, 48h, 96h). 
 
Genital model 
No significant changes were noticed in the measured epithelial thickness of the vestibulum 
vaginae as cultivation time passed by. A clear non-keratinized stratified squamous epithelium 
was visible for all samples (Figure 2a-b). 
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Figure 2. Photomicrographs of bovine stratified squamous epithelium lining the vestibulum vaginae at 
0h (a) and 96h (b) of in vitro cultivation (end of experiment) (HE-staining). One cow showed zones 
containing an active mucus-secreting (PAS +) stratified columnar to cuboidal epithelium, prominent 
at 0h of in vitro cultivation. This active epithelium is shown in c (HE-staining) and d (PAS-staining). 
 
However, for all cows, a few zones containing a stratified columnar to stratified cuboidal 
epithelium were observed. Moreover, one cow (1.03 ng/mL P4 level) showed especially at 0h 
of cultivation some columnar to cuboidal cells in the stratified columnar to cuboidal epithelial 
zones containing a strong periodic acid + Schiff (PAS) positive substance (Figure 2c-d). 
 
Transmission electron microscopy 
Respiratory model 
Transmission electron microscopy was applied to evaluate epithelial integrity (Figure 3).  
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Figure 3. Transmission electron microscopical (TEM) images of bovine respiratory epithelium at 0h 
and 96h of in vitro culture. Few intercellular spaces between basal cells appeared at 0h of in vitro 
culture. Starting from 72h of in vitro culture, they became more distinct and came into sight between 
some apical cells (black arrows). The luminal side of the epithelium is marked by an asterisk. 
Magnification 3000x. 
 
For all tissues at all collected time points, small intercellular spaces between basal epithelial 
cells were seen. These observations were not made between apical epithelial cells at 0h, 24h, 
and 48h of in vitro cultivation since apical cells were adjacent. However, it should be noted 
that starting from 72h of in vitro cultivation, intercellular spaces between basal epithelial cells 
became more distinct, and moreover, few intercellular spaces started to appear between apical 
epithelial cells. Figure 3 shows intercellular spaces. 
 
Genital model 
Overall integrity could be evaluated by means of transmission electron microscopy. During 
the entire cultivation period (96h) the epithelial structure was maintained (Figure 4a-b). 
Starting from 0h of cultivation, small intercellular spaces could be observed between some 
basal cells (Figure 4c). Remarkably, large apical electron-lucent cells randomly spread across 
the epithelium, were observed starting from time point 0h of cultivation. Conservation of 
microvilli at 0h, 24h, 48h, 72h and 96h of cultivation was noticed. 
 
Scanning electron microscopy 
Genital model 
Evaluating the epithelial integrity by scanning the surface of the epithelium, no significant 
changes were noticed in epithelial morphology during in vitro culture for up to 96h. Surface 
cells had an irregular pavement-like appearance (Figure 4d-e). Moreover, on the surface 
secretory blebs were visible. All epithelial cells contained stubby microvilli and at the cell 
borders, clear microridges were visible (Figure 4f). These cell surface structures could be 
maintained at all time points. 
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Figure 4. Transmission electron and scanning electron microscopical images of bovine vaginal 
epithelium. Epithelial integrity and structure was maintained at all time points (0h-96h) as seen with 
transmission electron microscopy (a-b). Starting from 0h of cultivation, small intercellular spaces 
between basal cells were observed (c, indicated by black arrows). The dotted line represents the 
basement membrane (BM). Pavement-like cells containing microvilli were seen at all time points (0h-
96h) of in vitro culture when evaluating the epithelial surface by means of scanning electron 
microscopy (d-e). Cells are aligned with clear microridges (f, indicated by white arrows). 
  
3.4.5 Basement membrane mophometry 
Light and Transmission electron microscopy 
Respiratory model 
No major changes were observed in the thickness of the reticular lamina when evaluating 
reticulin stainings during the in vitro culture of mucosae of the septum, conchae and trachea 
(Figure 5). At 0h, 24h, 48h, and 72h of cultivation, we noticed a significant difference in 
lamina reticularis thickness when comparing proximal trachea to the deeper part of the nasal 
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septum and ventral conchae. A smaller thickness of the lamina reticularis was observed in 
proximal trachea (P values ≤ 0.05). 
 
 
Figure 5. Light photomicrographs of bovine proximal trachea explants at different time points of in 
vitro culture (0h, 48h, 96h). For analysis of lamina reticularis thickness, a reticulin staining was used 
(lamina reticularis indicated by white arrows). The graph represents the measured thickness of the 
lamina reticularis in explants of the deeper part of the nasal septum, ventral conchae and proximal 
trachea at different time points of in vitro culture. Data are represented as mean values of three calves 
+ SD (error bars) (25 measurements/calf). Data with P values ≤ 0.05 were considered significant 
(marked by an asterisk). 
 
The continuity of the lamina densa of the BM was evaluated by means of TEM. For all 
explants and at all time points (up to 96h), no significant changes in lamina densa integrity 
were observed (Figure 6). 
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Figure 6. Detailed photomicrographs of respiratory tissue taken by a transmission electron 
microscope at 0h and 96h of cultivation. The continuity and integrity of the lamina densa of the 
basement membrane was maintained during the entire experiment (96h) (black arrows). Basal cells of 
the respiratory epithelium above the BM are visible (asterisk). Magnification 12000x 
 
Genital model 
After analysis of the reticulin stained sections, significant changes were not observed 
regarding the thickness of the lamina reticularis during in vitro culture (Figure 7a). 
By means of transmission electron microscopy, the continuity and integrity of the lamina 
densa of the basement membrane were evaluated. Throughout 96h of in vitro cultivation, no 
significant changes in lamina densa continuity and integrity were found (Figure 7b-c). 
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Figure 7. Evaluation of basement membrane (lamina densa and lamina reticularis) continuity and 
thickness by means of transmission electron microscopy and light microscopy (reticulin staining). 
Average thickness of the lamina reticularis was monitored throughout in vitro culture (a, black arrows 
indicate lamina reticularis). No significant changes were observed in lamina reticularis thickness 
when analyzing reticulin stainings. The lamina densa remained continuous at all time during the 
entire cultivation period (up to 96h) as shown by the transmission electron microscopical images (b-c, 
black arrows indicate lamina densa). Data are represented as means + SD (error bars).  
   
3.4.6 Morphometry of the lamina propria 
Light microscopy 
Respiratory model 
When analyzing Van Gieson stainings, no significant changes in relative amounts of collagen 
and nuclei were observed during the entire cultivation period for all tissues (Figure 8). 
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Figure 8. (a) Percentages of collagen within a region of interest and (b) percentages of nuclei within a 
region of interest in explants of the deeper part of the nasal septum, ventral conchae and proximal 
trachea at different time points of in vitro culture are given within the graphs. Data are represented as 
mean values of three calves + SD (error bars) (5 measurements/calf). (c) Light photomicrographs of 
bovine proximal trachea explants at different time points of in vitro culture (0h, 48h, 96h). Relative 
amounts of collagen and nuclei within a defined region of interest (roi indicated by black rectangle) 
were analyzed by means of a Van Gieson staining. By giving different colors to respectively collagen 
and nuclei (setting a threshold), the percentage of collagen and nuclei was counted within the roi. 
 
Genital model 
Using a Van Gieson staining, no significant changes were noticed in relative percentage of 
collagen and nuclei in the connective tissue with increasing time after sampling (Figure 9). 
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Figure 9. Average percentages of collagen and cells were measured in the connective tissue and 
assessed on conservation throughout cultivation (up to 96h) using Van Gieson stainings. By giving 
different colors to collagen and nuclei (setting a threshold), relative amounts of collagen and nuclei 
were measured within a region of interested (roi) (roi is indicated by a rectangle). Representation of 
the data is visualized as means + SD (error bars).   
 
3.5.  Discussion 
Little is known about the events happening upon host entry at mucosal surfaces early in the 
pathogenesis of several bovine micro-organisms. Nevertheless, getting a fundamental image 
on how these pathogens behave at their primary replication/colonization site can provide 
insights for prevention and treatment on a rational basis.  
A first aspect of the present study was to establish and optimize a bovine upper respiratory 
tract mucosa explant model allowing the study of various bovine respiratory pathogens in 
bovine respiratory mucosa. The use of respiratory organ cultures already proved to be of 
importance in different scientific areas. Insights in drug transportation, metabolic pathways, 
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and pathogen-host interactions are attained achievements based on organ culture arrays. The 
explant model is the perfect compromise between in vitro cell cultures and in vivo laboratory 
animals. In cell cultures, no tissue structure is present and therefore essential cell-cell and 
cell-extracellular matrix contacts are lost. Current in vivo model systems often used in 
alphaherpesvirus studies originated from rodents. However, these models create a 
heterologous situation since species specific cellular components, which may play a role in 
viral invasion, are absent. The bovine mucosa explant system represents a homologue model 
strongly resembling the in vivo situation and implements reduction, refinement, and 
replacement (3R principles). These unique systems may be used for screening of different 
potent antiviral molecules. Since intraspecies variation is excluded, a specific effect of a 
certain condition or virus strain related to the mock situation may be examined. Explant 
models of respiratory tissue have already been described in the literature for use in human (1, 
13, 14, 25), rat (8), canine (2), swine (10, 22) and equine models (12, 17, 29). In bovine 
models, respiratory organ cultures have been described in the literature but these explants 
were only maintained for up to 72h without extensive morphometrical analysis (3, 4, 9, 24, 
26-28). Recently, Niesalla and colleagues (2009) established an in vitro bovine respiratory 
organ culture system to use as a BoHV-1 infection model. Bovine tracheal and nasal mucosae 
were cultured for up to 72 hours and monitored for viability, integrity, and TNF-α gene 
expression. However, using latex beads clearance as a viability test only gives an indication 
about epithelial cell function. There was no information on the viability of the underlying 
layers. Moreover, a histological assessment of the organ culture using light microscopy and 
scanning electron microscopy showed evidence of progressive degeneration starting from 24h 
of cultivation. Although overall integrity of the epithelium was maintained, degeneration of 
mucus gland structures in the lamina propria, starting from 24h, and separation of collagen 
fibers from 48h onwards are reported. We believe it is essential to maintain the viability and 
integrity of the underlying layers when studying a virus-host interaction at mucosal entry 
ports. Therefore, we modified, optimized, and extended the bovine respiratory organ culture. 
By applying a precise, non-touch method of the tissues during manipulation and by fine-
tuning the cultivation medium, we succeeded in maintaining epithelium integrity and viability 
up to 96h of cultivation. During in vitro culture, intercellular spaces became more clear 
between basal epithelial cells, and starting from 72h of in vitro culture, few intercellular 
spaces appeared between the adjacent apical cells. These findings were also evident in 
respiratory mucosa explants of swine and horse. A possible explanation for the gapping is a 
decreasing strength of cell-cell contacts at different regions in the explants (10, 29). 
In vitro study of bovine respiratory and genital mucosa explants 3A 
 
111 
 
Regarding BM integrity and continuity, no significant changes were noticed during the entire 
culture. The trachea showed significant differences in lamina reticularis thickness compared 
to the other tissues at 0h, 24h, 48h, and 72h of cultivation. We can conclude that trachea 
seems to have a smaller thickness of the lamina reticularis compared to septum and conchae. 
When evaluating the connective tissue, we did not observe major significant changes in tissue 
morphometry. Concerning viability of the connective tissue, starting from 24h of in vitro 
culture, we noticed an increase in the occurrence of apoptosis, especially inside glandular 
structures. This could be caused by a lack of sufficient nutrients. However, during the entire 
cultivation period (96h) occurrence of apoptosis did not exceed 19.3 ± 4.3% and no 
significant differences were observed between septum, conchae, and trachea. Since we did not 
notice any severe degeneration of mucus gland structures and collagen fibers, we considered 
this an acceptable percentage. 
The second part of the current study consisted of the development of an organ culture of 
bovine vestibulum vaginae. Hitherto, organ cultures of bovine vestibulum vaginae have never 
been described. Some interesting facts were seen when evaluating tissue morphology. One 
cow showed highly active columnar to cuboidal cells in the stratified columnar to cuboidal 
epithelial zones containing a PAS positive substance. Taken into consideration that at the time 
of sampling this cow was in a transition phase of the reproductive cycle, namely from a 
progesterone to an estrogen dominance or vice versa (P4 1.03 ng/mL), this mucin production 
might be an outcome of estrogen influence on the epithelium (18). These hormone related 
findings are important since herpes virus infections at the genital site are known to be 
influenced by reproductive hormone levels (16). Starting from 0h of cultivation, few 
intercellular spaces were visible between basal cells of the epithelium. We made the same 
observations when establishing the bovine respiratory mucosa explant model. When using 
transmission electron microscopy, salient large electron-lucent apical cells, randomly spread 
across the epithelium starting from 0h of cultivation, were noticed. Regli and Kress saw 
similar cells in the vaginal epithelium of the Maruspial Monodelphis domestica, describing 
the remarkable fact as damaged cells by the previous desquamation process or not yet 
differentiated cells (23). However, no significant changes in the number of these particular 
cells were found throughout cultivation. We observed at 96h of cultivation a small increase in 
the number of apoptotic epithelial cells together with an increase in apoptotic lamina propria 
cells as culture time passed by. An analogous trend was seen in the viability assessment of 
upper respiratory tract cultured tissues. Overall, we can state that the newly developed organ 
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culture of bovine vestibulum vaginae was successfully maintained for at least 96h in culture at 
air-liquid interface without demonstrable changes in tissue architecture or viability. 
We can conclude that bovine respiratory and genital mucosa explants can be maintained in 
culture for up to 96h without any major changes regarding structural integrity and viability 
Moreover, because of their in vivo relevance, these in vitro models are highly appreciated 
since laboratory animal use is diminished and confounding factors such as individual animal 
variation and environmental factors are excluded. Therein lies their strength, when comparing 
an array of strains/subtypes on viral behavior at mucosal entry ports. 
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3.8.  Abstract 
Sexually transmitted infections (STI) globally account for the majority of infectious diseases 
amongst humans, resulting in substantial medical costs and severe health burden. At present, 
there is a huge lack in available preventive and/or curative measures for STI. In particular, 
viral STI, with human immunodeficiency virus (HIV) and human herpes simplex virus (HSV) 
as prototype members, are difficult to control. There is an urgent medical need for the 
development of novel anti-STI measures based on targets that have not been identified before. 
A big gap in our understanding of how these pathogens interact with their host is the mucosal 
behavior displayed by pathogens and the host invasion mechanisms they apply at these entry 
ports. Hence, we developed and optimized a human genital mucosa explant model 
(endocervix and ectocervix/vagina) to mimic the early steps of the pathogenesis of genital 
infections. During the optimization of this procedure, special emphasis was put on 
maintenance of tissue morphology as well as tissue viability during this in vitro cultivation by 
applying several techniques. 
 
3.9.  Introduction 
The lower reproductive tract of humans provides a unique site of host entry for many 
pathogens. In addition, microbial invasion of genital mucosal surfaces render microorganisms 
an ideal way for transmission between individuals (16). Sexually transmitted infections (STI) 
burden human populations not only because of the economical costs and implications on 
physical health but also because of the psychosocial problems post-diagnosis (19, 22). 
Globally, an estimated average of 35.3 million people are infected with human 
immunodeficiency virus (HIV) (31). Human genital herpes, caused by both herpes simplex 
virus 1 (HSV-1) and 2 (HSV-2), is worldwide one of the most prevalent causes of genital 
ulcer disease and with a prevalence reaching up to 80% one of the most important STI (1). No 
less than 610.000 cancers, mainly cervix cancer, of an estimated 12.7 million cancers 
occurring worldwide in 2008 could be attributed to sexually transmitted infections by human 
papillomavirus (HPV) (6). The most sexually transmitted bacterial pathogen is Chlamydia 
trachomatis with 3 million new infections each year in the United States (21). Available 
preventive and/or curative approaches against such infections are very limited and for most of 
them not existing (2, 11). Especially viral etiologies of STI are difficult to cure. This indicates 
that there is an urgent need for investigations that identify alternative targets for preventive 
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and curative measures. A major gap in our understanding of the pathogenesis of many STI is 
the delineation of events occurring at early stages of infection at the level of the mucosa. 
Epidemiological studies have shown that women suffer most often from STI although the 
reasons for this are not well understood (15). The local microenvironment of the female 
genital tract has unique features. Two different types of mucosal surfaces can be readily 
distinguished. The endocervix and endometrium are lined by a polarized single columnar 
epithelium. Moreover, the endocervix functions as the major site for cervicovaginal mucus 
production. By contrast, the ectocervix and vagina, nearly indistinguishable from each other, 
possess a stratified squamous epithelium that lacks polarity (16). The vaginal cavity is a 
hostile environment for incoming foreign particles. Several elements including (i) an acidic 
pH, (ii) an endogenous commensal bacterial flora, (iii) a mucus layer with known 
antimicrobial effects covering the epithelium and (iv) a physical well layered epithelial barrier 
possessing many resident immune cells, try to hamper free passage of foreign particles (12, 
16). It is highly intriguing to gain more knowledge on which mechanisms these pathogens 
have devised in order to overcome the latter obstacles. 
However, investigations leading towards novel information about the role of both 
endocervical and ectocervical/vaginal mucosa at very early events of STI is difficult to 
perform in humans. Several alternative in vivo models exist that allow in depth study of 
several STI, including the simian immunodeficiency virus (SIV)/macaque model, as model 
for HIV, and the HSV/guinea pig model, as model for genital herpes (14, 24). Despite their 
valuable contributions to the field, these animal models may not accurately reflect the 
infection of humans at mucosal surfaces. To circumvent this problem, the development of 
alternative homologous in vivo-related models such as tissue-derived organ cultures to model 
STI is crucial. Unlike the elaborately used cell lines, these models constitute a 3D 
environment and maintain the natural tissue architecture and microenvironment (27, 28). 
In the current study, we optimized a human genital mucosa explant model for future use in 
studies of pathogenic host entry mechanisms in the female genital tract of humans. Special 
emphasis was put on maintenance of tissue morphology as well as tissue viability during in 
vitro culture up to 96h: (i) epithelial thickness, lamina reticularis thickness and connective 
tissue composition were evaluated using light microscopy; (ii) epithelial integrity and 
basement membrane continuity were examined on conservation by means of transmission 
electron microscopy; (iii) occurrence of apoptosis was monitored by TUNEL-assay. 
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3.10.  Materials and Methods 
3.10.1.  Patients 
Pieces of healthy genital mucosa were gathered from women undergoing a routine 
hysterectomy (Ghent University Hospital). From all included patients, serum was collected. 
First, a progesterone and estradiol determination was performed. All persons provided written 
informed consent and the ethics committee of the Ghent University Hospital approved the 
study (EC/2010/152). Four different patients of various stages of the menstrual cycle were 
included for analyzing potential changes in tissue viability and morphology due to cultivation. 
 
3.10.2.  Human genital mucosa model set up 
A similar set up was used as for bovine respiratory and genital mucosal explants (27). Briefly, 
tissues were immediately placed in phosphate buffered saline (PBS), supplemented with 1 
µg/mL gentamycin (Invitrogen, Paisley, UK), 1 mg/mL streptomycin (Certa, Braine l’Alleud, 
Belgium), 1 mg/mL kanamycin (Sigma, St. Louis, MO, USA), 1000 U/mL penicillin 
(Continental Pharma, Puurs, Belgium) and 5 µg/mL fungizone (Bristol-Myers Squibb, New 
York, USA) for transportation to the laboratory. Genital mucosa was stripped from the 
underlying layers. Small square tissue pieces were made and placed on fine-meshed gauze for 
culture. The explants were cultivated in serum-free medium (50% DMEM (Invitrogen)/50% 
Ham’s F-12 GlutaMAX (Invitrogen)) supplemented with 0.1 mg/mL streptomycin (Certa), 
100 U/mL penicillin (Continental Pharma) and 1 µg/mL gentamycin (Invitrogen) for up to 
96h (37 °C, 5% CO2). 
 
3.10.3.  Tissue viability and morphology analysis during cultivation 
An analogous genital mucosa explant model was recently established in our laboratory for 
bovines. We applied similar techniques including TUNEL-assay, light and transmission 
electron microscopy for evaluating tissue viability/morphology at different time points of in 
vitro cultivation and are described in section 3.3 of this thesis (27). 
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3.10.4.  Statistical analysis 
SPSS software (one way ANOVA, Post-hoc Bonferroni and Tukey’s HSD) was used to 
evaluate the variance. The results are given as means + standard deviation of different (4) 
independent experiments. Results with P values of ≤ 0.05 were considered significant. 
 
3.11.  Results 
3.11.1.  Patients 
The 4 donor patients included in this study consisted of a 72 year old woman in post 
menopause (estradiol: 14.5 pg/mL; progesterone: 0.32 ng/mL), a 65-year old postmenopausal 
woman (estradiol: <12.0 pg/mL; progesterone 0.36 ng/mL), a 37-year old woman in the luteal 
phase (estradiol: 102 pg/mL, progesterone: 3.6 ng/mL) and a 45-year old woman in the 
follicular phase (estradiol: 36.2 pg/mL; progesterone: 1.1 ng/mL). 
 
3.11.2.  Viability analysis during tissue in vitro culture 
Values of the percentage epithelium and connective tissue TUNEL positive cells at the 
different time points for the different tissues are given in Table 1.  
Table 1. Occurrence of TUNEL-positive cells. The TUNEL assay was used as a parameter for the 
effect of in vitro culture on the viability of human mucosa explants. Values are given as means ± SD of 
4 different experiments.  
  % TUNEL-positive cells at … h of cultivation  
  0  24  48  72  96  
Ectocervix  Epithelium  0.0 ± 0.0  0.1 ± 0.1  0.7 ± 0.8  1.1 ± 1.1  1.3 ± 0.6  
 
Lamina propria  0.2 ± 0.3  1.1 ± 1.1  2.7 ± 2.7  3.5 ± 2.3  1.7 ± 0.5  
Endocervix  Epithelium  0.1 ± 0.1 0.2 ± 0.2 0.4 ± 0.4 0.2 ± 0.4 0.7 ± 1.0 
 Lamina propria 0.3 ± 0.3 0.8 ± 0.9 1.4 ± 1.1 1.2 ± 1.0 2.0 ± 0.6 
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No significant changes were observed in the occurrence of apoptosis, not within the 
epithelium nor in the lamina propria, during the in vitro cultivation of endocervical and 
ectocervical mucosa up to 96h (end of the experiment).  
 
3.11.3.  Morphology analysis during tissue in vitro culture 
Light microscopy 
Endocervix was found to be lined by a simple columnar epithelium interspersed by mucus-
producing cells. Measured values of epithelial thickness ranged from 12.9 ± 0.6 µm at 0h to 
12.0 ± 0.5 µm at 96h of cultivation (Figure 1). No differences could be found in between 
patients due to differences in menstrual cycle stage. No significant changes could be observed 
due to cultivation of explanted tissues. Ectocervical epithelium consisted of a nonkeratinized 
stratified squamous epithelium, similar as the vaginal epithelium. At 0h, the epithelial 
thickness was found to be 194.7 ± 87.0 µm. Measurements performed at 96h of cultivation 
resulted in an average value of 129.0 ± 106.6 µm (Figure 1). No significant changes in 
epithelial thickness due to in vitro culture were found. However, a substantial SD value was 
noticed which may be due to the different menstrual cycle stages of the donors. The smallest 
values were observed in tissues derived from postmenopausal women. Starting from 48h of 
culture we did see in some explants loss of the luminal layers of the epithelium, mainly 
stratum superficiale and less stratum spinosum. 
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Figure 1. HE staining light photomicrographs of human ectocervical (left) and endocervical (right) 
mucosa explants at 0h and 96h of in vitro culture. The measurements of epithelial thickness at various 
time points of tissue cultivation are given as means + SD within the graphs. 
 
Analysis of the composition of the connective tissue revealed no significant differences in 
percentage of nuclei or collagen due to cultivation. The connective tissue of the endocervix 
was found to be more cell dense compared to the ectocervix (Figure 2). 
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Figure 2. A Van Gieson staining to determine relative amounts of collagen and nuclei within a region 
of interest (black rectangle) was performed at different time points of cultivation. Values are given 
within the graphs as means of 4 independent experiments + SD. Pictures of ectocervical mucosa (a,b) 
and endocervical mucosa (c,d) at 0h and 96h of cultivation respectively are given underneath the 
graphs.  
 
The lamina reticularis thickness of the endocervix and ectocervix could be maintained 
throughout tissue culture. No significant differences were observed in between time points. 
Interestingly, we noticed a more profound thickness of the lamina reticularis in ectocervical 
mucosa compared to endocervical mucosa (Figure 3). 
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Figure 3. A reticulin staining was performed to determine lamina reticularis thickness (black arrows) 
in human genital mucosa explants. Ectocervical mucosa (a and b) and endocervical mucosa (c and d), 
both at 0h and 96h of cultivation respectively. The graph shows the measured values of lamina 
reticularis thickness at different time points of in vitro culture + SD (5 random measurements in 5 
random zones at all time points from 4 independent tissues). 
 
Transmission electron microscopy         
Epithelial integrity (Figure 4) and basement membrane continuity (lamina densa) (Figure 5) 
were found to be conserved at all time points for both endocervical and ectocervical tissues, 
as shown by the representative pictures at 0h and 96h of cultivation. 
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Figure 4. Representative photomicrographs (TEM) of ectocervical basal epithelium (a,b) and 
endocervical epithelium (c,d) at 0h and 96h of cultivation respectively. The location of the connective 
tissue is marked by an asterix. (4000 x) 
 
 
Figure 5. Representative TEM-images of the lamina densa (black arrows) in endocervical mucosa at 
0h and 96h of cultivation. (12 000 x) 
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3.12. Discussion 
Here we have described a newly developed and optimized organ culture model, derived from 
both squamous ectocervical and columnar endocervical tissues, for future host-pathogen 
studies in the female genital tract of humans. As this model uses tissues rather than a 
monolayer of cells (primary or transformed), it provides the natural in vivo tissue architecture, 
including epithelium, lamina propria, submucosa and immune cells. Alternative in vivo 
models to study genital infections in humans, such as different rodent models for genital HSV 
research and the SIV/macaque model for HIV research, have proven their usefulness (8, 14, 
24). However, small differences in cellular mediators of infection and invasion, which are 
often species-specific, exist and may generate inaccurate data when using these models. 
Different studies point out that extrapolations in between species must be carefully 
considered. First, one in vivo comparative study performed by Linehan and co-workers 
describes the expression pattern of nectin-1, an HSV entry receptor, in the human and mouse 
vagina. Interestingly, little extrapolation can be made from one to another. In humans, nectin-
1 expression and localization remains identical at the different stages of the menstrual cycle 
whereas in mice striking differences in expression levels were seen during estrous compared 
to diestrus (17). Second, although nectin homologues in mice resemble the human forms, 
mouse nectin-2 is not functional as entry receptor for HSV-1 and HSV-2 whereas human 
nectin-2 clearly mediates entry of HSV-2 and certain HSV-1 recombinants (30).  
In order to avoid such bias, we optimized in the present study homologous in vivo-related in 
vitro models for elucidating the host entry mechanisms of genital pathogens in the mucosa. In 
humans, genital organ cultures derived from ectocervical tissues (3, 4, 7, 9, 18) and 
endocervical (18, 20, 29) tissues have been described before. Collins and co-workers 
document the establishment and cultivation of an ectocervical organ culture for a duration of 
6 days. Preservation of structure was assessed by means of light microscopy and preservation 
of function was tested by checking expression levels of several immune cell and epithelial cell 
markers as well as a cell proliferation marker by means of immunofluorescence microscopy at 
different time points of in vitro culture (3). In addition, trans-epithelial leakage of blue 
dextran was performed at the last day of culture to check for epithelial functional integrity 
(10). Endocervix could also be maintained in in vitro culture for up to 6 days. As a parameter 
for functionality, mucus production was checked daily and could still be observed at day 6 of 
cultivation (18). In most of these studies, no clear information on preservation of basement 
membrane integrity and connective tissue composition of the cultured tissues is provided. 
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Given the fact that some microorganisms preferentially adhere to extracellular matrix proteins 
within the basement membrane and connective tissue, evaluating the preservation of these 
layers during in vitro conditions will be an added value when aiming for pathogen-mucosa 
interaction studies (26).        
Hence, when optimizing the human ectocervical and endocervical mucosa model in this 
study, special emphasis was put on preservation of viability and morphology of the 
epithelium, basement membrane and connective tissue during in vitro cultivation. Viability 
analysis of the tissues at different time points of cultivation showed no significant changes in 
the occurrence of apoptotic cells. Morphological analysis revealed a few interesting facts. 
First, HE-stainings showed that for ectocervical explants a substantial SD value was noticed 
which may be due to the different menstrual cycle stages of the donors. The smallest values 
were observed in tissues derived from postmenopausal women. This is in line with previously 
published results (23, 25). Starting from 48h of culture we did see in some explants loss of the 
luminal layers of the epithelium, mainly stratum superficiale and less stratum spinosum. 
However, the basal layer stayed intact for the entire experiment. Ectocervical epithelium is 
accepted to be non-polarized in its outer layers. Intercellular bridges are either weak or non-
existing and can explain the easy detachment in in vitro culture (24). Collins and co-workers 
also observed loss of the ectocervical superficial layers starting from 48h of in vitro culture. 
They mention that the basal layers remained intact at all times and that the epithelium started 
to regenerate after 6 days of in vitro culture (3). Second, the lamina reticularis was found to 
be thicker in ectocervical mucosa compared to endocervical mucosa. The lamina reticularis 
thickness is quite tissue-specific and differences may be observed (5). Third, we noticed a 
more cell-dense connective tissue for endocervical mucosa compared to ectocervical mucosa. 
Endocervix is known to be anatomically restrained because of its firm attachment mediated by 
the connective tissue to surrounding muscle fibers (13). In conclusion, we can state that we 
have set up, optimized and fully characterized both a human genital ectocervical and 
endocervical mucosa explant model. 
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4.1. Abstract 
Bovine herpesvirus 1 (BoHV-1) is a well-known disease-causing agent in cattle. There is little 
known detailed information on viral behavior with emphasis on host invasion at primary 
replication sites such as the mucosa of the upper respiratory tract. We previously optimized a 
bovine upper respiratory tract mucosa explant model and showed that tissues were maintained 
in culture for up to 96 hours without any significant changes in morphometry and viability. In 
this study, bovine upper respiratory tract mucosa explants were infected with BoHV-1 
(Cooper) and collected at 0, 24, 48, and 72 hours post inoculation (pi). Using a quantitative 
analysis system to measure plaque latitude and invasion depth, we assessed dissemination 
characteristics in relation to elapsed time pi and found a plaquewise spread of BoHV-1 across 
the basement membrane as early as 24h pi, similar to pseudorabies virus (PRV). Moreover, 
we observed that BoHV-1 exhibited an increased capacity to invade in proximal tracheal 
tissues compared to tissues of the deeper part of the nasal septum and ventral conchae. 
Revealing a more distinct invasion of BoHV-1 in proximal trachea, we can conclude that, in 
order to study an important aspect of BoHV-1 pathogenesis, the bovine upper respiratory tract 
mucosa explant model is the best suited model. 
 
4.2. Introduction 
The revised family Herpesviridae incorporates pathogenic members that can cause disease in 
mammals, birds, and reptiles. This family is the most important out of three families in the 
new order of the Herpesvirales (1). During evolution, these viruses developed different 
mechanisms to (i) penetrate different mucosal barriers and to reach internal organs via 
leukocytes and nerve endings (invasion), (ii) evade both specific and aspecific immunity 
(immune-evasion), and (iii) hide in the infected host (latency) (7-9). Many viruses from the 
Alphaherpesvirinae subfamily use the epithelium of the upper respiratory tract as an 
important mucosal portal of entry. In contrast to other respiratory viruses, these viruses can 
penetrate through the basement membrane (BM) after local dissemination. If during this 
mucosal invasion nerve endings or blood vessels are reached, these viruses can spread in the 
host, resulting in neuronal symptoms and viremia (14, 15). Bovine herpesvirus 1 (BoHV-1 ) is 
an important pathogen of cattle and can cause two major clinical entities: infectious bovine 
rhinotracheitis and infectious pustular vulvovaginitis/balanoposthitis (2). BoHV subtype 1.1 
(infectious bovine rhinotracheitis) spreads in the respiratory mucosa which leads to extensive 
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tissue destruction with ulceration in the upper respiratory tract. However, subtype 1.2 
(infectious pustular vulvovaginitis/balanoposthitis) replicates at the peripheral genital tract 
and is associated with pustular lesions. From the primary site of replication, the virus will gain 
access to local sensory neurons, reach corresponding ganglia, and establish lifelong latency. 
Following viremia, abortion in cows and fatal systemic infections in young calves may occur 
(13). How BoHV-1, as well as many other mammalian alphaherpesviruses, can penetrate so 
easily through the mucosal layer, despite the presence of barriers including the BM, is still 
unknown. Little is known about the mechanisms of replication and invasion in the respiratory 
tract for BoHV-1. We previously optimized a bovine upper respiratory tract in vitro explant 
model. The aim of the present study was to study the BoHV-1 dissemination kinetics in the 
upper respiratory mucosa, including nasal septum, ventral conchae and proximal trachea by 
applying the established in vitro model. 
 
4.3. Materials and methods 
4.3.1. Experimental design of a respiratory mucosa explant in in vitro culture 
Bovine respiratory tissue was obtained at a slaughterhouse and the bovine respiratory mucosa 
explant model was set up as previously described. In brief, samples were taken from four 
calves aged 6 months. The head was cut longitudinal into two pieces, exposing the nasal 
septum. We cautiously removed nasal septum from the caudal two thirds of the nasal cavity 
(septum), ventral conchae (conchae), and proximal trachea (trachea). Tissues were transported 
to the laboratory on ice in phosphate buffered saline (PBS), supplemented with 1 μg/mL 
gentamycin (Gibco), 1 mg/mL streptomycin (Certa), 1 mg/mL kanamycin (Sigma), 1000 
U/mL penicillin (Continental Pharma), and 5 μg/mL fungizone (Bristol-Myers Squibb). We 
collected blood to perform a complement-dependent seroneutralization (SN)-test to determine 
BoHV-1 specific antibody titers as an animal exclusion criterion. Using surgical blades 
(Swann-Morton), respiratory mucosa was carefully stripped from the underlying layers. 
Mucosal explants covering a total area of 0.7 cm2 were produced and placed in six well 
culture plates (Nunc) epithelium upwards on fine meshed gauze for culture. We added serum-
free culture medium (50% DMEM (Gibco)/50% Ham’s F-12 GlutaMAX (Gibco)) 
supplemented with 0.3 mg/mL glutamine (BDM Biochemical), 0.1 mg/mL streptomycin 
(Certa), 100 U/mL penicillin (Continental Pharma)), and 1 μg/mL gentamycin (Gibco) until 
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achieving an air-liquid interface. The explants were cultivated for up to 96h at 37°C and 5% 
CO2. 
 
4.3.2. Virus inoculation and assessment of dissemination kinetics 
Inoculation of the explants with BoHV-1 Cooper strain (Colorado) took place after 24h of 
cultivation (18). Explants were taken from their gauze and placed epithelium upwards in a 24-
well plate (Nunc). After double washing with warm medium, 1 mL medium containing 107 
TCID50/mL virus was added in each well thereby submerging the explant. After incubation 
for 1 hour at 37°C and 5% CO2, the explants were washed three times with warm medium and 
placed back on the gauze. 
To monitor kinetics of viral dissemination, explants were gathered at different time points 
post inoculation (pi). After collection, samples were carefully embedded in methocel (Fluka) 
and frozen at -70°C. Cryosections were made, fixed in methanol (-20°C, 100%), and kept at -
20°C until staining. For the evaluation of penetration through the BM, the BM in BoHV-1 
infected explants was stained. Mouse anti collagen VII antibodies (Sigma), directed against 
anchoring fibrils residing in the BM, and goat anti-mouse Texas Red antibodies (Molecular 
Probes) were used in a first step to mark the BM barrier. Secondly, a FITC -labeled goat anti-
IBR polyclonal antiserum (VMRD) staining was performed to visualize viral proteins. 
Mounted samples were analyzed using a confocal microscope (Leica TCS SP2 confocal 
microscope). Thereafter, plaque latitude and invasion depth (distance underneath the BM) 
were evaluated using the line-tool function of the software program ImageJ. Finally, at 24 and 
48h pi, the average number of plaques was measured in the entire evaluated surface of 
explants derived from either septum, conchae, or trachea. 
 
4.3.3. Statistical analysis 
Analysis of variance was performed on the obtained data using SPSS software (ANOVA). 
The results represent means + standard deviation of quadruple independent experiments 
performed for the analysis of viral dissemination. Data with P values of ≤ 0.05 were 
considered significant. 
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4.4. Results 
4.4.1. Evaluation of primary viral dissemination 
All four animals showed an SN-titer of < 2 for BoHV-1 specific antibodies and were therefore 
selected for this study. We observed clear distinct infected cells at 24h, 48h, and 72h pi. 
BoHV-1 was found to spread in a plaquewise manner in respiratory mucosa (Figure 1).  
 
Figure 1. Fluorescent images taken by means of confocal microscopy from different upper respiratory 
tissues infected with BoHV-1 Cooper strain at 24, 48 and 72h pi. Viral antigen was stained using a 
FITC®-labeled goat anti-IBR polyclonal antiserum (VMRD). To visualize collagen VII, mouse anti 
collagen VII antibodies (Sigma) and goat anti-mouse Texas Red® antibodies (Molecular Probes) were 
used. 
 
Starting at 48h pi and more pronounced at 72h pi, infected epithelial cells loosened and 
detached from the viral plaque. Both plaque latitude and invasion depth in septum, conchae, 
and trachea were evaluated at different time points pi. 
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Plaque latitude 
No plaques were visible at 0h pi for all tissues. Individual plaques were measured at 24h and 
48h pi Since almost all present epithelial cells in the bovine upper respiratory tract (bURT ) 
mucosa explants were infected, we were not able to measure individual plaques at 72h pi At 
24h pi, average plaque latitudes of 142.5 ± 67.4 μm in septum, 170.6 ± 32.4 μm in conchae, 
and 168.3 ± 43.4 μm in trachea were observed. Plaque latitude increased over time and at 48h 
pi, we measured average plaque latitudes of 275.5 ± 55.0 μm in septum, 312.3 ± 14.4 μm in 
conchae, and 317.9 ± 12.1 μm in trachea (Figure 2a). Plaque latitude rose significantly 
between 0h, 24h, and 48h pi. However, no major changes concerning the latitude were seen 
when comparing septum, conchae, and trachea. 
Plaque depth 
Plaque depth underneath the BM was evaluated at 0h, 24h, 48h, and 72h pi. In septum 
average plaque depths of 0.0 ± 0.0 μm at 0h pi, 1.3 ± 2.2 μm at 24h pi, 14.1 ± 9.0 μm at 48h 
pi, and 34.6 ± 13.1 μm at 72h pi were observed. Average plaque depths in conchae ranged 
from 0.0 ± 0.0 to 2.8 ± 2.1 μm, 25.9 ± 7.0 μm and 36.8 ± 11.6 μm at 0h, 24h, 48h, and 72h pi, 
respectively. When analyzing average plaque depth in trachea, values starting from 0.0 ± 0.0 
μm at 0h pi to 7.4 ± 5.4 μm at 24h pi, 50.7 ± 7.3 μm at 48h pi, and 64.7 ± 16.2 μm at 72h pi 
were observed (Figure 2b). There was a significant increase in plaque depth between 24h, 
48h, and 72h pi for all tissues. Except in tracheal tissues, between 48h and 72h pi there was no 
significant change in plaque depth underneath the BM. There was a clear significant 
difference when evaluating plaque invasion depth underneath the BM in trachea compared 
with that in septum (at 24h, 48h, and 72h pi) and conchae (at 48h and 72h pi) (Figure 1). 
Plaque number 
We did not see any significant changes in plaque number between the deeper part of the nasal 
septum, ventral conchae, and proximal trachea at 24h and 48h pi. Results of the average 
number of plaques are given per 5 mm2. At 24h pi, an average plaque number of 21.2 ± 14.8, 
42.3 ± 27.2, and 25.0 ± 0.8 was counted for septum, conchae, and septum. There was an 
average amount of 31.0 ± 5.6 plaques in septum, 24.5 ± 10.5 plaques in conchae, and 25.0 ± 
12.3 plaques in trachea at 48h pi. Moreover, no major differences in average plaque number 
were noticed when comparing time points 24h and 48h pi for septum, conchae, and trachea. 
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Figure 2. Evolution of BoHV-1 (a) plaque latitude and (b) plaque penetration depth underneath the 
basement membrane at 0, 24, 48h pi and 0, 24, 48, 72h pi, respectively. Data are given as means + SD 
(error bars). Significant differences are pointed out by the use of different letters (another letter means 
a statistical difference). Data with P values ≤ 0.05 were considered significant. 
 
4.5. Discussion 
Little is known about the primary replication and dissemination of different 
alphaherpesviruses at host mucosal entry ports. Nevertheless, getting a fundamental image on 
how the virus behaves at its primary replication site can provide insights for prevention and 
treatment on a rational basis. In the present study, a bURT mucosa explant model was set up 
to study BoHV-1 dissemination characteristics in bovine respiratory mucosa. The use of 
respiratory organ cultures already proved to be of importance in different scientific areas. 
Insights in drug transportation, metabolic pathways, and pathogen-host interactions are 
attained achievements based on organ culture arrays. The explant model is the perfect 
compromise between in vitro cell cultures and in vivo laboratory animals. In cell cultures, no 
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tissue structure is present and therefore essential cell-cell and cell-extracellular matrix 
contacts are lost. Current in vivo model systems often used in alphaherpesvirus studies mostly 
make use of rodents. However, these models create a heterologous situation where species 
specific cellular components, which may play a role in viral invasion, are absent. 
When comparing dissemination kinetics of BoHV-1 in septum, conchae, and trachea, we 
made some interesting findings. There was a significantly higher BoHV-1 invasion depth in 
tracheal tissues when compared to that in tissues of septum and conchae at 48h pi as well as 
72h pi. The reason for this difference may be the significantly smaller thickness of the lamina 
reticularis in trachea compared to septum and conchae, suggesting that the virus has to cross a 
thinner BM barrier in the trachea. Although speculative, an alternative hypothesis can be put 
forward to explain the rapid and efficient invasion in tracheal tissues. Evans and colleagues 
reported an attenuated fibroblast sheath located just underneath the BM zone (4). This sheath 
consists of large flat fibroblasts covering up to 70% of the BM zone and makes contact with 
the basal lamina. These contacts are mainly situated underneath basal cells, which form the 
contact between epithelium and BM (3, 6). Attenuated fibroblasts have only been described so 
far in trachea, intrapulmonary bronchi, and terminal bronchioles in different species (4, 5, 19). 
Alphaherpesviruses are known for their efficient cell-to-cell spread (14, 15). Since epithelial 
basal cells and attenuated fibroblast are in close proximity to each other, combined with the 
observed smaller reticular lamina thickness, this could explain why invasion in trachea is 
more efficient than in conchae or septum. These findings put emphasis on the involvement of 
the trachea in the clinical picture (IBR) caused by BoHV-1 and are correlated with the in vivo 
situation (14). 
Generally, we set up mucosa explant models of bovine, porcine, and equine in our laboratory 
to study aspects of viral mucosal invasion. BoHV-1 and pseudorabies virus (PRV) both 
exhibit a plaquewise spread across the BM in the in vitro mucosa explant model suggesting 
they have minor effort in passing this host defense line (10, 11). This is correlated with the 
severe upper respiratory tract in vivo symptoms of both viruses. On the contrary, equid 
herpesvirus 1 (EHV-1 ) spreads only laterally and does not pass the BM. EHV-1 developed 
another system to invade. It misuses local immune cells as carriers to penetrate the host (12, 
16, 17). The attenuated EHV-1 replication characteristics in respiratory mucosa correlate with 
the mild in vivo respiratory symptoms. Moreover, in striking contrast with what was observed 
for BoHV-1, EHV-1 dissemination characteristics in tracheal tissue did not differ at all from 
those in other respiratory tissues (17)(A. P. Vandekerckhove, Ghent University, personal 
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communication). These findings confirm the in vivo relevance of the mucosa explant in vitro 
model. During evolution, what is the reason different mechanisms of viral invasion occurred 
between different alphaherpesviruses? Is this inherent to the species and merely an adaptation 
of the virus to its host? Or did some strains become more virulent by acquiring advantageous 
genetic material over time? Further studies using the respiratory mucosal explants may 
provide answers to these questions. 
Conclusion 
We conclude that in vitro cultured upper respiratory tract mucosal explants are susceptible to 
BoHV-1 infection and therefore a good alternative for experiments on living animals (the 
three Rs of Russell and Burch). BoHV-1 was found to spread in a plaquewise manner when 
investigating the evolution of plaque formation at different time points pi in bURT mucosa 
explants. The crossing of the BM started from 24h pi onwards and all plaques crossed the BM 
at 48h pi. Furthermore, BoHV-1 invaded more efficiently in depth across the BM in proximal 
tracheal tissue. Therefore, the proximal trachea explant model seems to be the ideal tissue 
model for further investigations of the BoHV-1 stromal invasion mechanism through the BM. 
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4.8. Abstract 
In general, members of the Alphaherpesvirinae use the epithelium of the upper respiratory 
and/or genital tract as a preferential site for primary replication. Bovine herpes virus type 1 
(BoHV-1) may replicate at both sites and cause two major clinical entities designated 
infectious bovine rhinotracheitis (IBR) and infectious pustular vulvovaginitis/balanoposthitis 
(IPV/IPB) in cattle. Subtype 1.1 is hypothesized to invade preferentially the upper respiratory 
mucosa whereas subtype 1.2 favors replication at the peripheral genital tract. However, some 
studies are in contrast with that hypothesis. A thorough study of primary replication at both 
mucosae could elucidate whether or not different BoHV-1 subtypes show differences in 
mucosa tropism. We established bovine respiratory and genital organ cultures with emphasis 
on maintenance of tissue morphology and viability during in vitro culture. In a next step, 
bovine respiratory and genital mucosa explants of the same animals were inoculated with 
either the BoHV-1.1 Cooper, the BoHV-1.1 Lam, the BoHV-1.2a Schönböken or the BoHV-
1.2b K22 strain. A quantitative analysis of viral invasion in the mucosa was performed at 0h, 
24h, 48h and 72h post inoculation (pi) by measuring plaque latitude and penetration depth 
underneath the basement membrane. All BoHV-1 subtypes exhibited a more profound 
invasion capacity in respiratory tissue compared to that in genital tissue at 24h pi. However, at 
24h pi plaque latitude was found to be larger in genital tissue compared to respiratory tissue 
and this for all subtypes. These similar findings among the different subtypes take the edge 
off the belief of the existence of specific mucosa tropisms of different BoHV-1 subtypes. 
 
4.9. Introduction 
Alphaherpesviruses in general have a broad epithelial tropism. BoHV-1, the known 
etiological agent of infectious bovine rhinotracheitis (IBR) and infectious pustular 
vulvovaginitis/balanoposthitis (IPV/IPB) in cattle, may replicate in both respiratory and 
genital mucosa. However, respiratory and genital infections have been assigned to different 
BoHV-1 strains in the past (24). 
Although there is proof of the existence of the virus as early as 1941, BoHV-1 was firstly 
isolated in 1955 (10, 15). In the late 1950’s both the respiratory disease prototype strain 
Cooper and the genital disease prototype strain K22 were isolated from field cases of 
respectively IBR and IPV in the United States (14, 33). Importantly, before 1977, a 
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continental discrepancy was present. Genital infections were predominant throughout Europe 
whereas respiratory infections were mainly prevalent at feedlots in the United States and 
Canada. Some authors believe that the virulent respiratory strains emerged out of the less 
virulent genital strains. They state that the enhanced virulence of the virus for the respiratory 
epithelium is a consequence of rapid passages of the virus in crowded susceptible populations 
present in “feedlots”, typically for the United States at that time. Since 1977, severe “North 
American like” IBR emerged on the European continent (12, 18, 27).  
An attempt was made to see if BoHV-1 could be subdivided into distinct types with different 
tropisms i.e. whether a correlation could be found between IBR and IPV on the one hand and 
distinct virus subtypes on the other hand. Using restriction endonuclease digestion and 
reactivity tests to a panel of monoclonal antibodies, a classification was made of different 
BoHV-1 subtypes. BoHV-1.1 was associated with respiratory disease and abortion whereas 
BoHV-1.2 was regarded as a genital type (17, 19, 22). Subtype BoHV-1.3 was renamed into 
BoHV-5 as new findings showed significant differences in genomic and antigenic properties 
between BoHV-1.3 and other BoHV-1 strains (3, 20). Furthermore, a distinction was made 
between different BoHV-1.2 subtypes. BoHV-1.2b causes local genital lesions and possibly 
mild respiratory illness; BoHV-1.2a seems to have both tropism for the genital and respiratory 
mucosa and is associated with abortion (17, 19, 28). However, this postulation about several 
subtypes possessing diverse mucosa tropisms has been contested since several studies showed 
no correlation between the different genotypes and their clinical manifestations (1, 4, 12, 16, 
18, 23, 28).  
A good way to elucidate the relationship between the distinct viral BoHV-1 subtypes and the 
clinical entities would be to test isolates representing the different subtypes on similar groups 
of animals under identical conditions. Practical, ethical and financial reasons make this in 
vivo approach difficult to perform. For that purpose, suitable in vitro systems resembling the 
in vivo situation and implementing the three R’s principle of Russell and Burch (1959), are 
needed to study primary host-virus interactions. 
The aim of the present study was to evaluate quantitatively the replication characteristics of 
different BoHV-1 subtypes in in vitro systems of bovine respiratory and genital mucosa 
explants. Previously, we described the optimization of in vitro bovine respiratory and genital 
organ cultures. In this part of the study, bovine organ cultures of trachea and vestibulum 
vaginae derived from the same animals were infected with several BoHV-1.1, BoHV-1.2a and 
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BoHV-1.2b isolates. A quantitative analysis of viral mucosal invasion was performed for the 
different BoHV-1 subtypes and compared at 0h, 24h, 48h and 72h post inoculation (pi) by 
measuring plaque latitude and penetration depth underneath the basement membrane (BM). 
 
4.10.  Materials and methods 
4.10.1.  Selection of animals 
At the slaughterhouse, three different female slaughter animals between 3 and 5 years old 
were selected. Criteria to include the animals in this experiment were based on both female 
reproductive hormone level and BoHV-1 specific serological status. At slaughter, a thorough 
palpation and visual inspection of the ovaries was performed to select cows with a clear 
marked corpus luteum. Moreover, blood was collected at slaughter. On all sera, a 
progesterone determination and a complement-dependent seroneutralization (SN)-test were 
performed to determine peripheral blood progesterone levels and BoHV-1 specific antibody 
titers respectively. 
 
4.10.2.  Gathering of tissues and preparation of air-liquid interface organ cultures 
From three different cows, proximal trachea and vestibulum vaginae were collected at the 
local abattoir immediately after slaughter. A similar set up was used for bovine respiratory 
and genital mucosal explants. Briefly, tissues were immediately placed in phosphate buffered 
saline (PBS), supplemented with 1 μg/mL gentamycin (Invitrogen, Paisley, UK), 1 mg/mL 
streptomycin (Certa, Braine l’Alleud, Belgium), 1 mg/mL kanamycin (Sigma, St. Louis, MO, 
USA), 1000 U/mL penicillin (Continental Pharma, Puurs, Belgium) and 5 μg/mL fungizone 
(Bristol- Myers Squibb, New York, USA) for transportation to the laboratory. Respiratory and 
genital mucosa was stripped from the underlying layers. Small square tissue pieces were made 
and placed on fine-meshed gauze for culture. The explants were cultivated in serum-free 
medium (50% DMEM (Invitrogen)/50% Ham’s F-12 Gluta-MAX (Invitrogen)) supplemented 
with 0.1 mg/mL streptomycin (Certa), 100 U/mL penicillin (Continental Pharma) and 1 
μg/mL gentamycin (Invitrogen) for up to 96h (37 °C, 5% CO2). Both respiratory and genital 
tissue of three cows was used to evaluate BoHV-1 subtype replication characteristics. 
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4.10.3.  Inoculation of explants with different BoHV-1 subtypes 
Different strains were used, representing the known different genotypes of BoHV-1. The 
Cooper strain, which is considered as the prototype 1.1 subtype, was isolated in Colorado 
(33). Another 1.1 strain, Lam, was isolated in 1972 from an IBR-case in the Netherlands (8, 
31). The prototype 1.2 strain K22 is typed as a subtype 1.2b (17). This isolate was obtained 
from an IPV outbreak in New York (14). The Schönböken isolate is designated as a BoHV-
1.2a subtype and was isolated in Germany (6, 13). All strains obtained were from unknown 
passages. From each of them, a second passage was produced and utilized in our laboratory. 
After 24h of cultivation, explants were inoculated with the different strains. The explants were 
taken from their gauze and placed in a 24-well plate after rinsing with warm medium. In each 
well, 1 mL of virus-containing medium (107 TCID50/mL) was added. The submerged explants 
were incubated for 1h (37 °C, 5% CO2). Before the tissues were placed back again on their 
gauze, they were thoroughly washed. In that way, different explants, both proximal trachea 
and vestibulum vaginae from the same animal were infected with the different strains. 
Samples were collected at 0h, 24h, 48h and 72h pi. At every time point, 2 respiratory and 2 
genital explants from each animal for each strain were collected. Finally, all gathered explants 
were embedded in a cryoprotection medium (Methocel®, Fluka (Sigma)) and frozen at -70 °C. 
 
4.10.4.  Evaluation of BoHV-1 subtype kinetics 
From all collected samples, cryosections were produced, fixed in methanol (-20 °C, 100%) 
and kept at -20 °C until staining. An immunofluorescence staining was performed to evaluate 
plaque latitude and plaque penetration depth underneath the BM. Firstly, to stain the BM, 
mouse anti-collagen VII antibodies (Sigma) and goat anti-mouse Texas Red® (Molecular 
Probes (Invitrogen)) were used. Next, an FITC®-labeled goat anti-IBR polyclonal antiserum 
(VMRD, Pullman, WA, USA) directed against viral proteins was applied. Mounted samples 
were analyzed by means of a confocal microscope (Leica TCS SP2 confocal microscope). 
Using the software program ImageJ, dissemination characteristics were monitored. 
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4.10.5.  Statistical analysis 
The data obtained were assessed using SPSS software (ANOVA) to evaluate the variance. 
The results shown represent means + standard deviation of triple independent experiments for 
analysis of viral subtype replication characteristics. The results with P values of ≤ 0.05 were 
considered significant. 
 
4.11.  Results 
4.11.1.  Progesterone determination and Sn-test 
All animals included in the experiment had a peripheral blood progesterone (P4) level of > 1 
ng/mL, suggesting they were in the luteal phase of the reproductive cycle. Three animals 
showing an Sn-titer of < 2 for BoHV-1 specific antibodies were selected for the study of 
BoHV-1 subtype dissemination characteristics. 
  
4.11.2.  BoHV-1 subtype kinetics 
Individual plaques were visible starting from 24h pi for all strains in all tissues. All different 
BoHV-1 subtypes were found to spread in a plaquewise manner in both the respiratory and 
genital mucosa derived from three animals. The analysis of plaque latitude and penetration 
depth underneath the BM was performed at different time points pi for all BoHV-1 subtypes 
on proximal trachea and vestibulum vaginae (Figure 1). 
 
Plaque latitude 
Individual plaque measurement was performed at 0h, 24h, 48h and 72h pi (Figure 2a). 
In relation to time  
At 0h pi, no viral plaques were visible. A significant increase in plaque latitude was observed 
between 0h, 24h, 48h and 72h for all strains on the different tissues. 
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In relation to tissue  
Interestingly, we observed a significant difference in plaque latitude between proximal 
trachea and vestibulum vaginae at 24h pi. This was noticed for all different BoHV-1 subtypes. 
Lateral spread was more clear in vestibulum vaginae compared to the proximal trachea. At 
48h pi, the Lam and Schönböken strain still exhibited a higher dissemination capacity in the 
epithelium of the vagina compared to the trachea whereas Cooper and K22 did not. All strains 
no longer showed a significant difference in plaque latitude when comparing proximal trachea 
and vestibulum vaginae at 72h pi (Figure 2a). 
 
 
Figure 1. Confocal fluorescent images of bovine respiratory (a) and genital (b) mucosa explants 
inoculated with different BoHV-1 subtypes at 24h pi (left side) and 72h pi (right side). Viral antigen is 
colored with an FITC®- labeled goat anti-IBR polyclonal antiserum. Collagen VII is marked with 
mouse anti-collagen VII and goat anti-mouse Texas Red® antibodies. 
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In relation to strain  
When comparing the strains, no significant differences between the subtypes could be 
observed at 0h, 24h, 48h and 72h pi. All did exhibit a higher average plaque latitude at 24h pi 
in vestibulum vaginae compared to proximal trachea (Figures 1-2a). 
 
Plaque penetration depth underneath the BM 
The average invasion depth of different BoHV-1 subtypes was measured at 0h, 24h, 48h and 
72h pi (Figure 2b). 
In relation to time  
At 0h pi, no vertical spread was observed for all different BoHV-1 subtypes in both proximal 
trachea and vestibulum vaginae. All strains included showed an increase in plaque penetration 
depth between 0h, 24h, 48h and 72h pi in proximal trachea and vestibulum vaginae. This 
increase was significant for all strains on all tissues between 48h and 72h pi. 
In relation to tissue  
Both respiratory strains Cooper and Lam showed a clear advantage on proximal trachea 
compared to the vestibulum vaginae. The average invasion depth was significantly higher in 
respiratory tissue than in genital tissue and this at 24h (Lam en Cooper) and 48h (Cooper) pi. 
Interestingly, for both designated genital 1.2-strains Schönböken and K22, we did not see a 
significant difference when comparing both target tissues. However, we must mention that for 
both genital strains at 24h pi, not one plaque crossed the BM in the genital tract whereas some 
plaques did in the respiratory tract. At 48h (except Cooper) and 72h pi, no significant 
differences were found when comparing all strains on proximal trachea and vestibulum 
vaginae (Figures 1-2b). 
In relation to strain  
We observed no significant differences amongst strains at 0h, 24h, 48h and 72h pi. The 
penetration depth of the Cooper strain in the proximal trachea was significantly higher than 
the penetration depth of the Schönböken strain in the proximal trachea only at 24h pi. 
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Figure 2. Replication characteristics of different BoHV-1 subtypes in respiratory and genital tissues 
derived from the same animals. Evolution of plaque latitude (a) and plaque penetration depth 
underneath the basement membrane (BM) (b) was evaluated at 0h, 24h, 48h and 72h pi. Data are 
given as means + SD (error bars). Significant differences between respiratory and genital tissue are 
indicated by means of asterisks. 
 
4.12. Discussion 
In this study, we utilized bovine respiratory and genital organ culture systems to reconstruct 
key elements in BoHV-1 mucosal invasion and moreover, to shed some light on the current 
classification of different BoHV-1 subtypes with particular tropisms. Because of their in vivo 
relevance, these in vitro models are highly appreciated since laboratory animal use is 
diminished and confounding factors such as individual animal variation and environmental 
factors are excluded. Therein lies their strength, when comparing an array of strains/subtypes 
on viral behavior at mucosal entry ports.  
4B Comparative analysis of replication characteristics of BoHV-1 subtypes in bovine respiratory and genital mucosa explants: a phylogenetic enlightenment 
 
150 
 
Bovine respiratory and genital mucosa explants from the same animals were inoculated with 
several BoHV-1 subtypes. Both respiratory and genital mucosa were found to be susceptible 
to infection with all different BoHV-1 subtypes. This dual tropism is also seen in closely 
related animal alphaherpesviruses with either emphasis on the genital tract such as caprine 
herpesvirus type 1 and cervid herpesvirus type 2; or on the respiratory tract such as cervid 
herpesvirus type 1 and suid herpesvirus type 1 (PRV) (5, 21, 25, 29, 30). However, 
subdivision into different subtypes of the latter viruses never was an issue. Moreover, 
comparison of the DNA sequences of different BoHV-1 subtypes is generally accepted to 
show at least 95% homology (7, 26). Such genetic heterogeneity is also observed among field 
strains of other herpesviruses such as PRV (2, 9, 32).  
Next, a thorough analysis on the dissemination characteristics of different BoHV-1 subtypes 
on both respiratory and genital mucosa divulged important information on the current 
phylogenetic classification. Looking at average plaque penetration depth, key findings were 
twofold. Firstly, the so called respiratory subtypes Cooper and Lam invaded significantly 
deeper in respiratory tissue compared to genital tissue at 24h and 48h pi. However, secondly, 
in general all BoHV-1 subtypes exhibited a more profound invasion capacity in respiratory 
tissue compared to that in genital tissue at 24h pi. Massive accumulation of neutrophils and 
activation of macrophages reach peaks between 24-48h post BoHV-1 infection (11). Thus, the 
latter findings clearly demonstrate the outright advantage of all subtypes when invading 
respiratory tissues in pathogenesis. Caprine herpesvirus type 1, which is responsible for 
genital and respiratory disease in goats, shows a similar advantage on the respiratory tract. In 
general, infection by the genital route is often locally confined while the virus can spread by 
viremia after respiratory infection (29). The observed rapid spread through the BM towards 
blood vessels in respiratory tissues and the avoidance of the local immunity peak, might be an 
explanation why BoHV-1-induced abortion is mainly seen after a respiratory infection (24). 
Concerning average plaque latitude, all strains replicated to a similar extent in epithelial cells. 
It is noteworthy that at 24h pi, plaque latitude was found to be higher in genital tissue 
compared to respiratory tissue and this for all subtypes. This higher plaque latitude in the 
genital tract may be a compensation of the virus for the hampered spread into the depth 
compared to respiratory tissue, as mentioned above. Differences in BoHV-1 spread between 
upper respiratory and genital tissues could potentially be related to differences in apoptosis 
during cultivation of these different tissues. The only differences observed in BoHV-1 
subtype replication characteristics in the different tissues were noticed at 24h pi. However, at 
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this point (48h of cultivation), we see very little, if any, differences in the occurrence of 
apoptosis between the upper respiratory and genital tract. For this, we conclude that the small 
increase in apoptotic cells throughout cultivation is likely negligible for the replication 
characteristics of BoHV-1 strains.  
Our findings are in line with the vision of McKercher. He believes that virulent respiratory 
strains arose out of the less virulent genital strains and that in general the virus may be limited 
in invasion capacity due to biochemical and physiological characteristics of the vagina with 
emphasis on barrier function (12, 18). We can conclude that respiratory and genital organ 
cultures are suitable to study BoHV-1 invasion at primary entry ports and that they may be 
extrapolated to other species and viruses.  
Taken together, our findings and the existing knowledge on BoHV-1 classification, clearly 
take the edge off the belief of the existence of specific mucosa tropisms of different BoHV-1 
subtypes and make the phylogenetic BoHV-1 subdivision rather farfetched. The question 
arises whether this could reflect a difference in virulence between strains, as seen in all other 
viruses, rather than a difference in mucosa tropism? 
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5.1.  Abstract 
Bovine herpesvirus 4 (BoHV-4), a gammaherpesvirus widespread in cattle, mainly remains 
dormant but can cause significant economical losses as complicating agent in uterine diseases. 
Together with murid herpesvirus 4 (MuHV-4), BoHV-4 represents one of the best 
experimental models for studying gammaherpesviruses, which include the human pathogens 
Epstein-Barr virus (EBV) and Kaposi’s sarcoma-associated herpesvirus (KSHV). 
Nevertheless, a readily available, in vivo related, homologous in vitro tissue model for BoHV-
4 is still lacking and limits pathogenesis studies. In the present study, we established such a 
model by inoculating bovine respiratory and genital mucosa explants with BoHV-4 and 
evaluated whether these tissues support replication and act as primary host entry portals. In 
addition, we compared the dissemination kinetics of BoHV-4 with those of another bovine 
herpesvirus BoHV-1. In a last step, we studied the cell tropism of BoHV-4 at the level of the 
mucosa early upon host entry. Our salient findings are that BoHV-4 productively replicates in 
mucosal tissues and infects single individual cells in both epithelium and lamina propria of 
genital mucosa from 12h pi onwards. No signs of infection were observed in the epithelium 
and lamina propria of the respiratory tract. At both 12h and 24h pi, infected cells are 
identified as being cytokeratin+ (epithelial cells) and CD172a+ (monocyte/macrophage lineage 
cells). At 48h pi, clear BoHV-4 epithelial plaques are present in the genital tract. Unlike the 
aggressive basement membrane passage observed during BoHV-1 host entry, we propose that 
BoHV-4 uses a much more sophisticated mechanism for invasion consisting of an epithelial 
and myeloid infection pathway, bearing similarities with MuHV-4 and EHV-1. 
 
5.2.  Introduction 
Bovines host both alpha- and gammaherpesviruses. Most of these viruses are associated with 
severe clinical pathologies including infectious bovine rhinotracheitis and sheep-associated 
malignant catarrhal fever evoked by bovine herpesvirus 1 and ovine herpesvirus 2 
respectively. Until now, a lot of effort has been made to acquire more information on the viral 
molecular biology of many herpesviruses. However, data concerning the pathogenesis of 
these viruses with special emphasis on primary replication at entry ports within the host is far 
better documented for alphaherpesviruses than for gammaherpesviruses (4, 11). Several 
reasons can be put forward to explain this: some gammaherpesviruses can simply not be 
propagated in vitro thus far (e.g. OvHV-2), but most importantly, there is a lack of in vivo-
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related in vitro models valuing animal ethics that allow the study of primary host-pathogen 
interactions (3). To enable the investigation of bovine herpesviruses with both respiratory and 
genital mucosa, an in vitro model was set up recently (25, 26). As in the case of bovine 
herpesvirus 1 (BoHV-1), we have shown that BoHV-1 replicates plaquewise in both 
respiratory and genital mucosa, easily breaches the basement membrane barrier and invades 
the host. Moreover, all subtypes of BoHV-1 including 1.1, 1.2a and 1.2b replicated to a 
similar extent in both respiratory and genital mucosa thereby questioning whether specific 
tissue tropisms truly exist (25). At present, we are investigating which finely tuned 
mechanisms are necessary for BoHV-1 efficient penetration of the basement membrane 
barrier allowing pathogen invasion (24). 
Another major economical loss in the cattle industry are uterine infections. Although the 
major causative agents are bacteria, gammaherpesvirus bovine herpesvirus 4 (BoHV-4) has 
been shown to be a possible (co-)factor in post-partum metritis (29). BoHV-4 is widespread in 
natural populations and remains in the vast majority of infected individuals latent and 
asymptomatic. BoHV-4 persists within its host, favorably in peripheral blood leukocytes, 
lymphoid organs and the nervous system (1, 7, 10). Interestingly, in vivo studies have shown 
that in persistently/latently infected cattle and rabbits especially splenic cells located in the 
marginal zone, belonging to the non-T non-B cell compartment, harbor BoHV-4. This implies 
that other resident cells such as monocyte/macrophage lineage cells are a possible site of 
persistent/latent BoHV-4 infection (17, 21). Subsequently, Donofrio and Santen have shown 
that cells of the monocyte/macrophage lineage support BoHV-4 persistent infection. A small 
subset of macrophages survives after BoHV-4 inoculation and can be maintained several 
passages further. Interestingly, persistent infected macrophages contain both circular and 
linear BoHV-4 DNA and shed continuously small amounts of progeny virus (7). Information 
on viral entry mechanisms (16, 18) and immune evasion mechanisms (19) of BoHV-4 is on 
the increase. In addition, recent viral genome sequencing (31) and construction of a BoHV-4 
bacterial artificial chromosome (BAC) (14) have dramatically extended the available tools for 
viral molecular biology research. Nevertheless, development of novel vaccines and antivirals 
should be pathogenesis-based but available information is limited until now. Jacca and co-
workers put forward a hypothetical summary of what we know so far about the pathogenesis 
of BoHV-4: BoHV-4 establishes persistence in macrophages. Post-partum, infection of the 
uterus can be caused by environmental bacteria. In otherwise healthy animals such infection is 
cleared within 3 weeks. On the contrary, in animals persistently infected with BoHV-4, the 
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inflamed uterus routes macrophages carrying BoHV-4 to the inflamed endometrium. Once 
there, replication within macrophages might initiate and progeny virus spreads to endometrial 
stromal cells, which are highly susceptible for BoHV-4 (5, 15). However, little is known 
about BoHV-4 primary replication and putative entry sites.  
In this study we wanted to assess whether BoHV-4 is using similar primary replication sites 
namely respiratory and/or genital mucosa as other bovine herpesviruses like BoHV-1 do. In 
addition, we sought to identify the very first cells that are being targeted by BoHV-4 early in 
infection. Finally, we compared the replication and dissemination of both BoHV-4 and 
BoHV-1 in the same animals allowing unbiased comparison. 
        
5.3.  Materials and Methods 
5.3.1. Donor cows 
Otherwise healthy respiratory and genital tissues from adult donor cows, generally aged 2-5 
years, were obtained from a local slaughterhouse. In addition, peripheral blood was collected 
from all cows. Complement-dependent seroneutralization (SN)-tests were performed to 
determine both BoHV-1 and BoHV-4 specific antibody titers. Three different animals were 
included based on SN titers which ranged from 16 to 24 for BoHV-1 and < 2 for BoHV-4. 
Tissues from selected animals were used to set up bovine respiratory and genital mucosa 
explants. 
 
5.3.2. Bovine respiratory and genital mucosa model 
The cultivation of bovine respiratory and genital mucosa was performed similarly as 
described before (25, 26). In brief, tissues were immediately placed in phosphate buffered 
saline (PBS), supplemented with 1 µg/mL gentamycin (Invitrogen, Paisley, UK), 1 mg/mL 
streptomycin (Certa, Braine l’Alleud, Belgium), 1 mg/mL kanamycin (Sigma, St. Louis, MO, 
USA), 1000 U/mL penicillin (Continental Pharma, Puurs, Belgium) and 5 µg/mL fungizone 
(Bristol-Myers Squibb, New York, USA) for transportation to the laboratory. Tracheal 
(respiratory) and vaginal (genital) mucosa was stripped from the underlying layers. Small 
square tissue pieces (on average 40 mm2) were made and placed on fine-meshed gauze for 
culture. The explants were cultivated in serum-free medium (50% DMEM (Invitrogen)/50% 
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Ham’s F-12 GlutaMAX (Invitrogen)) supplemented with 0.1 mg/mL streptomycin (Certa), 
100 U/mL penicillin (Continental Pharma) and 1 µg/mL gentamycin (Invitrogen) for up to 
72h (37 °C, 5% CO2). 
 
5.3.3. Virus strains and inoculation procedure 
Virus strains used in this study were the V.test strain of BoHV-4 and the Cooper strain of 
BoHV-1. The BAC-cloned reference strain V.test belongs to the European clade of BoHV-4 
strains and was isolated from an infertile bull’s testicle (22). Cooper strain, considered as the 
reference BoHV-1 strain, was isolated in Colorado (30). All strains obtained were from 
unknown passage. From each of them, a second passage was produced and utilized in our 
laboratory. 
Inoculation of the explants was performed at 24h of cultivation. Respiratory and genital 
explants were taken from their gauze, placed in a 24-well plate and rinsed with warm 
medium. Next, explants were either mock inoculated or submerged in 1 mL of BoHV-4-
containing medium (107 TCID50/mL). As a control, different respiratory explants of all 
included animals were inoculated with 1 mL of BoHV-1 enriched medium (107 TCID50/mL). 
For BoHV-1, we limited ourselves to respiratory explants as we have shown before that 
BoHV-1 replicates to a similar extent in both respiratory and genital tissues (25). The 
submerged explants were incubated for 1h (37 °C, 5% CO2). Before the tissues were placed 
back again on their gauze, they were thoroughly washed. Inoculated tissues were collected at 
0h, 12h, 24h and 48h pi. At every time point, 2 respiratory and 2 genital explants from each 
animal were collected. All gathered explants were embedded in cryoprotection medium 
(Methocel®, Fluka (Sigma)) and frozen at -70 °C. In addition, at 2h, 12h, 24h, 36h and 48h pi, 
explant cultivation medium was collected of BoHV-4 inoculated tissues for virus titration. In 
comparison, explant medium from BoHV-1 inoculated explants was collected at 
representative time points 2h, 24h and 48h pi and submitted for virus titration. 
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5.3.4. Replication kinetics of BoHV within respiratory and genital mucosa 
Virus titration 
Explant cultivation medium was collected at 2h, 12h, 24h, 36h and 48h pi from mock 
inoculated, respiratory and genital BoHV-4 inoculated explants; and at 2h, 24h and 48h pi 
from respiratory BoHV-1 inoculated explants for analysis of viral titers. Briefly, 70-80% 
confluent Madin-Darby Bovine Kidney (MDBK) cells were inoculated for 1h (37°C, 5% 
CO2) with serial 10-fold dilutions (100 to 10-7 in quadruplicate) of BoHV-4 and mock 
inoculated explant medium. For BoHV-1 titration, confluent MDBK cells were used. 
Afterwards, MDBK’s were overlaid with medium and observed daily for cytopathic effect 
(CPE) for 7-9 days. Time point 2h was included to determine residual virus titers after 
inoculation. As a control, BoHV-4 and BoHV-1 inactivation at 37°C, 5% CO2 in explant 
medium was examined at 0h, 2h, 24h, 48h and 72h after adding either 107 TCID50/mL, 105 
TCID50/mL or 103 TCID50/mL of BoHV-4 or BoHV-1 as starting titers to control wells. 
  
Evaluation of primary viral dissemination in mucosa 
At least 100 cryosections (10µm) of the different inoculated explants were produced, 
methanol fixed for 20 min (100%,-20°C) and subsequently stained for BoHV-4 or BoHV-1 
specific antigens. A primary mouse monoclonal IgG2a antibody (Mab35) recognizing an 
early-late (E-L) glycoprotein complex gp6/gp10/gp17 was used for BoHV-4 (1:1000 in PBS). 
Classification as being early-late refers to the fact that both a precursor of two components 
gp10/gp17, expressed in the early phase, and the mature form gp6/gp10/gp17, expressed in 
the late phase, are recognized (8, 9). Next, a secondary goat anti-mouse IgG2a Alexa fluor® 
594 (Invitrogen) (1:500 in PBS) was applied. Staining of BoHV-1 was performed using an 
FITC®-labeled goat anti-IBR polyclonal antiserum (VMRD, Pullman, WA, USA) (undiluted). 
Analysis of all IF stainings was performed by using a DM2500(Sim) confocal microscope 
(Leica). Time points 0h, 12h, 24h and 48h pi were analyzed for BoHV-4 and mock inoculated 
explants. In comparison, we evaluated the replication of BoHV-1 at three representative time 
points namely 0h, 24h and 48h pi. 
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5.3.5. Quantification and characterization of BoHV-4 infected cells 
The number of single infected cells was evaluated at 0h, 12h, 24h and 48h pi in at least 100 
cryosections of 10µm using a BoHV-4 specific staining described above. In order to 
determine the nature of single BoHV-4 infected cells early after inoculation, we performed 
double immunofluorescence stainings using different cell surface markers at 0h, 12h and 24h 
pi. For each marker we made at least 100 cryosections of 10µm thick for both mock and 
BoHV-4 inoculated genital and respiratory mucosa, and subsequently fixed them for 20 min 
in methanol (100%, -20°C). In a first step, we visualized BoHV-4 antigens applying the 
procedure described above. In a second part of the staining, either CD3+ T lymphocytes (pan 
bovine T lymphocyte marker), CD172a+ cells (monocyte/macrophage lineage cells), 
cytokeratin+ cells (epithelial origin) or IgM+ B lymphocytes (B lymphocyte marker) 
antibodies were used to identify the type of infected cells. More specifically, a primary 
monoclonal rat IgG1 anti-human CD3 (AbD Serotec, Biorad-laboratories, Kidlington, UK) 
(1:100 in PBS) and secondary goat anti-rat Alexa fluor® 488 (Invitrogen) (1:200 in PBS) were 
applied to stain T lymphocytes. A primary monoclonal mouse IgG1 anti-bovine CD172a+ 
(VMRD) (1:100 in PBS) or monoclonal mouse IgG1 anti-human cytokeratin (Dako, Glostrup, 
Denmark) (1:50 in PBS) with both a secondary goat anti-mouse IgG1 FITC® (Abcam, 
Cambridge, UK) (1:100 in PBS) were used to stain monocytes/macrophages or epithelial cells 
respectively. A polyclonal sheep anti-bovine IgM labeled with FITC® (AbD Serotec) (1:150 
in PBS) was used to stain B-cells. In parallel, similar sections were stained with irrelevant 
isotype matching antibodies to determine specificity. All incubation steps were performed at 
37°C for 1h. In between, thorough washing steps were included. Hoechst was applied in all 
stainings as a last step in order to visualize cell nuclei. Finally, all samples were mounted with 
glycerin-DABCO and analyzed by means of confocal microscopy. Two regions of interest 
were taken into account: (i) epithelium and (ii) lamina propria. Only regions in the middle of 
explants were considered, excluding the edges and borders of the explant. 
 
5.3.6. Statistical analysis 
Data were processed by the SPSS software (SPSS) for analysis of variance (One-way 
ANOVA). The data are represented as means + standard deviations (SD) of three independent 
experiments. Results with P values of ≤ 0.05 were considered significant. 
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5.4.  Results 
5.4.1. Extracellular virus production shows the ability of BoHV-4 to replicate in respiratory 
and genital mucosa 
As a parameter for productive replication, viral titers were determined in the supernatant of 
inoculated mucosa explants (Figure 1). 
BoHV-4 was detected in both explant medium of respiratory and genital tissues at all time 
points. As a reference, viral titers indicating BoHV-1 replication in respiratory tissues were 
included. In addition, normal BoHV-4 and BoHV-1 inactivation curves at 37°C are given in 
Figure 1. 
Residual virus after inoculation, shown by time point 2h pi, was on average 103.7 TCID50/mL 
and was found to be similar for both tissues as well as for BoHV-1 and BoHV-4.  
 
 
 
A 
B 
Time post inoculation (h) 
Time post inoculation (h) 
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Figure 1. Virus shedding of respiratory BoHV-4-inoculated, genital BoHV-4-inoculated and 
respiratory BoHV-1-inoculated explants at 2h, 12h, 24h, 36h and 48h pi (A). BoHV-4 (B) and BoHV-1 
(C) titer decay at 37°C in explant medium due to inactivation events. Different starting titers were 
used and evaluation was performed at different time points. The horizontal dotted line represents the 
detection limit for the titration assay.   
 
No significant differences were observed in between all time points for BoHV-4 titers. 
However, taken into account the normal inactivation of BoHV-4 at 37°C, the observed titers, 
especially at 48h pi, indicate virus production rather than remaining residual virus after 
inoculation. For BoHV-1, titers rise significantly between 24h and 48h pi indicating active 
viral replication. In addition, at 48h pi, a significant difference is observed in virus shedding 
between BoHV-1 and BoHV-4 with BoHV-1 reaching titers of 105.69 TCID50/mL compared to 
an average of 103.7 TCID50/mL for BoHV-4. 
 
5.4.2. Single BoHV-4 infected cells are visible at 12h pi mainly in the epithelium, increase 
over time (24h pi) to become plaques at 48h pi 
BoHV-4 dissemination was examined in our recently established bovine respiratory and 
genital mucosa explant system. To this end, tissues from three different animals were included 
and inoculated with BoHV-4. Two explants for each tissue were collected at different time 
points (0h, 12h, 24h and 48h pi). 
 
C 
Time post inoculation (h) 
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Figure 2. Evaluation of BoHV-4 infection in bovine respiratory and genital mucosa explants at 0h, 
12h, 24h and 48h pi. (A) Number of individual BoHV-4 infected cells in both epithelium and lamina 
propria of respiratory and genital mucosa are given per 10 mm2 examined epithelial surface at 
different time points after inoculation. All data represent means + SD of triplicate independent 
experiments. (B) Representative pictures of BoHV-4 spread within genital mucosa at 12h, 24h and 48h 
pi. BoHV-4 single infected cells in the lamina propria are marked by white arrows. 
 
Single infected cells were visible as soon as 12h pi both in epithelium and lamina propria of 
genital mucosa. At none of the collected time points post inoculation, BoHV-4 positive cells 
were visible within the respiratory mucosa. The amount of cells increased significantly over 
time from 0h to 48h pi onwards in the genital epithelium (Figure 2A). At 12h pi, the amount 
of cells in the epithelium was on average similar as in the underlying lamina propria. 
However, starting from 24h pi, the majority of cells were detected within the epithelium. At 
24h pi, single cells in the epithelium were often clustered in groups of 5-10 cells, seemingly 
having intercellular contacts (Figure 2B). Nevertheless, these clusters did not have the 
appearance of an obvious herpes-induced epithelial plaque like f.e. BoHV-1 at 24h pi. 
However, at 48h pi, distinct BoHV-4 epithelial plaques could be observed without basement 
Time post inoculation (h) Time post inoculation (h) 
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membrane crossing. By applying the measurement tool of the DM2500(Sim) confocal 
microscope software (LAS AF Lite, Leica), we measured the plaque latitude of several 
BoHV-4 plaques. On average, plaque latitude was found to be 191.43 ± 76.16 µm. In close 
proximity of epithelial infection, sporadic single infected cells underneath the basement 
membrane could be observed (Figure 2B). 
 
5.4.3. BoHV-4 behaves differently at primary entry portals than BoHV-1 
Respiratory explants inoculated with BoHV-1 showed clear signs of infection as described 
previously (25, 26). BoHV-1 induced epithelial plaques were observed starting from 24h pi. 
At 48h pi, the majority of plaques showed a plaquewise penetration of the basement 
membrane proving that BoHV-1 is capable of drilling in an aggressive way through this 
barrier (Figure 3). Interestingly, this is in striking contrast to what is observed for BoHV-4 for 
which a quite different mechanism of dissemination within tissues of the same animals was 
observed (Figure 2).  
 
Figure 3. Representative confocal immunofluorescent images showing a different mode of mucosal 
dissemination for BoHV-1 compared to BoHV-4 within the same animals (for BoHV-4 see Figure 2). 
BoHV-1 induced plaques were observed at 24h and 48h pi. At 48h pi clear penetration of BoHV-1 
(FITC) through the BM (Texas Red) can be observed. 
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5.4.4. BoHV-4 cell tropism at 12h and 24h after initial inoculation 
To gain information on which specific cells are the first cells upon entry being infected by 
BoHV-4 in the host, we looked at the BoHV-4 cell tropism by means of immunofluorescent 
double stainings at 12h and 24h pi. We used several markers, staining epithelial cells 
(cytokeratin+), monocytes/macrophage lineage cells (CD172a+), T lymphocytes (CD3+) and B 
cells (IgM+), for identification (Figure 4). For BoHV-4, single infected cells in the epithelium 
and lamina propria were visible at 12h pi in genital tissues. The vast majority of infected cells 
in the epithelium were epithelial cells (cytokeratin+) whilst cells observed in the lamina 
propria were mostly CD172a+ monocyte/macrophage lineage cells (Table 1). At 24h pi, 
nearly all infected cells in the genital epithelium were epithelial cells and a small minority of 
CD172a+ were observed within the epithelium, often in proximity of infected epithelial cells. 
Within the lamina propria of the genital epithelium, BoHV-4 infected CD172a+ cells were 
scarcely present. However, at 12h and 24h pi we neither observed BoHV-4 infection of T 
lymphocytes nor of B cells. Interestingly, at 12h and 24h pi no infected cells were found in 
tracheal tissues. 
 
Table 1. Number of marker-positive BoHV-4 infected cells at early time points post inoculation in 
genital tissues (Epithelial surface covered within a cryosection is on average 0.03 mm2). 
Time 
point pi 
Tissue Zone Total amount of marker positive cells / Total amount of 
BoHV-4+ cells counted in ≥ 100 sections/animal 
(triplicate experiment) 
Cytokeratin+ CD3+ IgM+ CD172a+ 
12h Vagina Epithelium 6/6 0/2 0/1 0/8 
L. propria 0/0 0/3 0/1 5/7 
24h Vagina Epithelium 32/35 0/57 0/87 5/82 
L. propria 0/13 0/8 0/14 14/20 
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Figure 4. Cell tropism of BoHV-4 at 24h pi in genital epithelium. The row on top shows BoHV-4 
positive cells (Texas Red) within the epithelium (dotted line). The middle row shows respectively 
cytokeratin, CD172a, CD3 and IgM expression (FITC) in different cells (white arrows). The bottom 
row represents merges of the rows above. Only for cytokeratin and CD172a, double positive cells for 
the virus are observed. 
 
5.5.  Discussion 
In general, alphaherpesviruses initiate their pathogenesis at the level of the upper respiratory 
tract and/or the lower genital tract. Recently, we studied the mucosal behavior of a bovine 
alphaherpesvirus, BoHV-1 and visualized how BoHV-1 penetrates several barriers upon host 
entry for invasion (25, 26). Although there is growing evidence that gammaherpesviruses 
might use similar entry routes as alphaherpesviruses (12), proof of concept is lacking for the 
majority of them. BoHV-4, an often quiescent bovine gammaherpesvirus present in carrier 
animals, is thought to reactivate upon stress (e.g. partus) and aggravate uterine infections 
caused by primary agents such as bacteria (15). Thus even though disease is individually rare, 
the total burden in populations, by acting as a co-virulence factor, is large. However, no 
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information exists on how BoHV-4 gains access to its host and which mechanisms it implies 
to do so.  
In this study, we have utilized a previously established bovine respiratory and genital model 
to assess the potential involvement of these tissues in the early pathogenesis of BoHV-4. To 
this end, we inoculated several tissues and analyzed kinetically the mucosal behavior of 
BoHV-4. Moreover, we looked at BoHV-1 replication within tissues of the same animals as a 
comparative control. First, we observed a lower virus production in BoHV-4 explants 
compared to BoHV-1 explants, especially clear at 48h pi. BoHV-4 DNA synthesis, unlike 
BoHV-1, is documented to be dependent on the S phase of the cell cycle (dividing cells). This 
study describes that in resting cells (G0 phase), BoHV-4 DNA replication was found to be 
arrested due to a block in replication after early (E) protein expression (28). In general, 
epithelia are highly differentiated which is accompanied by irreversible cell cycle exit. The 
only cells still capable of mitosis in epithelia are basal and parabasal cells (20). Hence, this 
might imply that productive replication of BoHV-4 in mature epithelium happens with low 
efficiency and is restricted to parabasal and basal cells. These observations can explain the 
lower viral shedding seen in our experiments. Although no signs of infection were observed in 
the epithelium and lamina propria of the respiratory tract (our region of interest), we cannot 
firmly exclude infection of cells and productive replication at the lateral and bottom sides of 
explants. Indeed, our inoculation procedure allows the virus to come in contact with lateral 
and bottom sides of explants. As this route of infection does not reflect the in vivo situation, 
we did not take these regions into account. Second, we found that BoHV-4 infects single 
individual cells in the genital epithelium starting from 12h pi. The majority of these were 
from epithelial origin (cytokeratin+) and although a clear plaque-like appearance was lacking, 
they were often found in small clusters at 24h pi. Only from 48h pi, clear BoHV-4 plaques 
were visible in the epithelium. In addition, from 12h pi onwards few CD172a+ cells were 
found BoHV-4 positive in the lamina propria, underneath the basement membrane. Over time, 
the amount of single individually infected cells increased steadily in the epithelium, especially 
the number of epithelial cells. At 24h pi, cell tropism did not change as still only epithelial 
and monocyte/macrophage lineage cells are being infected. Interestingly, Frederico and co-
workers have recently analyzed how murine herpesvirus 4 (MuHV-4) enters the host via the 
upper respiratory tract by using a homologous mouse model. They found and proposed that 
rhadinoviruses (e.g. MuHV-4) in a sequential manner first infect epithelial cells, then myeloid 
cells and only then B cells (12, 13). In addition, BoHV-4 gp180, a major envelope protein, is 
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described to function as an O-glycan shield against neutralizing antibodies thereby covering 
otherwise vulnerable viral epitopes. The finding that this protein, if present, allows efficient 
infection of glycosaminoglycan (GAG)+ cells like epithelial cells and if absent, gives the virus 
the ability to more efficiently infect GAG-deficient cells such as monocytes, suggests that 
gp180 is probably shielding GAG-independent entry epitopes. Several hypotheses can be 
formulated but as previously described for MuHV-4 and EBV, possibly BoHV-4 binding to 
and/or infection of epithelial cells allows efficient subsequent myeloid/lymphoid cell infection 
(2, 12, 18, 19, 23). Therefore in our study, epithelial cells are likely the very first target of 
BoHV-4, as the vast majority of infected cells at 12h pi were found to be of epithelial origin. 
For BoHV-4, this epithelial infection occurs in the genital tract thereby pointing out that the 
virus has a tropism for the genital tract in general (e.g. metritis). Next to that, 
monocytes/macrophages are being infected and possibly confer the virus the ability to be 
transported inwards in a Trojan horse-like manner across the basement membrane, a 
mechanism previously described for alphaherpesvirus EHV-1 (27). We did not observe 
infection of T or B lymphocytes at 12h and 24h pi despite their presence in the mucosa. B-cell 
infection for MuHV-4 is described to be a late event in pathogenesis as the infection pathway 
is timely regulated in a cascade manner, going over epithelial cells and subsequent myeloid 
cells to B cells. Indeed, Frederico and co-workers identified a binding block to myeloid 
infection that was overcome by co-culture with epithelial cells, and a post-binding block to B 
cell infection that was overcome by virus propagation in myeloid cells (12). Therefore, it 
might be interesting for BoHV-4 to look at later time points in infection to see whether 
lymphocytes are eventually being targeted by the virus and if a similar 
epithelial/myeloid/lymphoid infection pathway exist for BoHV-4. Nevertheless, BoHV-4 is 
extensively documented to persist in macrophages (7, 17). Furthermore, there are currently no 
clear indications in favor of BoHV-4 infection of lymphocytes (17, 21). Thus, another 
explanation why no BoHV-4+ T or B lymphocytes are observed in our study might be that, 
unlike MuHV-4, epithelial/myeloid to lymphoid spread simply does not occur for BoHV-4. 
BoHV-1 and BoHV-4 clearly exhibit a different mechanism of invasion. BoHV-1 causes 
extensive epithelial plaque formation and exhibits a clear crossing of the basement membrane 
barrier. On the contrary, BoHV-4 causes subtle epithelial infection and possibly misuses 
resident individual monocytes/macrophages to be transported across the basement membrane. 
As explants are gathered from the same animals, any inter-cow variability can be excluded. In 
addition, we measured plaque latitude for BoHV-4 plaques in the genital epithelium at 48h pi 
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(191.43 ± 76.16 µm). If we compare this to previously measured plaque latitudes of BoHV-1 
plaques in the genital mucosa of similar aged cows at 48h pi (366.29 ± 55.84 µm) (25), 
clearly BoHV-4 less efficiently paves its way through the epithelium compared to BoHV-1. 
Taken together our findings with the hypothesis generated by Jacca and co-workers, we want 
to speculate about the pathogenesis of BoVH-4: BoHV-4 infects, like some 
alphaherpesviruses and gammaherpesviruses, the genital tract. Primary replication is 
established in epithelial cells and results in productive replication of BoHV-4, confirmed by 
the observed viral shedding in our study. We propose that the virus is transmitted in genital 
secretions and contributes to its widespread presence in populations. However, compared to 
BoHV-1, titers are much lower and might indicate a less efficient way of transmission to 
naïve animals. Whilst dissemination among epithelial cells proceeds through cell-to-cell 
spread, as virus positive epithelial cells are often found in small clusters and eventually 
plaques, infection of some resident monocytes, macrophages or dendritic cells can take place. 
The virus might use these cells to be transported across the basement membrane towards 
internal organs. BoHV-4 has been demonstrated in many tissues but is often found in 
lymphoid tissues. Transfer to T or B lymphocytes cannot be excluded at present. In BoHV-4 
persistently infected animals, BoHV-4 infection resides within macrophages. At parturition 
and post-partum, an inflamed uterus due to bacterial infection attracts macrophages and 
allows local reactivation of the virus. Endometrial stromal cells can become infected with 
newly replicating virus (6, 7, 15). Extracellular virus production of these infected stromal 
cells can contribute to BoHV-4 transmission. 
In conclusion, we have visualized the mucosal behavior of BoHV-4 in a bovine genital 
mucosa model and shed some light on the primary replication of BoHV-4. To our knowledge, 
this is the first report describing an invasion route of BoHV-4. At present, both BoHV-4 and 
MuHV-4 are accessible, animal gammaherpesviruses and serve as experimental models for 
the hard-to-study human Epstein-Barr virus (EBV) and Kaposi’s sarcoma-associated 
herpesvirus (KSHV). Therefore, homologous in vivo models are extremely important not only 
for pathogenesis studies but also to verify in vitro acquired results. We can only speculate on 
which mechanisms all these gammaherpesviruses imply in order to successfully establish host 
infection, but the observed striking parallels between BoHV-4 and MuHV-4 host colonization 
suggest that other lymphotropic viruses follow similar routes. 
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6.1.  Abstract 
In general, mucosal invasion is poorly characterized for herpes simplex virus 1 (HSV-1) and 2 
(HSV-2). We developed and morphologically characterized a human genital mucosa explant 
model (endocervix and ectocervix/vagina) to mimic genital herpes infections. Subsequent 
analysis of entry receptor expression, including nectin-1, nectin-2 and HVEM, throughout the 
menstrual cycle in genital tissues was performed and the evolution of HSV-1/-2 mucosal 
spread at different time points pi within ectocervical and endocervical mucosa was assessed. 
Nectin-1 and -2 were found to be expressed in both endocervix and ectocervix during all 
phases of the menstrual cycle. On the contrary, HVEM expression was limited to some cells, 
mainly present in the connective tissue. HSV-1 and HSV-2 exhibited a plaquewise mucosal 
spread, induced prominent epithelial syncytia in ectocervical mucosa and behaved in a similar 
way in replication at the genital tract. From 48h pi, epithelial plaques crossed the basement 
membrane in all tissues proving that the virus is able to breach a critical barrier and infiltrate 
the host. 
 
6.2.  Introduction 
Human genital herpes is worldwide one of the most prevalent causes of genital ulcer disease 
and with a prevalence reaching up to 80% (developing countries), one of the most important 
sexually transmitted infections (STI). The principal causative agent is herpes simplex virus 
type 2 (HSV-2); however, the frequency of primary genital herpes infections caused by herpes 
simplex virus type 1 (HSV-1) is on the increase. Genital manifestations of initial infection 
display an array of symptoms going from asymptomatic to severe bilateral vesicular lesions. 
Because of extensive replication of the virus these lesions can be purulent, and in some cases 
lead to necrotic trauma. Systemic consequences consist of flu-like symptoms (fever, 
headache, myalgia) and dysuria. Congenital and perinatal herpes infections, and brainstem 
encephalitis in neonates, are well known complications of maternal genital herpes (1, 21). 
Moreover, genital herpes lesions promote the transmission of HIV (1, 24). HSV-2 has been 
shown to modulate the mucosal microenvironment including recruiting of submucosal DC’s, 
influencing DC function, upregulating integrin α4β7 expression on CD4+ T-cells and 
stimulating retinoic acid production, an immunomodulator. These mechanisms might 
contribute to a more prone susceptibility to HIV (20, 32). No efficacious HSV-vaccine is 
currently on the market, and the likelihood of one coming to market soon is low (2). When 
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treating herpes virus infections with antiviral compounds, resistance occurs frequently which 
limits the application of these products. Indeed, acyclovir-resistant HSV strains are becoming 
increasingly common, especially in HIV+ individuals. Infection with acyclovir-resistant 
strains are 10-fold higher in HIV+ persons than in immunocompetent patients and appears 
related to the degree of immunosuppression and the duration of antiretroviral therapy (31). 
Rodent models are considered as golden standard for genital herpes research (9, 19). Although 
they play a robust role in elucidating aspects of primary genital mucosa infections, they 
clearly lack homology. Potential species-specific differences in cellular mediators of infection 
and invasion, impede extrapolation of results. For example, several entry mediators have been 
described for HSV, including nectins (nectin-1 and nectin-2), herpes virus entry mediator 
(HVEM) and specific sites in heparan sulfate (26). Apparently, both nectin-1 and HVEM 
mediate viral entry in vivo most efficiently (15). Although nectin homologues in mice 
resemble the human forms, mouse nectin-2 is not functional as entry receptor for HSV-1 and 
HSV-2 whereas human nectin-2 clearly mediates entry of HSV-2 and certain HSV-1 
recombinants (28). Interestingly, until now, information on either the presence and 
distribution of entry mediators or on its potential in vivo role within the genital tract is scarce. 
Previously we optimized a human genital mucosa explant model and extensively checked 
tissue viability and morphology during in vitro cultivation. This homologous model is a 
valuable tool to study the intriguing interplay of HSV with mucosal surfaces at the level of the 
genital tract. In a first part of the present study, we analyzed the expression patterns of 
different herpes virus entry receptors including nectin-1, nectin-2 and HVEM in both 
endocervix and ectocervix/vagina throughout the menstrual cycle. In a second part, we 
modeled the mucosal behavior in genital mucosa of both HSV-1 and HSV-2 by inoculating 
our established genital organ cultures and compared the HSV-1 and HSV-2 replication 
characteristics within the same patients. Nectin-1 and -2 showed a similar expression pattern 
in both endocervix and ectocervix/vagina and moreover, this was consistent at all stages of the 
menstrual cycle. On the contrary, HVEM was not expressed in endocervical or ectocervical 
epithelial cells. However, scarcely distributed cells in the epithelium and several cells in the 
lamina propria did express HVEM on the entire cell membrane. HSV-1 and -2 both exhibited 
a plaquewise mucosal spread and induced prominent epithelial syncytia. In addition, both 
endocervix and ectocervix were clearly susceptible to both HSV-1 and HSV-2 infection. 
Starting from 48h pi, few epithelial viral plaques crossed the basement membrane (BM) 
showing HSV-1 and HSV-2 can cause stromal invasion in the genital tract. 
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6.3.  Materials and methods 
6.3.1. Patients 
Pieces of healthy genital mucosa were gathered from women undergoing either a routine 
hysterectomy or a reconstructive plastic surgery (Ghent University hospital). Apart from this 
study, pieces of the mucosa were subjected to a pathological examination in order to exclude 
concurrent papilloma virus infection and early stages of papilloma virus induced endocervical 
adenocarcinoma. From all included patients, serum was collected. First, a progesterone and 
estradiol determination was performed by the hormonology department of the Ghent 
University Hospital to determine the ovarian cycle stage. Second, HSV specific antibody 
titers were determined by means of a complement-dependent seroneutralization (SN)-test. 
This test does not allow discrimination between antibodies raised against HSV-1 and HSV-2. 
All persons provided written informed consent and the ethics committee of the Ghent 
University Hospital approved the study (EC/2010/152). Different patients of various stages of 
the menstrual cycle were included for analyzing both herpes virus entry receptor expression 
and HSV-1/-2 mucosal dissemination kinetics (Table 1). 
 
6.3.2. Human genital mucosa model set up 
A similar set up was used as for bovine respiratory and genital mucosal explants (27). Briefly, 
tissues were immediately placed in phosphate buffered saline (PBS), supplemented with 1 
µg/mL gentamycin (Invitrogen, Paisley, UK), 1 mg/mL streptomycin (Certa, Braine l’Alleud, 
Belgium), 1 mg/mL kanamycin (Sigma, St. Louis, MO, USA), 1000 U/mL penicillin 
(Continental Pharma, Puurs, Belgium) and 5 µg/mL fungizone (Bristol-Myers Squibb, New 
York, USA) for transportation to the laboratory. Genital mucosa was stripped from the 
underlying layers. Small square tissue pieces were made and placed on fine-meshed gauze for 
culture. The explants were cultivated in serum-free medium (50% DMEM (Invitrogen)/50% 
Ham’s F-12 GlutaMAX (Invitrogen)) supplemented with 0.1 mg/mL streptomycin (Certa), 
100 U/mL penicillin (Continental Pharma) and 1 µg/mL gentamycin (Invitrogen) for up to 
96h (37 °C, 5% CO2). 
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6.3.3. Analysis of herpes virus entry receptor expression 
We used immunofluorescence stainings to determine the distribution of nectin-1, nectin-2 and 
HVEM in both endocervical and ectocervical tissue from women in different stages of the 
menstrual cycle. Evaluation of relative receptor expression was performed on non-cultured 
tissues (time point 0h) of 10 different patients (Table 1). Cryosections of 10µm were fixed in 
methanol (-20°C, 100%) for 20 min. We used mouse monoclonal antibodies CK41 (18), L14 
(3) and D-5 (Santa Cruz Biotechnology, Dallas, Texas, USA) directed against CD111 (nectin-
1) (1:50 in PBS); CD112 (nectin-2) (1:20 in PBS) and TR2 (HVEM) (1:50 in PBS) 
respectively. After 1 hour incubation at 37°C, samples were thoroughly washed and incubated 
at 37°C for another hour with goat anti-mouse FITC®. Next, nuclei were stained by Hoechst. 
Finally, all samples were mounted using glycerin-DABCO. 
 
6.3.4. Dissemination kinetics of HSV in genital mucosa 
HSV strains and tissue inoculation 
The strains used in this study were HSV-1 strain F (ATCC VR-733) and HSV-2 strain MS 
(ATCC VR-540). From each of them a second passage was produced on African green 
monkey kidney cells (Vero, ATCC CCL-81) and used for inoculation. 
Briefly, the inoculation procedure was as follows. Transfer of explanted tissue from the gauze 
to a 24-well plate was followed by several washing steps. After adding 1 ml of virus-
containing medium (106.5 TCID50/ml), the submerged tissues were incubated for 1 hour 
(37°C, 5% CO2). Afterwards, prior to transfer from the 24-well plate to the gauze, stringent 
rinsing was performed. Finally, samples were collected at different time points including 0h, 
24h and 48h pi. All gathered explants were embedded in a cryoprotection medium 
(Methocel®, Fluka) and frozen at -70°C. 
  
Plaque analysis by immunofluorescence stainings 
Series of 20µm thick consecutive cryosections were made from all collected explants and 
fixed in methanol (-20°C, 100%) for 20 min. In order to evaluate thoroughly the 
dissemination characteristics of HSV within the mucosa, we used immunofluorescent double 
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stainings. In a first part, to visualize the BM barrier and underlying connective tissue, we used 
primary goat anti-collagen IV antibodies (Southern Biotech, Birmingham, USA; 1:50 in 
PBS); secondary biotinylated rabbit anti-goat antibodies (Sigma, 1:100 in PBS) and tertiary 
streptavidin-Texas Red® antibodies (Molecular Probes, Invitrogen; 1:50 in PBS). In a second 
part, HSV-1 or HSV-2 antibodies were stained with primary mouse monoclonal antibodies 
against HSV-1 gD (Santa Cruz Biotechnology, 1:100 in PBS, 10% NGS) or HSV-2 gB (Santa 
Cruz Biotechnology, 1:50 in PBS, 10% NGS) respectively, followed by secondary FITC®-
labeled goat anti-mouse antibodies (Molecular Probes, 1:100 in PBS, 10% NGS). Analysis of 
all IF stainings was performed by using a DM2500(Sim) confocal microscope (Leica). Next, 
measurements of average HSV-1/-2 plaque latitude and plaque penetration underneath the 
BM were performed at 0h and 48h pi. 
 
6.3.5. Statistical analysis 
SPSS software (one way ANOVA, Post-hoc Bonferroni and Tukey’s HSD) was used to 
evaluate the variance. The results are given as means + standard deviation of different (≥3) 
independent experiments. Results with P values of ≤ 0.05 were considered significant. 
 
6.4.  Results 
6.4.1. HSV-specific neutralizing antibody and sex hormone level analysis 
An overview of the serum progesterone and estradiol levels of the included patients is given 
in Table 1. The seroprevalence within the included patients was found to be 71.4% (Table 1). 
 
6.4.2. Distribution of herpes virus entry receptors 
By means of immunofluorescence stainings, relative expression of different herpes virus entry 
receptors was evaluated in ectocervical/vaginal and endocervical tissues from 10 different 
patients, including premenopausal (follicular and luteal phase) and postmenopausal. At least 2 
different patients were included for each menstrual cycle stage. Evaluation was performed on 
non-cultured tissues (time point 0h). In general, for all patients, both nectins were clearly 
more abundantly expressed in endocervix compared to ectocervix/vagina. Regardless of the 
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phase of the menstrual cycle, expression pattern and localization was noticed to be consistent 
for both endocervix and ectocervix/vagina. 
Table 1. Overview of the included donor patients. Serum progesterone and estradiol levels were 
analyzed to determine menstrual cycle phase. HSV specific neutralizing antibodies were determined to 
investigate the seroprevalence within the group. ND = Not Determined.   
Patient Age Progesterone 
(ng/mL) 
Estrogen 
(pg/mL) 
Menstrual Cycle 
Phase 
HSV 
SN- 
Titer 
HSV 
Kinetics 
Entry 
receptor  
analysis 
001 67 0.36 <12.0 Menopause ND  Determined
002 70 <0.15 <12.0 Menopause ND  Determined
003 48 0.38 12.9 Menopause(Follicular) ND  Determined
004 33 0.38 36.1 Follicular <2 Determined Determined
005 41 9.0 145 Luteal <2  Determined
006 50 0.20 26.2 Menopause 96 Determined  
007 49 0.94 68.6 Follicular 256  Determined
008 34 1.5 49.6 Follicular ND  Determined
009 38 21 122 Luteal 128 Determined Determined
010 50 <0.15 13.9 Menopause 64 Determined Determined
011 31 0.92 32.9 Follicular 24  Determined
 
At all times, the nectin-2 antibody staining was found to be more intense than the antibody 
staining for nectin-1 in the genital tract. In endocervical epithelium nectins were highly 
present on the luminal side of the cell, thus apicolateral. In ectocervical/vaginal epithelium, 
nectin-1 and -2 expression was most intense in the stratum spinosum and minimal in the 
stratum basale. Loss of nectin-1 and -2 expression was seen within the superficial layers of 
the ectocervix/vagina. Consequently, whenever epithelial thickness shrivels, nectin expression 
was located closer to the luminal side, as was observed in postmenopausal women and women 
in the luteal phase of the menstrual cycle. The majority of HVEM expressing cells was 
observed in the lamina propria and deeper connective tissue. Scarcely distributed single cells 
resident within the epithelium were also found to be HVEM positive. Nevertheless, the 
majority of the endocervical and ectocervical epithelium clearly did not express HVEM. 
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Representative pictures of nectin-1, nectin-2 and HVEM expression for both 
ectocervix/vagina and endocervix are given in Figure 1. 
 
Figure 1. HSV entry receptor expression in human endocervical and ectocervical tissues. Nectin-1 (A) 
and nectin-2 (C) expression is mainly localized in the stratum spinosum of the ectocervix at all phases 
of the menstrual cycle. In the endocervix a strong nectin-1 (B) and nectin-2 (D) expression can be 
observed on mainly the apicolateral sides of the cell membrane throughout the menstrual cycle. (E) 
Especially during the follicular phase of the menstrual cycle, the ectocervical stratum superficial 
consists of multiple layers (double-headed arrow) of non-nectin expressing cells (dashed line marks 
the entire epithelium). (F) HVEM expression was observed on cells located in the lamina propria 
(arrows) and scarcely on individual cells residing in the epithelium (dashed arrow) regardless of the 
menstrual cycle stage. 
 
6.4.3. HSV-1 and HSV-2 genital mucosal spread 
HSV-1 and HSV-2 both replicated plaquewise in endocervical and ectocervical mucosa of all 
included patients to a similar extent (Figure 2). Importantly, we did not observe obvious 
differences in susceptibility to HSV and HSV dissemination due to the menstrual cycle stage. 
In ectocervical mucosa, HSV plaques were mainly localized at places of slight abrasion 
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within the superficial layers. All HSV-induced ectocervical plaques were situated within the 
stratum spinosum and some extended to the stratum basale. Infection within the stratum 
superficialis was never observed. Interestingly, large multinucleated giant cells were observed 
in HSV epithelial plaques in the ectocervix. Starting from 48h pi, few (<10%) ectocervical 
and endocervical epithelial viral plaques crossed the BM, albeit in a localized manner. 
 
Figure 2. HSV dissemination at 0 and 48h pi in genital mucosa. Representative immunofluorescent 
images of HSV-1 and HSV-2 plaques in endocervical and ectocervical mucosa are shown. (A) In 
ectocervical mucosa HSV-1 and -2 produced multinuclear giant cells (syncytia). (B) Few HSV-1/-2 
plaques in both endo- and ectocervix locally crossed the BM (indicated by white circle). The graphs 
show average measurements at 0h and 48h pi of plaque latitude and penetration underneath the BM 
for HSV-1/-2 in endo- or ectocervical mucosa. Data are represent as means + SD of three 
independent experiments. 
 
 
 
Time post inoculation (h) 
Time post inoculation (h) 
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6.5.  Discussion 
The mucosal behavior of genital herpes infection caused by HSV-1 and HSV-2 at the level of 
the mucosa within human tissues is poorly documented until now. Little information is known 
about the presence of herpesvirus entry factors at different menstrual cycle phases in both 
endocervical and ectocervical/vaginal epithelium. One in vivo comparative study describes the 
expression pattern of nectin-1 in the human and mouse vagina. Interestingly, little 
extrapolation can be made from one to another. In humans, nectin-1 expression and 
localization remains identical at the different stages of the menstrual cycle whereas in mice 
striking differences in expression levels were seen. We observed similar results when 
analyzing nectin-1 expression in human ectocervix/vagina for all menstrual cycle stages (19). 
Interestingly, we found that the localization of nectin-2 within the ectocervical epithelium was 
comparable with that of nectin-1. Membrane expression showed a dispersed pattern on 
ectocervical epithelial cells. The expression of nectin-1 and nectin-2 was found to be similar 
in endocervix at all times. The luminal half of these columnar cells, thus apicolateral, showed 
expression of nectins and this did not alter with change in menstrual cycle phase. Importantly, 
analysis of nectin-2 expression in endocervix revealed a more abundant presence of nectin-2 
compared to ectocervix/vagina during the entire menstrual cycle. In polarized epithelia, 
nectins localize in adherens junctions and contribute to their formation and maintenance (11). 
Our study confirms the preferential lateral sorting of nectins in polarized human endocervical 
epithelium compared to non-polarized ectocervical epithelium (25). HVEM expression was 
found to be limited to multiple cells in the connective tissue and some single cells residing in 
the epithelium. However, no clear expression within epithelial cells could be observed. 
HVEM is found in multiple tissues and, as a member of the TNF receptor family, broadly 
expressed in hematopoietic cells. Thus, its primary natural function is to act in immune 
responses. However, the level of HVEM expression on immune cells varies at different times 
in the immune response. For example, naïve and some memory CD4+ and CD8+ lymphocytes 
constitutively express HVEM (5, 16, 17). Assumedly, the HVEM+ cells we observed within 
the mucosa are resident immune cells strolling as sentinels in both the epithelium and 
underlying lamina propria. Recently, a study described that the interaction of gD and HVEM 
during acute infection with HSV may influence the magnitude and quality of the subsequent 
CD8+ T cell recall response at the genital mucosa, although its role in HSV pathogenesis is 
still unclear (16).   
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When testing the human genital mucosa explants for HSV susceptibility, we observed some 
interesting facts. HSV-1/-2 induced prominent epithelial syncytia, the latter unlike animal 
alphaherpesviruses act in mucosal tissues. Indeed, we did not observe polykaryocyte 
formation for BoHV-1, EHV-1 and PRV in both genital and respiratory mucosa (10, 27, 29). 
The core membrane fusion machinery in herpesviruses consists of glycoprotein B, a type III 
fusion protein and the gH-gL heterodimer. It has been shown that gB modulates cell-cell 
fusion in several herpesviruses. For most, if not all fusion proteins a conversion from an 
inactive pre-fusion to an active post-fusion state occurs. Assumedly, gH/gL uses triggering 
mechanisms that are functionally analogous to the known fusion triggering mechanisms like 
low pH or protease cleavage.  Interestingly, herpesvirus gB homologues can be subdivided 
into two groups based on whether a posttranslational proteolytic cleavage occurs or not. As 
such, gB of BoHV-1 and PRV is cleaved and HSV-1 gB remains uncleaved. Thus there may 
be some variability in how gB is activated. In addition, fusion triggering is regulated by other 
viral glycoproteins and their receptors as well. The question remains whether these slight 
differences in this exquisite mechanism of gB activation across herpesviruses have in vivo 
implications and if this might explain the different observed phenotypes of alphaherpesvirus 
mucosal replication (6, 14). Alternatively, the ability of human alphaherpesviruses to induce 
prominent syncytia in mucosal tissues might be an example of co-evolution with the host. 
Indeed, syncytia formation is also a hallmark of varicella-zoster virus (VZV) infection in vivo, 
another human alphaherpesvirus (6, 23). 
HSV-1/-2 replication was found to be hampered in intact ectocervical epithelium. In 
endocervical tissues, HSV was found to replicate well. Taken into account our observations 
that nectin-1 and -2 as well as HVEM expression is negligible in the most outer layers of the 
ectocervical/vaginal epithelium, this clearly confirms the need of HSV for epithelial 
microlaesions to initiate invasion in ectocervix/vagina. This is also reflected in the HSV 
plaque analysis we performed. Indeed, ectocervical HSV plaques were only found within the 
stratum spinosum and basale and extended by analogy with their entry receptors. In addition, 
HSV plaques were more frequently found at places of slight abrasion or in explants were the 
epithelium was slightly scarified before inoculation (data not shown). Also, the abundant 
presence of nectins, especially nectin-2, in endocervix renders this anatomical site a potential 
target for efficient invasion. Importantly, one key phenomenon, termed cervical ectopy, 
exposes the endocervical epithelium to the ectocervical/vaginal cavity due to hormonal 
influences. This is most commonly seen in adolescents and pregnant women as among 
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women using hormonal contraceptives. The endocervical epithelium on this squamo-
columnar junction converts into squamous epithelium over time (metaplasia). These regions 
of epithelial conversion are highly susceptible to HIV and other STI (30). Our results indicate 
that, since (i) nectins are abundantly present and (ii) endocervical epithelium sustains 
productive infection of HSV-1/-2, the squamo-columnar junction might be highly prone to 
herpesvirus infections. In line with the findings made by Mostad and co-workers, we did not 
see an association of HSV susceptibility and replication with phase of the menstrual cycle or 
with serum estradiol/progesterone levels (22). Although there are reports describing the 
regulation of HSV infections and immune responses to genital HSV by sex hormones, the 
majority is performed in mouse models (7-9). We did not evaluate the effect on HSV mucosal 
dissemination of more profound changes in hormone levels, e.g. pregnancy and hormonal 
contraceptives. 
At 48h pi, proof of HSV breaching through the basement membrane barrier was observed in a 
minority of endocervical and ectocervical plaques. However, this number might increase at a 
later time point post infection. This observation reflects what is seen in vivo. A study of 
Johnston and co-workers shows that primary HSV infections of the genital tract in humans are 
often followed by a clear HSV-viremia (12). In light of safe transfusion medicine, several 
patients with signs or history of herpes infections have been submitted to a screen for HSV 
DNA within their blood. Interestingly, in several primary genital herpes cases, significant 
levels of HSV DNA within the plasma could be demonstrated (13). This indicates that HSV is 
able to reach blood vessels and spread within the host by a yet unknown mechanism. Hence, 
the in this study established homologous model is an excellent tool for performing in-depth 
mechanistic studies of HSV host invasion. 
In summary, the results of this study document to our knowledge for the first time the 
distribution of nectin-1, nectin-2 and HVEM within the lower female genital tract including 
endocervix and ectocervix/vagina during different phases of the normal menstrual cycle and 
point out the anatomical relevance of nectins to act as entry receptor for HSV. In addition, we 
report the first comparison of the mucosal dissemination of both human herpes simplex 
viruses within endocervical and ectocervical/vaginal mucosa derived from the same patients. 
Despite their different tropism, these viruses are both able to replicate and spread to a similar 
extent within genital mucosa and penetrate the BM. This study puts emphasis on the observed 
trend of increasing HSV-1 genital infections seen in the field (4) and stresses the need to 
combat HSV as measure in aid of successful anti-HIV therapy. 
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7.1.  Abstract 
Recently, we described the mucosal behavior of alphaherpesviruses including HSV-1, PRV 
and BoHV-1. Stromal invasion originates from epithelial plaques, happens plaquewise mainly 
between 24h and 48h pi and is unrestrained by the basement membrane barrier. Movement of 
virus across cell-cell contacts and axonal transport of viruses both require a functional 
glycoprotein complex gE/gI. Hence, we investigated the role of gE/gI in BoHV-1 directional 
spread across the basement membrane. First, we analyzed the effect of deleting or inhibiting 
gE/gI by using recombinants of BoHV-1 and anti-gE/gI monoclonal antibodies respectively 
on viral replication, plaque latitude and penetration depth underneath the basement membrane 
in a bovine respiratory mucosa model at 48h pi. Knockout of either gE and/or gI resulted in 
strong reduction of plaque latitude (on average 41.2 ± 7.7%) and plaque depth (on average 
87.8 ± 6.0%) as well as viral replication (on average 1 to 2 log). Interestingly, usage of a gE 
cytoplasmic tail-truncated BoHV-1 (amber mutation at aa453) resulted in a similar phenotype 
as gE-. None of the anti-gE/gI antibodies affected plaque latitude or viral replication. 
However, a reduction in plaque depth of on average 53.0 ± 15.8% compared to the controls 
could be observed. Finally, the distribution of viral particles for wild-type and knockout 
strains within cells and on the surfaces of cells in contact with the BM was studied at 48h pi 
by TEM and revealed a hampered sorting towards the basement membrane in gE/gI 
knockouts. These data indicate that gE/gI mediates sorting towards basal domains and 
possibly orchestrates BoHV-1 invasion once present at basal domains. 
 
7.2.  Introduction 
Upon host entry, alphaherpesviruses are capable of breaching several selective barriers such 
as the basement membrane (BM) underneath epithelia in order to gain access to the stroma for 
further spread in the host by yet unidentified mechanisms (42). We used in vitro models 
consisting of excised mucosae as tools for visualization, identification and characterization of 
putative invasion mechanisms. At present, a classification can be made based on mucosal 
behavior of alphaherpesviruses. A first group spreads easily across the BM (e.g. PRV, BoHV-
1 and HSV-1) in a plaquewise manner (15, 16, 43, 44). An unidentified trypsin-like serine 
protease was found to be involved in PRV-BM crossing (17). A second group, hitchhikes 
across the BM (e.g. EHV-1) by using local immune cells as Trojan horses (50). A third group, 
remains locally confined to the epithelium (e.g. EHV-4) and lacks the capacity to efficiently 
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invade the host (51). Hence, for many alphaherpesviruses transport towards the BM is a 
crucial event in the pathogenesis but studies describing these mechanisms in the mucosa are 
limited. 
Glycoprotein E (US8) forms a non-covalently bound heterodimer with glycoprotein I (US7). 
They are both nonessential type 1 transmembrane proteins with a size of 575aa and 382aa 
respectively in BoHV-1 (5). BoHV-1 gE contains two cysteine-rich domains C1 and C2, and 
a GLYV domain on the N-terminal extracellular (ET) domain (1-421aa), whereas BoHV-1 gI 
only has one cysteine-rich domain on its ET domain (1-299aa). Both ET domains are 
sufficient for formation of the heterodimer (48). The C-terminal cytoplasmic tail (CT) of 
BoHV-1 gE (445-575aa) contains 4 YXXΦ motifs. There are three predicted tyrosine 
phosphorylation sites including residues 467-470aa (YTSL), 513-516aa (YDLA) and 563-
566aa (YTVV). In addition, two serine residues within the gE acidic domain, S493 and S499, 
could potentially be phosphorylated (29).  
gE and gI are multivirulence genes and are present in all field isolates, suggesting an 
important role for these proteins in pathogenesis (1, 39). The gE/gI complex promotes viral 
spread in many different ways (40). Herpesviruses use a direct cell-to-cell transmission to 
spread laterally across cell junctions and this is critical to successfully establish latency in 
neuronal cells. The molecular mechanism behind this event is not fully understood but shares 
similarities with the mechanism of entry employed by extracellular virions. Indeed, the core 
fusion machinery (gD, gH/gL, gB) is required but unlike for “cell-free” transmission, gE and 
gI heavily influence the efficiency of cell-to-cell spread. Mutants lacking gE and/or gI 
generate smaller plaques in cell cultures and moreover, are severely restricted for spread to 
neuronal cells (6, 7, 38, 55). For several alphaherpesviruses gE was found to modulate 
retrograde (e.g. HSV-1) and/or anterograde (e.g. BoHV-1, PRV, HSV-1) transport in neurons 
(10, 29, 31, 32). Similar observations are also made in several in vivo studies. Deleting gE in 
PRV resulted in decreased virulence and reduced stromal invasion (14, 19, 24). gE knockout 
in HSV-1 prevented the virus from causing severe stromal disease and potential encephalitis 
after epithelial keratitis (6). BoHV-1 gE null or gE truncated strains are strongly attenuated in 
vivo and all current “safe” vaccine strains are in fact gE deleted (3, 23, 29, 45, 49). In general, 
studies on gE/gI functionality have been performed mainly within the PRV and HSV 
background. However, BoHV-1 gE and gI can complement the virulence functions of PRV 
gE and gI (25, 26). The YXXΦ motifs on the gE CT allow the glycoprotein to interact with 
the trans-Golgi network (TGN) resulting in accumulation at the TGN. At the TGN, gE/gI 
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contributes to secondary envelopment of tegument-coated capsids but in addition it also 
routes TGN derived vesicles carrying mature virions towards lateral cell junctions. Indeed, the 
TGN is the major site for basolateral versus apical sorting in polarized cells as it regulates 
distribution of cellular membrane proteins into basolateral and apical domains (12, 21, 33, 
52). gE/gI specifically accumulates at lateral surfaces of epithelial cells in confluent 
monolayers and colocalizes with the adherens junction protein β-catenin (8, 34). Alterations 
in the gE CT reduce the number of virions at lateral cell junctions and instead virions 
accumulate on apical surfaces (22). Several tegument proteins including the triplex UL11-
UL16-UL21 are believed to play a role in trafficking of virions by binding the gE tail (13, 18). 
Once present at junctions, the ET domains of the complex gE/gI probably bind to extracellular 
ligands such as proteins of intercellular junctions and promote spread to adjacent cells (36). 
Interestingly, in some monolayers of epithelial cells viruses were found to be specifically 
routed to cell junctions in lateral domains, rather than to basal domains. Although, in cell 
biology it is accepted that the plasma membrane of polarized cells can be grossly subdivided 
in apical and basolateral domains, separated by tight junctions (30), it appears that additional 
sorting mechanisms might exist beyond the broad targeting of molecules to basolateral 
surfaces. Indeed, some proteins of cell-cell junctions in lateral domains are not found in basal 
domains of the plasma membrane and vice versa, proteins such as integrins are exclusive to 
cell-matrix junctions in basal domains (22, 53). 
Bovine herpesvirus 1 (BoHV-1) causes severe respiratory and genital lesions in ruminants that 
easily penetrate through both mucosa and submucosa (35, 43). We previously optimized a 
bovine respiratory mucosa model to study several aspects of the primary replication of BoHV-
1 and observed that most BoHV-1 plaques cross the BM at 48h pi (44). In this study, we 
applied this homologous model to specifically investigate the role of the viral complex gE/gI 
in vertical spread and hence the invasion mechanism of BoHV-1 through the BM. We 
constructed gE-null, gI-null, gEgI-null viruses and repaired strains by using a BoHV-1 
bacterial artificial chromosome (BAC) clone. In addition, a gE CT-truncated virus was 
included. Both usage of gE and/or gI knockout strains and gE and/or gI inhibiting monoclonal 
antibodies resulted in severe reduction in BoHV-1 vertical spread and invasion through the 
BM barrier. Moreover, gE/gI was found to mediate efficient sorting of vesicles and virus 
particles in basal cells towards the BM as shown by TEM. These observations put emphasis 
on the involvement of the gE/gI complex in BoHV-1 invasion through the BM towards the 
lamina propria. 
The gE/gI complex is a crucial viral factor during BoHV-1 stromal invasion in respiratory mucosa 7 
 
191 
 
7.3.  Materials and methods 
7.3.1. Construction of BoHV-1 gE null, gI null, gE/gI null by en passant mutagenesis 
We obtained a previously established BoHV-1 Cooper BAC clone (29) and stably 
transformed the BAC plasmid containing BoHV-1 genome into GS1783 (DH10B λ cI857 
Δ(cro-bioA)< >araC-PBAD I-SceI), which is the preferred host for en passant mutagenesis. This 
resulted in the construction of pBoHV-1_GS1783_GP1. Subsequent, en passant mutagenesis 
was performed as described earlier (46). In a first step, the mutated glycoprotein allele along 
with an antibiotic resistance gene and adjoining I-SceI recognition site was produced by 
polymerase chain reaction (PCR). To this end, primers BoHV-1_ΔgE-for, BoHV-1_ΔgE-rev, 
BoHV-1_ΔgI-for, BoHV-1_ΔgI-rev were designed to delete US7 and/or US8 (Table 1). The 
3’ end of the forward primers were designed in this way that it overlapped with an I-SceI site 
located upstream of aphAI (kanamycin resistance), and that the 3’ end of the reverse primers 
were complementary to the sequences downstream of aphAI of pEP-kan-S2. Second, 
approximately 100ng of DpnI-digested ΔgE PCR product was incorporated via 
electroporation into 50µl of recombinant- and electrocompetent pBoHV-1_GS1783_GP1. 
After arabinose induction, several kanamycin-sensitive clones were obtained and screened via 
RFLP, PCR and sequencing. This resulted in pBoHV-1_GS1783_ΔgEC6. Subsequently, a 
similar approach was applied to transform both pBoHV-1_GS1783_GP1 and pBoHV-
1_GS1783_ΔgE_P6C6 with DpnI-digested ΔgI PCR product to obtain pBoHV-
1_GS1783_ΔgI_P3C1 and pBoHV-1_GS1783_ΔgEgI_P7C1 respectively. Finally, to excise 
the BAC cassette, all obtained clones as well as the wild-type BAC clone were co-transfected 
along with pCAGGS-nls-cre into MDBK cells. At least three rounds of plaque purification 
were performed to obtain pure BAC-excised clones. Henceforth, reconstituted BAC-excised 
vBoHV-1_GS1783_GP1, vBoHV-1_GS1783_ΔgE_P6C6, vBoHV-1_GS1783_ΔgI_P3C1 
and vBoHV-1_GS1783_ΔgEgI_P7C1 are named WT, gE null, gI null and gE/gI null virus. 
   
7.3.2. Construction of BoHV-1 gE null, gI null and gE/gI null rescue BoHV-1 
Construction of repaired strains was performed in two phases. A first phase, consisted of the 
insertion of a kanamycin resistance gene into the open reading frame coding for gE(US8) of 
the pBoHV-1_GS1783_GP1 (WT BAC). A similar PCR was performed as described for the 
construction of mutant alleles using forward and reverse primers (Table 1) and plasmid pEP-
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kan-S2 to generate a PCR product for insertion in pBoHV-1_GS1783_GP1 by en passant 
mutagenesis. This resulted in pBoHV-1_GS1783_GP1_gEgIKan. 
Table 1. Primers used for generating gE and/or gI null and repaired strains  
Primers Nucleotide sequence (a) 
Mutants  
gE deletion  
  Forward 5’AACGGCGCACGCGAGAGGGTTCGAAAAGGGCATTTGGCAATG-TAA-
CCGGCCGCACCAGAT-aggatgacgacgataagtaggg 
  Reverse 5’ACTTGAGTCGCGCTGCTACCACGGTGTAATCTGGTGCGGCCGG-TTA-
CATTGCCAAATGCCCTT-caaccaattaaccaattctgattag 
gI deletion  
  Forward 5’ACTCAAGCCATTGCCGCGACCTTGTCCTCCGGCGCGCTCGCGATG-
TAA-ACGCCGCGCGCGGCA-aggatgacgacgataagtaggg 
  Reverse 5’GAAACCAAGACACACGCGAGCGAGATCGTTTGCCGCGCGCGGCGT-
TTA-CATCGCGAGCGCGCC-caaccaattaaccaattctgattag 
Rescues  
Kan insertion gE  
  Forward 5’AACGGCGCACGCGAGAGGGTTCGAAAAGGGCATTTGGCAATG-
CAACCCACCGCGCCGCCC-aggatgacgacgataagtaggg 
  Reverse 5’GCAGCAGCAGCGGCAGCAACCGCCGCCGGGGCGGCGCGGTGGGTTG-
CATTGCCAAATGCCCTT-caaccaattaaccaattctgattag 
Pull out gE/gI  
  Forward 5’CGCGGTGCGGGTCCGCTGCCCAGAAAGCCAAAAAAGCTGCCG-
CCATGG-ccacatgtggaattcccat (NcoI) 
  Reverse 5’CGCTCACCCGGGCAGCGCGCTGTAGTTGACGTTGCCAAAGGC-
GAATTC-gtcatccatatcaccacg (Eco-RI) 
a Nucleotides in lower case and italicized lower case share homology to pEP-kan-S2  and 
oriR6K+ampres (pGS1292) respectively. Sequences that are underlined are complementary to each 
other in inverse orientation. Finally, introduced stop codons in the mutant primers and introduced 
restriction endonuclease sites in the rescue primers are in bold.   
In a second phase, a pull-out of the gE/gI region out of the WT BAC was performed. For this 
purpose, primers were designed (Table 1) to anneal with their 5’ end to a region upstream of 
the gE/gI region and their 3’ end to pGS1292 (oriR6K+ampres). Upstream of the 3’ end 
homology of the primers with pGS1292 an NcoI RE-site and Eco-RI RE-site were introduced 
in the forward and reverse primer respectively. NcoI was chosen, as an endogenous NcoI RE 
site is located downstream of the gE/gI region and moreover does not cut the gE/gI region, 
nor the previously introduced kanamycin cassette (pEP-kan-S2), nor the oriR6K+ampres 
(pGS1292). Eco-RI was introduced to finally remove oriR6K+ampres (pGS1292). The 
obtained PCR product was finally employed to transform pBoHV-1_GS1783_GP1_gEgIKan 
The gE/gI complex is a crucial viral factor during BoHV-1 stromal invasion in respiratory mucosa 7 
 
193 
 
into pBoHV-1_GS1783_GP1_gEgIKanAmp. Next, a pull-out of the wild-type gE/gI region 
was performed using Nco-I. The obtained fragments were self-ligated and electroporated into 
GS111 (S17λpir). Correct clones were saved and subsequently Nco-I and Eco-RI were used to 
liberate the gE/gI region from oriR6K+ampres (pGS1292). Finally, we used the obtained pull-
out gE/gI fragment, which still possessed a kanamycin marker in US8 (first phase), to 
transform pBoHV-1_GS1783_ΔgE_P6C6, pBoHV-1_GS1783_ΔgI_P3C1 and pBoHV-
1_GS1783_ΔgEgI_P7C1. After arabinose induction, kanamycin sensitive clones were 
screened (RFLP, PCR and sequencing), co-transfected with pCAGGS-nls-cre into MDBK’s 
for BAC excision, trice plaque purified and finally named vBoHV-
1_GS1783_ΔgE_P6C6_RESC (gE rescue), vBoHV-1_GS1783_ΔgI_P3C1_RESC (gI rescue) 
and vBoHV-1_GS1783_ΔgEgI_P7C1_RESC (gE/gI rescue). 
   
7.3.3. Virus strains and cell line 
The BoHV-1 WT, gE null, gI null, gE/gI null, gE rescue, gI rescue, gE/gI rescue together with 
a previously constructed gE truncated CT tail gEAm453 (gE CT null) (29) were propagated 
(2nd passage) and titrated in Madin-Darby bovine kidney (MDBK) cells as previously 
described (2). 
 
7.3.4. Antibodies 
In the inhibition experiment we used several monoclonal antibodies including 14B11 (anti-
gE), 13E8 (anti-gE) and 2E12 (anti-gE/gI), which were a kind gift of the Veterinary and 
Agrochemical Research Centre Belgium. The gE/gI protein specificity of the monoclonal 
antibodies was determined via IPMA, IF stainings on cells inoculated with BoHV-1 WT, gE 
null, gI null, gE/gI null and all rescue strains; and by Western blot analysis. Isotype matched, 
irrelevant IgG1 (41D3) and IgG2a (XVI-11C) antibodies for the latter monoclonal antibodies 
against gE/gI were included in the inhibition experiment. 41D3 is directed against porcine 
Sialoadhesin (9) and XVI-11C/5-10F recognizes GP4 of the porcine reproductive and 
respiratory syndrome virus (PRRSV) (4). In addition, mouse anti-collagen VII antibodies 
(Sigma, St. Louis, MO, USA) and goat anti-mouse Texas Red® (Molecular Probes 
(Invitrogen, Paisley, UK)) were used to stain the basement membrane, and an FITC®-labeled 
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goat anti-IBR polyclonal antiserum (VMRD, Pullman, WA, USA) was used to stain the virus 
in immunofluorescence stainings. 
 
7.3.5. Selection of animals and set up of bovine respiratory mucosa explants 
Bovine respiratory mucosa explants were obtained as previously described (44). Briefly, from 
4 cows (2-5 years old) tracheal respiratory mucosa was obtained in the slaughterhouse. In 
addition, blood was collected to determine the BoHV-1 specific neutralizing antibody level. 
Tracheal tissue was immediately placed in tubes containing phosphate buffered saline (PBS), 
supplemented with 1 µg/mL gentamycin (Invitrogen), 1 mg/mL streptomycin (Certa, Braine 
l’Alleud, Belgium), 1 mg/mL kanamycin (Sigma), 1000 U/mL penicillin (Continental 
Pharma, Puurs, Belgium) and 5 µg/mL fungizone (Bristol-Myers Squibb, New York, USA) 
for transportation to the laboratory. Next, small square tissue pieces were produced and placed 
on fine-meshed gauze for culture. The explants were cultivated in serum-free medium (50% 
DMEM (Invitrogen)/50% Ham’s F-12 GlutaMAX (Invitrogen)) supplemented with 0.1 
mg/mL streptomycin (Certa), 100 U/mL penicillin (Continental Pharma) and 1 µg/mL 
gentamycin (Invitrogen) for up to 72h (37 °C, 5% CO2). Explants were kept in culture for 24h 
before inoculation and during the entire cultivation period, the culture medium was not 
replaced. 
 
7.3.6. Inoculation and inhibition method 
At 24h of cultivation, explants were taken from their gauze and placed in a 24-well plate after 
rinsing with warm medium. In each well, 1 mL of virus-containing medium (107 TCID50/mL) 
was added. The submerged explants were incubated for 1h (37 °C, 5% CO2). Before the 
tissues were placed back again on their gauze, they were thoroughly washed.  
For the gE/gI knockout experiment, we inoculated 2 tracheal explants of all the animals with 
all different BoHV-1 mutated and repaired strains as well as the wild-type strain and collected 
them at 0h and 48h pi for snap-freezing at -70°C. Mock-inoculated explants were included as 
controls. 
For the gE/gI inhibition experiment, we inoculated 2 tracheal explants of each animal with the 
wild-type strain. However, from 0h pi onwards, medium was replaced by either medium  
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supplemented with the different monoclonal antibodies against gE and/or gI or medium 
supplement with irrelevant, isotype-matching antibodies. As a control, several explants were 
cultivated in medium without antibodies. During the 1st h pi, all explants were completely 
submerged. At 0h and 48h pi, explants were collected and snap-frozen. 
For the analysis of subcellular gE, several explants were wild-type BoHV-1-inoculated. At 
48h pi, we rinsed the tissues before submerging them in an anti-gE monoclonal antibody, 
14B11, rich medium for 4h at 4°C, allowing the antibodies to bind to gE. Afterwards, 
explants were gathered and snap-frozen. 
For the assessment on the localization of virions within basal cells by TEM, we inoculated 
several explants of all animals either mock or with WT, gE null, gI null, gE/gI null, gE rescue, 
gI rescue and gE/gI rescue strains. At 48h pi, tissues samples were taken for an overnight 
incubation at 4°C in Karnovsky’s fixative (2% paraformaldehyde and 2.5% glutaraldehyde in 
0.2 M sodium cacodylate buffer (pH 7.4)). After overnight fixation, samples were washed in 
sodium cacodylate buffer and post-fixed for 1.5h in 2% osmium tetroxide (4°C). 
Subsequently, dehydration of tissue, using a graded series of alcohol (50–100%) was 
performed and finally samples were embedded in Spurr's resin. For localization of viral 
plaques within the epithelium (region of interests), semithin sections stained with 
haematoxylin-eosin staining were analyzed. Afterwards, ultrathin sections of 60nm thickness 
were made using a Leica EM UC 6 ultramicrotome (Leica Mircosystems GmbH), and 
mounted on formvar coated single slot copper grids (Laborimpex N.V., Brussels, Belgium). 
The sections were post-stained with uranyl acetate and lead citrate (Leica EM Stain, Leica 
Microsystems GmbH) and viewed on a Jeol 1200 EXII TEM (JEOL Ltd., Tokyo, Japan) at 
80 kV accelerating voltage. 
     
7.3.7. Analysis of virus replication and dissemination in mucosa 
Growth kinetics 
We first performed one-step growth kinetics of both wild-type, mutants and revertants on 
MDBK cells. Confluent MDBK cells in 6-well plates were inoculated with 1mL of 103 
TCID50/mL virus containing medium for 1h (37°C, 5% CO2). Cell supernatant was harvested 
at 2h, 24h and 48h after inoculation and submitted for virus titration. 
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In a second step, from all explants either inoculated with wild-type, mutants and revertants 
(gE/gI knockout) or with monoclonal antibodies (gE/gI inhibition), explant cultivation 
medium was collected at 2h, 24h and 48h pi for analysis of viral titers.  
Briefly, for virus titration of all samples, confluent MDBK cells were inoculated for 1h (37°C, 
5% CO2) with serial 10-fold dilutions (100 to 10-7 in quadruplicate) of virus-containing 
medium. Afterwards, MDBK’s were overlaid with medium and observed daily for cytopathic 
effect (CPE) for 7-9 days. Time point 2h was included to determine residual virus titers after 
inoculation. As a control, BoHV-1 inactivation at 37°C, 5% CO2 in explant medium was 
examined at 0h, 2h, 24h, 48h and 72h after adding either 107 TCID50/mL, 105 TCID50/mL or 
103 TCID50/mL of BoHV-1 as a start titer to control wells. 
  
Immunofluorescence staining and plaque analysis 
In general, cryosections were made from all frozen explants and fixed in methanol (-20°C, 
100%) for 25 minutes. 
The immunofluorescence staining aimed at visualizing the effect of gE/gI knockout and 
inhibition on plaque characteristics was a double staining, as previously described (43). 
Firstly, to stain the BM, mouse anti-collagen VII antibodies (Sigma) (1:300 in PBS) and goat 
anti-mouse Texas Red® (Molecular Probes (Invitrogen)) (1:50 in PBS) were used. Next, an 
FITC®-labeled goat anti-IBR polyclonal antiserum (VMRD, Pullman, WA, USA) (undiluted) 
directed against viral proteins was applied. Before mounting with glycerin-DABCO, a 
Hoechst staining, visualizing nuclei, was included (1:100 in PBS). In between each step, 
thorough washing steps were included. 
When staining cryosections for the localization of gE within an BoHV-1 epithelial plaque, we 
first used secondary goat anti-mouse Texas Red® to detect the already bound mouse 
monoclonal antibodies on gE. Secondly, we used FITC®-labeled goat anti-IBR polyclonal 
antiserum and Hoechst. Secure washing was performed at each interval of the 
immunofluorescence staining before mounting with glycerin-DABCO. 
Finally, all samples were analyzed by using a DM2500(Sim) confocal microscope (Leica). 
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7.3.8. Statistical analysis 
Evaluation of variance was performed using SPSS software (ANOVA) to analyze the data 
statistically. Differences in results that had P values of ≤ 0.05 were considered as being 
significant. All data represent means + SD of ≥ 3 independent experiments. 
 
7.4.  Results 
7.4.1. BoHV-1 gE null, gE CT null, gI null and gE/gI null strains are severely impaired in 
stromal invasion 
We previously observed that the majority of BoHV-1 plaques is penetrating the basement 
membrane at 48 pi. Therefore, respiratory tissues from different animals, infected with 
different infectious clones were analyzed for the effect of gE/gI knockout on plaque latitude 
and plaque penetration depth underneath the basement membrane at 48h pi. We analyzed the 
dissemination characteristics of on average 8-10 plaques for each condition. 
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Figure 1. Dissemination characteristics of wild-type; gE and/or gI null; and repaired strains in 
respiratory mucosa at 48h pi. The graphs show quantitative data (relative) comparing the plaque 
latitude and penetration depth underneath the BM of mutant and repaired strains in relation to the 
wild-type. The data are given as means + SD and represent three different independent experiments. 
In addition, representative confocal immunofluorescence images are shown for wild-type, gE and/or 
gI null and gE and/or gI rescued strains. Viral antigens are stained by FITC, the BM by Texas Red 
and cell nuclei by Hoechst. 
 
The gE null mutant caused a significant reduction in plaque latitude and plaque penetration 
depth compared to the wild-type strain (Figure 1). Knockout of gI in both WT (gI null) and gE 
null (gE/gI null) resulted in a strong decrease in plaque latitude and plaque penetration depth. 
Next, we applied a gE cytoplasmic tail-truncated BoHV-1 (amber mutation at aa453). 
Interestingly, a similar phenotype as gE null could be observed (Figure 1). All revertant 
strains (gE rescue, gI rescue and gE/gI rescue) displayed similar dissemination characteristics 
as the wild-type strain. 
 
7.4.2. Anti-gE/gI monoclonal antibodies inhibit BoHV-1 invasion through the basement 
membrane 
Several wild-type inoculated explants were submerged for 1h after inoculation within medium 
enriched with anti-gE/gI monoclonal antibodies or irrelevant, isotype matching antibodies, or 
in medium without antibodies (mock). Afterwards, they were further cultivated on gauze in 
medium containing or lacking antibodies until collection (48h pi). 
None of the gE and/or gI-specific monoclonals affected plaque latitude. However, when 
analyzing BoHV-1 penetration depth underneath the basement membrane, all gE/gI-specific 
monoclonals did exhibit to some degree a reduction compared to the mock-treated and 
irrelevant antibodies-treated situation. However, the reduction did vary in between the 
different monoclonals tested. Both 14B11 and 13E8 showed a significantly stronger reduction 
compared to the mock and isotype controls. In contrast, although 2E12 shows reduction, this 
difference was found not to be significant. In general, the observed effect of gE/gI inhibiting 
antibodies on BoHV-1 stromal invasion was less dramatic than the effect seen with gE/gI 
knockout strains. 
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Figure 2. The effect of anti-gE/gI monoclonal antibodies on BoHV-1 stromal invasion. A comparison 
between the plaque latitude and penetration depth underneath the BM of wild-type virus within 
respiratory mucosa treated with gE/gI inhibiting antibodies or irrelevant, isotype matching control 
antibodies and mock-treated explants is given in the graphs (relative data). Data are given as means 
+SD of three different experiments. Moreover, illustrative photomicrographs taken by a confocal 
microscope depict BoHV-1 (FITC) invasion through the basement membrane (Texas Red) in either 
mock-treated, gE/gI inhibiting antibodies-treated or isotype control antibodies-treated explants. 
Nuclei are stained by Hoechst. 
    
7.4.3. Knockout of BoHV-1 gE/gI results in a kinetic defect in virus production in both cell 
culture and tissue 
We analyzed growth kinetics to determine viral replication (Figure 3). First, we looked at the 
replication characteristics of gE/gI knockout strains in both MDBK cells and respiratory 
mucosa explants. In both cell culture and tissue we could observe a kinetic defect in viral 
replication in both gE null, gE CT null, gI null and gE/gI null strains compared to wild-type 
and repaired strains. Interestingly, at 24h pi this discrepancy in replication efficiency was 
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already visible in tissues but not in cell culture. Although at 48h pi a clear reduction in viral 
titers of gE and/or gI knockouts can be observed in cell culture as well as tissue, the most 
dramatic effect is seen in tissue replication. In tissue, knockout of gE resulted in a 1 log 
reduction whereas knockout of gI resulted in a 2 log reduction in viral progeny titers. In cell 
culture, knock-out of gE and/or gI resulted in smaller plaques. In cell culture, much higher 
viral titers were reached within the same time span compared to tissues. Second, when 
analyzing viral titers of the gE/gI inhibition experiment using anti-gE/gI monoclonal 
antibodies, we could not observe any effect on virus production due to the presence of 
antibodies in the medium. In addition, a normal BoHV-1 inactivation course over time at 
37°C is given in Figure 3D.  
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Figure 3. Representative graphs showing one-step growth curves of (A) BoHV-1 wild-type, gE and/or 
gI null and rescued strains in MDBK cells; (B) BoHV-1 wild-type, gE and/or gI null and rescued 
strains in respiratory mucosa explants and (C) BoHV-1 wild-type strain in the presence of either anti-
gE/gI, irrelevant or no antibodies in respiratory mucosa explants. Samples were taken at 2h, 24h and 
48h pi. As a reference, a normal BoHV-1 inactivation curve over time at 37°C for different starting 
titers is given in D. 
 
7.4.4. gE predominantly localizes at basal cell sides near the basement membrane in BoHV-1 
epithelial plaques 
Distribution of subcellular gE was assessed by looking at wild-type inoculated explants that 
were submerged for 4h at 4°C within gE monoclonal antibodies before snap-freezing. Within 
the majority of BoHV-1 plaques, a strong expression of gE was observed near the basement 
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membrane at 48h pi in respiratory mucosa explants. Less expression of gE was found in 
between cells and was even negligible at the luminal side of epithelial plaques. On the 
contrary, a polyclonal antibody recognizing multiple proteins of BoHV-1 we employed in 
double stainings showed a dispersed pattern ranging from the apical to basal sides of BoHV-1 
induced epithelial plaques. Representative pictures are provided in Figure 4. 
 
 
Figure 4. Double immunofluorescence stainings showing a predominant basal expression of gE within 
BoHV-1 epithelial plaques. First, a BoHV-1 polyclonal anti-serum, staining multiple proteins (FITC) 
was used. Next, a Texas Red conjugate was used to visualize the already bound gE monoclonals within 
the tissues. Pictures in row A and B show representative pictures for gE localization. Row B is taken 
at a higher magnification than row A.  
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7.4.5. Basal sorting in basal epithelial cells towards the basement membrane depends upon 
gE/gI    
Analysis of virion localization within basal epithelial cells and on the surface of basal 
epithelial cells near the basement membrane by means of transmission electron microscopy 
(TEM) was performed on respiratory tissues at 48h pi inoculated with either wild-type, gE 
and/or gI null or gE and/or gE rescue strains. It is noteworthy that this study is technically 
difficult to perform as fewer epithelial cells are being infected compared to monolayers of 
cells. For wild type and repaired strains, we observed several virus-containing vesicles being 
sorted towards the basement membrane and noted several virus particles crossing the 
basement membrane barrier (Figure 5). In addition, the majority of virus particles 
accumulated near lateral and especially basal borders of cells. We did not observe many 
apical sorted virions.  
 
Figure 5. Images taken by TEM showing (A) sorting virus-containing endocytotic vesicles towards the 
basement membrane and (B) virus particle passage across the basement membrane in wild-type and 
rescue BoHV-1 strains inoculated respiratory mucosa explants. Vesicles carrying virions and free 
virions are marked by a white arrow. The basement membrane barrier is indicated by a dashed white 
arrow. Magnification 30.000x (A) and 40.000x (B).  
 
On the contrary, when looking at gE null, gE CT null, gI null and gE/gI null strains, a highly 
reduced percentage of virions were found on basal domains compared to the WT and rescue 
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strains (Figure 6). The majority of virions accumulated more frequently on non-basal cell 
sides and showed a more dispersed pattern within cells. Importantly, the gE CT null resulted 
in a similar phenotype as gE null indicating that, taken into account all latter findings, gE/gI 
appears to have the ability to govern basal sorting of virus particles towards basal cell sides of 
cell in direct contact with the basement membrane. 
 
Figure 6. Representative TEM images of a basal cell infected with either wild-type (above, 
representative for WT and rescue strains) or gE null (below, representative for gE and/or gI null 
strains) of BoHV-1 at 48h pi in bovine respiratory mucosa. The majority of wild-type and rescue 
strain virions accumulated near the basement membrane at basal plasma membrane domains. On the 
contrary, gE and/or gI null strains particles were more frequently observed on the non-basal sides of 
basal epithelial cells. Virions are indicated by white arrows and the basement membrane barrier by a 
white dashed arrow. An asterisk marks the location of the basal cell nucleus. Magnification 15.000x. 
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7.5.  Discussion 
Bovine herpesvirus 1 (BoHV-1) uses the respiratory epithelium as an important portal for host 
entry. A hallmark for many herpesviruses is that protective barriers such as the basement 
membrane (BM) underneath epithelia are not able to restrain these viruses. They devised 
ingenious mechanisms to overcome these barriers and spread within the host (42). To date, 
knowledge on viral invasion mechanisms within mucosal tissues is however, largely 
unknown. Recently, we studied the mucosal behavior of BoHV-1 at the level of the 
respiratory and genital tract. BoHV-1 induces prominent epithelial plaques and penetrates in a 
plaquewise manner the BM starting from 24h pi. At 48h pi, nearly all plaques show a clear 
stromal invasion (43). Thus, a crucial step in this dissemination process is virus transport 
towards the BM. The main cell type in contact with and covering the BM are basal cells (11). 
This could involve a directed transport via basal cells by a so far, unidentified mechanism. In 
addition, when comparing different zones of the upper respiratory tract, including nasal 
septum, ventral conchae and proximal trachea; we could observe a more efficient spread of 
BoHV-1 in tracheal tissue compared to septum and conchae. Therefore, tracheal tissue is an 
interesting target tissue to unravel BoHV-1 stromal invasion (44). 
In the present study, we found different indications that gE/gI mediates efficient invasion of 
BoHV-1 at mucosal surfaces. In a first part, we constructed gE null, gI null and gE/gI null 
strains and their respective rescued strains. Analysis of growth kinetics of gE and/or gI null 
infectious clones in both cell culture and tissue showed a kinetic defect that was most clear at 
48h pi compared to wild-type and repaired strains. At 24h pi, this effect was already observed 
in tissue but not in cell culture. Unlike a monolayer of cells, tissues are a 3D-structure. Any 
defect in spread to naïve cells is exponentially more substantial within a 3D compared to a 2D 
model. Both gE null, gI null and gE/gI null viruses resulted in severely suppressed BoHV-1 
spread within respiratory mucosa. All mutants were analyzed for plaque latitude and 
penetration depth underneath the BM in respiratory mucosa at 48h pi. Knockout of gI caused 
an even more dramatic phenotype, both in a wild-type background (gI null) as in a gE null 
background (gE/gI null) compared to knockout of gE. Both observations indicate that a full 
functional gE/gI complex is required for BoHV-1 invasion. In addition, application of a gE 
cytoplasmic tail-truncated BoHV-1 (amber mutation at AA 453) produced a similar 
phenotype as gE null. This observation suggests that sorting, mediated by previously 
identified cytoplasmic tail motifs, is required for basal migration of viral particles. HSV-1 and 
PRV gE are known to mimic intracellular sorting pathways to route viral particles towards 
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cell-cell junctions in lateral domains (6, 8, 55). Especially in certain polarized epithelial cells 
a predominant transportation towards cell-cell junctions in lateral domains is observed and 
less to basal domains (22). It should be noted that these observations have been made in 
monolayers of cells, a 2D environment. As these cells are not anchored via cell-matrix 
adhesions to the stroma, additional sorting pathways towards basal domains might simply not 
be present/functional. Reasons to believe additional basal sorting pathways exist in tissues, 
representing a 3D structure, are threefold. First, some proteins present in basal domains (e.g. 
integrins) are not present in lateral domains whereas proteins in lateral cell-cell junctions are 
not found basally (53). Second, HSV virions were found to accumulate in some epithelial 
cells mainly on lateral sides and only scarcely basal and apical (22). Third, during interkinetic 
nuclear migration (INM), the nuclei in many epithelial cells specifically migrate between 
apical and basal surfaces, coordinating with the cell cycle. INM is observed in a wide variety 
of tissues and species but especially in pseudostratified epithelia such as the neuroepithelium 
but also the respiratory epithelium. This directed transport is either actomyosin-driven or 
microtubule-driven. As such, basal movement of nuclei requires either myosin II or motor 
protein kinesin 3 KIF1A (28, 41, 47). Herpesviruses are known to misuse motor proteins in 
general including kinesin and dynein for anterograde and retrograde transportation 
respectively within neuronal cells (37, 54). Interestingly, it has been recently shown for PRV 
that the gE/gI complex is vital in mediating binding of US9 to motor protein KIF1A for 
anterograde microtubule-mediated transport in neurons (27). It is likely, that a similar 
anterograde mechanism, away from the nucleus towards basal domains, exists within 
epithelial cells using a KIF motor. In addition, another study describes the presence of a 
kinesin 2 family member KIF17 in polarized epithelial cells and elaborately summarize the 
role of KIF17 in the establishment of polarized trafficking routes to the apical pole (20). 
Another speculation might be that herpesviruses interact with different kinesin motors to be 
specifically targeted towards apical, basal or lateral domains.    
In a second part, we looked at the distribution of gE in epithelial plaques as well as the 
localization of virions of wild-type, gE and/or gI null and repaired strains in inoculated 
tissues. Confocal analysis of subcellular gE presence within epithelial plaques revealed a 
predominant basal localization near the BM. TEM analysis showed that virus particles of 
wild-type and repaired strains accumulated mainly near basal sides of basal cells or on the 
surface of basal cells next to the BM. On the contrary, virions of gE and/or gI null strains 
were more frequently found on non-basal cells sides and some were randomly distributed 
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within cells. These observations confirm our previous findings suggesting that gE/gI mediated 
sorting is required for virion transport towards the BM. 
In a last part of the study, we enriched the medium of WT inoculated explants from 0h pi 
onwards with monoclonal antibodies 14B11 (anti-gE), 13E8 (anti-gE), 2E12 (anti-gE/gI); and 
evaluated the effect on plaque latitude and plaque penetration depth underneath the BM at 
48hpi. None of the antibodies affected plaque latitude. However, 14B11, 13E8 and 2E12 
caused a severe reduction in plaque penetration depth underneath the BM compared to the 
controls suggesting that gE/gI exerts another function in invasion once sorted correctly. In 
line with this finding, the extracellular domains of the complex gE/gI are suggested to bind to 
unidentified extracellular ligands such as cell surface components of intercellular junctions 
and promote spread to adjacent cells (36). Although speculative, they might in a similar way 
associate with receptors present at basal cell surfaces such as integrins within cell-matrix 
adhesions. At the moment, we cannot exclude the fact that binding of monoclonals directed 
against other membrane-anchored viral proteins (glycoproteins) at the level of the BM might 
disturb the BoHV-1 invasion process as well. 
In conclusion, we can state that the gE/gI complex plays a crucial role in BoHV-1 stromal 
invasion through the BM barrier. Although at this moment still speculative, it seems that 
gE/gI mimics a basal sorting pathway via its cytoplasmic tail motifs towards basal domains in 
basal cells and orchestrates invasion once present near the BM. Further work is necessary to 
determine all different players of this herpesvirus directed transport towards the BM for 
successful host invasion. 
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Species of both vertebrates and invertebrates host various herpesviruses and may suffer from 
a diverse array of pathologies induced by these pathogens (22). Many structural and 
functional similarities exist amongst herpesviruses: (i) they encode essential viral protein 
homologues for successful replication (31), (ii) they are able to establish latency (55) and (iii) 
they use mucosal surfaces such as respiratory and genital mucosa for host entry (72). A 
rational thought would be to use these common characteristics of herpesviruses as targets for 
the development of preventive and curative approaches to counteract these viruses. However, 
so far this has proven to be far from axiomatic. Current existing vaccination strategies and 
antiviral compounds work against some herpesviruses while they have no to little effect 
against other herpesviruses. 
Vaccination strategies and eradication programs have been developed for pseudorabies virus 
(PRV) and bovine herpesvirus 1 (BoHV-1) (57, 94), although they are not perfect. In the case 
of BoHV-1, vaccination with the current marker vaccines does not prevent BoHV-1 infection 
but reduces the severity of disease and viral shedding (7, 13, 14, 92). This implies that even 
vaccinated and seemingly healthy animals might be virus carriers. Within the context of an 
eradication program, this means that eventually stamping out of seropositive animals is 
inevitable in the process of acquiring an official IBR-free status. So far, not a single country 
that entered an IBR eradication campaign succeeded. Whenever a re-introduction occurs in an 
official IBR-free country, the current vaccines are less ideal. In this case, culling of 
seropositive animals should be chosen above the application of the current vaccines (2). In 
addition, many herpesviruses can simply not be controlled at present via vaccination. Equine 
herpesvirus 1 (EHV-1) is still able to cause nervous disorders and abortion despite vaccination 
(67). No efficacious herpes simplex virus (HSV)-vaccine is present on the market (8). When 
treating herpes virus infections with the current antiviral compounds, resistance has been 
reported to occur, which limits the application of these products (97). Moreover, some 
antiviral compounds simply have a low efficacy when used against animal and/or human 
herpes virus infections, despite their in vitro potency (38, 39). 
It is clear that combating herpesvirus infections is not a race we can win hands down and 
novel approaches are urgently needed for the design of novel antiviral strategies. In our 
laboratory, research is conducted to specifically target the mucosal invasion mechanism of 
herpesviruses, a rationale aimed at future development of novel, alternative and 
complementary anti-herpetic measures. Previous work revealed that PRV breaches the 
basement membrane plaquewise after epithelial infection, involving protease-mediated 
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breakdown of the extracellular matrix (42). In striking contrast, EHV-1 does not cross the 
basement membrane in such a way but instead infects resident immune cells within the 
epithelium and appears to misuse their motile nature to invade the host (95). These 
observations clearly underpin differences on how these otherwise closely related 
herpesviruses behave at the primary replication site. Many questions remain however on how 
other devastating respiratory and genital herpesviruses, BoHV-1/-4 and HSV-1/-2 in cattle 
and human respectively are causing infection and subsequent host invasion. In the current 
thesis we sought to establish models that allow the study of the mucosal invasion mechanism 
used by BoHV-1/-4 and HSV-1/-2. 
 
 Establishment of ex vivo organ cultures of bovine and human origin consisting of 
either respiratory or genital mucosa 
Since experiments to address specific questions about host invasion are difficult to conduct in 
vivo, development of model systems to elucidate pathogenic invasion mechanisms are 
essential. Typical monolayers of cells represent a poor structural approximate of the complex 
3D architecture of tissues. These 2D models fail to reconstitute the complex in vivo cellular 
microenvironment. Features of living tissues that are crucial for their function include tissue–
tissue interfaces (e.g. between epithelium and connective tissue), cell-ECM interaction, 
spatiotemporal gradients of ions and oxygen and a mechanically active microenvironment 
(75, 76). The establishment and maintenance of cell and tissue polarity is a prerequisite for 
normal function of biological processes including oriented cell division, migration, adhesion 
and barrier function. In addition, tissue homeostasis depends on resident mononuclear 
phagocytes, that is, dendritic cells and macrophages (62). Adding the third dimension to a 
cell’s environment might generate significant differences in cellular behavior and 
characteristics and create a greater similarity to conditions in living organisms, which will 
lead in turn to more integrated data and thus relevant research (75). Ex vivo organ cultures 
provide these requirements and are an elegant, reproducible and physiologically relevant 
compromise between in vivo and in vitro models. They value an important ethical dogma: 
Refinement, Reduction and Replacement (3R principle), regarding the use of laboratory 
animals (84). Moreover, typical in vivo models in order to study aspects of herpesvirus 
induced diseases are rodents (21, 91). Although these models have proven to be of use to 
address certain questions, they clearly lack homology as the virus is not interacting with 
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tissues from its natural host. Again, ex vivo organ cultures provide an advantage in this 
context, as they may allow the study of a herpesvirus with tissues derived from its natural 
host. Furthermore, the natural route of infection can be mimicked when applying these 
models. Several conditions can be tested on different explants derived from the same animal 
and thus inter-animal variation is greatly reduced. Despite all the important advantages of 
organ cultures, there are also some disadvantages. First, working with mucosa explants is 
rather labor-intensive, especially when including various strains and/or conditions. Second, 
despite their very close resemblance to the in vivo situation, there are some important 
drawbacks. No blood flow is present in the mucosa model, hence mimicking a full 
inflammatory reaction upon stimulation by pathogens is limited. Certain aspects such as 
innate immune mechanisms can be studied to a certain extent though (79). Third, unlike 
continuous cell lines, tissue explants can only be cultivated for a limited time span.   
In the first part of our study, Chapter 3, bovine respiratory and genital tissues, as well as 
human genital tissues were used for the in vitro culture of mucosa explants. Explants were 
maintained in vitro up till 96h. Different methods of organ culture exist including stationary 
air-liquid cultures, rocker/rotor cultures with alternating air and medium exposure and 
stationary immersion cultures (79). We applied metal gauze as platforms for the tissue 
explants to set up air-liquid interface cultures as this closely resembles the physiological 
conditions. Tissue viability (function) and morphology (structure) could be maintained at all 
times as demonstrated by TUNEL staining assays, and light microscopical, scanning electron 
microscopical and transmission electron microscopical analyses at different time points of 
tissue culture. All together, we successfully established valuable in vitro models that closely 
mimic in vivo tissue. 
 
 The established mucosa explant models are susceptible to herpesvirus infections, 
making them suitable to study and compare herpesvirus invasion mechanisms at 
mucosal surfaces. 
A next step in the investigations of this thesis was to evaluate whether the established mucosa 
explant model supports herpesvirus infection and replication. The use of mucosa explants to 
study aspects of pathogen host invasion is not new. It is widely used in the field of virology 
(e.g. HIV) (1, 18), bacteriology (e.g. Staphylococcus) (12, 90) and mycology (e.g. 
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Aspergillus) (74). However, the application of mucosa explant cultures in herpesvirus 
research was limited until now. 
In Chapter 4, we showed that bovine nasal mucosa, conchal mucosa, tracheal mucosa and 
genital mucosa explants are susceptible to bovine herpesvirus 1 (BoHV-1) infection. 
Moreover, our data convincingly show that both respiratory and genital mucosa are 
susceptible to infection with all different BoHV-1 subtypes despite their assumed different 
tissue tropism. Especially at 24h pi, some interesting findings were observed about BoHV-1 
dissemination in mucosal surfaces. In respiratory tissue and even more profound in tracheal 
mucosa, the virus is able to quickly disseminate in a plaquewise manner and invade by 
breaching the basement membrane barrier. This clearly shows that the virus is well adapted to 
disseminate within tracheal mucosa. This potent invasive capacity in the respiratory tract may 
explain why severe tracheitis is part of the clinical entity caused by BoHV-1 and perhaps also, 
why abortion is mainly seen after respiratory infection (72). In genital tissues, BoHV-1 
plaques were found to have a bigger latitude compared to plaques in the respiratory tract. It is 
important to mention that the respiratory epithelium is a pseudostratified epithelium which 
gives the impression that there are multiple layers of cells (63, 96). The genital epithelium on 
the contrary is a true multilayered epithelium (6). Assumedly, within a similar area of 
epithelial surface, more cells are present in the genital epithelium compared to the respiratory 
epithelium. Thus, replication and dissemination might be more exponential in the genital tract 
considering the density of naïve cells in close proximity to each other. A reflection of this 
more efficient replication might be that BoHV-1 titers in nasal secretions range from 108 – 
1010 Tissue Culture Infectious Dose (TCID50)/ gram mucus whereas BoHV-1 titers in genital 
secretions may go as high as 1011 TCID50/ gram mucus in vivo (28). Unfortunately, we did not 
perform titrations on explant supernatant in this part of the study to verify this hypothesis.  
The recently established homologous model allows the study of other/additional respiratory 
pathogens as well. In animals, a productive BoHV-1 respiratory infection can easily be 
complicated by secondary bacterial pathogens which aggravate the disease image 
substantially (72). It would be highly interesting to investigate how a BoHV-1 infection will 
influence secondary bacterial colonization and invasion. Especially interactions with bacteria 
such as Fusobacterium necrophorum, a normal inhabitant of the respiratory tract and 
causative agent of severe necrotic laryngitis in calves, and Arcanobacter pyogenes, involved 
in clinical laryngitis, would be highly interesting (50, 73). Recently, HSV-1 infection was 
found to facilitate Staphylococcus invasion in human nasal mucosa (98). We made the 
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observation in this chapter that starting from 48h pi and more pronounced at 72h pi, infected 
epithelial cells loosened and detached from the viral plaque, thereby exposing the basement 
membrane. Likely, this allows efficient colonization of bacteria as the latter often adhere to 
ECM proteins via bacterial adhesins, as described in point 1.3.1 of this thesis.    
In Chapter 5, we compared the mechanism employed by BoHV-1 to that of a related but 
scarcely documented bovine gammaherpesvirus namely bovine herpesvirus 4 (BoHV-4). 
Several respiratory and genital mucosa explants were inoculated with either BoHV-4 or 
BoHV-1 and analyzed for replication and dissemination parameters within mucosa. A key 
finding was that we did not observe signs of BoHV-4 infection in tracheal mucosa as we did 
see for BoHV-1. On the contrary, clear BoHV-4 and BoHV-1 infection was seen in vaginal 
mucosa, indicating a possible route of infection and transmission for BoHV-4. BoHV-4 
displayed both an epithelial and monocyte/macrophage tropism. A scant amount of in vivo 
studies describe that BoHV-4 could be readily recovered from monocytes (9, 33, 66). Unlike 
BoHV-1, BoHV-4 epithelial plaques were only seen from 48h pi and plaques never crossed 
the basement membrane in a plaquewise manner.  
Interestingly, several studies indicate that closely related gammaherpesviruses such as human 
Epstein-Barr virus (EBV) and Kaposi’s sarcoma-associated herpesvirus (KSHV) as well as 
murine herpesvirus 4 (MuHV-4) have a tropism for the genital tract. About thirty cases of 
ulcerative vaginal manifestations associated with EBV have been reported with some of them 
being primary infections (45, 64). The presence of KSHV in the cervix of some women and in 
semen suggests that replication and transmission via this site is a possibility (23, 100). Genital 
reexcretion, in general weak and transient, is documented for BoHV-4 to occur after the 
establishment of latency in mice and contributes to transmission of the virus (36). An 
intriguing fact is that for EBV, KSHV and MuHV-4, sexual transmission has been proposed 
(20, 36, 77). At this moment, we must be careful with stating that BoHV-4 has a strict tropism 
for the genital tract. Similar as for EBV, KSHV and MuHV-4, co-existence of multiple routes 
of dissemination is possible and makes it relatively difficult to elucidate what the preferred 
mode of host invasion and transmission is (36, 61, 71, 88, 100). For example, respiratory 
tract-associated lymphoid tissue such as tonsils was not included in our study. Tonsillar 
lymphocytes are a known EBV replication site (48). As several gammaherpesviruses show 
such  a lymphoid tropism (37, 48), it might be wise to test other topologically and structurally 
different respiratory areas as well in the future. Nevertheless, the finding that BoHV-4 is able 
to replicate and produce progeny virus in the vaginal mucosa has important implications for 
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the field. BoHV-4 is mainly associated with postpartum problems such as postpartum metritis 
and possibly mastitis (49, 99). Like most herpesviruses, BoHV-4 is able to reactivate from 
latency upon stress stimuli of which the final days of gestation and parturition are important 
examples (15, 30). Although speculative at the moment, active recurrent infection in the 
vaginal mucosa, as shown for MuHV-4 in mice, might be a possible route of transmission. 
Passage of the newborn calf through the genital tract during natural birth might result in peri-
natal infection. Post-natal exposure to the virus through an active shedding dam is an 
additional possible route of transmission. Considering this, veterinarians that perform a 
vaginal exploration during parturition should carefully respect the necessary hygienic 
measures if they decide to perform a subsequent caesarian section and/or udder examination 
in order to prevent iatrogenic introduction of BoHV-4 in the uterus or udder. As for BoHV-1, 
true horizontal sexual transmission of BoHV-4 is probably greatly reduced through artificial 
insemination. 
In Chapter 6, we evaluated the mucosal dissemination characteristics of HSV-1 and HSV-2 in 
human genital mucosa during different phases of the menstrual cycle. Somewhat similar as 
for the different subtypes of BoHV-1 in Chapter 4, we observed no differences between the 
behavior of HSV-1 and HSV-2 in genital mucosa despite their different tissue preference. In 
the field, there is also an increasing trend of HSV-1 induced primary genital herpes cases (16). 
Clearly, as we have shown in this thesis for both a veterinary and human herpesvirus, tissue 
tropism is a relatively abstract concept. More likely, factors such as (social) behavior of 
individuals as well as genetics are the true determinants of where these viruses tend to 
replicate. For example, especially in young adolescents HSV-1 infections of the genital tract 
are on the increase because of increasing oro-genital contact (4). In cattle, the incidence of 
genital infections with BoHV-1 has drastically diminished due to increased good-practice 
artificial insemination and reduced natural mating (72). We were somewhat surprised to see 
that the human ectocervical/vaginal mucosa is a very protective barrier against HSV-1/-2, not 
only because of the physical epithelial thickness measured in our study, especially under 
estrogen influences, but also when it comes to barrier function of the basement membrane. 
Indeed, we did observe only a limited number of plaques in both endo- and ectocervix that 
penetrated the basement membrane at 48h pi and this in a localized manner. We cannot 
exclude that at a later time points post inoculation the amount of BM penetrating plaques may 
increase. Nevertheless, it is clear that even in these few BM-penetrating plaques, the virus can 
easily spread further to blood vessels. Several in vivo studies strengthen our observation by 
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documenting clear episodes of HSV-viremia after primary HSV infections of the genital tract 
in humans (53, 56). Remarkably, we detected several syncytia or multinucleated giant cells 
within HSV-induced epithelial plaques. Cell-cell fusion is a key process in the formation of 
multinucleated giant cells. Residing macrophages in the epithelium have the ability to 
undergo cell-cell fusion upon specific stimuli, resulting in multinucleated giant cell formation. 
Hence, syncytia may play a beneficial role in the elimination of pathogens and foreign 
particles. However, they may also be deleterious to the host, by promoting tissue destruction 
and facilitating microbial survival (81). Suggestively, HSV might be subverting this 
mechanism of macrophages within plaques to promote prolonged persistence in the 
epithelium as an immune evasion strategy. 
In conclusion, Figure 1. provides an overview of the observed invasion mechanisms for the 
viruses used in this thesis. A comparison of the mucosal behavior is made for all viruses in 
(pseudo)stratified epithelia at time point 48h post inoculation. Data of a previously published 
study of our laboratory describing the dissemination characteristics of HSV-1 in respiratory 
mucosa are included (41). Bovine herpesvirus 1 replicates plaquewise in both respiratory and 
genital mucosa to a similar extent and aggressively breaches the basement membrane barrier 
starting from 24h pi. However, in general at 48h pi, plaque latitude is larger in genital tissues 
compared to tracheal tissues. Vice versa, plaque penetration depth is more profound in 
respiratory tissues compared to genital tissues. We must say that this discrepancy is even 
more clear at 24h pi but is absent at 72h pi. In summary, BoHV-1 rapidly spreads lateral in 
genital tissues and more efficiently invades respiratory tissues very early after host infection. 
A closely related bovine gamma herpesvirus, BoHV-4, also displays an epithelial tropism but 
seems to be limited to infect the genital tract. BoHV-4 infects single epithelial cells starting 
from 12h pi. At 24h pi, small clusters of epithelial cells are visible and grow to plaques at 48h 
pi. We did not observe breaching of the basement membrane barrier for BoHV-4. Instead, at 
all time points, few single individual monocytic lineage cells can be observed in the 
epithelium and lamina propria. This indicates that BoHV-4 might be using these cells to be 
efficiently invade deeper tissues. It is known that BoHV-4 can easily infect macrophages and 
establish persistence within them (29).  
Interestingly, if we compare the plaque latitude at 48h pi of BoHV-1 and BoHV-4, clearly 
BoHV-4 less efficiently paves its way through the epithelial layer. HSV-1 and HSV-2 are 
both able to replicate in ectocervical/vaginal epithelium. Plaque latitude increases over time 
and at 48h pi, few epithelial plaques show signs of basement membrane penetration, albeit in 
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a localized manner. Comparison of the plaque latitude and penetration depth values of HSV-1 
in genital mucosa with the data of HSV-1 spread in respiratory mucosa, suggests that HSV-1 
can spread more efficiently lateral in genital mucosa compared to respiratory and more 
efficiently in the depth in respiratory compared to genital tissues (Figure 1). Importantly, this 
trend is also observed for BoHV-1 in respiratory and genital tissues, especially at early time 
points post inoculation, and stresses out an important similarity between an animal and a 
human alphaherpesvirus. Two side remarks have to be made. Firstly, the data acquired by 
Glorieux and co-workers document HSV-1 mucosal spread only until 36h pi (41). So at this 
point, we compare the values of HSV-1 in the genital tract at 48h pi to values of HSV-1 in the 
respiratory tract at 36h pi, which might be an important bias. Nevertheless, we believe it is 
unlikely that the virus is able to nearly double its plaque latitude in the respiratory tract within 
a 12h time span. For the plaque penetration depth, the difference observed in favor of the 
respiratory tract might be even more profound at 48h pi compared to the genital tract at 48h 
pi. Second, it is important to point out we are not comparing the values for HSV-1 in tissues 
derived from the same individuals, as we did for BoHV-1 in the different tissues.  
Although speculative, we believe that the bigger plaque latitude of BoHV-1 and HSV-1 in the 
genital tract compared to the respiratory tract might be a result of the presence of a different 
type of epithelium, as mentioned above (6, 63, 96). This may result in more quicker 
dissemination and replication in the genital tract considering the density of naïve cells in close 
proximity to each other. Considering the more efficient invasion capacity in respiratory 
tissues compared to genital tissues, we hypothesize that the determining factor is the BM 
rather than the different epithelium type and amount of epithelial layers. A reason to assume 
this is the fact that the invasion depth of HSV in human endocervix, which contains a one 
layer epithelium, was similar as in the multi-layered ectocervix. In addition, HSV-1 was 
found to efficiently invade across pseudostratified respiratory epithelium (41). Basement 
membranes barriers are not static structures, they can vary both in composition, thickness and 
biomechanical properties depending on the tissue/organ and age (32, 44). TEM studies have 
shown that the thickness of BMs can range from 100nm for average BMs to over 10µm for 
the lens capsule, the thickest BM in humans (44). Though we did not observe differences in 
lamina reticularis thickness of the genital and respiratory mucosa, we have neither 
information about the thickness of another part of the BM called lamina densa nor about the 
composition of the entire BM scaffold. If BMs of genital mucosa are structurally more 
complex and thick, this might require more effort of particles and time to penetrate. 
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 The heterodimer gE/gI plays a crucial role in plaquewise crossing of the basement 
membrane by alphaherpesviruses like BoHV-1. 
In Chapter 4 we found that BoHV-1 is able to cross the basement membrane in a plaquewise 
manner, quite similar as what is previously observed for pseudorabies virus (PRV) in 
respiratory mucosa. Therefore, we were interested in which viral effectors are required for the 
viral invasion mechanism of this group of alphaherpesviruses and applied the established 
model of BoHV-1 on respiratory mucosa for investigation. As we found before that at 48h pi 
most, if not all, BoHV-1 plaques cross the basement membrane barrier, invasion of different 
mutant BoHV-1 strains was analyzed at 48h pi. 
In Chapter 7, the role of two virulence genes, US7 (gI) and US8 (gE), in BoHV-1 invasion 
through the basement membrane was assessed. Glycoprotein E and glycoprotein I seem ideal 
candidates to be involved in efficient host invasion. First, they are present in all field isolates, 
pointing out their important role in pathogenesis (3, 82). BoHV-1 gE null or gE truncated 
strains are strongly attenuated in vivo and all current “safe” vaccine strains are in fact gE 
deleted (17, 57, 65, 87, 93). HSV-1 gE null viruses are severely impaired in establishing 
stromal disease and potential encephalitis after epithelial keratitis (26). Second, these 
glycoproteins, present in a complex, govern directional movement in different cell types for 
efficient spread to naïve cells and tissues. As such, movement of virus across cell-cell 
contacts and axonal transport of viruses both require a functional gE/gI complex (26, 27, 80, 
103). Third, Glorieux and colleagues previously reported a possible role of gE in the PRV 
mucosal invasion mechanism towards the lamina propria (40). Taken into account these data, 
the gE/gI complex is of paramount importance for virus spread and invasion. 
We used different approaches to investigate whether this complex plays a role in BoHV-1 
invasion. First, we used either gE/gI knockout virus strains or we inhibited the gE/gI function 
by applying blocking monoclonal antibodies and looked at the effect on different 
dissemination parameters. Second, we analyzed the distribution of gE within epithelial 
plaques and in addition we also assessed whether gE/gI is required for efficient sorting of 
virus particles towards the basement membrane by using TEM. Both knocking out and 
inhibiting gE/gI resulted in a highly reduced penetration depth underneath the basement 
membrane. In addition, knock out of gE/gI resulted in a reduced plaque latitude and reduction 
in progeny virus production. Next, glycoprotein E was found to be highly present near the 
basement membrane in BoHV-1 epithelial plaques. TEM analysis revealed that gE/gI is 
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required for routing viral particles to basal sides of epithelial cells. In basal cells, adjacent to 
the basement membrane, many particles were found to sort near the basement membrane if a 
functional complex was present whereas knockout of gE/gI resulted in reduced amount of 
virions near the basement membrane. The observation that a gE CT null virus and thus a 
knockout of the gE sorting motifs resulted in a similar phenotype as gE null in our analysis 
supports the idea that gE/gI sorts virus particles towards the basement membrane. 
Virus sorting towards integrins near the basement membrane, which are present in cell-matrix 
adhesions, and mimicking or inducing integrin signaling would represent an efficient way of 
transport through the basement membrane. Preliminary experiments have been performed in 
this context by adding a function-inhibiting monoclonal antibody directed against either the 
β1 or β4 subunit of integrins to the medium of wild type BoHV-1 inoculated explants from 0h 
pi onwards. Nine different integrins are expressed in epithelial cells of which two, α3β1 and 
α4β6, recognize basement membrane components and are abundantly present in anchoring 
cell-matrix junctions (11, 58). We observed a relative reduction of ±80% in plaque 
penetration depth underneath the basement membrane compared to the mock and isotype 
control condition when blocking both subunits. This observation suggests a direct role of 
integrins, as cell-matrix anchors, in the BoHV-1 invasion mechanism but more data have to 
be acquired in this context. 
In conclusion, we want to speculate on the role of gE/gI and other potential proteins and 
pathways in the invasion mechanism of BoHV-1 via basal epithelial cells through the 
basement membrane barrier (Figure 2).  
Soon after synthesis, gE and gI quickly form heterodimeric complexes. The gE CT domain 
promotes extensive accumulation of gE/gI in the trans-Golgi network (TGN) in infected cells 
at early times of infection. We suggest that the gE/gI complex functions as a chaperone to 
orchestrate trafficking, sorting and distribution of many other viral proteins including gD, 
UL11, UL16 and VP22 (19, 35, 46). Selective partitioning, with gE/gI at the steering wheel, 
topologically targets essential proteins such as gD, gB and gH/gL to the virion envelope and 
proteins required for efficient sorting such as US9 and UL56 to the transport vesicle (10, 60). 
Indeed, gE/gI is a central figure in a complex network of interacting tegument proteins 
including UL11, UL16, VP22 and UL21 that link the complex to other major proteins such as 
gD (35, 46, 59). From the TGN, the major sorting station for newly synthesized proteins and 
lipids, several trafficking routes originate towards apical, lateral and basal plasma membrane 
domains (34).  
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In monolayers of epithelial cells, the gE/gI complex accumulates specifically on those lateral 
surfaces of epithelial cells that are forming cell junctions whereas they are not observed on 
lateral surfaces of epithelial cells that are not in contact with other cells (52). We observed in 
this thesis that gE/gI sorts virus towards basal cell sides of basal epithelial cells that form 
adhesive junctions with the extracellular matrix (3D), which are absent in monolayers (2D). In 
addition, subcellular gE localization showed a predominant presence of gE on basal cell sides 
adjacent to the basement membrane within BoHV-1 epithelial plaques.  
Cellular cargo including proteins and lipids are transferred between compartments by the 
formation, movement and subsequent specific fusion of transport intermediates. These 
vesicles must be coupled to the cytoskeleton via motor proteins that drive motility (83). 
Ample data describe the interaction of herpesviruses with microtubule-associated motor 
proteins and thus microtubule-based transport of virions, mainly in neuronal cells (25, 43, 47, 
52, 60, 101, 102). As such, during anterograde transport of herpesviruses, it is described that 
US9 interacts with KIF1A, a microtubule interacting motor protein; an interaction which is 
dependent upon lipid raft association and stabilization by gE/gI (60). HSV-1 tegument protein 
US11 was found to bind KIF5B (24). VP1/2, an inner tegument protein, is also implicated in 
recruiting a kinesin motor to cytoplasmic vesicles filled with viral particles late in infection 
(85). Hence, we believe that cellular motor proteins are misused within epithelial cells quite 
reminiscent to herpesvirus axonal transport, to specifically route virions towards adhesive 
structures either in contact with other cells or with the extracellular matrix. We suggest that 
coat-mediated targeting to either apical, lateral or basal domains is dependent upon several 
limiting factors: (i) formation of adhesive junctions and thus establishment of directional 
microtubule transport, (ii) the kinesin motor, (iii) the adaptor protein and (iii) the viral protein 
interacting with the motor/adaptor complex. Epithelial cells contain different kinesin motors 
for anterograde transport or “away from the nucleus”, including KIF5B, KIF13A, KIF16A 
and KIF17 (51, 63, 86, 89). During interkinetic nuclear migration (INM), a common event in 
(pseudo)stratified epithelia, KIF1A traffics to basal cell sides (63). On the other hand, KIF17 
is involved in sorting towards the apical pole (51). In addition to US9, US11 and VP1/2 
mentioned above, there is increasing evidence that other motor engaging viral proteins such as 
UL56 might contribute to directional transport (59). Therefore, it is likely that different viral 
proteins engaging different cellular motors might determine the employed trafficking route. 
Because of the selective partitioning ability of gE/gI, the complex probably orchestrates the 
destination of vesicles by incorporating different viral effectors of cell transport such as US9 
and/or UL56. 
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Second, gE/gI accumulates at cell junctions late in infection, apparently tethered there in a 
manner similar to that of various cell adhesion molecules (78). Although speculative, we 
believe that the gE/gI complex may be targeted to integrins within lipid rafts and activates 
and/or mimics integrin-mediated signaling. We do not observe common acidic peptide 
integrin-binding motifs such as RGD, RSD, LDV or DGE in the extracellular parts of either 
gE or gI of BoHV-1, suggesting no direct role for gE/gI but instead an indirect recruiting role 
of other proteins that can cause integrin activation (via the Eukaryotic Linear Motif resource 
for functional sites in proteins (ELM)-software http://elm.eu.org/). Such a candidate might be 
BoHV-1 gC as an RGD motif is located on its extracellular domain. On the other hand, 
another mechanism might be mimicking of integrin-signaling through the cytoplasmic tail of 
both gE and gI. Both BoHV-1 gE and gI have three predicted SH3-domains in their 
cytoplasmic tail. In addition, the CT of gE possesses a predicted MAPK docking motif and 2 
predicted SH2 domains (ELM-software). SH3, SH2 and MAPK domains are often found in 
signal transduction proteins such as integrins and are important for various cellular processes 
including cytoskeleton remodeling, which on its turn can induce inside-out signaling allowing 
extracellular matrix remodeling (69, 70). Importantly, for example BoHV-1 gB, gD and gC do 
not possess such motifs in the cytoplasmic domain. Moreover, glycoprotein E and I of EHV-1 
also lacks such predicted motifs, which makes this interesting as we do not observe a similar 
mechanism of invasion for EHV-1. EHV-1 is not able to mediate an aggressive breakdown of 
ECM for successful basement membrane passage.  
We have to emphasize that the current hypothetical pathways are at present highly speculative 
and future research will be needed to explore all different possibilities that allow efficient 
invasion of herpesviruses through the basement membrane barrier for host invasion. 
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 Future directions – vaccination and antiviral therapy 
Interfering with alphaherpesvirus invasion 
We found BoHV-1 and HSV-1/-2 to cross the basement membrane in a plaquewise manner 
similar as previously described for PRV. In addition, for PRV, a trypsin-like serine protease 
was found to be involved in successful viral passage of the BM (42). Likely, BoHV-1 and 
HSV-1/-2 might apply a similar mechanism. In this context, the topical use of antiviral 
compounds that specifically inhibit the activity of involved proteolytic enzymes will be an 
interesting strategy. Moreover, we showed in this thesis that the heterodimeric complex gE/gI 
is crucial for efficient sorting of virus particles towards the basement membrane in basal 
epithelial cells and subsequent invasion. Antivirals that specifically inhibit gE/gI-mediated 
viral transport might be an additional interesting approach. These proposed invasion-
inhibiting products can potentially be used complementary to current existing compounds 
(cocktail therapy) and might provide necessary alternatives when dealing with resistant 
strains. In humans, such products could be beneficial during clinical episodes or as preventive 
measures around the moment of child birth. In bovines, the application of such products may 
be economically justified in light of an outbreak during re-introduction in IBR-free countries, 
both for protecting contact animals as for ring-block measures. Indeed, because of the 
drawbacks of the current vaccines, using marker vaccines should not be the preferred antiviral 
strategy at that time. We want to point out that the established explant models are ideal tools 
to screen for novel potent antiviral compounds.  
Induction of a specific cellular and humoral immunity via vaccination is another antimicrobial 
(preventive) measure. Deletion of gE/gI will result in replication-competent, live attenuated 
strains that might be good candidates for vaccine strains. If our hypothesis holds truth for viral 
effectors of virus transport in epithelial cells, then additional deletion of US9 and UL56 may 
make sense. Our results suggest that these strains will be severely impaired in spreading 
beyond the basement membrane barrier. In addition, as it is known that gE/gI and US9 play a 
role in viral transport in neurons, these strains will also be hampered in their neuroinvasive 
capacity (60). In line with our results, a recent publication shows that gE null HSV-2 strains 
are impaired in efficient spread from epithelial cells to axons and in anterograde transport 
from the neuronal cell body to axon termini. The authors propose the use of a gE null HSV-2 
strain as MLV (5). Moreover, gE null and US9 null strains were found to be safe in calves as 
they are attenuated in spread and are not able to reactivate from latency (54). The best results 
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will be obtained after inducing a strong local immunity at the level of the mucosa and hence, 
MLV should be applied either intranasally or intravaginally. 
   
Vaccination against gammaherpesviruses? 
In this thesis we identified the vaginal mucosa as a possible primary (and recurrent) site for 
BoHV-4 replication. Because of the ubiquitous nature of the virus and its association with 
economical losses due to postpartum diseases, vaccination might be a considerable option. 
The established homologous model in this thesis can be applied to test several mutant BoHV-
4 strains. Since glycoproteins are important in essential virus-cell interactions like adherence, 
penetration and spread, they might be interesting candidates. Machiels and co-workers have 
recently shown that the function of one of the main envelope glycoproteins of BoHV-4, 
gp180, is quite reminiscent to that of the MuHV-4 gp150 and EBV gp350 homologues as they 
all seem to play a role in cell type tropism (68). Mutants that are able to replicate in the 
epithelium but are locally confined, thus incapable of hijacking immune cells, can be selected 
for further study as potential MLV candidates. However, we first have to acquire an idea 
about the seroprevalence and also the incidence of postpartum problems caused by this virus 
in Belgian cattle farms. At farms with a high seroprevalence and a high incidence of 
postpartum diseases, intravaginal vaccination with an MLV might be economically justified. 
This valuable knowledge might also contribute to the development of antiviral measures for 
other gammaherpesviruses such as EBV and KSHV in humans. 
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Summary 
Alphaherpesviruses, like bovine herpesvirus 1 (BoHV-1) in cattle and herpes simplex virus 1 
(HSV-1) and 2 (HSV-2) in humans, preferentially initiate host invasion at mucosal surfaces 
such as the upper respiratory and lower genital tract. This local dissemination often leads to 
destruction of mucosal and submucosal layers, resulting in ulcerative disease. To limit free 
pathogen invasion, the host possesses several selective barriers. Such a barrier is the basement 
membrane (BM) barrier underneath epithelia. In order to successfully establish viremia and 
neuronal infection, pathogens need to develop various mechanisms to overcome the BM. 
However, data describing these mechanisms of stromal invasion for viral infections, 
particularly, herpesviruses, are rather scarce. Nevertheless, insights in these putative viral 
invasion mechanisms will provide us new incentives for antiviral intervention strategies. The 
major aim of this thesis was to thoroughly study mucosal invasion mechanisms of both 
veterinary herpesviruses BoHV-1 and BoHV-4 as well as human herpesviruses HSV-1 and 
HSV-2 to: (i) point out differences and similarities at the level of mucosal invasion and (ii) 
provide insights for the development of alternative preventive and curative approaches 
representative for animal and human viruses. 
 
Chapter 1 provides an introduction on herpesviruses and an overview on the 
characteristics of respiratory and genital mucosa. In addition, different microbial 
interactions with the basement membrane are reviewed.  
The first section consists of a brief introduction on herpesvirus biology in general. As the 
major players within this thesis are bovine herpesvirus 1 (BoHV-1) and 4 (BoHV-4), as well 
as human herpesvirus 1 (HSV-1) and 2 (HSV-2), more detailed information is provided about 
their respective pathogenesis and symptomatology.  
The second section focuses on structural and functional aspects of upper respiratory and lower 
genital tract tissues with emphasis on several barriers including mucus, junctional complexes 
and the basement membrane.  
The third section of this chapter describes the current knowledge on existing microbial 
mechanisms to circumvent the basement membrane barrier for host invasion. 
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In Chapter 2, the aims of this thesis are formulated. 
 
Chapter 3 describes the development of ex vivo organ cultures of respiratory and 
genital mucosa with the purpose to create a homologous model for the study of 
herpesvirus invasion.  
A first part describes the establishment of explant models for both bovine upper respiratory 
tissues, including nasal septum, ventral conchae and proximal trachea; and genital tissues 
including vestibulum vaginae.  
A second part tackles the optimization of a human genital organ culture consisting of either 
ectocervix/vagina or endocervix.  
All explant models could be maintained for at least 96h of in vitro culture. During cultivation, 
no significant changes in tissue viability or tissue morphology were observed as shown by 
TUNEL assay and light, scanning electron and transmission electron microscopy. Several 
parameters such as apoptosis, epithelial integrity, basement membrane continuity and 
connective tissue morphology were evaluated at different time points of cultivation. The use 
of the present modeling tools is in line with the 3R principle of Russell and Burch 
(Refinement, Reduction and Replacement). The major advantage of these 3D models is the 
maintenance of normal cell-cell contacts and tissue structure compared to 2D cell monolayers.  
 
Chapter 4 describes BoHV-1 mucosal dissemination and invasion at host entry ports.  
In a first part, several mucosal explants derived from upper respiratory tissues were inoculated 
with the Cooper BoHV-1 strain. The salient findings were that BoHV-1 displays a plaquewise 
spread during its dissemination in respiratory mucosa explants. In addition, from 24h pi 
onwards crossing of the BM was observed and the majority of plaques crossed the BM at 48h 
pi. Furthermore, BoHV-1 invaded more efficiently across the BM in proximal tracheal tissue. 
Hence, proximal trachea appears to be an interesting target tissue to unravel BoHV-1 invasion 
mechanisms in respiratory mucosa.  
In a second part, to address whether different BoHV-1 subtypes display a different tissue 
tropism, we inoculated several respiratory and genital mucosa explants derived from the same 
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animals with the different existing BoHV-1 subtypes 1.1 (respiratory tropism), 1.2a (genital 
tropism) and 1.2b (genital tropism). A quantitative analysis of viral invasion in the mucosa, 
performed at 0h, 24h, 48h and 72h post inoculation (pi) revealed that all subtypes 
disseminated quite alike. All BoHV-1 subtypes exhibited a more profound invasion capacity 
in respiratory tissue compared to that in genital tissue at 24h pi. However, at 24h pi plaque 
latitude was found to be larger in genital tissue compared to respiratory tissue and this for all 
subtypes. These similar findings among the different subtypes take the edge off the belief of 
the existence of specific mucosa tropisms of different BoHV-1 subtypes.  
 
In Chapter 5, the invasion mechanism of a bovine gammaherpesvirus, BoHV-4, is 
compared to invasion mechanisms employed by alpha- and gammaherpesviruses.   
The pathogenesis of bovine herpesvirus 4 (BoHV-4) is not well characterized. We sought to 
investigate the early steps in the pathogenesis of this pathogen known for its contribution to 
cases of post-partum metritis. To this end, both bovine respiratory and genital explants were 
inoculated with BoHV-4. First, we looked whether these tissues support replication and may 
act as primary host entry portals. In addition, we compared the dissemination kinetics of 
BoHV-4 with results obtained before with BoHV-1. In a last step, we studied the cell tropism 
of BoHV-4 at the level of the mucosa early upon host entry. Interestingly, only genital 
mucosa proved to be susceptible to BoHV-4 infection shown by multiple single epithelial 
(cytokeratin+) cell infection at 12h pi. These infectious centers grew steadily over time and 
became plaques as soon as 48h pi. In addition, scarcely distributed single infected cells in 
both epithelium and lamina propria could be seen mainly at 24h pi, and were found to be of 
monocytic/macrophage (CD172a+) origin. Unlike BoHV-1, plaques were not observed at 24h 
pi and plaques never breached the basement membrane. This is the first report describing 
aspects of the early steps of the BoHV-4 pathogenesis. Moreover, the established system 
might be an accessible, animal gammaherpesvirus homologous model system for the hard-to-
study human gammaherpesviruses Epstein-Barr virus (EBV) and Kaposi’s sarcoma-
associated herpesvirus (KSHV). 
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Chapter 6 explores the mucosal behavior of human herpes simplex virus 1 (HSV-1) 
and 2 (HSV-2) in a human genital organ culture 
Human genital herpes is worldwide one of the most prevalent causes of genital ulcer disease 
and with a prevalence reaching up to 80% (developing countries), one of the most important 
sexually transmitted infections (STI). Firstly, we looked at the distribution of several HSV 
entry receptors including nectin-1, nectin-2 and herpesvirus entry mediator (HVEM) within 
endocervical and ectocervical/vaginal non-cultured tissues by means of immunofluorescence 
stainings. This was performed on tissues in various stages of the menstrual cycle. In a second 
part, we modeled the dissemination in genital mucosa of both HSV-1 and HSV-2 by 
inoculating our previously established human genital organ culture and compared the HSV-1 
and HSV-2 replication characteristics for different cycle stages within the same patients. 
Nectin-1 and -2 showed a similar expression pattern in both endocervix and ectocervix/vagina 
and moreover, this was consistent at all stages of the menstrual cycle. On the contrary, HVEM 
was found not to be expressed in endocervical or ectocervical epithelial cells. However, we 
noticed scarcely distributed cells in the epithelium and several cells in the lamina propria to be 
HVEM positive, presumably immune cells. Both endocervix and ectocervix were found 
susceptible to both HSV-1 and HSV-2 infection. HSV-1 and -2 both exhibited a plaquewise 
mucosal spread in all tissues and induced prominent epithelial syncytia in ectocervical tissues, 
all independent of hormonal cycle stage. Starting from 48h pi, few epithelial viral plaques 
crossed the basement membrane (BM) showing that HSV-1 and HSV-2 can cause stromal 
invasion in the genital tract and subsequent HSV viremia. 
 
Chapter 7 investigates the role of the glycoprotein gE/gI complex in the plaquewise 
crossing of the basement membrane displayed by alphaherpesviruses such as BoHV-1. 
To assess the role of gE/gI in the plaquewise penetration of the BM displayed by some 
alphaherpesviruses, we used the previously established bovine respiratory model and BoHV-
1. Movement of virus across cell-cell contacts and axonal transport of viruses both require a 
functional gE/gI complex. Hence, we investigated the role of gE/gI in BoHV-1 directional 
spread across the basement membrane. We analyzed the effect of deleting gE/gI using virus 
recombinants or inhibiting gE/gI by monoclonal antibodies on viral replication, plaque 
latitude and penetration depth underneath the basement membrane in a bovine respiratory 
9 Summary – Samenvatting 
 
240 
 
mucosa model at 48h pi. In addition, virion distribution at the basal cell surface of wild-type 
and gE and/or gI knockout strains and gE membrane expression was analyzed in inoculated 
explants at 48h pi by means of transmission electron and confocal microscopy respectively. 
Strains deleted for either gE and/or gI resulted in a strong reduction in viral replication, 
plaque latitude and penetration depth underneath the basement membrane. Importantly, a gE 
CT deleted virus showed an identical phenotype as a complete gE null virus. Addition of 
monoclonal antibodies directed against gE/gI to the cultivation medium of wild-type 
inoculated explants from 0h pi onwards, suppressed plaque penetration depth underneath the 
basement membrane without affecting plaque latitude and viral progeny titers. Subcellular 
distribution of gE within BoHV-1 epithelial plaques revealed a predominant localization of 
gE alongside the basement membrane. Next, TEM analysis showed that the majority of wild-
type virus particles are located near the basal cell side within basal epithelial cells in contrast 
to knockouts for gE and/or gI which were mainly found on non-basal cell sides of basal cells 
and more randomly spread within basal cells. In conclusion, we provided various indications 
that the gE/gI complex plays a crucial role in BoHV-1 stromal invasion through the basement 
membrane barrier. Although at this moment still speculative, it seems that gE/gI mimics a 
basal sorting pathway via its cytoplasmic tail motifs by interacting with specific motor 
proteins towards basal domains in basal epithelial cells and orchestrates invasion once present 
near the basement membrane. 
 
Chapter 8 summarizes the obtained results in this thesis and presents a general 
discussion on the acquired knowledge. 
The main conclusions drawn from this thesis are threefold: 
 Ex vivo organ cultures were successfully established for bovines and humans 
consisting of either respiratory or genital mucosa. These alternative experimental 
models allow mechanistic studies of mucosal invasion of bovine and human 
pathogens. 
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 The established mucosa explant models are susceptible to herpesvirus infections, 
which allows to study and compare herpesvirus invasion mechanisms at mucosal 
surfaces. All herpesviruses used in this study clearly exhibited an epithelial 
tropism, irrespective of their taxonomy or host tropism. Each of these viruses 
appears to apply finely tuned mechanisms for efficient invasion within the host. 
 
 The viral heterodimer gE/gI plays a crucial role in the invasive pathway of 
BoHV-1 through the basement membrane in respiratory mucosa. We suggest 
that in epithelial cells gE/gI selectively and topologically distributes other viral 
proteins in membranes, stabilizes the (mis)usage of cellular motor proteins quite 
reminiscent to herpesvirus axonal transport, to specifically route virions towards 
adhesive structures either in contact with other cells or with the extracellular 
matrix and orchestrates invasion at the basement membrane once sorted 
correctly. 
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Samenvatting 
Voor alfaherpesvirussen zoals het bovien herpesvirus 1 (BoHV-1) bij runderen en het humaan 
herpes simplex virus 1 (HSV-1) en 2 (HSV-2) bij mensen dienen mucosale membranen van 
zowel het respiratoir als genitaal stelsel vaak als voorkeursplaatsen voor primaire 
vermeerdering. Deze lokale spreiding in het epitheel resulteert vaak in destructie van zowel 
mucosa als submucosa met ulcererende ziektesymptomen tot gevolg. De gastheer probeert 
deze vrije passage van pathogenen te verhinderen door de aanwezigheid van enkele barrières 
zoals de basaalmembraan onder epithelia. Om succesvol te zijn in het infiltreren van de 
gastheer moeten pathogenen dus beschikken over een aantal mechanismen om deze barrières 
te omzeilen. Het aantal studies rond deze mechanismen van stromale invasie gebruikt door 
virussen is echter zeer beperkt. Niettemin zouden nieuwe inzichten in deze specifieke 
mechanismen ons toelaten om op een rationele basis nieuwe antivirale toepassingen te 
ontwikkelen. Het hoofddoel van deze thesis was om de invasiemechanismen van zowel een 
animaal (BoHV-1) als een humaan (HSV) alfaherpesvirus te onderzoeken en ook met elkaar 
te vergelijken. Dit zou enkele gelijkaardigheden maar ook tegenstellingen aan het licht 
kunnen brengen welke van belang zouden kunnen zijn bij het ontwikkelen van alternatieve 
preventieve en curatieve behandelingen voor herpesvirussen in de diergeneeskundige en 
geneeskundige sector. 
 
Hoofdstuk 1 leidt herpesvirussen in en geeft daarnaast een overzicht van de 
karakteristieken van respiratoire en genitale mucosa. Verder worden er verschillende 
gekende microbiële interacties met de basaalmembraan beschreven. 
Het eerste deel geeft een introductie in de algemene herpesvirus biologie. Daarnaast wordt er 
uitvoerig gedocumenteerd over pathogenese en symptomatologie van de hoofdspelers in deze 
thesis namelijk bovien herpesvirus 1 (BoHV-1) en 4 (BoHV-4) alsook humaan herpes 
simplex virus 1 (HSV-1) en 2 (HSV-2). 
Het tweede deel focust op structurele en functionele aspecten van zowel de bovenste 
ademhalingswegen als het genitaal stelsel met bijzondere aandacht voor verschillende 
barrières zoals de mucus laag, het epitheel en de basaalmembraan. 
Het derde deel beschrijft de huidig gekende mechanismen die pathogenen gebruiken voor 
interactie met de basaalmembraan. 
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In Hoofdstuk 2 worden de algemene doelstellingen van deze thesis uiteengezet. 
 
Hoofdstuk 3 handelt over het opzetten en ontwikkelen van ex vivo orgaan culturen 
bestaande uit zowel respiratoire als genitale mucosa als tools voor de studie van 
herpesvirus invasie.  
Een eerste deel beschrijft het opzetten van explant culturen voor boviene respiratoire mucosa, 
meer specifiek nasaal septum, ventrale conchae en proximale trachea maar ook voor boviene 
genitale mucosa zoals het vestibulum vaginae. 
Het tweede deel behandelt de optimalisatie van een humane genitale orgaan cultuur bestaande 
uit enerzijds ectocervix/vagina en anderzijds uit endocervix. 
Alle opgezette orgaanculturen konden gecultiveerd worden in vitro voor minstens 96h na 
opzet. Tijdens deze cultivatie werden er geen significante verschillen geobserveerd in weefsel 
viabiliteit of morfologie wat werd aangetoond met behulp van lichtmicroscopie, scanning 
elektronenmicroscopie en transmissie elektronenmicroscopie. Verschillende parameters zoals 
het aantal apoptotische cellen, epitheliale integriteit, basaalmembraan continuïteit en 
bindweefsel structuur werden zo geëvalueerd op behoud tijdens cultivatie. Het gebruik van 
deze modellen is in lijn met het 3 V principe van Russell en Burch (Verfijning, Vermindering 
en Vervanging). Het grote voordeel van deze 3D modellen is dat ze perfect de noodzakelijke 
normale weefsel structuur en celcontacten behouden in tegenstelling tot de huidige 2D 
celculturen. 
 
Hoofdstuk 4 gaat over de spreiding van BoHV-1 in mucosale weefsels en welke 
mechanismen er gebruikt worden door dit virus om efficiënt doorheen de 
basaalmembraan te dringen. 
In een eerste deel, werden verschillende respiratoire mucosale explanten geïnoculeerd met de 
Cooper stam van BoHV-1. Vervolgens werd de kinetiek van virusspreiding nagegaan op 
verschillende tijdstippen na inoculatie. BoHV-1 bleek zich op een plaque-gewijze manier te 
verspreiden in het epitheel. Daarenboven braken enkele plaques vanaf 24h pi doorheen de 
basaalmembraan. Dit werd duidelijker op 48h pi aangezien het merendeel van de plaques zich 
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op dat moment een weg hadden gebaand doorheen de basaalmembraan. Vooral in tracheale 
explanten werd een zeer efficiënte spreiding doorheen de basaalmembraan geobserveerd 
waardoor we konden concluderen dat deze regio uit de bovenste ademhalingswegen een 
interessant weefsel is voor gebruik in verdere studies. 
In een tweede deel, om specifiek de vraag te beantwoorden of er effectief verschillende 
subtypes bestaan binnen BoHV-1 met een verschillend weefsel tropisme, werden er 
verschillende respiratoire en genitale explanten afkomstig van dezelfde dieren geïnoculeerd 
met de verschillende gekende BoHV-1 subtypes namelijk 1.1 (respiratoir tropisme), 1.2a 
(genitaal tropisme) en 1.2b (genitaal tropisme). Opnieuw werd er met behulp van een 
kwantitatief analyse systeem gekeken naar virus spreiding in de mucosa op 0h, 24h, 48h en 
72h pi. Alle subtypes spreidden gelijkaardig, zowel in respiratoir als in genitaal weefsel. Voor 
alle subtypen werd een meer efficiëntere invasie capaciteit doorheen de basaalmembraan 
vanuit epitheliale plaques geobserveerd in respiratoir weefsel dan in genitaal weefsel op 24h 
pi. Daarnaast, op 24h pi, was de plaque breedte groter in genitale weefsels in vergelijking met 
respiratoire weefsels, opnieuw voor alle subtypes. Deze toch wel frappante gelijkenissen in 
spreiding van de verschillende subtypes, ondanks de vermeende verschillende weefsel 
voorkeur, stellen de huidige subtype verdeling erg in vraag. 
 
In Hoofdstuk 5 wordt uitvoerig de studie, wat betreft het invasiemechanisme van een 
ander boviene herpesvirus, bovien gammaherpesvirus BoHV-4, beschreven voor 
vergelijking van de invasiemechanismen gebruikt door alfa- en gammaherpesvirussen. 
De pathogenese van BoHV-4 is niet goed gekend. Nochtans speelt dit pathogeen een 
belangrijke rol in post-partum baarmoederontsteking bij runderen. De ontwikkelde 
respiratoire en genitale explant modellen werden zodoende aangewend om de vroege aspecten 
van de BoHV-4 pathogenese te visualiseren. Eerst werd er nagegaan welke weefsels BoHV-4 
replicatie ondersteunen. Vervolgens werd er gekeken naar de verschillen en gelijkenissen met 
BoHV-1. Finaal, werd er ook getracht de BoHV-4 geïnfecteerde cellen te identificeren. 
BoHV-4 bleek enkel in staat de genitale mucosa explanten te infecteren. Op 12h pi, werden er 
afzonderlijk geïnfecteerd cellen geobserveerd in het epitheel. Deze bleken hoofdzakelijk van 
epitheliale oorsprong (cytokeratine+) te zijn. Epitheliale infectieuze centra groeiden uit tot 
echte plaques op 48h pi. Daarnaast werden er voornamelijk op 24h pi ook individuele 
geïnfecteerde cellen gekarakteriseerd als cellen van de monocyt/macrofaag lijn (CD172a+), dit 
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zowel in het epitheel als lamina propria. In tegenstelling tot BoHV-1, werden er geen BoHV-4 
epitheliale plaques geobserveerd op 24h pi en meer nog, BoHV-4 epitheliale plaques 
penetreerden op geen enkel tijdstip de basaalmembraan. Dit is de eerste studie die de vroege 
aspecten van de pathogenese van BoHV-4 beschrijft. Het gebruikte homologe systeem kan in 
de toekomst dienen als een goed alternatief diermodel voor de moeilijk te bestuderen humane 
gammaherpesvirussen Epstein-Barr virus (EBV) en Kaposi’s sarcoma-associated herpesvirus 
(KSHV). 
 
Hoofdstuk 6 geeft weer op welke manier er onderzocht werd hoe het humane herpes 
simplex virus 1 (HSV-1) en 2 (HSV-2) zich gedragen in humane genitale mucosa, wat 
toelaat om invasiemechanismen van animale en humane alfaherpesvirussen te 
vergelijken. 
Humane genitale herpes is wereldwijd de meest voorkomende oorzaak van het ulceratieve 
urogenitale ziektebeeld en met een prevalentie tot 80% bij volwassenen 
(ontwikkelingslanden), één van de belangrijkste seksueel overdraagbare aandoeningen (SOA). 
Eerst werd er een analyse van de aanwezigheid en lokalisatie van gekende HSV entry 
receptoren, met name nectine-1 en -2 alsook herpesvirus entry mediator (HVEM), uitgevoerd 
en dit op ongecultiveerde ectocervicale/vaginale en endocervicale weefsels afkomstig van 
patiënten uit verschillende stadia van de menstruele cyclus. Vervolgens, werd er nagegaan 
hoe HSV-1 en HSV-2 spreiden in humane genitale mucosa op verschillende tijdstippen van de 
menstruele cyclus. Nectine-1 en -2 vertoonden een gelijkaardig distributie patroon, zowel in 
endocervix als ectocervix/vagina en bleken ook consistent te zijn tijdens de gehele menstruele 
cyclus. HVEM daarentegen kwam niet tot expressie in endocervicale en 
ectocervicale/vaginale epitheelcellen, maar werd geobserveerd in zeldzame cellen in het 
epitheel en in meerdere cellen in het bindweefsel welke naar alle waarschijnlijkheid immuun 
cellen waren. Zowel endocervix als ectocervix/vagina bleken gevoelig te zijn aan een infectie 
met HSV-1 en HSV-2. Beide virussen vertoonden een plaque-gewijze spreiding in alle 
weefsels en induceerden de vorming van celfusies (syncytia) in ectocervicale/vaginale 
mucosa. Vanaf 48h pi werd geobserveerd dat een aantal plaques doorheen de basaalmembraan 
penetreerden, zij het subtiel. Dit gaf een duidelijke indicatie dat HSV het lichaam kan 
invaderen via de genitale mucosa en zo mogelijks een viremie kan veroorzaken. 
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In Hoofdstuk 7 onderzochten we de rol van het virale glycoproteïnen gE/gI complex in 
de plaque-gewijze spreiding doorheen de basaalmembraan van alfaherpesvirussen zoals 
BoHV-1. 
De bijdrage van een multivirulentie glycoproteïnen complex gE/gI in het invasiemechanisme 
van alfaherpesvirussen werd onderzocht met behulp van het geoptimaliseerde respiratoire 
explant model en BoHV-1. Zowel het cel tot cel spreiden van herpesvirussen als het transport 
in neuronale axonen heeft een functioneel gE/gI complex nodig om optimaal te functioneren. 
Vandaar onderzochten we specifiek de rol van dit complex in spreiding doorheen de 
basaalmembraan. Zo analyseerden we op 48h pi het effect op virale replicatie, plaque breedte 
en plaque penetratie diepte onder de basaalmembraan van enerzijds het volledig uitschakelen 
van de genen coderend voor gE/gI in het virus zelf en van anderzijds het inhiberen van hun 
functie door het toevoegen van monoklonale antistoffen die specifiek binden aan deze 
proteïnen. Daarnaast werd er ook gekeken door middel van transmissie elektronenmicroscopie 
naar de lokalisatie van zowel wild-type virus partikels als dat van gE en/of gI gedeleteerde 
virus partikels in basale epitheliale cellen. Meer nog, ook de subcellulaire lokalisatie van gE 
in BoHV-1 epitheliale plaques werd nagegaan met behulp van confocale microscopie. 
Virussen die gedeleteerd werden voor gE en/of gI bleken erg gehinderd te zijn in virale 
replicatie en in spreiding, zowel lateraal (plaque breedte) als in de diepte (plaque penetratie 
diepte). Belangrijk was de observatie dat een mutant waar enkel de cytoplasmatische staart 
van gE werd gedeleteerd hetzelfde fenotype vertoonde als een mutant met een volledig 
gedeleteerd gE. Het toedienen van monoklonale antistoffen, specifiek gericht tegen gE en/of 
gI, in het explant medium vanaf 0h pi resulteerde enkel in een sterk gereduceerde plaque 
penetratie diepte zonder effect op plaque breedte of virale replicatie. De distributie van gE 
bleek overduidelijk zich basaal te bevinden ter hoogte van de basaalmembraan. Er werd ook 
waargenomen dat wild-type virions zich eerder basaal en soms lateraal in basale epitheliale 
cellen afzetten waar gE en/of gI gedeleteerde virions zich eerder op niet-basale zijden 
bevinden en vaak ook verspreid doorheen de ganse cel. In conclusie kunnen we stellen dat 
deze studie op verschillende manieren aantoonde dat het gE/gI complex een cruciale rol speelt 
in het BoHV-1 stromale invasie mechanisme doorheen de basaalmembraan. Na analyse van 
de resultaten, kwamen we tot de volgende speculatie: gE/gI medieert via zijn 
cytoplasmatische staart motieven een basale sortering van virions richting basale 
plasmamembraan domeinen en stabiliseert hierbij mogelijks de interactie met cellulaire motor 
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proteïnen. Eenmaal aanwezig ter hoogte van de basaalmembraan, dirigeert het complex 
vervolgens invasie doorheen de basaalmembraan. 
 
In Hoofdstuk 8 wordt een algemene discussie opgebouwd rond de bekomen resultaten 
in deze thesis. 
De volgende algemene conclusies kunnen naar voren geschoven worden: 
 Er werd succesvol een ex vivo mucosaal explant model voor gebruik bij runderen 
en mensen op punt gezet bestaande uit respiratoire of genitale mucosa. Deze 
broodnodige, alternatieve experimentele modellen correleren zeer goed met de 
natuurlijke situatie en laten studies toe van mucosale invasiemechanismen 
gebruikt door verschillende ziekteverwekkers. 
 
 De ontwikkelde modellen ondersteunen productieve replicatie van herpesvirussen 
en zijn bijgevolg zeer geschikte ‘tools’ om de invasiemechanismen van 
verschillende herpesvirussen te vergelijken maar ook in detail te bestuderen. Alle 
herpesvirussen gebruikt in deze studie vertoonden een duidelijke voorkeur voor 
epitheliale cellen, ongeacht hun fylogenetische classificatie of gastheer 
specificiteit. Niettegenstaande, werd er ook aangetoond dat ze allen hun eigen 
manier ontwikkelden om gastheer invasie te veroorzaken. 
 
 Mechanistisch toonden we aan dat het heterodimeer gE/gI een cruciale rol speelt 
in het invasiemechanisme van BoHV-1 doorheen de basaalmembraan in 
respiratoire mucosa. Met de bekomen resultaten brengen we de volgende, hoewel 
speculatieve, hypothese aan: in epitheliale cellen, drijft gE/gI heel selectief andere 
virale proteïnen naar topologisch verschillende membraancompartimenten, 
stabiliseert het vervolgens het misbruik van cellulaire motor proteïnen om 
getransporteerd te worden richting naburige cellen of de basaalmembraan, heel 
gelijkaardig aan wat al gekend is voor axonaal transport van herpesvirussen in 
neuronen, en zal het tenslotte, eenmaal aanwezig ter hoogte van de basale zijde 
van cellen naast de basaalmembraan ook verdere invasie bewerkstelligen. 
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DANKWOORD 
“Appreciation is a wonderful thing. It makes what is excellent in others belong to us as well.”- 
Voltaire 
Hier ben ik dan…aan het einde van een heel avontuur…een 5-jarige periode van noeste arbeid 
dat (gelukkig) heeft geleid tot een samenhangend geheel. Naast de symboliek die het 
dankwoord traditioneel inluidt als zijnde het ‘echte’ einde van het proefschrift, wil ik het ook 
oprecht gebruiken om de mensen te bedanken die, elk op hun eigen manier, hebben 
bijgedragen tot het tot stand komen van deze thesis. 
Graag wil ik starten met een dankwoord aan mijn promotor Prof. Dr. Hans Nauwynck. 
Gebeten door virale ziekten en meer specifiek herpesvirussen dankzij mijn laatstejaarsscriptie, 
waagde ik me de oversteek naar de Hoogbouw op zoek naar het labo Virologie, wat geen 
sinecure was als je uit de optie Herkauwers kwam. Ik weet nog goed hoe ik resoluut binnen 
stapte om te vragen of ik een doctoraat mocht doen op een gammaherpesvirus bij schapen en 
buiten stapte met een doctoraat over een alphaherpesvirus bij runderen aan men been. Dat was 
mijn eerste kennismaking met een barstend vat vol ideeën (het ene al wat gekkere dan het 
andere), jouw overtuigingskracht en passie voor het vak. Hans, bedankt om de talrijke kansen 
die je me gegeven hebt, de nodige wetenschappelijke vrijheid maar ook de kritiek waar nodig. 
Ook wil ik je bedanken om me meermaals mee te nemen naar het internationale herpesvirus 
congres. Ik ben blij dat ook ik heb kunnen bijdragen tot de reputatie van “the Belgians” op de 
dansvloer ;) 
Herman het was me echt een eer om jou te leren kennen, zowel binnen de wetenschap als 
daarbuiten! Bedankt voor de talloze keren dat je met de juiste wijze woorden op de proppen 
kwam als ik even niet meer wist waar naartoe. Ik bewonder de manier waarop jij aan 
onderzoek doet!! Daarbuiten heb ik je ook beter leren kennen. Het werd me al snel duidelijk 
op congres dat de sportmicrobe ook wel in jouw bloed zit. Ik ben dan ook blij dat ik mede 
dankzij onze squash en tennis partijtjes je goed heb leren kennen. Ik voel me verplicht om hier 
officieel te moeten toegeven dat ondanks jouw leeftijd (), je me echt wel op het 
squashterrein tot het uiterste kan doen drijven. Winnen is natuurlijk nog iets anders…maar 
goed . 
Greg! Of course, some words of gratitude to my American promotor have to be in my 
acknowledgments!! Many thanks to support my international fellowship, to let me work in 
your lab and to introduce me in the wondrous world of molecular biology. It is deeply 
appreciated. You are without question one of the most brilliant people I have ever met (and if 
you would check my facebook you will see that I’ve had many encounters ). I still have to 
beat you though in a game of Settlers of Catan. All the best with your future scientific 
endeavors!! And as far as I’m concerned, I will always be a proud member of the Smith lab!   
Ook de overige leden van de begeleidings- en examencommissie, Prof. Dr. E. Claerebout, 
Prof. Dr. P. Deprez, Prof. Dr. P. De Sutter, Prof. Dr. W. Van den Broeck, Prof. Dr. L. Gillet, 
Prof. Dr. A. Vanderplasschen and Dr. S. Glorieux, wens ik oprecht te bedanken voor het vele 
lees- en verbeterwerk. Bedankt voor de waardevolle opmerkingen en suggesties! 
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Verder zou ik nog 2 andere professoren willen bedanken. Eerst en vooral Prof. Dr. Van de 
Walle, Gerlinde, momenteel werkzaam aan Cornell University. Toen ik aan mijn doctoraat 
begon, kwam jij net terug vanuit the USA om een post-doc te starten aan ons labo. We hebben 
dan ook geruime tijd samen gespendeerd in de vergaderzaal bij gebrek aan plaats in de 
bureaus. Wat een reis heb jij al gemaakt in de wetenschap, echt bewonderenswaardig! Ik gun 
het je dan ook van harte dat je hopelijk nu eindelijk beloond wordt voor die vastberadenheid 
met een vaste academische positie. Het ga je goed en wie weet tot snel ;)!! Daarnaast had ik 
graag Prof. Dr. Roger Maes willen bedanken. Roger, ik weet nog goed dat je contact met me 
hebt opgenomen toen ik op het Smith labo werkte in Chicago. Je belde toen rechtstreeks naar 
de bureau van Greg (zonder dat die van iets wist) met de simpele vraag: Het is hier met Prof 
Maes uit Michigan, kan je Lennert eens doorgeven…alsof Greg mijn persoonlijke secretaris 
was. Ik moet toegeven, ik voelde me toen wel even ongemakkelijk  Nu, ik ben enorm blij 
dat we mekaar hebben leren kennen, mede dankzij een bezoek aan jouw universiteit in 
Michigan. Bedankt dat ik telkens weer bij jou en Maria mag overnachten als ik in de buurt 
ben. Het voelt steeds aan alsof ik jullie al jaren ken, ik voel me dan ook echt thuis!! Hopelijk 
tot snel!! 
Uiteraard is een academisch labo een komen en gaan van heel veel inspirerende mensen. Ik ga 
dan ook trachten om niemand te vergeten die tijdens mijn doctoraat de revue is gepasseerd. 
Ik kan niet anders dan te starten met mijn partners-in-crime, het aanvankelijke explanten 
team!! Sarah Glorieux, waar moet ik beginnen! Ik zou echt wel een aantal chapters kunnen 
schrijven over avonturen die we samen hebben meegemaakt gaande van onze Valentijn-date 
 (ja, ne mens moet zijne post-doc in de watten leggen hé) over het van je stoel vallen in de 
bureau van Hans tot het bakken van worstjes op de steengrill als de plaat nog niet heet genoeg 
was (en dus strikt verboden omwille van de rookontwikkeling). Je bent een knappe madame! 
Heel veel succes met Joost, jullie kleine wonder en toekomst samen!! En dan dat ander zot 
geval, Annelies!! Wat hebben wij toch gelachen samen, en om mensen tegen te komen waar 
je dat mee kan is één van de mooiste dingen in het leven. Weet je nog onze talloze ritten naar 
het slachthuis? Die keren dat ik je nog half slapend om half 5 kwam oppikken om naar het 
slachthuis te gaan? Dat je de tekst van A whole new world (dixit Aladdin) moest van buiten 
leren zodat we in de wagen een duet konden zingen? Dikke fun, steeds opnieuw!! Trouwens, 
onze jaarlijkse bureaustoel-race wordt enorm gemist (ook al maakte je steeds weinig kans 
omwille van je lange benen hé)  Heel veel succes met jouw prachtige gezin, Lieven en 
Bas!! 
Toen ik mijn vaste plaats kreeg in de eerste bureau had ik het genoegen om dit te delen met 
een aantal fijne mensen! Sarah Costers, jij bent toch ook een fenomeen hoor! Altijd kei tof om 
met jou onnozel te doen. Ik wou je nog zeggen: bedankt om voor mijn poes te zorgen maar 
dat klinkt zo raar hé, vind je niet?  Och ja, het is gezegd zie! Ik heb nog steeds jouw 
ondertekende versie van de apoptose pathways die je mij met hand en tand hebt uitgelegd 
voor mijn IWT verdediging. Wees er maar zeker van dat het ooit veel geld waard zal zijn!! 
Evelien, Miss February, jij weet ongetwijfeld al welk verhaal ik ga vertellen waar we toch 
écht hebben om gelachen. Op een vrijdag vroeg Evelien aan Lennert om de volgende 
maandag de confocale microscoop laten aan te staan ‘s avonds aangezien Evelien nog wat 
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wou komen werken. Nu vond Lennert maandagmorgen op zijn bureau een briefje met het 
volgende opschrift: “Lennert, ik heb mij er van ’t weekend al opgezet…(Lennert fronst de 
wenkbrauwen)…..op de confocale hé ”. Heel veel succes met jouw prachtige dochter 
Juliette en man Lieven. Sjouke, een madame die stevig in haar schoenen staat en heel 
gedreven te werk gaat! Een echte dierenarts waar ik nog eens goed over diergeneeskundige 
zaken mee kon praten! Heel veel succes in jouw toekomstige carrière als met de 
verbouwingen van je huisje! Hannah, als één van de grondleggers van het FIP-onderzoek, ben 
jij altijd voor vele een bron van inspiratie geweest. Doe dat nog heel goed in het onderzoek en 
ook in de verdere groei van je nu al talrijke gezin! Tenslotte wil ik ook nog Leslie en Ben 
bedanken voor de steun tijdens onze gezamenlijke IWT aanvraag het eerste jaar! Leslie, ik 
heb bewondering voor het feit dat je hebt kunnen zeggen dat het je ding niet was en heb nog 
meer bewondering voor het feit dat je jezelf hebt gesmeten op de pathologie (en met succes). 
Ben, enorm merci voor je hulp met allerlei computergerelateerde dingen, de leuke 
gesprekken, maar ook je bezoek in Chicago! Beide veel geluk in alles wat jullie doen!! 
Over de jaren heen, hebben ook een heel aantal andere mensen de bureau met mij gedeeld: 
Hossein, Ilias, Amy, Kathlyn, Jing, Wander, Mieke, Uladzimir, Sabrina, Annick, Iris. 
Hossein, you are probably the most special Iranian guy I’ve ever met! The way you move on 
the dancefloor is beyond my imagination! It is nice to see that someone else from the lab also 
has a keen interest for human diseases. Ilias, Ευχαριστώ for the nice conversations. All the 
best and we will see each other again somewhere in Greece . Amy (Xiaoyun), you have 
learned me so many things about life and a different culture!! I still remember the day you 
walked into our office, all shy, but look at you now…you have grown to such a strong, 
independent woman and scientist. At present, the level of your English is just amazing 
considering where you were in the beginning. I think you are really a true example of perfect 
adaptation, integration and motivation for many foreign students. I hope your topic, which is 
not that easy, will finally give you the well earned doctoral degree!! We will for sure keep in 
touch and like I promised we will visit you in China. Kathlyn, je vous souhaite bonne chance 
pour ta thèse de doctorat. Jing, also for you, good luck! May both of you solve important 
questions about EHV-1 . Wander, zo ongeveer mijn lengtegenoot, het was me een enorm 
genoegen om de bureau met jou te mogen delen. Voor de laatste nieuwe roddels op het labo 
moest ik niet bij jou zijn, jij volgde meestal pas enkele maanden later  maar wat ben jij een 
wandelende wetenschappelijke codex zeg. Diep respect en ik ben er zeker van dat jou nog een 
mooie toekomst in het onderzoek is weggelegd. Je mag me zo nu en dan wel eens verwachten 
voor wat advies (allé, zo lang het gratis blijft natuurlijk ). Mieke, de rust zelve, Atilla de 
Hun, Mcdonalds fanaat, koekjesmonster,…er zijn veel aliassen die jou beschrijven. Het was 
me een enorm plezier om samen met jou in de bureau te zitten. Ik respecteer de moedige 
beslissing die je genomen hebt, ik wens je dan ook alle succes in de toekomst! Sabrina, ai ai 
ai, è quasi impossibile dire qualqose su da te in poche parole  but I think the words Italian 
Fury are getting pretty close!! A true honor to meet someone like you that has acquired 
already so much baggage in life! I hope the future may bring you joy, love and fortune. Good 
luck with Alicia and expect me in Torino !! Annick, een dierenarts in hart en nieren! Je hebt 
me absoluut alles geleerd over paarden en hun infectieuze ziekten! De diagnostiek floreerde 
tijdens jouw aanwezigheid op het labo. Van heinde en verre kwam men met stalen voor Dr. 
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Gryspeerdt! Heel veel succes in de toekomst, zowel op het werk als privé, en het zou tof zijn 
moest je het volgende kindje, als het een jongen is, Lennard noemen . Iris en Uladzimir, 
bedankt voor de aangename babbels. 
Ook talloze andere collega’s wil ik graag bedanken. Eerst en vooral, twee mensen die me 
nauw aan het hart liggen Marc en Maria. You guys, I am really fortunate to have two friends 
(Maria hates it when I call her just a “colleague”) like you. We have been through so many 
crazy adventures together and I enjoyed literally every second of it! Marc, je bent een 
fantastisch persoon, je staat altijd voor iedereen klaar. De talloze keren dat we samen naar de 
fitness zijn gegaan was echt de max. Proficiat met het behalen van je doctoraat, het is er hé!!! 
Ik ben er zeker van dat het volgend jaar je heel wat betere dingen te bieden heeft dan 2013. 
Bijt nog even op je tanden!! Maria, my Portuguese bunny, you are truly an amazing person, 
don’t let anyone tell you otherwise! All your gifts from Portugal (food and wine) made me 
really crave for that country ;) Good luck in the future, you can count on me! Graag, wil ik 
verder gaan met nog een aantal leuke collega’s. Dominique, die omwille van een bepaalde 
reden altijd Lieve naar me riep , ook jij bent er bijna! Hou nog even vol en jouw 
welverdiende doctoraat is daar! Erna kan je dan terug richting de Kempen. En dan spreken we 
nog ne kiejer af veur es iejene te pakken oep café in Nodderwaak ofzoewe hé  Veel succes!! 
Annelike, ook voor jou is het einde in zicht al staat er je eerst nog iets heel belangrijk te 
wachten: mama worden!! Proficiat daarvoor en geniet er met volle teugen van. Bas!!! De man 
uit Lier!! Het was me een plezier om met jou samen te werken (nu, voor je natuurlijk dikke 
vriendjes werd met Leuven )! Men hoort jou al van ver lachen!! Ik vergeet nooit meer de 
dag dat je me kwam vertellen dat je cola bij je explanten ging doen :D Lowieseke, onze 
FWO-er (BOOOOEEEE) (mopje hé), ge zijt een straffe madame jong. Ik denk dat er 1 ding 
wel duidelijk is, er wacht jou nog een mooie toekomst in het onderzoek! Ga ervoor!! Inge R., 
als onze FIV’er én Limburger, een apart ras in onze middens! Ik bewonder hoe jij soms 
snedig uit de hoek kan komen! Jij bent een goed onderzoekster, geef niet op!! Isaura, nog een 
speciaal geval op het labo , bedankt voor de zeer leuke momenten samen binnen en buiten 
het labo, voor de ontelbare wetenschappelijke discussies, voor je enorm vermogen om 
crypto’s op te lossen,… Je bent één van de nieuwe centrale personen in het labo en die rol 
gaat je wel af! Het bewijs dat je een enorm sterk en gedreven persoon bent! Jij komt er wel!! 
Karentje Ooms, de no-matter-what-ik-heb-iedere-dag-een-mega-glimlach-op-mijn-gezicht-
persoon, ik ben heel blij dat ik je het laatste jaar nog beter heb leren kennen. Merci om een 
luisterend oor te zijn in de finale dagen van het schrijven van een thesis. Ik ben blij dat we die 
periode samen hebben kunnen delen! Heel veel succes nog!! Nina, wat hadden wij toch 
plezier tijdens onze trip naar Yellowstone! Ik heb toen echt het privilege gehad om jou beter 
te leren kennen. Je bent een toffe, vlotte madame waar ik gerust nog eens mee op reis zou 
kunnen gaan (vraagt ge dat dan eens aan Guillaume?) . Hanne!!! Hoe plezant was het om 
iemand van de Kempen tegen te komen in San Fransisco!! Onze lunch samen met de partners 
is iets om nooit meer te vergeten! Geef er nog een lap op! Heel veel geluk in jullie nieuwe 
stek in Sint-Denijs. Miet, ik bewonder hoe jij op overtuigende wijze de job op het CODA hebt 
binnengehaald en die ook met verve uitvoert. Je bent een ferme madame! Daarnaast, was het 
ook altijd enorm leuk om met jou eens goed op stap te gaan! Jochen, ik heb je zien groeien 
van een onzekere thesisstudent tot een echte onderzoeker! Ga ervoor, de topic en de promotor 
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lijken mij een mooie combinatie! Céline, hoe jij dat lijntje van jou blijft behouden ondanks 
het feit dat je een echt baby-machien bent is echt wel frappant. We hebben veel gelachen op 
het labo maar ook op congres! Merci!! Ook tijdens het laatste congres heb ik Thary (my 
roomy), Korneel en Kristof beter leren kennen. Ik vond het dan ook enorm tof om met jullie 
rond te hagen en van wat wetenschap te genieten! Heel veel succes in jullie verdere 
loopbaan!!  
Zeger, onze stoere bink van het labo, je bent ondertussen de ancien en contactpersoon uit onze 
steriele keuken en je weet als geen ander alle kleine details van het labo. Doe zo verder, je 
bent goed bezig! Loes, als recente aanwinst én dan nog samen werken met Zeger, daar kan je 
alleen maar respect voor hebben  Je weet echt wel van aanpakken! En trouwens, die 
‘woman’s touch’ was hoog nodig in de keuken! Melanie, uit het welgekende rijmpje Melanie 
doet… , waarmee ik lustig op regenachtige dagen Vlaamse schlagers kon zingen! Bel me 
schrijf me, laat iets van je weten…. Jij verdient een extra woord van dank voor al het harde 
werk, vooral tijdens mijn laatste jaar, dat je gedaan hebt in het kader van mijn thesis. Je bent 
uitgegroeid tot een echte boviene (herpes) virus experte die meerdere testen foutloos uitvoert 
(allé, meestal toch, als je men plaatjes niet vergeet bij 4°C ). Carine, onze moederkloek, 
stuurt feilloos het reilen en zeilen van het kleurlabo én de diagnostiek. Ik denk dat jouw werk 
soms zwaar onderschat wordt. Je bent een crack in wat je doet! Bedankt voor alle leuke 
babbels gaande van mijn nieuwe ramen tot panna cotta (shit, nu denk ik eraan, die moet ik 
nog maken ). Chantal, jij ook bedankt voor de leuke gesprekken en ook om heel vaak jouw 
appelsien naast mij op te eten tijdens de middagpauze . Lieve al vanaf dag 1 op het labo heb 
ik vele dingen kunnen opsteken van jou. Iedere dag gedurende mijn doctoraat gaf je me wel 
enkele tips and tricks mee waar ik zeker op moest letten tijdens mijn experimenten. Zo veel 
technische bagage die jij bezit, is echt iets om jaloers op te zijn. Je bent dan ook een 
steengoede laborante, iets wat meerdere mensen zullen beamen. Sorry, voor de vele overuren 
waarmee ik je opzadelde tijdens mijn eerste week op het labo (bloedingskalveren nvdr.). 
Ongetwijfeld zal je wel gedacht hebben, die puber hier van Antwerpen met zijn dikke nek   
Neleeeeeuhhh! Ik hoop jou nog vele malen tegen te komen op 1 van de volgende “Missions”. 
Het was altijd enorm tof om samen met jou doorheen al die raadsels te manoeuvreren. Tim, 
veruit de knapste vent van ons labo!!, we hebben jou een tijdje moeten missen maar we zijn 
heel erg blij om jou terug bij ons te hebben! Heel veel levensvreugde toegewenst samen met 
Nel, Mauro en Ada Luz!! Ytse, de jongste telg zeker?, het is mooi om te zien hoe jij je zo 
bekommert om onze FIP’ertjes. Ik denk dat ze met jou wel een goede laborante bij hebben. 
Fijn je te leren kennen!! Gert wat ben jij een enorm sympathieke secretaris! Soms wat vettige 
klap, maar dat kan ik zo wel eens smaken! Mieke G., sinds onze deelname aan Twee tot de 
zesde macht heb ik jou heel intens leren kennen samen met de rest van jouw prachtige familie. 
Als ik jou moet omschrijven dan zou ik je een flamboyante, zelfverzekerde, hardwerkende 
feministe noemen in de positieve zin hé  Je staat steeds klaar voor iedereen en dat siert jou 
enorm! Wat meer respect van een aantal mensen voor wat jij allemaal doet zou wel op zijn 
plaats zijn! Ann, ook jij merci om de nodige telefoontjes te doen naar al die ambetante 
leveranciers, zeker op het einde van men doctoraat. Toke, Leen, Lobke, Myriam en Liliane, 
duizend maal dank om jullie zo hard in te zetten voor de verwerking van al mijn stalen voor 
morfologische analyses. Nicole, Marijke, Fatima en de mensen van het ISS-team, bedankt 
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voor de leuke gesprekken (Nicole, wij gaan al even terug hé ) maar zeker het superwerk dat 
jullie dag in dag uit leveren op onze faculteit. Ook Lars en Ria van de dienst verloskunde zou 
ik heel graag willen bedanken voor hun vriendschap! Jullie zijn twee warme personen die me 
nauw aan het hart liggen. 
Bauke, Dipu, David, Inge, Merijn, Nick, Karl, Yewei, Pépé, Yu, Jolien, Caroline, Karen 
VdM, Kristien, Joao, Matthias D., Matthias C., Irene, Veerle, Sabine, Debbie, Els, Eva, Lang, 
Tù, Zhongfang, Wengfeng, Angela, Liping, Vishi, Haileleul, Ivann, Kevin, Charlie, Chris, 
Bart, Geert, Fernand, Marijke, it was my pleasure to get to know you and to share numerous 
nice moments with each and everyone of you. 
Gina, Nick, Dongshang, Sofia, Jen, Kevin, Mindy aka the Smith lab!! It was mind blowing to 
be able to work with such a nice colleagues. Living and working in the States changed my life 
for good! Chicago and the people I got to know there will always be a part of me! Gina, you 
are only at the beginning of your journey but Im sure you will end up just fine. You shouldn’t 
be that modest about yourself, you are an intelligent person and a fabulous scientist. I’m sure 
Greg realizes that and if not, he might be reading this . I’m glad to call you my friend. Nick, 
thank you so much for all the effort you made for guiding me around. Probably the best way 
to show you my appreciation is by getting you some Belgian beers, right?!  Kevin, another 
brilliant scientist!! I’ve heard you are going to do your postdoc in Pennsylvania, good luck 
with that!! Sofia, a true Russian!! Strict but lovely!! I enjoyed our dinners and movie nights 
together! Good luck with your green card application! I mean, with your recent publications 
in Cell, Host and Microbe, they SHOULD give you one  Jen, thank you for all the technical 
assistance and conversations we shared! Dongshang, I will never forget your one-liner when 
we met again this year in Chicago: “Oooh, you look stronger!” You taught me how to say 
“Oooh, you look fat” in a more polite way !! Finally, Mindy…where to start girl!! You 
became one of my closest friends over there…I followed you all the way to Washington DC 
(as you moved there after your PhD) and now you moved again to Lima in Peru. I should 
follow you once more right?!  We had so many fun moments, you showed me around pretty 
much everywhere. You are a trustworthy, warm person; someone to truly cherish. I wish you 
the best of luck for the future together with Nate and Pierre!! We will see each other again my 
friend!! 
Jana, Sara, Liesbeth, Jody, Maud en Klaas, Evelien; waarde confraters . Jullie verklaarden 
mij allemaal voor gek dat ik nog eens minstens 4 jaar langer aan de faculteit vrijwillig wou 
blijven plakken maar hier sta ik nu dan hé... Vanaf nu mogen jullie mij dan ook aanspreken 
met Doctor Lennert, een titel die jullie volgens de Orde niet mogen voeren héhé  Het is zeer 
fijn om te zien dat onze hele bende zo dicht bij elkaar blijft en ook steeds aangroeit (2de kindje 
net gearriveerd). We gaan snel moeten kijken voor een groter vakantiehuisje in de Ardennen 
voor onze jaarlijkse Vets-weekend. Bedankt voor jullie steun en om mij telkens weer te doen 
snakken naar de praktijk als ik jullie sappige verhalen hoor!! 
Graag wil ik ook mijn buren bedanken. Bij onze verhuis van de parking (Gent) naar de enige 
echte stad Antwerpen, zijn we terecht gekomen in een zeer warme buurt. Hector en Lieve, 
merci voor de lekkere confituur/groentjes-uit-de-tuin/soep/slaatjes waar ik van genoten heb 
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tijdens het schrijven van mijn thesis thuis. Jullie zijn prachtige mensen. Martina en Dirk, 
bedankt voor de interesse en steun ivm mijn doctoraat. Martina, als praktijklector vroedkunde 
moet je dan het stuk over genitale herpes maar eens lezen hé  Dirk, bedankt om te zorgen 
dat mijn haar er steeds weer feilloos uitziet!   
Vervolgens wil ik graag een aantal belangrijke mensen bedanken die me zeer nauw aan het 
hart liggen. Rienke, men seutje, men lekker wijf, wat is het een deugd om iemand zoals jij in 
mijn leven te hebben. Het werd me overduidelijk dat Seutkers echt niet zonder die andere S 
kan toen ik in de States woonde. Ons lange email verkeer heeft onze banden nog eens extra in 
de verf gezet. Weet je, ik kijk echt op naar iemand die zo sterk in haar schoenen staat en met 
de glimlach rondloopt, na al zo veel meegemaakt te hebben. Heel veel geluk samen met 
Fouwé! Lies, die andere sprouwat, een zotte doos dat er hopelijk nooit zal uitgaan! No 
nonsense, écht…dat is hoe ik onze vriendschap ervaar. Het feit dat je mama bent geworden én 
dan nog van mijn petekindje Wannes, heeft van jou een enorm mooie madam gemaakt. Ik ben 
trots om jou 1 van mijn beste vrienden te mogen noemen. Hopelijk vind je snel iemand die net 
als ons ziet wat voor een schat jij bent! Britt, mijn vriendinnetje van het eerste uur! Wij gaan 
waarschijnlijk al het verste terug. Ik had al snel door dat die kleine blonde vamp uit mijn 
straat heel wat te bieden had! Merci om er altijd voor mij te zijn…ook tijdens alle moeilijke 
momenten… Emilie, ook jou ken ik al een hele lange tijd! We zijn elkaar even uit het oog 
verloren, maar ik ben blij dat we elkaar hebben teruggevonden. Altijd fijn om samen met jou 
herinneringen op te halen over de muziekschool en juffrouw Schellekens  Kevin en Niels, 
mijn schatten! Wat is onze band op zo’n korte tijd zo intens geworden…ik sta er echt van 
versteld! Om van dichtbij jullie intens geluk samen te mogen meemaken is gewoon 
fantastisch. Jullie vriendschap is iets om te koesteren! Ook aan de andere ‘guys from 
Antwerp’, enorm bedankt voor alle steun en begrip voor mijn vele ‘ik heb geen tijd want die 
thesis’-excuses. Fré, mijn kotgenootje, de laatste jaren zien we elkaar iets minder maar dat 
neemt niet weg dat ik ook jou wil bedanken voor alle steun, al van tijdens mijn studies 
diergeneeskunde. Heel veel succes in de toekomst! Jo, mijn persoonlijke chiropractor! Wij 
gaan ook al even terug hé… In het middelbaar al dikke fun met onze nu nog steeds 
legendarische imitaties van Lieve Proost, Bea Vanvooren en Olga Van de Peer , maar ook 
tijdens je bezoek aan Chicago! Ook al woon je nu in Frankrijk (en ja ik moet dringend eens 
afkomen), het leuke is dat we in een vingerknip terug het gevoel van vroeger kunnen 
oppikken…en dan weet je dat je met een echte vriend te maken hebt  
En dan nu nog enkele woorden gericht aan mijn familie. Alle tantes, nonkels, neven, nichten, 
moeke genk, enz., kortom de hele Genkse helft van de familie, enorm bedankt om mij al van 
kleins af te steunen gedurende mijn levenswandel ;) Vake Genk, hopelijk ben je trots op wat 
ik met deze thesis bereikt heb! Geniet nog van je rust! Verder wil ik heel graag mijn 
(toekomstige) schoonouders bedanken. Geert en Greta, of zoals ik ze noem Poeps en Moeps 
, jullie zijn beide fantastische, warme mensen. Ik moet toegeven dat het, als Antwerpenaar 
zijnde, aanvankelijk niet simpel was om jullie ten volle te verstaan . De nodige training de 
voorbije jaren zorgde er echter voor dat ik me toch ook comfortabel ben beginnen voelen met 
dat West-Vlaams. En dan Pieter, mijn broer uit Kortrijk , ongetwijfeld 1 van de meest 
sociaal geëngageerde personen die ik ken!! Ik bewonder en heb enorm veel respect voor wat 
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jij allemaal doet als priester en als leerkracht! Het warme hart dat jij aan ieder, die er nood aan 
heeft, toedraagt is een uitzonderlijke eigenschap! Ook het door jou opgezette goede doel 
Boeta (http://www.boeta.be/) is iets om terecht trots op te zijn!! Moemoe en vava, op momenten 
zoals deze doet het mij extra pijn om dit niet met mijn grootouders te kunnen delen… Vava, 
Bert Plo, mama vertelde me dat jij altijd heel erg veel belang hechtte aan studies… ik hoop 
echt dat je zo toch trots bent op mij en op de nieuwe generatie Plo’s. Moemoe, als het even 
kon, dan had ik jou echt graag meegenomen om je te trakteren op een gebakken vis om dit 
alles te vieren. Je hebt er nog eentje van mij te goed (nadat ik als klein mannetje 500 BEF wist 
kwijt te spelen toen ik voor jou een gebakken vis moest gaan halen) en eerlijk…het knaagt dat 
ik je dat niet kan terugbetalen. Ahja, ook sorry voor het eruit rijden van de garagepoort met de 
auto toen ik 5 jaar was . Nonkel Ludwig! Ik had mij geen betere nonkel kunnen inbeelden 
dan jou… Vanaf mijn 5de nam je mij jaarlijks mee om te gaan skiën in Oostenrijk wat ik écht 
de max vond!! Wat hebben wij daar toch plezier gehad! Al die gebakjes, apfelstrudels, 
Schnapps,…als ik er aan denk krijg ik er weer zin in! Bedankt voor alle steun en voor het feit 
dat je voor iedereen uit onze familie altijd zo klaar staat! Er zijn de voorbije jaren al eens wat 
strubbelingen geweest met je gezondheid maar maak je daar niet al te veel zorgen in, dat komt 
wel goed!! Zoals jij er altijd voor ons was, zullen wij er nu ook voor jou zijn! Broer en zus, 
Griffin en Yentl, Bif en Jenny,… :D Jullie beseffen het misschien niet maar jullie maken 
‘dienen oudste’ iedere dag weer super trots…gewoon om te zien hoe jullie in het leven staan 
en daarin ook jullie weg vinden. Een leven zonder jullie zou er heel anders uitzien, ik kan dus 
écht niet zonder jullie!! Grif, ruwe bolster blanke pit omschrijft jou héél goed. Je bent echt als 
mens door en door goed!! Heel veel succes met Robyne ;) Yentl, mijn kleine zus, wat voelen 
wij elkaar toch goed aan! Een ergotherapeute om U tegen te zeggen!! Ze zeggen altijd dat wij 
2 dezelfde zijn en awel, ik denk dat eigenlijk ook :D Jij hebt alleen borsten…lol :D Heel veel 
succes met Pieter en de zoektocht naar jullie huisje! En dan uiteraard nog ons mama en onze 
papa…ik weet eigenlijk niet goed waar ik moet beginnen want het is onmogelijk om in een 
aantal zinnen weer te geven wat jullie betekenen. Papa, mijn liefde voor de dieren heb ik 
ongetwijfeld van jou meegekregen!! Het bouwen van konijnenhokken, volières, vijvers,… ik 
ben altijd heel erg trots geweest op wat mijn papa allemaal kon! Ook het geduld dat jij aan de 
dag kan leggen is bewonderenswaardig (en is iets dat ik helaas niet heb meegekregen ;)). 
Mama, en wat voor één! Toeval wil dat je zwanger raakte van mij enkele dagen nadat papa 
voor jou een hondje kocht. De gynaecoloog had je aangeraden om op die manier je zinnen te 
verzetten na aanhoudende problemen om zwanger te raken. Je was dan ook niet verbaast toen 
ik je als 10-jarig manneke vertelde dat ik dierenarts wilde worden. Een teken, zei je!!  Wat 
herken ik toch zoveel aspecten van jou in mij… je zegt wel altijd dat we waarschijnlijk alle 
“slechte” eigenschappen van jou hebben maar daar ben je fout in hoor. Gedreven zijn, oog 
voor detail, respectvol, mondig, warm… zijn maar enkele van de vele dingen die ik van jou 
heb! Merci om er te zijn tijdens alle mooie maar ook moeilijke momenten. Ik hoop dat je trots 
bent op mij! Mams en paps, bedankt om mij altijd alles te laten doen/geven wat mijn hartje 
begeerde... Ik heb mijn jeugd mogen doorbrengen in een warm gezin, het was dan ook even 
moeilijk toen jullie besloten om niet meer voor elkaar te gaan, maar achteraf gezien is dat toch 
allemaal goed gekomen ;) Ik wil dan ook oprecht bij deze de nieuwe partners Johny en Kim 
bedanken voor hun steun de voorbije jaren, merci!!!! ;) 
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En dan last but allerminst least, mijn steun, mijn toeverlaat, mijn partner-in-crime, mijn 
alles…Jasper. Wat ben jij een pracht persoon en een lekker ding, dat ook! Het hart op de 
juiste plaats, zorgzaam, ambitieus,… Hoe jij privé en werk en politiek (nen tsjeef btw) weet te 
combineren is echt bewonderenswaardig. Ik ben nog steeds onder de indruk van jouw kennis 
over allerhande zaken. Ondanks het feit dat ik er wel eens mee grap, hoef jij absoluut niet 
onder te doen omdat je “maar” hogeschool hebt gedaan hoor! Ik weet écht wel wie er van ons 
twee het meest beleerd is (en laat ons zeggen dat het niet diegene is met het recente doctoraat 
). Wat 6 jaar geleden begon als een nerveus gesprekje in de Pallieter in de Overpoort in 
Gent, is uitgegroeid tot een mooi verhaal!! Ik weet ook dat het niet altijd even gemakkelijk is 
geweest mede dankzij het doctoraat maar ook door het feit dat ik niet altijd een even 
makkelijk persoon ben om mee samen te leven (ik ZAAG nogal gemakkelijk (dixit Jasper)), 
wil ik je echt bedanken voor alles wat je hebt gedaan en nog steeds doet. Gedurende mijn 
verblijf in the States is, ondanks de afstand, onze relatie echt sterker geworden! Ik heb altijd 
gehoopt dat mijn partner ook mijn beste vriend zou zijn…merci om die voor mij te zijn! Ik zie 
je graag en kijk uit naar onze toekomst samen!!       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
